Impact of cannabis inhalation on driving skills in occasional smokers by Thomas, A. et al.
T2010 Conference
Oslo – Norway – 22. - 26. August 2010
Layout and printing: www.presis.no
SPONSORS
We thank our sponsos for their cooperation
MAIN SPONSOR
National Highway Traffic
Safety Administration
T2
0
1
0
 C
O
N
FER
EN
C
E O
S
LO
 –
N
O
R
W
A
Y
 –
2
2
. - 2
6
. A
U
G
U
S
T 2
0
1
0

Scientiﬁc Program Chairs
Barry Logan, NMS Labs, PA, USA
Jørg Mørland, Norwegian Institute of Public Health, Oslo, Norway
Committee Members
Inger Marie Bernhoft, DTU Transport, Denmark
Asbjørg S. Christophersen, Norwegian Institute of Public Health, Oslo, Norway
Richard Compton, NHTSA, Washington DC, USA
James Fell, PIRE, MD, USA
Susan Ferguson, Ferguson International, USA
Han de Gier, University of Gronigen, The Netherlands
Charles Mercier-Guyon, CERMT Annecy, France
Paul Marques, PIRE, MD, USA
Christine Moore, Immunalysis, CA, USA
Wolf-Rüdiger Nickel, Germany Society for Traﬃc Psychology
Jan Ramaekers, University of Maastricht, The Netherlands
Robyn Robertson, Traﬃc Injury Research Foundation, Toronto, Canada
Kathryn Stewart, SPI, and Prevention Research Center, Lafayette CA , USA
Karen Scott; University of Glasgow, Scotland
David Shinar, Ben Gurion University, Israel
Phillip Swann, Vic Roads, Melbourne, Australia
Annemiek Vermeeren, University of Maastricht, The Netherlands
Joris Verster, Utrecht University, the Netherlands
Robert Voas, PIRE, MD, USA
J Michael Walsh, The Walsh Group, MD, USA
2
CONGRESS ORGANIZERS
Young Scientists Sub-Committee 
Robyn Robertson, Traﬃc Injury Research Foundation, Toronto, Canada
Joris Verster, Utrecht University, the Netherlands
Scientiﬁc Advisory Committee
Gary Kay, CogRes, Tampa, USA 
Hallvard Gjerde, Norwegian Institute of Public Health, Oslo, Norway
Svetlanda Skurveit, Norwegian Institute of Public Health, Oslo, Norway
Local Organizing Committee
Asbjørg S. Christophersen, Norwegian Institute of Public Health (leader)
Toril Grytli, Norwegian Council for Road Safety
Gunnar D. Jenssen, SINTEF
Terje Assum, Institute of Transport and Communication
Stig Erik Sørheim, Norwegian Directorate of Health
Lennart Garnes, Ministry of Transport and Communication 
Roar Skjelbred Larsen, National Mobile Police Service
Hanna Hånes, Norwegian Insitute of Public Health
Grete Wethe (Secretary)
Participant Service Oﬃce 
Thue & Selvaag Forum AS
P.O.Box 14
N-2601 Lillehammer
Norway
e-mail: icadts2010@tsforum.no 
Tel:  +47 61 28 73 20
Fax: +47 61 28 73 30
CONGRESS ORGANIZERS
3
The 19th International Conference on Alcohol, Drugs and Traﬃc Safety (ICADTS) - organized by the
Norwegian Institute of Public Health in Oslo, Norway - is coinciding with the 60th anniversary of ICADTS.
It is the fourth time an ICADTS meeting is conducted in Scandinavia and the ﬁrst one in Norway.
ICADTS was founded in 1950 during the ﬁrst conference from August 30 - September 1 in Stockholm,
Sweden. The founding fathers and the relatively small group of researchers and scientists discussing
their ideas and ﬁndings had come together for the purpose of putting special focus on the role of alcohol
in traﬃc. They would certainly look upon the achievements of the organization with pride as we today
express our gratitude to the outstanding contribution of Robert Borkenstein and his colleagues.
In the past 60 years, ICADTS has developed into an organization dedicated to the dissemination of know-
ledge on alcohol and drugs in all ﬁelds of transportation holding triennial conferences in North America,
Australia and Europe. In addition to 19 international conferences, ICADTS has conducted, sponsored and
co-sponsored satellite meetings symposia and workshops; and many working groups have been establis-
hed and produced highly useful reports that have become internationally recognized. From the early
90-ties, increasing focus has been paid to the drug related problems in transportation.
We are convinced that the 19th ICADTS conference in Oslo will continue the tradition and yield knowledge
that will help reduce fatalities and injuries in many countries around the world, making new contacts for
inspiration and future collaboration. 
Welcome to ICADTS 2010 in Oslo.
Wolf-Rüdiger Nickel Asbjørg S. Christophersen    
President ICADTS                                                    Local President ICADTS2010               
Organized by:
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09.00-14.00 Young Scientists.  ICADTS Working groups                                                     
10.00-12.30 Illegal Drugs & Driving. Chair: Michael Walsh
10.00-12.00 Interlock. Chair: Paul Marques
10.00-12.00 Young Drivers. Chair: Andrew Murie
14.00-17.00 Workshop A and B
WORKSHOP A: Trends in Alcohol and Other Drug
Involvement in Drivers Killed in Crashes
Chair: James Fell
Jeaun Paul Assaily   Recent French Trends in acohol and Other Drug Involvement in Drivers Killed in Crashes
Douglass Beirness A Comparison of Drug-and Alcohol-involved Motor Vehicle Driver Fatalities
Paul Boase Fatally Injured Drivers in Saskatchewan 1988 to 2008
James Fell Alcohol Involvement in Fatally Injured Drivers in the United States
Ralph Hingson Alcohol and Drug Use in Fatally Injured Drivers in States that Test over 80% for Both Alcohol and 
Drugs
A.W. Jones Occurence of Alcohol and Other Drugs in Femoral Blood Samples from Drivers Killed in Road-Traﬃc 
Crashes in Sweden
Daniel Mayhew Trends in Alcohol-Fatal Crash Problem in Canada
Oliver Plaut Alcohol and Drugs in Fatal Road Crashes in Western Schwitzerland in 2009
Monica Colas Drugs and Driving in Spain
René Mathijssen Drink-Driving Trend 2000-2008 and the Actual Alcohol-Related Road Toll in the Netherlands
Susanne Schönebeck      Alcohol related Road Accidents in Germany-Status Till 2008
Ian Faulks Trends in Impaired Driving in Australia in 2010
WORKSHOP B: Drug analyses in alternative matrices
Chair: Alain Verstraete 
Martin Boorman Victorian Impaired Driving Legislation (2000) and Random Roadside Oral Fluid Legislation (2004):
Philip Swan Theory and  Results of 2 Diﬀerent Enforcement Strategies.
Gert de Boeck The New Legislation on Saliva Testing in Belgium
Alain Verstraete External quality assessment of multi-analyte chromatograﬁc methods in oral ﬂuid
Alain Verstraete Comparison of the Concentrations of Drugs in Saliva Collected by Two Sampling Methods
Rainer Polzius THC Detection in Oral Fluids: Can the Challenge be overcome? Author: Stefan Steinmeyer
Robert Kronstrand   An Introduction to Hair Analysis in Driving License Regranting.
17.30 Welcome Reception
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PROGRAM SUNDAY 22 AUGUST
09.00 Opening
- Local President, Asbjørg S. Christophersen
- Minister of Transport and Communication, Magnhild Meltveit Kleppa
- President ICADTS, Wolf-Rüdiger Nickel
- Awards
10.00-11.00 Break at posters and exhibition
11.00-13.00 Pleary Lectures, Chair Barry Logan
Plenary 1: ICADTS - Looking back and into the future.
Wolf Rüdiger Nickel
Plenary 2: Risk factors in car crashes. Fred Wegman
Plenary 3: DRUID - review and perspective. Horst Schulze
13.00-14.00 Lunch at posters and exhibition
14.00-17.00 Workshop C and D
WORKSHOP C: DRUID I Epidemiology
Chair: Inger Marie Bernhoft
Inger Marie Bernhoft An overview of the epidemiological studies in DRUID
Inger Marie Bernhoft Methodologies for relative risk estimations of driving while impaired and results so far
Tove Hels Prevalence of impaired drivers in the general driving population in Europe
René Mathijssen Guidelines for DRIUD roadside surveys, and the resulting design for the Netherlands
Silvia Ravera Prevalence of drugs in the general population in Europe
Sonja Forward Driving under the inﬂuence of alcohol or narcotics: An in-depth study with convicted drivers
Alain Verstraete The problem of collecting diﬀerent body ﬂuids from drivers in the surveys
Martina Walter Situational Aspects of Drug-Driving Incidences – Results of the German Cell Phone Survey
WORKSHOP D: Driving simulators for impairment research
Chair: Joris Verster
Joris Verster Introduction
Monique Mets Postive eﬀects of Red Bull Energy Drink on driving performance during prolonged driving
J.L. Veldstra Risk taking in traﬃc: comparing simulated driving with on-road GPS measured driving behaviour. 
Jan Raemakers Residual eﬀects of esmirtazapine on actual driving performance: overall ﬁndings ans an exploratory
analysis
Eef Theunissen Acute and subchronic eﬀects of bilastine (20 and 40 mg) and hydroxyzine 50 mg on actual driving 
performance. 
Arne Helland Development of a driving simulator test battery for assessing drug inﬂuence on driving
performance. Author: Gunnar Jenssen
Robert Kronstrand Simulator driving performance after oral dextroamphetamine 
PROGRAM MONDAY 23 AUGUST
9
08.30 Plenary 4: Social control of the drinking driver. Mary Sheehan
Chair: Ralph Hingson
09.15-09.30 Break
09.30-11.30 Symposium 1 - 4       
Symposium 1: Interlock Chair: Javier Alvarez / René Mathijssen
Bo Bjerre A sum up of the Swedish alcohol ignition interlock program (AIIP)  after eleven years and the
resulting new legislation
Voijtech Eksler The use of alcohol interlocks in EU Member States and the role of EU as a regulator
Anne McCartt Eﬀects of Washington State's First-Oﬀender Alcohol Ignition Interlock Law
Robyn Robertson A Case Study on the Implementation of First Oﬀender Alcohol Interlock Programs
Ward Vanlaar An illustration of knowledge utilization to inform implementation and delivery of an alcohol
interlock program
Robert Voas Monitored Drinking: An Alternative to the Interlock for Oﬀenders Without Cars?
Robert Voas Is monitoring drinking an eﬀective alternative to the interlock?
Symposium 2: Toxicology Chair: Elisabeth Øiestad / Merete Vevelstad
Ronald Agius Increased detection rates of drug use by lowering cut-oﬀs in urine and hair
Thomas Blencowe Scientiﬁc evaluation of the DrugWipe® 5+ and RapidSTAT® devices for the detection of drugs of 
abuse in oral ﬂuid
Ronald Colin Denney Misuse And Abuse Of Urine Sampling For Alcohol In The United Kigdom
Marilyn Huestis Paired Oral Fluid and Whole Blood Cannabinoids From the National Roadside Study
Ray Liu Analysis of Opiates, Amphetamines and Buprenorphine in Oral Fluid by Rapid Screen Device,
GC-MS, and LC-MSMS
Per Mansson Mass screening for drug abuse in traﬃc
Elisabeth Øiestad Comparison of drug concentrations in whole blood and oral ﬂuid collected with the StatSure
collection device
Eef Thenuissen Tolerance and cross-tolerance to neurocognitive eﬀects of THC and alcohol in heavy cannabis users
Symposium 3: Biomarkers - Breath Chair: Christine Moore/ Paul Marques
Hicham Kharbouche Incorporation of Ethyl Glucuronide into rat hair: inﬂuence of hair pigmentation and ethanol dose
Paul Marques Comparison of First and Repeat Oﬀenders on Independent Drinking Indicators
Dariusz Zuba Signiﬁcant diﬀerences in dublicate breath alcohol testing
Barry Logan Approches to estimate uncertainty
David Shinar An analyses of Alcohol breath test results with portable and desktop
Annika Kaisdotter Andersson Physiological and usability aspects of breath alcohol estimation
Martin Boorman An Evaluation of the Deterrent Value of Random Breath Testing (RBT) and Random Drug Testing (RDT)across 
Australia
Don DeVol SPEED-02: On the eﬃciency of a psychological rehabilitation
Symposium 4: Special projects Chair: Asbjørg S. Christophersen / Tori Grytli
Edward Ogden An integrated software model for alcohol absorption and metabolism
Henriette Skretteberg Death Trip
Carina Ophus Girls take action
Kathryn Stewart The Young Impaired Driver Problem: A Status Report and Plan for the Future
Terje Tørring "I CAN`T AFFORD TO LOOSE ANY FRIENDS-DON`T DRINK AND DRIVE
Anne Leonard Road Stories for Young Drivers
Kenneth Beck A Descriptive Analysis of the Social Contexts of Drinking Among
12.30 - 16.30 Boat trip10
PROGRAM TUESDAY 24 AUGUST
08.30-09.15 Plenary 5: Acute disinhibiting effects of alcohol. Mark Fillmore
Chair: Ralph Hingson
09.15 09.30 Break
09.30-11.00 Symposium 5 - 7 + Workshop developing countries
11.00-11.30 Break
11.30-13.00 Symposium 5 - 7 + Workshop developing countries
14.00-17.00 Workshop E and F
Symposium 5: Legislation - Enforcement Chair: Jørg Mørland / Erika Chamberlain
Matthew Baldock The ﬁrst year of roadside drug testing of drives in Western Australia
Douglas Beirness Drugs and Driving Legislation: Challenges and Choices
Erika Chamberlain Current Criminal and Administrative Vehicle Forfeiture Provisions in Canada: The Need for an
Eﬀective Program
Anne Leonard Successful Implmentation of New Legislation
Grete Mathisrud LEGISLATION PACKAGE - regarding law and enforcement for driving under the inﬂuence of other 
drugs than alcohol. 
Robert Solomon The Case for RBT in Canada: Balancing Traﬃc Safety and Civil Liberties in an Advanced Democracy. 
Author: Erica Chamberlain
Jens Stener Tryg Vesta
Matus Sucha Eﬀectiveness of Breath Testing of Drivers for Alcohol at Road Checks
Peter Thompson Driver Drug Testing - The South Australian Enforcement Model
Roar Skjelbred Larsen Enforcing drug drivers by the Norwegian Police Service
Norwegian police Demonstration of suspected impaired drivers
Symposium 6: Epidemiology - Accidents, injuries
Chair: Liliana Bachs / Knut Hjelmeland
Giorgetti Raﬀaele Accident-proneness of DUI oﬀenders in treatment with medications
Narelle Haworth Should we be concerned about alcohol in bicycle crashes?
Ajman Khan Khoso Analyis National Highway & Motorway Police injury Surveillance
Ajman Khan Khoso Trends in road traﬃc crashes and assiated injury fatallity in Pakistan
Karen Scott Drug Involvement in Road Traﬃc Oﬀences and Fatalities in Scotland (1998-2009)
Priscilla Martinez Drinking and other traﬃc accident risk factors in Africa: Data from the World Health Surveys
Edeaghe Ehikhamenor       The role of psychoaktive drugs on highway safety
Per Trygve Normann How to get high inclusion rates in prevalence studies
Jørgen G. Bramness Methadone, benzodiazepines and traﬃc accident risk
Edward Ogden The relationship between responsibility for vehicle accident and presence of drugs in blood of inju
red drivers in Victoria, Australia.
Raquel de Boni Alcohol availability and DUI in a driver probabilistic sample from Porto Alegre, southern Brazil:
preliminary ﬁndings.
Merete Vevelstad Gamma-hydroxybutyrate (GHB), pregabalin and driving impairment
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Symposium 7: Prevention and rehabilitation 
Chair: Marilyn Huestis  / Katryn Stewart
Mark Johnson A Field Experiment on the Eﬀect of Norms Correction on Alcohol Consumption
Klaus-Peter Kalwitzki Individual psychological rehabilitation programmes and their eﬀectiveness on DUI-oﬀenders
Charles Mercier-Guyon Evaluation of 3 levels pictograms on medicines boxes in drivers and health professionals in France
Lenka Stastna Eﬀectiveness of Alcohol-Oriented Road Safety Measures in Selected EU Countries
Sheilagh Stewart A Preliminary Proﬁle of Warn Range Suspended Drivers in Ontario 
Sara.Ann Legrand Survey of prevention and information campaigns on psychoactive drugs and driving. Author Alain 
Verstraete
Robert Voas Toward a National Model for Impaired Driver Treatment and Monitoring Programs 
Jeremy Davey Deterring Drug Drivers: A Study into the Initial Impact of Oral Random Roadside Drug Testing in 
Queensland 
James Fell Minimum Legal Drinking Age 21 in the United States: Why It is an Eﬀective Policy
Tanya Smyth Medication warnings about driving:Risk perceptions among french and australian communities
Antje Buettner-Telega Prevalence measurement of sleep apnea syndrome in neurological patients 
Susana Monteiro Evaluating new ways to communicate risk: how patients perceive pictograms about medicines and 
driving ability.
WORKSHOP DEVELOPING COUNTRIES Chair: Alain Verstraete, Han de Gier
Jonathon Passmore Preliminary eﬀorts to strengthen prevention of drinking and driving in Vietnam
Martha Hijar Road traﬃc injuries and alcohol in Mexico
Ashis Das Road traﬃc accidents vis-à-vis substance use in India
Flavio Pechansky Summary of presentation about the Brazilian situation
Francis Kwaku Afukaar Road traﬃc injuries in Ghana: Challenges and measures for improvement
Wilson Odero Alcohol and Road Traﬃc Crashes in Kenya
WORKSHOP E: DRUID ll Experimental studies Chair: Jan Ramaekers
Marie- Laure Bocca Combined eﬀects of zolpidem and codiliprane on simulated driving
Wendy Bosker Ecstasy Eﬀects on Actual Driving Before and After Sleep Deprivation
Wolfgang Grellner Pharmacokinetic models of performance impairment as assessed in experimental studies
Volker Hargutt Converting drug eﬀects on experimental performance measures to odds ratios
K.A. Brookhuis The eﬀects of MDMA (100 mg) and alcohol (0.5 ‰), alone and in combination, on simulated driving 
performance 
Anja Knoche Goals and current status of experimental work in DRUID
Tim Leufkens Eﬀects of insomnia and chronic use of hypnotics on driving performance
Marieke Martens Dexamphetamine eﬀects on simulated driving, alone and in combination with alcohol
WORKSHOP F: Use of biomarkers to estimate risk of DUI drivers
Chair: Paul Marques
Marques/ Moore Introduction, Overview of the session
Bo Bjerre Introduction/Clinical uses of alcohol biomarkers in Traﬃc medicine
Paul Marques Changes in alcohol biomarkers during an average 8 months of interlock controlled driving
Maria Portman Predicting DUI recidivism: A study of the impact of alcohol markers and previous drunken driving.
Gordon Smith EtG as a possible indicator of hangover in crash trauma patients with BAC=0
Discussion and break
Donata Favretto Phosphatidylethanol molecular species in heavy and social drinkers
Ronald Agius Ethyl glucuronide in hair – a highly eﬀective test for the monitoring of Alcohol Abstinence
Christine Moore Detection time of direct alcohol markers, ethyl glucuronide (EtG) and ethyl sulfate (EtS), in oral ﬂuid 
and urine
Open discussion
19.30 Conference Dinner12
PROGRAM WEDNESDAY 25 AUGUST
08.30-09.15 Plenary 6: Non alcohol drug driving. Jørg Mørland
Chair: Han de Gier 
09.15-09.30 Break
09.30-11.00 Symposium 8 - 11
11.00-11.30 Break
11.30-13.00 Symposium 8 - 11
13.00-13.30 Closing Ceremony
Symposium 8: Epidemiology - Roadside surveys / Impaired drivers
Chair: Wayne Jones   /  Dominique Lopez
Douglas Beirness Drug and Alcohol Use Among Drivers: Findings from the British Columbia Roadside Survey 2008
Wayne Jones What non-alcohol drugs are used by drinking drivers in Sweden? Toxicological results from 10-years 
of forensic blood
John Lacey 2007 U.S. National Roadside Survey: Methodology
John Lacey 2007 U.S. National Roadside Survey: Alcohol Results
John Lacey 2007 U.S. National Roadside Survey: Drug Results
John Lacey National Roadside Survey 2007: Results from paired Specimens of Oral Fluid and Whole Blood
Seyed Abbas Motevalian Random drug tests among public vehicle drivers of Iran
Francois Riguelle Three editions of the Belgian drink driving roadside survey: results and lessons learned
Hallvard Gjerde The use of zopiclone among random drivers, arrested drivers and fatally injured drivers in Norway
Dominique Lopez State of Drugs problem in Europe, innovations in the drug market challenge routine detection
Barry Logan Case Reports of Impaired Driving Resulting from Butalbital Use
Kerry Armstrong The culture of young womens drinking in Australia
Symposium 9: Drinking and drugged drivers Chair: Pirjo Lillsunde / Mark Vollrath 
Antti Impinen The eﬀect of socio-demographic determinants on drinking and driving.
Karoliina Karjalainen Socio-economic determinants of drugged driving a register-based case-control study
Karin Müller Women driving while intoxicated
Evelyn Vingilis Alcohol, Drugs and Street Racing: Results from the Ontario Student Drug Use and Health Survey
Sheilagh Stewart A Proﬁle of Stunt Drivers in Ontario
Wolfgang Schubert Indication for the examination of drivers ﬁtness after problematic alcohol consumption
James Freeman Psychiatric and Substance Abuse Comorbidity among a Large Sample of DUI Texas Oﬀenders
Donata Favretto Genetic susceptibility to alcohol drinking and abuse in drunk-drivers
Katherine Stewart Social Media and Its Impact on Introducing Legislation Aﬀecting Young Drivers
Pirjo Lillsunde The life course of DUI oﬀenders
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Symposium 10: First-time and repeat oﬀenders
Chair: Sjoerd Houwing  / Kerry Armstrong
Kerry Armstrong Proﬁling the oﬀence patterns of disqualiﬁed drink drivers in Queensland, Australia
James Fell An Evaluation of Three Driving-Under-the-Inﬂuence Courts in the United States
James Fell An Evaluation of Three Intensive Supervision Programs for Serious Driving-While-Intoxicated
Oﬀenders
Terje Assum Drink driving in Norway:  How to reduce a small, but important problem?
Julie Tison Patterns of DWI Recidivism by Diﬀerent Court Adjudications
Hollie Wilson Who are the real ﬁrst oﬀenders?
Katherine Wood I-95 High-Risk Driver Program Analysis
Marie Claude Ouimet The neuroscience of recidivism in DWI oﬀenders: implications for prevention and intervention.
Thomas Brown Sex and gender eﬀects in DWI ﬁrst time oﬀenders: Neurocognitive diﬀerences 
Thomas Brown Readiness to change and help seeking as mediators of brief intervention action in DWI recidivists 
Sophie Couture Multidimensional arousal-seeking model of ﬁrst-time DWI oﬀenders 
Sioui Maldonado Multiple DWI Oﬀenders Show Poorer Decision-making Performance than Healthy Controls 
Symposium 11: Experimental studies/ Assessment of impairment
Chair: Charles Mercier-Guyon  / Anja Huemer
Mark Vollrath Is it really alcohol-induced impairment of cognitive functions that leads to crashes?
Charles Mercier-Guyon Signs of impairment:clinical or behavioral ? from medicine to ﬁeld evaluation
Amy Porath-Waller Simplifying the Process for Identifying Drugs by Drug Recognition Experts
Maren Strand Psychomotor and cognitive functions in subjects receiving methadone and buprenorphine
Michael Berg The assessment of impairment by test methods: The role of individual variability
Ingebjørg Gustavsen Psychomotor impairment on three levels of behaviour after intake of zopiclone or ethanol
Christian Giroud Impact of cannabis inhalation on driving skills in occasional smokers.
Alexander Brunnauer Aﬀective disorders and antidepressants: Comparative eﬀectiveness of newer antidepressants on 
ﬁtness to drive
Sara-Ann Legrand Comparison of a checklist for clinical signs of impairment and detection of drugs in saliva.
Author: Alain Verstraete
Anja Huemer Alcohol eﬀects on driving performance: Compensation may protect controlled actions
Marie-Laure Bocca 1 to 3 therapeutics doses of codeine/paracetamol did not impair driving performance in
monotonous surrounding.
René Mathijssen Evaluation of a checklist of clinical signs of impairment (CSI) during drug
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Road traﬃc injuries in Ghana: Challenges and
measures for improvement
Afukaar Francis Kwaku, Building & Road Research Institute
Road traﬃc crash fatalities and injuries have become a major health and socio-economic burden confron-
ting most developing countries including Ghana. Unlike the high-income countries, where the incidence of
road traﬃc fatalities has been reduced, in Ghana, traﬃc crash fatalities have been on the rise. The road
traﬃc injury pattern is arguably diﬀerent and comprises mainly vulnerable road users. A crash database
has been developed since 1991 from police reports at the Building and Road Research Institute (BRRI) and
it is managed using the Microcomputer Accident Analysis Package (MAAP) software, developed by the
Transport Research Laboratory, UK. Traﬃc crash injury statistics for the period 2000-2008 showed that
pedestrians were the road users most at risk, constituting 42% of all road traﬃc fatalities and children
below the age of 16 years accounted for one-third of all pedestrian fatalities. Over two-thirds (67.8%) of
all road traﬃc fatalities occur on the non-urban highways where speeds are excessively high with over
90% of vehicles exceeding the posted speed limit of 50 km/h in settlement areas. Twenty-one percent
(21%) of drivers tested in a random roadside breathalyzer survey in Ghana had a detectable Blood Alcohol
Concentration (BAC) while 7.3% of the drivers had a BAC greater than the maximum permissible limit of
80 mg/dl. Though there is legislation on drink-driving, enforcement by the police has not been vigorous.
To curb speeding and improve pedestrian safety in village settlements along the major highways, speed
humps have been installed to slow down traﬃc. The National Road Safety Commission (NRSC) in colla-
boration with the Ghana Education Service has also been training school children on safer road user
behaviour. 
Key words: Pedestrians, traﬃc injuries, excessive speeds, speed humps, training
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Ethyl glucuronide in hair   a highly eﬀective test
for the monitoring of Alcohol Abstinence in the
Rehabilitation of Alcohol impaired drivers
Agius Ronald, Labor Krone
Objectives: 
Ethyl glucuronide is a direct, non-volatile, water soluble, stable metabolite of ethanol which has been in-
cluded in the recently revised guidelines used to rehabilitate alcohol impaired drivers in Germany. The aim
of this paper is to compare the number of positive ethyl glucuronide samples in urine with ethyl glucuro-
nide in hair samples of alcohol impaired drivers and hence to compare the eﬃcacy of both tests in driving
licence re-granting medical and psychological assessment (MPU).
Methods:
Urine samples were screened for ethyl glucuronide using a commercial enzyme immunoassay test and
conﬁrmed with gc-ms. Hair samples were analysed with a HS-SPME-GC-MS/MS method . All methods
were fully validated and accredited according to forensic guidelines. 
Results:
The new guidelines deﬁne a positive sample when its ethyl glucuronide value is greater or equal to 0.1
mg/L urine or 0.007 ng/mg hair using a 3cm segment. Using these guidelines, 20% (80 out of 386 sam-
ples) tested positive for ethyl glucuronide in hair, compared to only 2.9% (124 out of 4248 samples) in
urine. Additionally 50% of the samples positive for ethyl glucuronide in hair had ethyl glucuronide values
greater than 0.03 ng/mg hair , indicating chronic alcohol consumption in the last three months.
Conclusions:
This study shows that ethyl glucuronide in hair reveals a much higher percentage of alcohol impaired dri-
vers who fail to be sober over a three month period than does the test in urine over a three day period;
presumeably is the hair test more adequate to monitor long term alcohol abstinence than the urine test
as required for the driving licence re-granting medical and psychological assessment (MPU) for alcohol
impaired drivers in Germany. 
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Increased detection rates of drug
use by lowering cut-oﬀs in urine and hair
Agius Ronald, Labor Krone
The criteria used for the medical and psychological assessment (MPU) to judge if a person is ﬁt to drive in
order to regain a revoked driving licence were revised by the German Society of Traﬃc Psychology
(DGVP) and German Society of Traﬃc Medicine (DGVM). The revision entered into force on the 1st July
2009 and includes a polytoxicological drug screening in urine and hair to assess abstinence. The aim of
this paper is to compare the rate of conﬁrmed positive samples before and after the introduction of new
guidelines.
Before the introduction of the new guidelines, urine samples were screened for drugs of abuse using
EMIT using the suppliers  cut-oﬀs   50 ng/mL for cannabinoids, 500 ng/mL for amphetamines, 300 ng/mL
for opiates and cocaine.  Screenings for drugs as deﬁned in the new guidelines (10 ng/mL for cannabi-
noids, 50ng/mL for amphetamines, 25 ng/mL for opiates and 30 ng/mL for cocaine metabolite) were per-
formed using ELISA technique. Positive samples were conﬁrmed by GC-MS or LC-MS/MS. All drug
screening and conﬁrmation methods were fully validated and accredited according to forensic guidelines. 
371 out of 5058 urine samples were conﬁrmed positive for amphetamines, cannabinoids, cocaine or opia-
tes using ELISA as opposed to 124 out of 3536 urine samples using EMIT screening methods. An average
of 70% of the conﬁrmed positive tests lie under the old cut-oﬀs. Out of 3760 hair samples, 57% of the
conﬁrmed positive samples (208) for cannabis were below 0.1ng/mg hair but above the new cut-oﬀ
0.02ng/mg.
In this study we show that lowering the cut-oﬀs for drugs of abuse in urine and hair results in a signiﬁ-
cantly increased detection rates of drug use or exposure and hence proving the eﬃcacy of the new guide-
lines in detecting drivers who are not ﬁt to drive. 
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Proﬁling the oﬀence patterns of disqualiﬁed
drink drivers in Queensland, Australia
Armstrong Kerry, CARRS-Q
Barry Watson, Dr.; Kerry Armstrong, Dr, CARRS-Q, Brisbane, Australia; Kerrie Livingstone, Ms,
CARRS-Q, QUT, Kelvin Grove, Australia; Angela Watson, Ms, CARRS-Q, Brisbane, Australia
Objectives:
While unlicensed driving does not play a direct causative role in road crashes, it represents a major pro-
blem for road safety. A particular subgroup of concern is those oﬀenders who continue to drive after ha-
ving their licence disqualiﬁed for drink driving.  Surveys of disqualiﬁed drivers suggest that driving among
this group is relatively common. 
Method:
This paper reports ﬁndings from an analysis of the driving records of over 545,000 Queensland drivers
who experienced a licence sanction between January 2003 and December 2008. The sample included dri-
vers who were disqualiﬁed by a court (e.g., for drink driving); those who licence had been suspended admi-
nistratively (e.g., for accumulation of demerit points); and those who were placed on a restricted licence.
Results:
Overall, 95,461 of the drivers in the sample were disqualiﬁed from driving for a drink driving oﬀence. Du-
ring the period, these drivers were issued with a total of 2,644,619 traﬃc infringements with approxima-
tely 12% (n = 8, 095) convicted of a further drink driving oﬀence while disqualiﬁed. Other traﬃc oﬀences
detected during this period including unlicensed driving (18%), driving an unregistered vehicle (27%), spe-
eding (21%), dangerous driving (36%), mobile phone use (35%), non-restraint use (32%), and other moving
violation (23%). Oﬀending behaviour was more common among men than women.
Conclusions:
While licence disqualiﬁcation has previously been shown to be a relatively eﬀective sanction for mana-
ging the behaviour of drink driving oﬀenders, the results of the current study highlight that it is a far from
perfect tool since many oﬀenders continue to commit both drink driving and other traﬃc oﬀences while
disqualiﬁed.  As such, this study highlights the ongoing need to enhance the detection of disqualiﬁed and
unlicensed driving in order to deter this behaviour. 
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The Culture of Young Womens Drinking
in Australia
Armstrong Kerry, CARRS-Q
Patricia Obst, Dr, School of Psychology and Counselling, Brisbane, Australia; Hanna Thunstrom, Ms,
CARRS-Q, Brisbane, Australia; Helen Haydon, Ms, CARRS-Q, Brisbane, Australia; Jeremy Davey, Profes-
sor, CARRS-Q, QUT, BRISBANE, Australia
Objectives:
The purpose of this investigation was to move away from research that is based on male constructs re-
garding drinking of alcohol and to undertake pilot research to develop an understanding of the current
culture of young Australian women s (18-25 years) drinking behaviour from a uniquely female perspective.  
Methods:
Two separate focus group interviews were undertaken with women (N = 11) aged between 18 and 25 years
living in South-East Queensland, Australia. Women were asked to openly discuss how and why they drink
alcohol (ie., their regular drinking behaviour), with an emphasis on the attitudes and values that their inﬂu-
ence their behaviour.
Results:
Consumption of alcohol was found to be a largely social phenomenon, where pressures to match the into-
xication levels of social group members directly inﬂuenced the quantity of alcohol drunken by individual
members. Family inﬂuence was not found to be signiﬁcant at this age; rather the focus group data indica-
ted that parental eﬀorts centred on harm minimisation rather than abstinence. In terms of drinking beha-
viours, particulars drinking venues that tolerated greater levels of patron inebriation were purposely
sought out as the women often planned levels of intoxication on given nights. Females did however report
that sexual harassment is also tolerated to a greater extent in such venues, which formed part of the se-
xual abuse risks encountered by young intoxicated females. Other perceived risks related by the women
were social (embarrassment). The perceived risks resulted in risk aversion strategies however women did
not engage in risk avoidance. 
Conclusion:
It is proposed that the ﬁndings of this investigation could be used to improve current knowledge regar-
ding young women s drinking culture, associated risks and risk prevention strategies.  Further investiga-
tion is needed to inform alcohol-related education. 
ORAL ABSTRACT
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Recent French trends in alcohol and other drug
involvement in drivers killed in crashes
Assailly Jean-Pascal, INRETS
This is an invited presentation to J. Fell 's workshop Recent  trends in alcohol and other drug involve-
ment in drivers killed in crashes
Objectives: 
This paper will review trends in alcohol use in traﬃc fatalities in France.  In 2002, France resolved to make
a strong reinforcement of its traﬃc safety policy, directed mainly towards speed violations (development
of 2000 speed cameras, increase of fees, increased license actions, intense media campaigns, and the
concept of  tolerance zero ). The result have been spectacular - in 3 years, the annual number of traﬃc fa-
talities fell from 8000 to 4000.
Methods:  
Statistics from traﬃc collisions and fatalities in France involving alcohol use have been collected and
evaluated.  The review also considers if a policy directed mainly toward speed has or not also eﬀects on
alcohol.  
Results: 
The latest ﬁgures show that alcohol is present in 11% of traﬃc casualties, in 28% of traﬃc fatalities and
in 50% of weekends nights accidents. As the number of traﬃc fatalities is currently around 4000 in
France, we can estimate that around 1200 French traﬃc fatalities are related to alcohol.
Considering the role of speed enforcement on alcohol use must consider that there are always many cau-
ses in an accident.  A measure directed towards a risk factor may have eﬀects on other risk factors (for
example, with speed cameras, drunk drivers may drive more slowly and will  recuperate  their mistakes
due to impairment more easily, or it will transform a fatal accident into a casualty, or there is a general fe-
eling of  surveillance  given by the speed cameras, etc).
Conclusions: 
The examination of very high B.A.C. indicating problems of alcohol dependence  shows clearly that we
cannot rely only on enforcement considering drunk driving but that we have also to develop a medical
psychological help for these subjects. This means also that traﬃc safety research on D.U.I. has to set
strong links with psychological research on alcohol dependence, as the predictive risk factors and the
causes of evolutions are strongly interrelated. 
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Drink driving in Norway:  How to reduce
a small, but important problem?
Assum Terje, Institute of Transport Economics - TOI
Objectives:
The objective is to outline the possible reduction of alcohol-related road accidents in Norway.  About 0.3
% of all drivers in Norway are above the legal limit of 0.2 g/l, whereas 18-30 % of the fatalities are alcohol
related. The oﬃcial ambition is a 33 % reduction of fatalities and severe injuries from 2005-08 to 2020 in
spite of an expected 13 % growth in road traﬃc volume. A 33 % reduction of fatalities will require a re-
duction in the alcohol-related fatalities. Reducing the number of alcohol-related fatalities and injuries is a
challenge when the alcohol prevalence in general road traﬃc is almost zero. Some 80 % of the drivers
charged for DWI are already in the criminal records, and a third of the drivers causing fatal accidents were
already convicted. Another challenge is to keep these delinquents oﬀ the roads. The obvious solutions are
compulsory alcolocks in all motor vehicles, increased enforcement, more severe penalties, and increased
information and education. However, these measures have to be well targeted to avoid diﬃculties in im-
plementation or eﬀectiveness.  
Methods:
A ﬁrst step can be an analysis of the in-depth reports from all fatal accidents during 2005-2009, some
1250 fatal accidents, to achieve accurate ﬁgures of alcohol-related fatalities. A second step can be to test
the preventive eﬀects of alcolocks for certain target groups and contribute to the development of alco-
locks into  inexpensive and easily operated devices. 
Results:
Estimating a reliable the percentage for alcohol-related fatalities of all fatalities is necessary to make a
realistic plan to reduce these accidents. The results will show the accurate number of alcohol-related
fatal accidents, where the killed person or some other person involved was under the inﬂuence of alcohol,
when and where the accidents happened, and if possible, characteristics of the drink drivers involved in
these accidents. 
Conclusion.:
The results will indicate how the authorities may proceed to reduce the alcohol-related fatalities and inju-
ries. The police may use the results as guidelines for targeting their DUI enforcement activities. 
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The ﬁrst year of roadside drug testing
of drivers in Western Australia
Baldock Matthew, Centre for Automotive Safety Research, University of Adelaide
Jeremy Woolley, Dr, Centre for Automotive Safety Research, University of Adelaide, Adelaide, SA,
Australia; Mary Lydon, Prof, Centre for Automotive Safety Research, University of Adelaide, Adelaide,
SA, Norway
Objective:
In 2007, the Western Australian Road Traﬃc Act 1974 was amended to allow for new police enforcement
practices designed to reduce the incidence of drug driving. The amendment made provision for two new
oﬀences: driving with the presence of a prescribed illicit drug in oral ﬂuid or blood, and driving while im-
paired by a drug. The prescribed drugs were methamphetamine, methylenedioxymethamphetamine
(MDMA or ecstasy) and delta-9-tetrahydrocannabinol (THC, the psychoactive compound in cannabis). The
Centre for Automotive Safety Research at the University of Adelaide was asked to review the ﬁrst year
of this amended legislation and associated drug driving law enforcement. The present paper does not
summarise the entire review but is focused on analysis of the data concerned with roadside oral ﬂuid tes-
ting of drivers. 
Method:
WA Police provided the authors with all data relating to roadside drug driving law enforcement, including
the number of roadside oral ﬂuid tests, the rate of drug positive results in the roadside tests, and the out-
comes of laboratory-based conﬁrmatory analyses. 
Results:
A total of 9,716 roadside screening tests were carried out in the ﬁrst 13 months of enforcement. Of these,
517 were positive to one or more of the prescribed drugs (5.3%). The secondary screening test required in
the legislation indicated that 109 of these 517 oral ﬂuid samples were negative. However, a follow-up labo-
ratory analysis of 515 of the 517 samples indicated that only 57 were negative, indicating a low level of sen-
sitivity of the second screening test. 
Conclusions:
Overall, the roadside oral ﬂuid testing program in WA was found to be successful but a problem with one
of the drug testing devices was identiﬁed. A positive result on this screening device is necessary (but not
suﬃcient) to obtain a conviction, so the sensitivity of this device needs to be improved. 
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A Descriptive Analysis of the Social Contexts
of Drinking Among
Beck Kenneth, University of Maryland School of Public Health
Ashraf Ahmed, Professor, Morgan State University, Baltimore, United States; Z. Andrew Farkas,
Professor, National Transportation Center, Baltimore, MD, United States
Objectives:
To understand the role of social context in contributing to the incidence of alcohol-impaired driving.
Methods:
Telephone interviews were conducted with 80 individuals who received a ﬁrst time DUI  citation.  They
were predominantly white (70%), male (62%) and 21   45 years of age (62%).  They were paid $25 for their
participation. Questions asked about their social network, the social context in which they typically drink,
the speciﬁc location and circumstances where they were drinking at the time of their citation, as well as
their risky driving behaviors in the last month. 
Results:
Two reliable social contexts of drinking were identiﬁed through principle components factors analysis;
emotional pain and social facilitation.  Analyses of variance showed that drinking in a context of emotio-
nal pain (e.g., to deal with depression, stress) was related to drinking alone at this location and driving
when they know they ve had too much to drink.  Drinking in a context of social facilitation (e.g., with fri-
ends, to be sociable) was related to drinking more frequently (at least several times a month) and with ot-
hers (versus alone) at this location.  Social facilitation was also positively related to going over the speed
limit and running a red light/stop sign. 
Conclusion:
The social context of drinking is important for understanding the social network of drinking drivers, as
most (86%) said that someone from their social network was with them at this drinking location.  The
need to understand how signiﬁcant others inﬂuence the context of drinking as well as the likelihood of im-
paired driving is critical for program development. 
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Drugs and Driving Legislation:
Challenges and Choices
Beirness Douglas, Canadian Centre on Substance Abuse
Objectives:
The primary objective of this paper is to outline the issues surrounding the three major options for drugs
and driving legislation   impairment-based statues, per se laws, or zero tolerance. 
Methods:
A comprehensive review of the literature on drugs and driving was conducted with particular emphasis on
increased risk of crash involvement associated with various types of drugs.  Examples of the types of
laws in place around the world and the various approaches to enforcement were then examined. 
Results:
There is a wide array of substances   both illegal and medicinal -- that adversely aﬀect the operate a
motor vehicle safely and increase the risk of crash involvement.  In an attempt to deal eﬀectively with the
problem, governments have generally implemented one of three legal approaches.  Impairment laws
focus on the extent to which the driver s ability to operate the vehicle safely has been compromised by
drugs.  Per se laws establish a quantitative value of drug concentration above which it is an oﬀence to
operate a vehicle.  Zero tolerance laws are a special case of per se laws whereby the limit is set at zero
i.e., any measurable amount of the substance in the driver s blood is deemed an oﬀence.  Few countries
have evaluated the impact of their drug-driving laws or their methods of enforcement.  
Conclusions:
There are beneﬁts and liabilities associated with each type of law. No one type of legislation stands out
as being clearly superior to the others.  In developing a strategy for dealing with drugs and driving, one
need to carefully consider the numerous complexities involved in the issue. 
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ORAL ABSTRACT
Drug and Alcohol Use Among Drivers:
Findings from the British Columbia Roadside
Survey 2008
Beirness Douglas, Canadian Centre on Substance Abuse
Erin Beasley, Research and Policy Analyst, Canadian Centre on Substance Abuse, Ottawa, Canada
Douglas J. Beirness and Erin E. Beasley
Objectives:
The purpose was to collect information on the prevalence of alcohol and drug use among nighttime dri-
vers in British Columbia. 
Methods:
Vehicles were randomly selected from the traﬃc stream between the hours of 9 pm and 3am on Wednes-
day through Saturday nights in three cities in British Columbia in June 2008. Drivers were asked to pro-
vide a voluntary breath sample to measure their alcohol use and an oral ﬂuid sample to be tested
subsequently for the presence of drugs. 
Results:
Of the 1,533 vehicles selected, 89% of drivers provided a breath sample and 78% provided an oral ﬂuid
sample. It was found that 10.4% of drivers tested positive for drug use and 8.1% of drivers had been drin-
king. Overall, 15.5% of drivers tested positive for alcohol, drugs or both. Cannabis and cocaine were the
drugs most frequently detected.  Drugs and alcohol appear to have diﬀerent patterns of use among dri-
vers. For example, whereas alcohol use among drivers was most common on weekends and during late-
night hours, drug use was more evenly distributed across all survey nights and times.  Alcohol use was
most common among younger drivers; drug use was more evenly distributed across age groups.  Driver
perceptions of the likelihood of being stopped by the police after drug or alcohol use were also be exami-
ned in relation to driver alcohol and drug use status.
Conclusions:
The ﬁnding that drug use is now more common than alcohol use among drivers highlights the need for a
unique and separate societal response to the use of drugs by drivers comparable to that directed at drin-
king and driving over the past three decades. 
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A Comparison of Drug- and Alcohol-involved
Motor Vehicle Driver Fatalities
Beirness Douglas, Canadian Centre on Substance Abuse
Erin Beasley, Research and Policy Analyst, Canadian Centre on Substance Abuse, Ottawa, Canada;
Jacques LeCavalier, Research Associate, Canadian Centre on Substance Abuse, Ottawa, Canada;
Daniel Mayhew, Mr., Traﬃc Injury Research Foundation, Ottawa, Cana
Objectives: 
The objectives of the project were to:
- Compare and contrast the characteristics of fatally injured drivers who test positive for alcohol
and those who test positive for psychoactive drugs, and drugs plus alcohol;
- Compare and contrast the characteristics and circumstances of fatal collisions involving alcohol
and/or drugs
Methods:
Data from coroners  reports and motor vehicle crash records were linked to compare and contrast the
characteristics of fatal collisions involving drivers who have used either alcohol, drugs, or both. The  Fata-
lity Database houses information on all drivers killed in motor vehicle collisions in Canada.  This database
contains the results of alcohol and drug tests performed by coroners on victims of motor vehicle collisi-
ons in Canada from 2000 to 2007.  These data will be linked with detailed information about the crash
contained in the National Collision Database.
Results:
Among the over 14,000 driver fatalities in the database, 33% tested positive for at least one psychoac-
tive substance and 38% tested positive for alcohol. The most commonly detected drugs were depres-
sants, cannabis, stimulants and narcotic analgesics. Among alcohol-positive cases, 82.2% of drivers had a
Blood Alcohol Concentration over 80 mg%. The ﬁndings reveal similarities and diﬀerences in the circum-
stances and characteristics of the crashes of drivers who test positive for alcohol and/or drugs. The
paper will describe these key factors and outline the implications for prevention and enforcement. 
Conclusions: 
The ﬁndings provide greater understanding of the impact of the use of psychoactive substances (both il-
legal and medicinal) by drivers and provide new knowledge that contributes to the development of pre-
vention eﬀorts to improve overall road safety in Canada.  In addition, knowledge of the characteristics of
collisions that involve a driver who has used psychoactive will provide enforcement with greater ability to
identify drug-involved crashes and take measures to investigate and prosecute those responsible. 
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The assessment of impairment by test
methods: The role of individual variability
Berg Michael, I.T.E.A.
Objectives: 
The aim of our contribution is to suggest that psychological tests assessing individual performance diﬀe-
rences can be helpful to study impairments challenging driving behavior.   It is proposed that an observer
of driving behavior cannot tell what kind of cognitive impairment caused any given faulty driving, which
can derive from several cognitive dysfunctions.
Methods:
First we examined typical impairment caused by alcohol abuse, the so-called tunnel vision eﬀect.  Se-
condly, we examined the working memory performances of senior citizen drivers, especially regarding the
share of attentive functions.  Poor working memory performance is not necessarily caused by disturban-
ces of the retrieval process, it can also be caused by a lack of attention.  We used a test system with maxi-
mal comparability of the subtests. Thus, important diagnostic information can be achieved regarding the
individual variance.   First, performance of selective versus divided attention were compared, secondly a
task of spatially focused attention was used to establish baseline performance for the following memory
task and later compared to it. 
Results: 
As suggested by other workers, the ﬁrst investigated impairment can be explained by a lack of divided ,
as opposed to selective, attention. Although a diﬀerent paradigm was used, the same result was obtai-
ned.  Secondly, in the memory assessment, the share of retrieval, as opposed to intentional deﬁcit  is gre-
ater than expected.
Conclusion: 
Considering individual diﬀerences it is possible in both cases to assess impairment disregarding the sta-
tistical norm. To create individual references can be more eﬃcient.  In real life, if people say "I feel impai-
red", than they mean a change within themselves, not in comparison 
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Methodologies for relative risk estimations
of driving while impaired and results so far
Bernhoft Inger Marie, Department of Transport, Technical University of Denmark
Objectives:
To describe the various relative risk estimations of driving while impaired within the DRUID project (Dri-
ving under the Inﬂuence of Drugs, Alcohol and Medicines) and results so far.
Methods:
Risk estimates for drug impaired drivers are based on linkage of drugs in drivers in traﬃc to drugs in inju-
red drivers, of medication records to accident data and of responsible and non-responsible drivers invol-
ved in accidents with drugs as well as without. 
Results: 
The prevalence of drugs in accident involved drivers will be compared to the prevalence of drugs in the
general driving population, resulting in a calculation of the relative risk for drug drivers of being seriously
injured in an accident. The inﬂuence of confounding factors (like gender, age, day of the week and time of
the day) will be adjusted for. 
Risk estimations will also be based on a comparison of individual medication records with the person s
accident data. The impact of speciﬁc medicinal drug use patterns will be revealed, like the risk associated
with the ﬁrst period after the start of medication
Finally, the relative risk for being responsible for a fatal accident or being killed as a driver while impaired
will be based on drivers who are responsible for the accident and those who are not. 
Conclusion: 
Relative risk estimates will serve as input to recommendations for drug thresholds in relation to traﬃc
safety, classiﬁcation of medicines and guidelines to medical and pharmaceutical practice.
Disclaimer:
This abstract has been produced under the project  Driving Under the Inﬂuence of Drugs, Alcohol and Me-
dicines  (DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework
Program.
This abstract reﬂects only the author's view. The European Community is not liable for any use that may
be made of the information contained therein. 
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An overview of the epidemiological studies
in DRUID
Bernhoft Inger Marie, Department of Transport, Technical University of Denmark
Objectives:
To describe the various epidemiological studies within the DRUID project (Driving under the Inﬂuence of
Drugs, Alcohol and Medicines).
Methods:
Several methodological approaches are used both for estimating the prevalence of drug driving and the
accident risk for drug impaired drivers, each with diﬀerent sensitivity and speciﬁcity. 
Results: 
The prevalence in the general population is described my means of a literature review. The prevalence of
drug driving is estimated by means of road side surveys and a travel survey and the prevalence of drugs in
injury accidents is estimated by means of hospital surveys of seriously injured and killed drivers. Accident
risk estimates for drug impaired drivers are based on linkage of results on drugs in drivers in traﬃc to
drugs in injured drivers, on linkage of medication records to accident data and linkage of analyses of acci-
dents with drug impaired drivers to accidents without. Furthermore, characteristics of drivers who have
been involved in accidents while drug impaired or convicted for drug driving are investigated by means of
interviews. 
Conclusion:
The results from the various studies in various European countries (e.g. Northern, Western, Southern and
Eastern Europe) will be compared in order to reveal any diﬀerences regarding use of psychoactive sub-
stances. 
Disclaimer:
This abstract has been produced under the project  Driving Under the Inﬂuence of Drugs, Alcohol and Me-
dicines  (DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework
Program.
This abstract reﬂects only the author's view. The European Community is not liable for any use that may
be made of the information contained therein. 
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A sum up of the Swedish alcohol ignition
interlock program (AIIP)  after eleven years
and the resulting new legislation
Bjerre Bo, Transportstyrelsen
Introduction:
In Sweden an AIIP has been running for more than eleven years. The AIIP is a voluntary 2-year program
open for all DWI oﬀenders and includes regular medical checkups. 
Objectives: 
AIIP aims to change the alcohol and driving habits of drink-drivers.  
Methods:
Regular medical checkups are designed to alter alcohol use habits by continuously following alcohol bio-
markers. 
Results: 
A signiﬁcant reduction of alcohol consumption was found while participating in the program. Compared
to controls the self-reported alcohol consumption  was lower among the AIIP participants after one year
in the program as well as one year after having completed the program.   
While in the AIIP the DWI recidivism was 0.4%/year, whereas those DWI oﬀenders who did not partici-
pate had about the same rate of recidivism during the revocation period as before the DWI oﬀence.  The
rate of police-reported traﬃc accidents was similar among AIIP participants and  controls. Signiﬁcantly
fewer in the AIIP group needed hospital care and sick leave relative to the control group.
The long-term eﬀects have been studied in the maximum 7-year follow-up time after completing the AIIP.
Among all participants the rate of recidivism was reduced by 32% compared to the rate of recidivism du-
ring the ﬁve years before the DWI oﬀence. Among those who completed the 2-year program the reduc-
tion was 58%. Among controls, being relicensed after a DWI oﬀence, the recidivism rate was only reduced
by 4%.
Conclusions:
The present Swedish AIIP has favourable long-term eﬀects compared to conventional licence revocation,
but it also has some disadvantages. There are too few participants and there are too many  (almost 40%)
excluded participants. The pilot AIIP will now be replaced by a permanent program trying to force (wit-
hout excluding) all DWI oﬀenders to participate in an alcolock program before being relicensed. This new
program will be presented. 
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Scientiﬁc evaluation of the DrugWipe® 5+ and
RapidSTAT® devices for the detection of drugs
of abuse in oral ﬂuid
Blencowe Thomas, National Institute for Health and Welfare, Finland
Objectives: 
On-site tests for screening of drugs in oral ﬂuid (OF) are used as a means of detecting driving under the in-
ﬂuence cases. As part of the EU-project DRUID a number of devices were evaluated. The aim of this study
was to determine the reliability of the DrugWipe® 5+ and RapidSTAT® devices.
Methods: 
In this study 136 cases were screened with the DrugWipe® 5+ and 132 cases with the RapidSTAT®. Altoget-
her 221 subjects were tested. In addition, a reference OF sample was collected. Devices were evaluated ac-
cording to manufacturer cut-oﬀs and DRUID cut-oﬀs used in the project. Manufacturer cut-oﬀs for the
DrugWipe® 5+ and RapidSTAT® devices respectively were, for example, 50 ng/ml and 25 ng/ml for amphe-
tamines and 30 ng/ml and 15 ng/ml for cannabis. The respective DRUID cut-oﬀs were 25 ng/ml and 1 ng/ml.
Results: 
At manufacturer and DRUID cut-oﬀs both devices showed a relatively high sensitivity for amphetamines,
although the RapidSTAT® was somewhat less sensitive. However, both tests gave some false negative re-
sults at quite high concentrations of amphetamines. At the manufacturer cut-oﬀs for cannabis, the Rapid-
STAT® performed well whilst the DrugWipe® 5+ was relatively poor; however at the DRUID cut-oﬀ neither
device was satisfactory. The benzodiazepine test of RapidSTAT® appears to be at a relatively good level,
although the stated manufacturer cut-oﬀ appears to be high in relation to actual concentrations detected.
Evaluation of the opiates and cocaine tests of either device and for the methamphetamine test of the Ra-
pidSTAT® was not possible. 
Conclusions:
There is still potential for improvement to be made in OF screening for drugs with on-site devices, particu-
larly for cannabis. Despite some false negative tests both devices had a comparatively good sensitivity for
amphetamines. The range of concentrations of these false negative cases was still relatively low compared
to that of true positives, but this does not diminish the concern that cases with such concentrations of am-
phetamines might conceivably be missed by OF screening. 
DRUID disclaimer:
This report has been produced under the project Driving Under Inﬂuence of Drugs, Alcohol and Medicines
(DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework Program.
This report reﬂects only the authors  view. The European community is not liable for any use that may be
made of the information contained therein. 
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Fatally Injured Drivers in Saskatchewan
1988 to 2008
Boase Paul, Trasport Canada
Kwei Quaye, Dr.; Brian Jonah, Dr.
The objective of this project was to merge data collected by Saskatchewan Government Insurance with
data on alcohol use by fatally injured drivers provided by the coroner in order to assess the level of alco-
hol use on various elements of the collision and how these may vary based on licence status or over time
as new laws have been introduced.
Methods: 
Collision records for the 535 fatally injured drivers in Saskatchewan from 1988 to 2008 were identiﬁed.
These records were merged with licence status from SGI as well as outcomes from coroners  inquests.
The resulting database contains information on licence status, environmental, temporal and contributing
factors related to the collision.   Blood Alcohol Concentration Level (BAC) and their licence status were
used to categorize the drivers.  
Results: 
Of the 534 drivers, 333 were reported as having a valid licence for the vehicle they were driving.  A further
138 did not, which could indicate an expired licence or driving a vehicle for which they were not licensed.
The ﬁnal 63 drivers had no licence status found.  Of all the fatally injured drivers, 208 had no alcohol recor-
ded, 19 were reported with alcohol but below the administrative threshold, 16 were over the administra-
tive threshold but under the legal threshold, 291 were over the legal threshold, with 211 of them having a
BAC over 160mg%.  These two variables were used to categorize the drivers to examine the other envi-
ronmental, temporal and contributing factors in the collision.
Conclusion: 
The number of drivers without a valid permit for the vehicle being driven is concerning and requires a
more in depth study to determine if drivers are driving without a licence or driving vehicles they are not li-
censed for.  A number of diﬀerences were found related to the BAC level of the drivers and their licence
status. 
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Combined eﬀects of zolpidem and codiliprane
on simulated driving
Bocca Marie-Laure, INSERM ERI27
JN Amato, ., .; Sullivan Marie, PhD, INSERM ERI27, Caen, France; Magalie Loilier, PhD, INSERM ERI27,
Caen, France; Véronique Lelong-Boulouard, PhD, PharmD, INSERM ERI27, Caen, France; Pierre Denise,
Professor, INSERM ERI27, Caen, France; Catherine Berthel
Objectives:
Elderly people already represent a large part of drivers and the proportion will increase in the future in
most occidental countries. Paradoxically, while insomnia is more frequent with age, most experimental
studies assessing drugs eﬀects are conducted on healthy young subjects. It is well known that the majo-
rity of older adults regularly use several medications. With age, pain and sleep are two of main patholo-
gies. Zolpidem is the ﬁrst hypnotic prescribed in numerous countries. The antalgics are the most
prescribed drugs with around 150 millions of pillboxes per year in France. In previous studies, we have exa-
mined separately the eﬀects of hypnotics and antalgics on driving.  The aim of this study was to evaluate
the eﬀects of the combination of zolpidem taken at bedtime and codoliprane taken at awakening.
Methods:
Sixteen healthy subjects aged 55 to 65 years participated in this cross-over, double-blind, placebo-con-
trolled study. Each subject took, at 11.00 pm the day before each session, a therapeutic dose tablet of zol-
pidem 10 mg or a placebo. At 8.00 am, they ingested a therapeutic dose of codoliprane (codeine 20 mg -
paracetamol 400 mg) or a placebo. Four combinations were also tested: placebo-placebo, zolpidem-pla-
cebo, zolpidem-codoliprane, placebo-codoliprane. Mono-screen driving simulator was used. Subjects per-
formed three driving test one hour after the codoliprane intake: monotonous, urban accident scenarios
and following car tests. Two blood samples were collected during the morning.
Results and conclusion:
Preliminary results on urban driving did not reveal drugs eﬀects. 
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1 to 3 therapeutics doses of codeine/paraceta-
mol did not impair driving performance in mono-
tonous surrounding in healthy young volunteers
Bocca Marie-Laure, INSERM ERI27
Jean-Noel Amato, INSERM ERI27, Caen, France; Sullivan Marie, PhD, INSERM ERI27, Caen, France; Cat-
herine Berthelon, Dr; Magalie Loilier, PhD, INSERM ERI27, Caen, France; Antoine Coquerel, Professor,
INSERM ERI27, Caen, France; Véronique Lelong-Boulouard, P
Objectives:
Epidemiological studies have revealed that drug consumption is suspected to increase the risk of driving ac-
cidents. Among drugs, the association of codeine/paracetamol who is considered one of the most eﬃcient
to ease pain as compared to other analgesics of level II in the WHO classiﬁcation, could decrease vigilance
and thus impair driving performance. 
The aim of the present experiment was to determine the behavioural eﬀect of therapeutic doses of co-
deine/paracetamol on driving and psychomotor performance. 
Methods:
Sixteen healthy volunteers participated in this study. Monotonous driving performance was evaluated after 1
to 3 doses of codeine/paracetamol. The doses of codeine/paracetamol were 20mg/400mg, 40mg/800mg,
60mg/1200mg. The 3 doses were compared to a placebo. Psychomotor function was tested with the Psycho-
motor Vigilance Test (PVT), which is highly sensitive in evaluating sleepiness. Visual analogue scales were
used to assess the subjective feelings in change of mood and in driving performance. 
Results:
Our study did not reveal any eﬀects of codeine/paracetamol doses on the standard deviation of lateral posi-
tion, which is considered as the most sensitive parameter to investigate drugs eﬀects. The other driving
parameters (speed, road exits) were not aﬀected. None of the PVT parameters were impaired. Moreover,
subjective scales did not reveal any alertness decrement.
Discussion/Conclusion:
Up to 3 doses of codeine did not impair the driving behaviour. The lack of a codeine/paracetamol eﬀect in
driving is supported by the lack of impairment of the vigilance evaluated by PVT and the subjective feelings. 
Our results are in agreement with other studies revealing that analgesics did not appear at risk for driving, in
healthy young subjects. 
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Victorian Impaired Driving Legislation (2000)
and Random Roadside Oral Fluid Legislation
(2004): Theory and Results of 2 Diﬀerent
Enforcement Strategies
Boorman Martin, Victoria Police
Philip Swann, Dr.
Objectives and Methods:
The Parliament of Victoria Final Report Road Safety Committee  Eﬀects of Drugs (Other than Alcohol) on
Road Safety in Victoria  No 28 Session 1996  rejected the traditional 1949 law of the concept of  driving
under the inﬂuence of drugs  which was in the current Road Safety Act and recommended that new laws
be made, to tackle   driving whilst impaired  and secondly  roadside testing  .This presentation presents
the new legislative frameworks that were introduced in 2000 and 2004, the enforcement strategies
which had to be developed and the  results of nine years of implementation. 
Results:
The Road Safety (Amendment) Act 2000 Act No. 14/2000 Parliament of Victoria Melbourne Australia es-
tablished a new law of  driving while impaired by a Drug  and allowed for psychomotor Impairment testing
by Police to decide on whether to take a blood sample from a driver. It also provided for laboratory chemi-
cal tests of the blood sample. The oﬀence was proven when a positive drug result was obtained, subject
to the drivers observed psychomotor impairment being consistent with the scientiﬁcally established im-
pairment characteristics of the positive drug result. The prevalence of the drugs found and the characte-
ristics of the positive drivers in the 1500 prosecutions are presented. 
The 1996 Parliamentary Inquiry had also supported the development in Australia of random urine drug
testing programs both at the place of employment 
and at the roadside. However random roadside urine testing was not supported by the key stakeholders,
but there was support for oral ﬂuid testing and in 2004, Victoria implemented random oral ﬂuid based
per se  legislation for illicit drugs methyl amphetamine and THC the active substance in cannabis. Then 2
years later added MDMA (ecstasy) to this group. The prevalence of the drugs found and the characteris-
tics of the drug positive drivers after more than 100,000 tests are presented.
Conclusions:
The changes in the prevalence of drugs in drivers killed each year, during the last nine years of enforce-
ment of the legislation shows a stabilising of the percentages of drivers killed testing positive to the le-
gislated drugs. The overall numbers of drivers killed during the same period has decreased to a historic
low in 2009. 
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An Evaluation of the Deterrent Value of
Random Breath Testing (RBT) and Random
Drug Testing (RDT) Across Australia
Boorman Martin, Victoria Police
Katherine Owens, Dr.
In 2009, the National Drug Law Enforcement Fund (NDLERF) funded a project to evaluate the deterrent
value of random breath testing (RBT) and random drug testing (RDT) across Australia. The study involved
n=60 depth interviews with drivers who drink alcohol and take drugs, asking them about their drug taking
behaviours, what motivates them to drink and/or drug drive, how eﬀective they perceive law enforce-
ment to be in deterring drink and drug driving, and what strategies they use to avoid police detection.  The
interviews with drug takers were instrumental in developing a survey that was administered to over
n=3,000 Australian drivers who drink alcohol and take drugs.  The research evaluates which activities of
RBT and RDT law enforcement practice have the greatest inﬂuence (deterrence value) on a drivers inten-
tion to drink/drug drive in the future.  The results have signiﬁcant implications for law enforcement best
practice and may help guide interventions aimed at reducing the incidence of alcohol and drugs in traﬃc
crashes 
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Ecstasy Eﬀects on Actual Driving Before and
After Sleep Deprivation
Bosker Wendy, Maastricht University
KPS Kuypers, ., ., .; Silke Conen, Maastricht university, Maastricht, Netherlands; Jan Ramaekers, Dr., Fa-
culty of Psychology and Neuroscience, Maastricht University, Maastricht, Netherlands
Objectives: 
It has been shown that the main psychoactive constituent of ecstasy, 3,4-methylenedioxymethampheta-
mine (MDMA or  ecstasy ), has impairing as well as stimulating eﬀects on driving performance when te-
sted during the day. Since most people who use MDMA take this drug at dance parties and drive home
afterwards when they are sleep deprived, we investigated the eﬀects of MDMA on psychomotor perfor-
mance and driving during and after a night without sleep. 
Methods:
Sixteen recreational MDMA users received single nocturnal doses of 25, 50 and 100 mg MDMA in a rando-
mized double-blind placebo-controlled 4-way cross-over design. Driving performance was assessed at
peak plasma levels and after a night of sleep deprivation using 2 standardized on-the-road driving tests:
the road tracking task and the car-following task. The primary driving parameters were standard devia-
tion of lateral position (SDLP) and time to speed adaptation respectively.
Results:
Results showed that sleep loss produced signiﬁcant driving impairment as evinced by a large rise in SDLP.
Driving performance during MDMA intoxication was not aﬀected in the evening, but was grossly impaired
in the morning after a nigh of sleep loss. Increments in SDLP were equal or larger than those observed
after a BAC of 0.8 mg/ml. Driving performance as a function of MDMA concentrations in plasma yielded
similar results. MDMA concentration ranging 0-100 ng/ml tended to improve road tracking performance
in the evening, but the same concentration range was associated with impairment when measured in the
morning.
Conclusion:  
It is concluded that stimulant eﬀects of MDMA are not suﬃcient to overcome the impairing eﬀects of
sleep loss on psychomotor performance and driving. 
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Methadone, benzodiazepines
and traﬃc accident risk
Bramness Jørgen G., University of Oslo
Svetlana Skurtveit, professor, Norwegian Institute of Public Health, OSLO, Norway; Jørg Mørland, pro-
fessor, Norwegian Institute of Public Health, OSLO, Norway; Anders Engeland, professor, Norwegian In-
stitute of Public Health, BERGEN, Norway
Objectives:
Methadone is one of two major opioid maintenance treatment (OMT) drugs in Norway, and approximately
2000 patients are presently substituted with this drug. Methadone may, as other opioids, acutely result in
psychomotor impairment, but tolerance to this eﬀect appears with regular medication over time. Norwe-
gian OMT patients are thus allowed to drive after a period of stable use over 6 months. Quite a few OMT
patients will however also be co medicated with benzodiazepines, drugs that may cause impairment, wit-
hout total tolerance to these eﬀects over time. The aim of this study was to investigate whether metha-
done substituted OMT patients had an increased traﬃc accident risk and if so, whether this could be due
to co prescribing of benzodiazepines.
Methods: 
Information on prescriptions, road accidents, and emigrations/deaths was obtained from 3 registries
2004-6. Data on people between the ages 18-69 (N = 3.1 million) were linked. Exposure consisted of ever
receiving a prescriptions for methadone. Standardized incidence ratios (SIRs) were calculated by compa-
ring the incidence of accidents in patients receiving methadone with other patients. Among these OMT
patients time exposed to benzodiazepines (clonazepam, diazepam, oxazepam, alprazolam, nitrazepam
and ﬂunitrazepam) was compared to time not exposed to benzodiazepines.
Results:
During the period, 20,494 road accidents with personal injuries occurred, including 26 in which the driver
was ever exposed to methadone. Traﬃc accident risk was increased for these drivers (SIR = 2.4, 95% CI =
1.5 to 3.6). None of the accidents appeared in periods where the patients were also exposed to benzodia-
zepines, but quite a few among those ever receiving benzodiazepine treatment.
Conclusions: 
There was an increased risk of being involved in a traﬃc accident among those receiving prescriptions for
methadone. This increased risk did not seem to be related more to periods of benzodiazepine use. 
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The eﬀects of MDMA (100 mg) and alcohol
(0.5 0), alone and in combination, on
Brookhuis Karel, University of Groningen
J.L. Veldstra, phs student, University of Groningen, Groningen, Netherlands
Objectives : 
Licit and illicit drug use, in particular multiple drug use and drug-alcohol combinations among drivers are
important risk factors in traﬃc. Medicine and drug use are steadily increasing in traﬃc over the years, re-
ason for the EU-project DRUID (Driving under the Inﬂuence of Drugs, Alcohol and Medicines) to give sci-
entiﬁc support to the EU transport policy (White Paper, 2001) by establishing guidelines and measures to
combat impaired driving caused by (combinations of) psycho-active substances.
Methods: 
In the framework of the DRUID-project a study is conducted to assess the eﬀects of 100 mg (±) 3, 4-Met-
hylenedioxymethamphetamine (MDMA, "ecstasy") and alcohol (BAC of 0.5 0), and a combination of the
two, on simulated driving performance. A group of 20 experienced, healthy MDMA-users are administe-
red two doses of MDMA (0 and 100 mg) and two doses of alcohol (aiming at BACs of 0.0 and 0.5 0) accor-
ding to a double-blind, repeated measures, two by two cross-over design.  
Expected Results: 
Driving performance is assessed at three levels: strategical level (general plans), manoeuvring level (con-
trolled action patterns) and control level (automatic action patterns). As usually found, the alcohol aﬀec-
ted performance mainly at the control level, expressed as an increase of the amount of swerving and a
prolonged reaction time to manoeuvres of a car in front. The main negative eﬀect of MDMA is at the ma-
noeuvring level expressed as an increase in the risk a participant is willing to take. For the alcohol-MDMA
combination it is found that the stimulating eﬀects of MDMA moderated alcohol induced eﬀects at the
control level, however, at the same time has led to even greater impairment at the manoeuvring level by
inducing increased risk taking as compared to the placebo conditions. 
Conclusion:
Data from the present experiment conﬁrm the common eﬀects of alcohol and MDMA, as found in earlier
experiments, and indicate the increased risk of the interaction by the two substances. 
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Sex and gender eﬀects in DWI ﬁrst time
oﬀenders: Neurocognitive diﬀerences
Brown Thomas, Douglas Hospital Research Center
Marie Claude Ouimet, Dr, University of Sherbrooke, Longueuil, Canada; LOUISE NADEAU; Martin Le-
page, Dr., Douglas Hospital Research Centre, Verdun, Canada; Jens Pruessner, Dr., Douglas Hospital Re-
search Centre, Verdun, Canada
Objectives:
With male drivers over-represented among DWI oﬀenders,  being male  has been considered a risk factor
for DWI. Nevertheless, the proportion of female drivers involved in DWI convictions and fatalities is incre-
asing. Little is known concerning the underpinnings of female DWI. Previous research suggests that the
trajectory to female DWI may be distinct. In this study, we pursue these strands of evidence by probing
putative neurocognitive mediators of these distinct behavioural patterns. Main hypothesis Male oﬀen-
ders will show more impairment in executive functioning (e.g., planning, problem solving, impulse control)
than female DWI oﬀenders; female oﬀenders will show a more distinct psychosocial pattern of malad-
justment. 
Methods:
92 male and 20 ﬁrst-time female oﬀenders, and 25 controls have been recruited to date, and over-sam-
pling of females continues. Main measures were Connor s Continuous Performance Task (CPT), The Wis-
consin Cart Sort (WCS), the Stroop Colour-Word Task, the Barratt Impulsivity Scale (BIS), and the
Sensation Seeking Scale (SSS), alcohol abuse and psychosocial adjustment measures, and anatomic mag-
netic images of candidate brain structures. 
Results :
Preliminary analyses on the available data indicate signiﬁcantly greater impulsiveness and disinhibition in
male vs. female oﬀenders. Female oﬀenders had greater diﬃculty in sustaining successful cognitive stra-
tegies vs. female non-oﬀenders. Male oﬀenders had more severe alcohol abuse history than female of-
fenders, but current alcohol use diﬀerentiated between female oﬀenders and non-oﬀenders, but not in
the males. 
Conclusions :
These preliminary results suggest that executive functioning deﬁcits play a more important role in male
DWI behaviour, while current alcohol abuse is strongly tied to female DWI. Alcohol-based DWI risk assess-
ment and intervention may be preferentially eﬀective in female DWI, while more focus on self-regulation
deﬁcits and environmental restraint technologies (e.g., interlock) may be needed for male DWI oﬀenders. 
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Readiness to change and help seeking as
mediators of brief intervention action in DWI
recidivists
Brown Thomas, Douglas Hospital Research Center
Background:
Understanding about how psychosocial therapeutics achieve their outcomes is generally wanting. In a
previous randomized control trial (Brown et al., 2010), we established the superiority of Brief Motivational
Interviewing (BMI) over an information and advice intervention (both one session, 30-40 min) in reducing
problem drinking in alcohol abusing driving while impaired (DWI) recidivists over a 12-month follow-up.
Both interventions were associated with improvement. Increasing motivation (or readiness to change)
and the probability of additional help seeking are two integral objectives of Motivational Interviewing
posited to contribute to its impact.
Objectives:
We investigate putative mediators to explain brief intervention outcome. Hypotheses 1) Exposure to
BMI results in enhanced readiness and more help seeking over the information and advice intervention,
and these diﬀerential changes mediate BMI s positive outcomes. 2) Initial readiness moderates meditati-
onal eﬀects. Methods Participants are 182 DWI recidivists with current alcohol abuse problems recrui-
ted from the community and randomly assigned to receive BMI or the information/advice control
intervention. They were followed over a 12-month period for outcome on self-reported and biological me-
asures of excessive drinking.  Readiness to change was measured using the Readiness to Change Questi-
onnaire at baseline and 6-month follow-up. Frequency of psychosocial and health services consumed was
measured at 6-month follow-up. We use both traditional multistep (Baron and Kenny, 1986) and more re-
cent path analytic approaches (Edwards and Lambert, 2007) to test mediation and moderation models.
Results Initial multistep analyses indicated that group assignment did not inﬂuence change in readiness
from baseline to 6-month follow-up. In the control group alone, baseline readiness was signiﬁcantly and
inversely related frequency of risky drinking at 6- and 12-month follow-up. This preliminary result sug-
gests that initial readiness to change is more important to outcome when intervention does not speciﬁ-
cally seek to address it. 
ORAL ABSTRACT
41
Aﬀective disorders and antidepressants:
Comparative eﬀectiveness of newer anti-
depressants on ﬁtness to drive
Brunnauer Alexander, Inn-Salzach-Klinikum Academic Hospital of Psychiatry, Psychotherapy and
Neurology, Department of Neu
Gerd Laux, Prof. Dr., Inn-Salzach-Klinikum, Academic Hospital of Psychiatry, Psychotherapy and
Neurology, Wasserburg/Inn, Germany
Objectives:
Most antidepressants in use are comparable in their therapeutic eﬃcacy but diﬀer concerning their side
eﬀects. So far there is little research available about patients ﬁtness to drive while receiving clinically re-
levant dosages of antidepressants.
Methods:
A sample of 40 depressive inpatients diagnosed according to DSM-IV criteria were randomly assigned to
treatment with either escitalopram (n=20) or reboxetine (n=20). To control for retest eﬀects 15 healthy
controls were examined in the same time schedule. Participants were tested before pharmacologic treat-
ment (t0), and on days 7 (t1) and 14 (t2) with computerized tests related to car driving skills. Data were col-
lected with the Act and React Testsystem (ART 90) and the Wiener-Testsystem (WTS) measuring visual
perception, reactivity, stress tolerance, concentration and vigilance. Additionally patients went through
various risk simulations on a static driving simulator. 
Results:
Patients showed signiﬁcant improvements in most functional domains related to driving skills after 14
days of treatment with newer antidepressants. Especially in concentration, reactivity and stress tole-
rance distinct a clear advantage could be demonstrated in contrast to the untreated phase. Statistically
signiﬁcant diﬀerences between treatment groups could not be shown.
Conclusions:
Data point to an advantage of partly remitted depressive patients under escitalopram and reboxetine in
contrast to untreated patients with respect to driving skills. Results have important implications for risk
calculations within legal requirements. It seems that factors of the illness itself should be considered to a
greater extent than pharmacologic eﬀects, especially in the case of newer, selective antidepressants. 
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Prevalence Measurement Of Sleep Apnea
Syndrome In Neurologic Patients - Prevention
Of Traﬃc Risk
Buettner-Teleaga Antje, Woosuk University
Introduction:
Sleep apnea syndromes (SAS) are common disorders, which are characterized by repeated oropharyng-
eal occlusions repetitive transient reversible upper airway obstructions during the sleep time. Apart from
a multitude of physical complaints, both obstructive sleep apnea syndrome (OSAS) patients and neurolo-
gical patients suﬀer from excessive daytime sleepiness, reduced sustained attention, limited memory
processes and cognitive functions. Among other aspects, such a decline in performance inﬂuences the
persons aﬀected in their ability to drive a car.
The objective of our study was to estimate the prevalence of OSAS and their comorbidities (cardiovascu-
lar diseases; adipositas) in neurological patients and to prevent further traﬃc risk. 
Methods:
Our study was carried out involving neurologic patients (phases C and D at neurological rehabilitation).
During admission to the clinic, these patients were examined neurologically and neuropsychologically and
with a special SBAS Questionnaire. So far, data have been gathered for 89 neurologic patients (49 male;
39 female; mean age: 59.27+/-14.89; Barthel index: 87.76+/-21.33). Patients with negative questionnaire re-
sult were screened with MicroMesam (MAP).
Findings:
Among the 89 patients included in the study, the prevalence of patients with negative questionnaire re-
sult was 82.02% (73). The distribution of these patients was 3 nCPAP treated patient (4.1%), 43 patients
with OSAS diagnosis (58.9%), 14 high risk patients (19.2%), 4 excluded patients (5.5%). 9 patients (12.3%)
couldn´t be evaluated.
79 of 89 examinated patients (88.76%) suﬀered additional under cardiovascular diseases and/or adiposi-
tas: 59 hypertension (66.29%), 2 coronary heart disease (2.25%), 5 myocardial infarction (5.62%), 18 ar-
rhythmia (20.24%) and 50 adipositas (56.18%).
Conclusion:
Our data indicates that there is a causal relationship between OSAS and development of some neurologi-
cal diseases (e.g. stroke, cerebrovascular diseases etc.) and cardiovascular status is an important factor
to reveal OSAS in neurologic patients. So it is very important to research this prevalence for prevention
of traﬃc and driving risk. 
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The Case for RBT in Canada: Balancing Traﬃc
Safety and Civil Liberties in an Advanced
Democracy
Chamberlain Erika, Faculty of Law, University of Western Ontario
Robert Solomon, Professor, The University of Western Ontario, London, Canada
Objective:
Despite signiﬁcant legislative reforms (particularly in the provinces), increased penalties, expanded reme-
dial programs, and awareness campaigns, Canada has one of the worst impaired driving records among
comparable democracies. Millions of Canadians continue to drink and drive, because they can do so with
little fear of being apprehended, let alone charged or convicted. The purpose of this paper is to examine the
case for and challenges to implementing random breath testing (RBT) in Canada.
Methods:
This paper reviews Canada s recent impaired driving record, charge and conviction rates, and the persi-
stence of impaired driving. It then reviews the impact that RBT programs have had in comparable coun-
tries. Finally, it examines whether the enactment of RBT would be upheld under Canada s Charter of Rights
and Freedoms.
Results:
Canada has made little progress in reducing impaired driving deaths since the late-1990s. The technical,
time-consuming nature of enforcement has discouraged police from laying criminal charges. This helps to
explain why 2006 Canada s charge rate per 100,000 licensed drivers was less than 38% that of the United
States.
Faced with similar challenges, Australia, New Zealand, Ireland and most EU countries have introduced RBT
programs. RBT has been shown to signiﬁcantly reduce impaired driving deaths and injuries.
Proposals to enact RBT will inevitably generate claims that it violates the rights of drivers under the Char-
ter. Similar arguments have been raised in opposition to RBT in other countries. We will demonstrate that
RBT is compatible with the existing Charter case law involving traﬃc legislation, and border and airline se-
curity.
Conclusion:
In the absence of RBT, Canada will continue to lag behind the world leaders in reducing impaired driving de-
aths and injuries. Experience in other countries indicates that RBT is a minimally intrusive, cost eﬀective
and publicly accepted impaired driving countermeasure. Moreover, RBT is compatible with the Charter. 
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Current Criminal and Administrative Vehicle
Forfeiture Provisions in Canada: The Need for
an Eﬀective Program
Chamberlain Erika, Faculty of Law, University of Western Ontario
Robert Solomon, Professor, The University of Western Ontario, London, Canada
Objectives:
Canada s Criminal Code and various provincial statutes contain provisions that could theoretically allow
for the forfeiture of vehicles driven by repeat impaired or unlicensed driving oﬀenders. However, to date,
those programs have been underused and relatively ineﬀective. The purpose of this paper is to identify
the reasons why these forfeiture programs are not used on a more widespread basis, and to propose a
more practical model.
Methods:
This paper reviews the relevant legislative provisions and identiﬁes the legal and practical impediments
to their eﬀective implementation. It then proposes a model that is based on administrative, rather than
court-based, procedures.
Results:
Currently, the various forfeiture programs in Canada largely depend on court-based procedures. For in-
stance, Ontario s recent Civil Remedies Act, 2001 requires that procedures be commenced by the Attor-
ney General in the Superior Court of Justice. These procedures are time-consuming and cumbersome, and
provide judges the discretion to refuse forfeiture if it is  not in the interests of justice.  Accordingly, their
use in impaired or unlicensed driving cases has and will likely continue to be very limited.
As an alternative, we propose a model that is based on administrative procedures, and implemented by
police and licensing authorities. It would operate much more immediately than court-based programs,
thereby minimizing the chance that the oﬀender will sell or transfer title to the vehicle in the interim. The
forfeiture program could be tied to the existing impoundment programs in the provinces, with forfeiture
being used as a sanction against drivers with multiple vehicle impoundments. 
Conclusion:
Drivers who commit multiple impaired or unlicensed driving oﬀences have demonstrated that they are
unwilling to be bound by existing licence provisions, and often have limited or no third-party liability insu-
rance. Given the physical and ﬁnancial risks posed by these drivers, a more widespread forfeiture pro-
gram is justiﬁable. 
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Drugs and Driving in Spain
Colas Monica, DGT
Juan Carlos González Luque, Medical Adviser, DGT, Madrid;
Javier Álvarez, Dr, Universidad de Valladolid, Valladolid, Spain
Aims:
Main aim: to calculate prevalence of driving after psychoactive substance use in vehicle drivers on
Spanish roads. Secondary aims: to characterize socio-demographic proﬁle of drivers who consume sub-
stances.
Spain is one of the participants in the DRUID project carrying out an epidemiological study through a road
side survey.
Methodology:
Target population: motor vehicle drivers using public roads, both rural and urban. The sample population
was made up of recruited drivers from 32 diﬀerent areas (municipalities) chosen at random using a syste-
matic random sampling in size-population strata (<20,000; 20,000-100,000; 100,001-500,000 and
>500,000 inhabitants) and geographical criteria (Cantabria, North, Mediterranean and South).
Four control points were selected for each municipality (a total of 128 control points on a national level) in
order to improve the studys representativeness and to reduce the controls  predictability. Four daily and
weekly periods were established for the control sessions. The selection of the case (driver) in each ses-
sion was done at random in accordance with the inclusion and exclusion criteria established in
the study. The police oﬃcers stopped drivers on a random basis, depending on the saturation of the con-
trol point. Controls were mandatory. Two biological saliva samples and one of breath were obtained from
the participating drivers.
Results:
The ﬁeld work was carried out from September 2008 to August 2009. 731 sessions were done and 3.407
cases were recruited with a rejected rate of 1.9% and a 97% of valid samples. Rejected cases didn t show
any speciﬁc distribution for independent factors.
Sample has been adjusted with risk exposure (traﬃc volume in each of the 128 points selected). Two diﬀe-
rent cut oﬀs have been taking into account: DRUID-agreement cut-oﬀ and laboratory cut-oﬀ.
Conclusions:
This study will contribute to improve knowledge about drugs and driving problem in Spain and could sti-
mulate policymakers and politicians for develop enforcement strategies and public conscience about
psychoactive drugs and traﬃc risks.
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Multidimensional arousal-seeking model of
ﬁrst-time DWI oﬀenders: a neurobiological
mechanism explaining a high-risk behaviours
pathway
Couture Sophie, Douglas Mental Health University Institute
Thomas Brown, Dr., Douglas Hospital Research Center, Montreal, Canada; Serge Brochu, University of
Montreal, Montréal, Canada; Christina Gianoulakis, Douglas Mental Health University Institute,
Montréal, Canada
Our research team recently showed a negative association between hypothalamic-pituitary-adrenal
(HPA) axis response to stress and driving-while-impaired (DWI) convictions frequency. The neurobiology
of DWI recidivism has been neglected in the literature. This is unfortunate since HPA axis dysregulation is
related to risk-taking behaviour, criminality and excessive drinking, all characteristics correlated to reci-
divism. The signiﬁcant heterogeneity of ﬁrst-time DWI (fDWI) population makes detection of high-risk of-
fenders diﬃcult. We investigated whether HPA axis dysregulation could underpin a multidimensional
framework for distinguishing a high-risk subgroup. Arousal-seeking theory explains the association bet-
ween low arousal and antisocial behaviours with two assumptions: sensation seeking and fearlessness.
Objectives Accordingly, our ﬁrst hypothesis is that HPA axis response will be negatively correlated to
high-risk behaviours (i.e. traﬃc safety attitude, traﬃc infractions, criminal behaviours and standard drink
consumed per day). Secondly, we expect to identify a mediational model, with HPA axis explaining experi-
ence seeking (ES) variance which then mediates high-risk behaviours. Methods 100 fDWI oﬀenders will
answer to the Sensation Seeking Scale form V, Questionnaire Analyse des Comportements Routiers, Ad-
diction Severity Index, and Timeline Follow-Back procedure. Results Preliminary non-parametric analyses
among 26 oﬀenders showed that HPA axis response to stress was solely correlated (Spearman) to ES (R2
= -0.28, p = 0.005) and criminal behaviours (R2 = -0.15, p = 0.050). ES was correlated to traﬃc safety atti-
tude (R2 = 0.21, p = 0.02) and number of standard drinks per day (R2 = 0.28, p = 0.005). Conclusion Our ﬁrst
hypothesis was partly supported as we uncovered a signiﬁcant negative correlation between HPA axis re-
sponse and criminal behaviours. For our second hypothesis, both direct and indirect meditational relati-
onships between HPA axis, ES and the high-risk behaviours may be at work. Such preliminary analyses are
promising, and our hypotheses will be more completely tested in the complete sample. 
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Road traﬃc accidents vis-à-vis substance use
in India
Das Ashis, Public Health Specialist
Ashis Das, Dr, Public Health Specialist, India
Road traﬃc accident (RTA) is one of the emerging public health challenges in India contributing 10 deaths
per 100,000 population. With only 1% of the world s motor vehicles, it is the leading country in the world
accounting for 6% of the total global RTA deaths. Every 4.5 minutes a person dies due to RTA in India. Du-
ring the decade 1995-2005, RTAs have increased by 25%, whereas there is an upsurge in injuries by 44%
and deaths by 34%. RTAs contributed to 78% of deaths due to injury, major cause of mortality for young
adults of less than 45 years, disability to 2 million people, and economic loss of USD 12.5 billion (3% of
GDP) during the last two years. The burden varies from setting to setting depending on infrastructural ca-
pacity, law enforcement and behavioural pattern.  
Major causes for RTA are speeding, drunk driving, and improper planning of highways and roads. Indepen-
dent assessments attribute 11-40% of the accidents to alcohol inﬂuence. The per capita alcohol consump-
tion is 1 litre with an increasing trend over then years. There have been no studies on the impact of other
substances on road accidents so far. The legal limit for alcohol is 0.03 g/dl. Random assessments across
the country show alcohol inﬂuence on both vehicle riders and pedestrians. However, the enforcement is
sporadic and limited to random breath testing only in a few cities and nearby highways.  
The information related to RTA are collected by the local police, which later on gets compiled at the crime
records bureau and transferred to the transport department. The police do not have adequate training on
traﬃc conditions or injury epidemiology leading to erroneous reporting. 
India needs in-depth research to bring in the evidences and various dimensions of diﬀerent substances on
RTAs across the country. A separate policy is essential to ensure convergence among diﬀerent depart-
ments and entities on substance use vis-a-vis RTAs. Law enforcements need to be context speciﬁc with
the participation of community level organizations for awareness and compliance. The systematic collec-
tion of information and capacity building of the various agents involved should strengthen the surveil-
lance system. 
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Empirical basis for adopting a theory-driven
approach to preventing alcohol and other drug
(AOD) impairment: implications for traﬃc safety
Davey Tamzyn, Queensland University of Technology
Objectives:
Forty percent of all work place deaths are transport related.  A State-based industry in Australia is in the
process of developing a programme to prevent AOD impairment in the workplace. Preventing AOD im-
pairment is important in this industry because the majority of its employees operate large machinery and
or vehicles. The objective of this study was to determine whether the Theory of Planned Behaviour can
help explain the mechanisms by which behaviour change occurs with regard to AOD impairment. 
Method:
A survey of 1165 employees of a State-based industry in Australia was conducted, and a response rate of
98% was achieved. The survey included questions relevant to the Theory of Planned Behaviour: behavi-
our; behavioural intentions; attitude; perceptions of social pressure; and perceived behavioural control
with regard to workplace AOD impairment. 
Findings:
Less than 3% of participants reported coming to work impaired by AODs. Fewer than 2% of participants
reported that they intended to come to work impaired by AODs. The majority of participants (over 80%)
reported unfavourable attitudes toward AOD impairment at work. Logistic regression analyses suggest
that, consistent with the theory of planned behaviour: attitudes, perceptions of social pressure, and per-
ceived behavioural control with regard to workplace AOD impairment, all predict behavioural intentions
(P < .001); and behavioural intentions predict (self-reported) behaviour regarding workplace AOD impair-
ment  (P < .001).  
Conclusions:
The Theory of Planned Behaviour appears to assist with understanding the mechanisms by which behavi-
our change occurs with regard to AOD impairment in the workplace. An occupational AOD programme
which targets those mechanisms for change may improve its impact in preventing workplace AOD impair-
ment, and reduce AOD-related injury and road traﬃc crashes. 
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Deterring Drug Drivers: A Study into the Initial
Impact of Oral Random Roadside Drug Testing
in Queensland
Davey Jeremy, CARRS-Q, QUT
James Freeman, Dr, CARRS-Q Queensland University of Technology, Kelvin Grove, Australia; Gavan
Palk, Dr, CARRS-Q, QUT, KELVIN GROVE, Australia
Objective:
The global implementation of oral random roadside drug testing is relatively limited, and correspondingly,
the literature that focuses on the eﬀectiveness of this intervention is scant.   This study aims to provide a
preliminary indication of the impact of roadside drug testing in Queensland.
Methods:
A sample of Queensland motorists  (N= 922) completed a self-report questionnaire to investigate their
drug driving behaviour, as well as examine the perceived aﬀect of legal sanctions (certainty, severity and
swiftness) and knowledge of the countermeasure on their subsequent oﬀending behaviour.  
Results:
Analysis of the collected data revealed that approximately 20% of participants reported drug driving at
least once in the last six months.  Overall, there was considerable variability in respondent s perceptions
regarding the certainty, severity and swiftness of legal sanctions associated with the testing regime and a
considerable proportion remained unaware of testing practices.  In regards to predicting those who inten-
ded to drug driving again in the future, perceptions of apprehension certainty, more speciﬁcally low cer-
tainty of apprehension, were signiﬁcantly associated with self-reported intentions to oﬀend.
Additionally, self-reported recent drug driving activity and frequent drug consumption were also identi-
ﬁed as signiﬁcant predictors, which indicates that in the current context, past behaviour is a prominent
predictor of future behaviour. To a lesser extent, awareness of testing practices was a signiﬁcant predic-
tor of intending not to drug drive in the future.  
Conclusion:
The results indicate that drug driving is relatively prevalent on Queensland roads, and a number of factors
may inﬂuence such behaviour.  Additionally, while the roadside testing initiative is beginning to have a de-
terrent impact, its success will likely be linked with targeted intelligence-led implementation in order to
increase apprehension levels as well as the general deterrent eﬀect. 
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The introduction of saliva roadside
drug testing in Belgium
De Boeck Gert, NICC
Sarah Wille, Dr, NICC, Brussels, Belgium; Nele Samyn, Dr, NICC, Brussels, Belgium
In June 2009 the Belgian parliament voted an amendment of the law of 1999 on driving under the inﬂu-
ence of certain illegal drugs. The revision of the law was based on the increased scientiﬁc knowledge and
progress of the last decade in the ﬁeld of the detection of drugs of abuse in saliva. The former procedure
consists of a time consuming test battery, which is possibly followed by a urine test and a subsequent
blood test.
The revised procedure also contains three steps but is less time-consuming and more practical.
On the basis of a checklist it is examined whether there are signs that could indicate recent drug use.
Tests like walking on a line and ﬁnger-to-nose are excluded. If the checklist indicates signs of recent drug
use, an onsite saliva test is performed. A positive saliva test is continued by the collection of a saliva sam-
ple which is analyzed in the laboratory. Only if the analysis result of the collected sample demonstrates
that the concentration of a certain drug exceeds a ﬁxed concentration, the driver will be sanctioned for
driving under the inﬂuence of drugs. Following substances are taken into account by mass spectrometric
analyses: THC (10 ng/ml), amphetamine (25ng/ml), MDMA (25ng/ml), morphine or 6-acetylmorphine
(5ng/ml) and cocaine or benzoylecgonine (10 ng/ml).
The revised legislation will be applicable in October 2010 and has an increase of the number of roadside
tests as an objective. 
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Alcohol availability and DUI  in a driver
probabilistic sample from Porto Alegre,
southern Brazil: preliminary ﬁndings
De Boni Raquel, UFRGS- HCPA
Mauricio Vasconcellos, IPEC-FIOCRUZ, Riuo de Janeiro, Brazil; Francisco Bastos, ICICT-FIOCRUZ, Rio de
Janeiro, Brazil; Flavio Pechansky, Dr., Center for Drug and Alcohol Research, UFRGS, Porto Alegre, Brazil
Background:
Brazil has 35,000 traﬃc accidents (TA) deaths /year and almost 40% of fatal TA victims in Porto Alegre
had positive Blood Alcohol Concentration (BAC). Literature shows that drinking at on-premises outlets
may increase DUI chance. 
Aim:
To compare DUI prevalence and risk factors in a sample of drivers who leave pubs from high and low alco-
hol outlets (AO) concentration areas of Porto Alegre. 
Method:
Census enumeration areas (CEA) with high (S1) and low (S2) concentration of alcohol outlets were identi-
ﬁed using geoprocesing and statistical spatial analysis. A driver probabilistic sample was selected in 3
phases: 1) CEA with probability proportional to size (PPS- AO number), stratiﬁed in S1 and S2; 2) AO and
time period (PPS based on time lag); and 3) drivers (inverse sampling with the screening of every adult
who left AO). Selected drivers were interviewed, breathalized, and had saliva tested for drugs when they
left the premises.
Results:
3018 subjects were approached, and 2023 met inclusion criteria. S1 had more women (36% x 25%, p<0.05)
and higher DUI prevalence (29% x 24%, p<0.05). Among those who were drinking (n=1070), we intervie-
wed everyone who would drive in the next 60 min (n= 499, male 76%, 37.2 y) and one fourth of those who
would not (n=183, male 64.2%, 37.7 y). Drivers who were drinking on S2 were less educated, had higher
AUDIT scores and lower risk perception. There was no diﬀerence on BAC and drug use between S1 and S2.
Conclusions:
Geoprocessing is a key tool in the assessment of DUI risk factors and policymaking. There are signiﬁcant
diﬀerences between the characteristics of drivers from high and low AO density areas of the city, as well
as in DUI prevalence. Law enforcement activities should prioritize speciﬁc areas of the city in order to
better use limited resources 
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Misuse And Abuse Of Urine Sampling
For Alcohol In The United Kingdom
Denney Ronald Colin, Dr. Ronald C. Denney & Co.
Objectives:
Drink-drive legislation in the United Kingdom includes provision of urine samples for alcohol analysis in
certain circumstances.  The purpose of this study has been to consider recent analytical results obtained
in the UK from urine samples obtained from drink-drivers and to assess their validity in the light of the re-
quirements of the various Acts of Parliament since 1962.  Where urine is requested the law requires two
separate urine samples to be provided within a set period of time.  This paper considers the procedures
used for obtaining these two samples and their suitability for analysis.
Methods:
An initial assessment is made of the criteria that are required in order to obtain reliable urine samples.
This paper explains the procedures used and cites instances in which the integrity of urine samples and
their analytical results have been undermined by procedures adopted by police oﬃcers which circumvent
the scientiﬁc principles which underpin the basis of urine sampling for this purpose.
Urine alcohol values have been collected at random over twelve months from various police forces
around the country and these have been examined to determine the procedures followed and the time
factors involved in the provision of two urine samples.
Results:
The study has shown that police procedures for obtaining urine samples vary greatly and are often car-
ried out  in a manner intended to get the process over as rapidly as possible.  Because of this prosecutions
are sometimes discontinued due to short cuts having been taken.  In other cases prosecutions are suc-
cessful even if the time interval between the two urine samples is too short for truly separate urine sam-
ples to have been provided.  Examples are given of these cases and of the limited time periods involved in
the urine sampling.
Conclusions:
The results of this study show that the legal requirement for the provision of urine samples in the UK is
badly expressed in law.  As a result the law is open to abuse to the extent that it does not satisfy basic cri-
teria for the provision of reliable urine samples suitable for analysis that are representative of the body
alcohol content at the time the urine sample is provided.  In this respect the law in the UK requires rewri-
ting. 
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SPEED-02: On the eﬃciency of a psychological
rehabilitation
DeVol Don, TÜV Thüringen Fahrzeug GmbH & Co. KG
Georg Rudinger, Prof. Dr., University of Bonn, Bonn, Germany; Norbert Hilger, Dr., University of Bonn,
Bonn, Germany
In 1998 the RWTÜV developed the psychological rehabilitation program SPEED-02 (Safety by Prevention:
Experience with and Engagement against Drugs) for drivers who have been identiﬁed as cannabis and/or
amphetamine consumers (Sulzbach & DeVol, 2002). SPEED-02 is based on the concepts of cognitive be-
haviour therapy and aims at the reﬂection of the individual drug history. The goal is to develop and esta-
blish alternatives to drug consumption in everyday life in order to reduce the probability of a DWI-relapse.
Methods:
Within an initial Medical-Psychological Assessment (MPA) it is decided whether the driver is potentially
able to assess his personal drug history and to eventually give up drug-consumption. The rehabilitation
program takes place during a period of 28 weeks and consists of three phases. A trained psychologist su-
pervises the whole course, which includes 8 sessions with 22 hours.
The evaluation study was conducted during 2002-2008 following the guidelines of the Bundesanstalt für
Straßenwesen (BASt, 2002). Altogether 500 participants were tested by means of a questionnaire two
times within the course and interviewed by telephone 3 years after the program. In addition, the psycholo-
gists were asked to evaluate the compliance and change-motivation. The relapse-quotient of the partici-
pants was calculated over a 3-year period and tested against a comparable group of clients who were
evaluated positively within the initial MPA.
Results:
(1) The analyses of the questionnaire data revealed that the program was successful. (2) There was a high
acceptance of the program and the rate of abstinent participants was reasonably high. (3) The psycholo-
gists evaluated their clients positively. (4) The relapse-quotient was almost as low as that of the control-
group.
Conclusions:
Altogether the results support the assumption that SPEED-02 is highly eﬃcient in reducing the probabi-
lity of a DWI-relapse. But additionally the MPA can also be regarded as an important traﬃc safety mea-
sure within the German legal system. 
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The Role Of Psychoactive Drugs On High Way
Safety
Ehikhamenor Edeaghe, UNIBEN/SAVAN
Hope Obianwu, Prof, University Of Benin, Benin City, Edo State
Introduction:
Publication by World Health Organization (WHO) in collaboration with World Bank and Harvard university
as at 1999 on  Global Burden of Disease  revealed that out of 100 diseases globally, road traﬃc acci-
dent(RTA) ranked 9th in terms of mortality with forecast that by 2020 it would rise to 3rd position unless
something is done urgently to remedy the trend.  The role of screening road users for psychoactive sub-
stances is  to act as deterrent and evident based scientiﬁc fact to prosecute oﬀenders and legislate
against impaired driving. Nigeria as one of the low motorized country with high rate of RTAs due to alco-
hol and psychoactive drugs based on anecdotal report will therefore beneﬁt from screening of substance
of abuse.
Methods:
An immunoassay digital oral screen portable machine was used along side that of multi-drugs urine scree-
ning tools for selected participants. Biological ﬂuids such as blood, saliva and urine was screened. . Total
population of 1725 were screened with the use of these digital screening tools.  Conﬁrmatory test was
done with modiﬁed GC-MS-method.
Result:
The oral screen pre-crash results showed that participants that used cannabis, cocaine, amphetamine
were present as follow; 23.65%, 4.50% and 2.45% respectively, while urine screening  was positive as fol-
low, cannabis, amphetamine, cocaine  19.56%, 2.65% and 2.15% respectively. Males were predominantly
more prone to use psychoactive drugs than females in ratio of 6.5;1,while age incident showed that age
group20-30 were the highest incidence of drug abuse that were more likely to drive under the inﬂuence of
drugs.  Post-crash results showed that cannabis is more implicated than other psychoactive drugs
with&exception of  alcohol .
Conclusion:
The ﬁndings here conﬁrm incidence of impaired driving in Nigeria with use of several psychoactive drugs.
The use of new digital screening will certainly enhance safety on the highways. 
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The use of alcohol interlocks in EU Member
States and the role of EU as a regulator
Eksler Vojtech, European Transport Safety Council (ETSC)
Deaths from road crashes associated with the illegal BAC level have been decreasing at the same pace as
non-alcohol related deaths in Europe since 2001 and still represents up to 25% of annual road toll in the
EU. But great diﬀerences exist between EU countries in the rates the alcohol related road deaths have
been decreasing in past years as shows the results from the recent ETSC study. 
Beside traditional methods used to hinder drunk driving, some European countries have recently introdu-
ced a legislation paving a way towards the use of alcohol interlocks, as the ultimate measure to prevent
drink driving.  This paper provides an overview of the usage of alcohol interlocks in EU Member States. It
further looks at the existing and future EU regulatory framework for hindering drunk driving. A special at-
tention is given on the role of alcohol oriented regulations provided for in the new EU Road Safety Action
Programme being published this summer. 
A unique role of the EU in raising standards for alcohol interlocks across Europe and promoting their use
in Member states is highlighted. Besides, a new light is shed on the role of employers, insurance compa-
nies and health sector in the implementation of alcolock oﬀenders programmes. 
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Trends in impaired driving in Australia in 2010:
A status report
Faulks Ian, Safety and Policy Analysis International and Department of Psychology,
Macquarie University
Julia Irwin, Dr, Macquarie University, Macquarie University NSW , Australia; Barry Watson, Dr.;
Mary Sheehan, Professor, CARRSQ, Australia
This paper reviews the status of alcohol, drugs and traﬃc safety in Australia, with particular emphasis on
developments in the period 2008-2010. Australian jurisdictions have made impressive improvements in
road safety since the early 1970s. Enforcement and public education campaigns that speciﬁcally target
drink driving have been successful, with resultant long-term reduction in alcohol-related fatalities. There
is a high level of community disapproval of drink driving and strong support for countermeasures. Many
best-practice countermeasures targeting impaired driving are in place, including general prevention/ de-
terrence programs such as random breath testing (RBT), random roadside drug testing legal alcohol li-
mits, responsible service of alcohol programs, public education and advertising campaigns and
designated driver programs, and oﬀender management programs such as driver licensing penalties and
ﬁnes, alcohol ignition interlocks and vehicle impoundment for high risk drink drivers, and oﬀender educa-
tion programs. There continue to be enhancements occurring, particularly in the areas of drug-impaired
driving and oﬀender management, but also in addressing the fundamental policy and legislative fram-
ework to address impaired driving (e.g., a current national debate about lowering the permissible blood
alcohol for all drivers from 0.05 to 0.02 or 0.00 gm/100 ml BAC). However, there are major challenges that
may be impacting on programs targeting impaired driving, including the rapid development of a binge
drinking culture among young Australians, the extension of trading hours of licensed premises, continued
problems with secondary supply of alcohol to minors, and increases in the marketing of alcopops and
ready-to-drink spirit-based beverages. This paper addresses the question: Are impaired driving counter-
measures in Australia continuing to achieve reductions in road traumas and rates of oﬀending, or are they
plateauing? If they are plateauing, is this due to declining eﬀectiveness of countermeasures or the need
to  hold the line  against societal inﬂuences encouraging impaired driving? 
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Phosphatidylethanol molecular species in
heavy and social drinkers
Favretto Donata, University of Padova
Guido Viel, Dr., Forensic Toxicology - University of Padova, Padova, Italy; Alessandro Nalesso;
Giovanni Cecchetto, University of Padova, Italy; Massimo Montisci, Prof., Forensic Toxicology
- University of Padova, Italy; Davide Mioni, Dr., Parco dei Tigli
Objectives:
Phosphatydilethanol (Peth) is a group of abnormal phospholipids formed in cell membranes, in the pre-
sence of ethanol, by the catalytic action of the enzyme phospholipase D on phosphatidylcholine. Recently
published literature has demonstrated the existence of several molecular species of Peth in alcohol de-
pendent subjects. 
The aim of this study was to evaluate the concentration of Peth molecular species in blood collected from
heavy and social drinkers through a liquid chromatography-high resolution mass spectrometry (LC-
HRMS) method.
Methods:
Chromatography was performed on a C18 column using acetonitrile, ammonium acetate, and 2-propanol
as mobile phases. HRMS experiments were performed on an LTQ-Orbitrap mass spectrometer equipped
with an electrospray ionization (ESI) source operated in negative ion mode (resolution of 30000). 
The identiﬁcation of Peth species was performed by searching the expected theoretical masses of the
targeted compounds (with a maximum mass tolerance of 3 ppm) in the acquired full-scan LC-HMRS chro-
matogram. The LC-HRMS method was utilized for the quantitative proﬁling of Peth homologues in blood
samples of heavy (n = 11) and social drinkers (n = 11).
Results: 
More than 20 diﬀerent Peth molecular species were identiﬁed and quantiﬁed in blood collected from
heavy drinkers (the mean concentration of each species ranging from 0.001 to 3.000 μM). For the ﬁrst
time, Peth 18:1/18:1 and 16:0/18:2 were quantiﬁed also in blood collected from social drinkers with a daily
alcohol intake of about 20-30 g (mean Peth concentrations ranging from 0.001 to 0.100 μM). 
Conclusions:
The identiﬁcation of Peth homologues also in social drinkers raises the question on which molecules
should be used to diagnose a harmful drinking and whether an interpretative cut-oﬀ might be utilized for
each molecular species or for a combination of homologues. 
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Genetic susceptibility to alcohol drinking and
abuse in drunk-drivers
Favretto Donata, University of Padova
Massimo Montisci, Prof., Forensic Toxicology - University of Padova, Italy
Objectives:
This study focuses on the identiﬁcation of genetic characteristics involved with alcohol metabolism, as
susceptibility  factors to alcohol abuse and dependence. Our hypothesis is that genetic variants of key en-
zymes in alcohol metabolism may inﬂuence alcohol drinking behaviour and abuse. In particular the functi-
onal polymorphisms of alcohol dehydrogenase [ADH1B (rs1229984) and ADH1C (rs698)], and the
mitochondrial aldehyde dehydrogenase [ALDH2 (rs671)] genes were examined.
Methods:
The study population, all Caucasian males living in North-East Italy, consisted of 150 drunk-driving traﬃc
oﬀenders recruited after an accurate evaluation of their "alcohol abuse/dependence" history with Alco-
hol Use Disorders Identiﬁcation Test (CAGE and AUDIT) questionnaires, and 282 social drinkers as con-
trols. For each of them a questionnaire on alcohol intake, on exposure to genotoxins with smoke, diet,
indoor and outdoor conditions, and data of conventional biomarkers of alcohol [serum ?-glutamyltrasfe-
rase (GGT), carbohydrate-deﬁcient transferring (CDT), aspartate and alanine aminotrasferase (AST and
ALT) and mean corpuscular volume of erythrocytes (MCV)] were collected. Genotype analyses were per-
formed by PCR on DNA from blood.
Results:
We found that the protective ADH1B*2 polymorphism, metabolizing ethanol up to 100 times quicker than
the common ADH1B*1, was signiﬁcantly more frequent in controls than drunk-driving traﬃc oﬀenders
(13% vs. 4% OR 0.29, 95% CI:0.14-0.56), alcohol intake being equal in the two groups. No diﬀerences for
the other variants were detected. Moreover subjects (both drunken drivers and controls) with this functi-
onal polymorphism drank signiﬁcantly less than those with the unfavourable ADH1B*1 (p < 0.001).
Conclusions:
The results indentify in ADH1B *1/*2 a polymorphism that inﬂuences both alcohol drinking and abuse. Mo-
reover this study suggests that people exhibiting the presence of this variant ADH1B*1 could be at higher
risk than controls for drinking and driving disability. 
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Minimum Legal Drinking Age 21 in the United
States: Why It is an Eﬀective Policy
Fell James, Paciﬁc Institute for Research & Evaluation
The United States (US) Congress enacted the National Uniform Drinking Age 21 Act in 1984 to protect the
health and safety of the public. The experience of other countries that have tried lowering the drinking
age show that the federal government s decision was a wise one. In 1999, New Zealand lowered its drin-
king age from 20 to 18. The result, according to a recent study, was a dramatic increase in automobile cras-
hes. The rate of traﬃc crashes and injuries to 18- and 19-year-old males increased 12 percent and
increased 14 percent for males aged 15 to 17. For females, the eﬀect was even greater rates increased 51
percent for 18- to 19-year-olds and 24 percent for 15- to 17-year-olds.  If the minimum drinking age is lowe-
red to 18 in the United States (U.S.), the result will be greater availability of alcohol not only to 18-20 year
olds but also to those younger than 18. Studies in the U.S. have shown that lowering the drinking age to 18
also increases alcohol-related crashes for 15- to 17-year-olds. 
European countries are often held up as examples of where liberal drinking age laws and attitudes result
in responsible styles of drinking by young people. U.S. adolescents show a moderate rate of intoxication
(18%) compared with their European peers, and one that is substantially lower than in most other coun-
tries. Minimum Legal Drinking Age (MLDA 21) laws save approximately 800-900 lives each year in reducti-
ons in traﬃc fatalities involving young drivers. Medical research shows that excessive drinking by youth
aged 20 and younger may cause brain damage as well as reduce brain function. Early onset of drinking be-
fore age 21 increases the risk for future alcohol abuse, automobile crashes, and assaults, among other al-
cohol-related problems. 
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An Evaluation of Three Intensive Supervision
Programs for Serious Driving-While-Intoxicated
Oﬀenders in the United States
Fell James, Paciﬁc Institute for Research & Evaluation
A. Scott Tippetts, Senior Statistician, PIRE, Calverton, United States; A. Scott McKnight, Senior
Program Manager, PIRE, Calverton, United States; Connie Wiliszowski, Research Scientist, Bedford
Research, Bedford, United States
There are many variations of supervision and probation programs for convicted driving-while-intoxicated
(DWI) oﬀenders in the United States (US). Oﬀenders who receive probation through intensive supervi-
sion programs (ISPs) have more contact with probation oﬃcers, a judge, or other designated authorities
compared to standard probation programs. The objective of this study was to determine if three ISPs
were eﬀective in reducing the recidivism of oﬀenders compared to similarly matched oﬀenders not expo-
sed to the ISP programs. The recidivism data for all oﬀenders were analyzed using survival analyses, na-
mely Cox regression models that account for varying exposure periods and swiftness to recidivate. The
survival analyses contrast the ISP groups against comparison groups within the same state while adjus-
ting for all relevant factors such as age, sex, and prior oﬀenses as covariates.
The Minnesota Program had a signiﬁcant 30.6 percent lower recidivism rate (p=.017) up to 4 years post-
oﬀense and prevented an estimated 15 to 23 re-arrests for DWI due to its eﬀectiveness. The Westchester
County program was eﬀective in the short term (18.1% lower recidivism in 5 years post-oﬀense [p<.001])
and resulted in an estimated 78 fewer re-arrests for DWI in the ﬁrst 5 years. The Oregon DISP interven-
tion group had 54.1 percent lower recidivism up to 8 years post-index oﬀense and prevented 67 re-arrests
for DWI in the ﬁrst 8 years. The beneﬁt/cost of ISPs appears to be very good for the prevention of re-ar-
rests. Preventing re-arrest for DWI for multiple oﬀenders saves thousands of dollars in sanctions (jail
time) and rehabilitation. 
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An Evaluation of Three Driving-Under-the-In-
ﬂuence Courts in the United States
Fell James, Paciﬁc Institute for Research & Evaluation
A. Scott Tippetts, Senior Statistician, PIRE, Calverton, United States
It is well known that many repeat driving-under-the-inﬂuence (DUI) oﬀenders have serious alcohol pro-
blems that make it diﬃcult to curb their drinking and driving behaviors. Following the model of Drug
Courts in the United States (US), three DUI Courts in the State of Georgia were designed to address the
underlying alcohol problems of repeat DUI oﬀenders through continuous and frequent judicially supervi-
sed treatment, periodic alcohol and other drug testing, the use of graduated sanctions, and other appro-
priate rehabilitative services. The objective of this study was to determine if oﬀenders assigned to these
DUI courts had lower recidivism rates than similar matched oﬀenders not exposed to the DUI court pro-
grams. Recidivism rates were determined using survival analyses, namely Cox Regression models and Ka-
plan-Meier models that take into account varying exposure periods and time to recidivate.     
The DUI graduates had a signiﬁcantly lower recidivism rate (63.5% lower) (p<.001) than the matched con-
temporary oﬀenders from other counties who completed traditional programs and 79.3 percent lower
(p<.001) than the retrospective oﬀenders from the same counties who would have been eligible for the
DUI Court had it been operating at the time. The recidivism rate for the Terminated Group was 26 percent.
Even when the terminated oﬀenders were combined with the DUI Court graduates, the DUI Court oﬀen-
ders had signiﬁcantly lower recidivism rates: 38 percent lower (p<.001) than the Contemporary Group and
65 percent lower (p<.001) than the Retrospective Group. The recidivism rate for the combined DUI Court
graduates with those terminated was 15 percent over 4year period. It is estimated that the DUI Courts
prevented between 47 and 112 arrests for repeat DUI over the four year period of analysis which saved the
State of Georgia a substantial amount of funding that would have been needed for jail conﬁnement, treat-
ment and probation. 
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Alcohol Involvement in Fatally Injured Drivers
in the United States
Fell James, Paciﬁc Institute for Research & Evaluation
A. Scott Tippetts, Senior Statistician, PIRE, Calverton, United States
The Fatality Analysis Reporting System (FARS) is a census of all fatal crashes (deﬁned as a death of a par-
ticipant within 30 days of the crash event) occurring on United States (US) public roadways and reported
to the police. Alcohol involvement is documented through blood alcohol concentration (BAC) test results
collected by police or coroners. Where such data are not available, the BACs of drivers, pedestrians, and
cyclists are statistically imputed using crash characteristics (such as a police report of driver impairment)
to obtain more complete and accurate alcohol data.
In many countries around the world, it is policy to test drivers killed in traﬃc crashes for alcohol involve-
ment. In 1982, 54% of fatally injured drivers were tested for a BAC in the US. In 2008, 71% of fatally inju-
red drivers were tested for a BAC. Eighteen states tested 85% or more fatally injured drivers for a BAC in
2008. Using the imputation methodology on the 29% of fatal drivers where no BAC test was taken, it was
determined that 38% of fatally injured drivers in 2008 had some alcohol in their system (BAC >=.01 g/dL).
Thirty-three percent (33%) of US fatally injured drivers were at or above the illegal BAC limit
(BAC>=.08g/dL) in 2008. Fifteen percent (15%) had very high BACs (>=.20g/dL). These percentages are a
vast improvement over 1982 when 55% of fatally injured drivers had some alcohol, 49% were at or above
the illegal level (.08) and 22% had very high BACs (>=.20g/dL). However, since 1994, these percentages
have not changed substantially and stagnation in any progress has occurred. Reasons for the decline bet-
ween 1982 and 1994 will be discussed and strategies to further reduce impaired driving in the USA will be
suggested. 
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Acute Disinhibiting Eﬀects of Alcohol
as a Factor in Risky Driving Behavior
Fillmore Mark, University of Kentucky
Automobile crash reports have shown that up to 40% of fatal crashes involve alcohol and that younger
drivers are over-represented among these statistics. The impaired ability to drive under alcohol is usually
attributed to the drug s disruptive eﬀects on motor coordination and the ability to sustain attention. Ho-
wever, there is also growing evidence that alcohol use among young drivers is associated speciﬁcally with
risky driving behaviors which likely contribute to the over-representation of these individuals in alcohol-
related crashes. The ability of alcohol to impair cognitive mechanisms that normally serve to inhibit or
suppress inappropriate actions could account for the association between alcohol use and risky driving
behavior. The results of recent laboratory studies are reviewed that address this working hypothesis.
Studies that model behavioral control are described to show how alcohol impairs the ability to inhibit pre-
potent (i.e., instigated) responses resulting in the display of impulsive and under-controlled behavior. The
research is extended to the study of alcohol eﬀects on simulated driving performance and evidence is
presented to show that some driver impairments might be due to the acute disinhibiting eﬀects of the
drug, especially at low blood alcohol concentrations (i.e., below 0.08%) that are insuﬃcient to disrupt
motor coordination. Personal attributes, situational contexts, and pharmacokinetic inﬂuences are also
examined as factors that might exacerbate the disinhibiting eﬀects of alcohol to further disrupt driver
performance. The presentation concludes with a discussion of how these results highlight the importance
of examining the joint inﬂuence of multiple factors as contributing to impaired driver performance and its
negative impact on traﬃc safety. Other factors, such as impulsivity and conduct disorder, might also be
associated with the tendency to engage in risky driving behaviors while intoxicated and should be investi-
gated in future studies. Research supported by grants R01 AA012895, R01 AA018274, and R21 DA021027
from the National Institutes of Health. 
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Driving under the inﬂuence of alcohol or narco-
tics: An in-depth study with convicted drivers
Forward Sonja, Swedish Road and Transport Research Institute
Objectives:
Through the use of in-depth interviews determine what motivates driver to drive under the inﬂuence of
alcohol and psychoactive substances.
Methods:
In this interview study, thirty persons participated who had driven under the inﬂuence of alcohol or illegal
drugs. All had been convicted and charged by the police. The interviews dealt with the perception of
themselves and others, the risk of being sanctioned and interventions needed to stop the habit of drin-
king and driving
Results: 
Most of the drivers had driven under the inﬂuence of alcohol or illegal drugs on several occasions and
many had also previous convictions. However, the history of drug drivers and drunk drivers were very dif-
ferent, the latter group was living a more normal life, at least on the surface with work and family. For
them losing the license because of DD was seen as something very shameful. Losing the license many
times started a process when they became more aware of their drinking problems and pushed them to
ask for help. In contrast drug drivers had from an early age failed to conform. Many of them had served
long sentences for crimes not necessarily related to driving. Both groups were constantly aware of the
police and had developed strategies to avoid being caught. However, drug drivers were more afraid of
being charged with possessing drugs than drug driving or indeed driving without a licence. They did not
perceive any pressure from others not to drive. The car was important for getting to places and bringing
home stolen goods.
Conclusion:  
Previously convicted drug drivers and drink drivers exhibited a problem behaviour not easily dealt with
and it is suggested that sanctions by the police will not prevent future oﬀences. Instead a more long term
form of treatment is needed. 
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Psychiatric and Substance Abuse Comorbidity
among a Large Sample of DUI Texas Oﬀenders
Freeman James, CARRS-Q Queensland University of Technology
Jeremy Davey, Professor, CARRS-Q, QUT, BRISBANE, Australia; Jane Maxwell, Dr, University of Texas at
Austin, austin, TX, United States
Objective:
Research is indicating that individuals who present for DUI treatment may have competing substance
abuse and mental health needs.  This study aimed to examine the extent of such comorbidity issues
among a sample of Texas DUI oﬀenders.    
Method:
Records of 36,372 DUI clients and 308,695 non-DUI clients admitted to Texas treatment programs bet-
ween 2005 and 2008 were obtained from the State's administrative dataset.  The data were analysed to
identify the relationship between substance use, psychiatric problems, program completion and recidi-
vism rates. 
Results:
Analysis indicated that while non-DUI clients were more likely to present with more severe illicit sub-
stance use problems, DUI clients were more likely to have a primary problem with alcohol.  Additionally, a
cannabis use problem was also found to be signiﬁcantly associated with DUI recidivism in the last year.  In
regards to mental health needs, a major ﬁnding was that depression was the most common psychiatric
condition reported by DUI clients, including those with more than one DUI oﬀence in the past year. This
group were also more at risk of being diagnosed with Bipolar Disorder compared to the general popula-
tion, and such a diagnosis was also associated with an increased likelihood of not completing treatment.
Interestingly, female DUI and non-DUI clients were also more likely to be diagnosed with mental health
problems compared to males, as well as more likely to be placed on medications at admission and have
problems with methamphetamine, cocaine, and opiates.  
Conclusion: 
The ﬁndings highlight the complex competing needs of some DUI oﬀenders who enter treatment.  The re-
sults also suggest that there is a need to utilise mental health and substance abuse screening methods to
ensure DUI oﬀenders are directed towards appropriate treatment pathways as well as ensure that such
interventions adequately cater for complex substance abuse and psychiatric needs. 
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Accident-Proneness Of Dui Oﬀenders In
Treatment With Medications
Giorgetti Raﬀaele, Institute of Legal Medicine, Polytechnic University
Raﬀaele Giorgetti, Professor, Section Of Legal Medicine, Department Of Neurosciences, Marche Poly-
technic University, Ancona, Italy; Franscesco Brandimarti, Doctor, Section Of Legal Medicine, Depart-
ment Of Neurosciences, Marche Polytechnic University, Anc
Objectives:
To study the risk factors for recurrent drunk driving and the generic and speciﬁc risk factors for acci-
dents, with special reference to the role of psychoactive prescription drugs, in subjects whose driving li-
cence has been suspended for driving under the inﬂuence of ethyl alcohol (DUI).
Methods:
A sample of 4634 subjects (91% males, 9% females) aged 16 to 84 years, seeking regranting of their dri-
ving license, was examined at the Legal Medicine Section of the Polytechnic University of Ancona, Italy,
between April 2005 and October 2009. Besides demographic data, information was collected on the num-
ber of previous domestic and work accidents, sports injuries, traﬃc crashes, current use of psychoactive
prescription drugs, and number of DUI suspensions. Blood and urine were analysed for current alcohol
abuse.
Results:
The risk of DUI recidivism seemed to be mainly related to male gender (multivariate adjusted odds ratio
[OR] 2.683); use of antidepressants (OR 1.968); number of every kind of accidents (OR 1.785); marital sta-
tus (separated-divorced-widower: OR 1.694; single: OR 1.347); and serum carbohydrate-deﬁcient transfer-
rin above threshold (CDT: OR 1.303).
The risk of generic adverse events is correlated mainly with use of antiepileptic drugs (OR 2.740) or tran-
quillizers (OR 1.976), and to the number of recidivism in drunk driving (OR 1.726).
Conclusions:
An association was found between use of psychotropic drugs and number of accidents, in line with the im-
paired psychomotor performance known to result from the synergistic action of alcohol and psychoac-
tive prescription drugs. Interestingly, the association was with speciﬁc types of psychoactive
prescription drugs. Analysis of the abundant data collected also provided insights into the main factors
for DUI recurrence, which should be taken into account when examining DUI oﬀenders seeking regranting
of their license. 
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Impact of cannabis inhalation on driving skills
in occasional smokers
Giroud Christian, University Center of Legal Medicine
Thomas Aurélien, University Center of Legal Medicine, Lausanne- Geneva, Switzerland; Giovanni
Battistella, Dep of Radiology and CIBM, Centre Hospitalier Universitaire Vaudois and University of
Lausanne, Lausanne- Geneva, Switzerland; Philippe Maeder, Dep
Objectives:
Our aim was to study the brain regions involved in a divided attention tracking task related to driving  in
occasional cannabis smokers. In addition we assessed the relationship between THC levels in whole blood
and changes in brain activity, behavioural and psychomotor performances.
Methods:
Twenty-one smokers participated to two independent cross-over fMRI experiments before and after
smoking cannabis and a placebo. The paradigm was based on a visuo-motor tracking task, alternating ac-
tive tracking blocks with passive tracking viewing and rest condition. Half of the active tracking conditi-
ons included randomly presented traﬃc lights as distractors. 
Blood samples were taken at regular intervals to determine the time-proﬁles of the major cannabinoids.
Their levels during the fMRI experiments were interpolated from concentrations measured by GC-
MS/MS just before and after brain imaging. 
Results:
Behavioural data, such as the discard between target and cursor, the time of correct tracking and the re-
action time during traﬃc lights appearance showed a statistical signiﬁcant impairment of subject s skills
due to THC intoxication.
Highest THC blood concentrations were measured soon after smoking and ranged between 28.8 and 167.9
ng/ml. These concentrations  reached values of a few ng/ml during the fMRI.
fMRI results pointed out that under the eﬀect of THC, high order visual areas (V3d) and Intraparietal sul-
cus (IPS) showed an higher activation compared to the control condition. The opposite comparison sho-
wed a decrease of activation during the THC condition in the anterior cingulate gyrus and orbitofrontal
areas. In these locations, the BOLD showed a negative correlation with the THC level. 
Conclusion:
Acute cannabis smoking signiﬁcantly impairs performances and brain activity during active tracking
tasks, partly reorganizing the recruitment of brain areas of the attention network. Neural activity in the
anterior cingulate might be responsible of the changes in the cognitive controls required in our divided at-
tention task. 
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The use of zopiclone among random drivers,
arrested drivers and fatally injured drivers in
Norway
Gjerde Hallvard, Norwegian Institute of Public Health
Ingebjørg Gustavsen, Norwegian Institute of Public Health, OSLO, Norway; Per T. Normann, Dr., Norwe-
gian Institute of Public Health, OSLO, Norway
Objectives:
Zopiclone is the most frequently prescribed hypnotic drug in Norway. The aim of this study was to com-
pare the use of zopiclone among random drivers with arrested drugged drivers and drivers killed in traﬃc
accidents.
Methods:
Oral ﬂuid was collected from random drivers by using the Intercept® Collection Device. Blood samples
were collected from arrested drugged drivers and killed drivers. Samples were analysed by LCMS. Analy-
tical cutoﬀs: 0.3 ng/ml in oral ﬂuid-buﬀer mixture and 10 ng/ml in blood.
Results:
Zopiclone was detected in samples from 2.1% of random drivers, 4.6% of arrested drugged drivers and
3.4% of drivers killed in road traﬃc accidents. The use of diﬀerent cutoﬀ thresholds in oral ﬂuid and
blood made comparison of prevalences diﬃcult.  
The mean oral ﬂuid/blood concentration ratio was found to be 3.8. A cutoﬀ in blood of 10 ng/ml therefore
corresponded to about 38 ng/ml in undiluted oral ﬂuid, or 10 ng/ml in oral-ﬂuid buﬀer mixtures (i.e. 30
times higher than the limit for the roadside study) assuming an average volume of oral ﬂuid collected.
Zopiclone concentrations in samples of oral ﬂuid from a population may be used to roughly estimate the
distribution of zopiclone concentrations in blood. When using two estimation procedures, we found it
plausible that about 0.7% of the random drivers had blood zopiclone concentrations >10 ng/ml.
We assume that a zopiclone concentration >25 ng/ml is incompatible with safe driving, and estimated
that about 10% of the zopiclone-positive drivers found in the roadside survey had blood zopiclone con-
centrations above this limit, corresponding to 0.2% of all drivers.
Conclusion:
A small proportion of random zopiclone-positive drivers were impaired. The proportion of impairment
was higher among arrested drivers and drivers killed in traﬃc accidents. 
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Pharmacokinetic models of performance im-
pairment as assessed in experimental studies
Grellner Wolfgang, 
G Sticht, ., ., .; Günter Berghaus, Dr.
Objectives:
Assessment of performance impairment by medicaments by means of a meta-analytic approach using
published experimental studies and kinetics. Depiction of dose-dependent and concentration-dependent
dynamics.
Methods: 
A search in data bases concerning experimental studies (hypnotics and sedatives, anxiolytic benzodiaze-
pines, antidepressants, neuroleptics, antihistamines) with at least one performance test under the eﬀect
of a medicament and kinetic experiments was conducted. According to deﬁned criteria about 1,500 stu-
dies with about 34,000 test results were statistically evaluated.
Results:
The meta-analytic approach had to be restricted to studies with single oral applications in healthy sub-
jects. Including the calculation of kinetics for each substance a  pharmacokinetic proﬁle  could be esta-
blished: the dose- and time-dependent dynamics in terms of percentage of signiﬁcantly impaired
performance results. After a curve ﬁtting, the results were compared with the equivalent impairment by
known concentrations of alcohol. Thus, it was possible to present curves on the concentration-dependent
dynamics of a substance (correlation between concentration and percentage of performance impair-
ment). 
The performance results after multiple applications in healthy subjects and studies with ill persons were
assessed by reviews. The results seem to demonstrate less severe impairment.
Conclusion: 
It is possible to give dose-dependent recommendations regarding the duration of impairment in patients.
The  danger  of agents can be compared with deﬁned alcohol levels. Concerning  reality  it must be consi-
dered that the traﬃc-related  danger  of a medicament depends on more inﬂuencing variables than only
on its performance impairment. In addition, the possible improvement of the underlying disease by the
medication should be kept in mind. 
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Psychomotor impairment on three levels of
behaviour after intake of zopiclone or ethanol
Gustavsen Ingebjørg, Norwegian Institute of Public Health
Knut Hjelmeland; Jean-Paul Bernard; Jørg Mørland, Prof MD, Norwegian Institute of Public Health,
OSLO, Norway
Objective:
A recent study found that use of zopiclone (Z) composes increased traﬃc accident risk. It has further
been demonstrated that Z is the most common drug detected in oral ﬂuid among regular Norwegian dri-
vers. In the present study we wanted to test the eﬀects of Z in comparison with ethanol (E) on driving re-
lated behaviours. 
Methods:
We performed a controlled randomized double blinded trial on 16 healthy male volunteers who attended 4
sessions separated by 10 days and were given placebo, 5 mg Z, 10 mg Z or 50 g E in a cross-over design. E
served as a standard reference to quantify impairment by Z. The volunteers performed computerized
tests at baseline, 1, 3.5 and 6.5 hours after intake, accompanied by blood sampling. The psychomotor tests
included the three recommended core levels to predict traﬃc accident risk; Automotive behaviour (A),
Control behaviour (B) and Executive planning (C). 
Results:
The mean blood drug concentrations 1 hour after intake of  5 mg Z, 10 mg Z or 50 g E were respectively
19.0 μg/l (SEM 1.8), 39.1 μg/l (SEM 4.4), and 0.074 g/l (SEM 0.003). At this point of time signiﬁcant impair-
ment was found in 6, 6 and 5 of the 7 A-tests; in 1, 6 and 3 of the 9 B-tests, and in 2, 3 and 5  of the 10 C-
tests, respectively. The psychomotor performance for placebo did not diﬀer from baseline for any tests.
Conclusion:
10 mg Z impaired the A and B-tests most severely. The higher Z-dose, the more performance decrements
were observed. E impaired the C-tests more than Z. For performance in the A- and B-tests 1 hour after in-
take, 5 mg Z caused impairment roughly comparable to that observed at a BAC of approximately 0.07 g/l. 
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Converting drug eﬀects on experimental
performance measures to odds ratios
Hargutt Volker, Center for Traﬃc Sciences at the University of Wuerzburg
HP Krüger, ., ., .; E Schnabel, ., ., .
Objectives: 
The aim of DRUID is to gain new insights into the real degree of impairment caused by psychoactive drugs
and their actual impact on road safety. An important issue within WP 1 is the recommendation of thres-
holds for psychoactive substances in traﬃc based on the diﬀerent data pools within DRUID.
Methods: 
Within DRUID all sources of information are used to estimate the traﬃc risk for diﬀerent substances.
Odds ratios are calculated from epidemiological data as the golden standard of risk estimations. More-
over experimental driving studies and meta-analyses are conducted. Unfortunately neither the results
from experimental studies nor from meta-analyses are directly comparable to risk measures like odds ra-
tios. In order to facilitate the comparison of diﬀerent data pools a pragmatic method is developed, which
converts the results from experimental data in odds ratios. For this aim an alcohol calibration study at
0.05% BAC was implemented in the diﬀerent experimental studies in DRUID, which is conducted e.g. in
diﬀerent driving simulators. 
Results: 
The results of the converted experimental data in odds ratios show, that the odds ratio of the alcohol cali-
bration study at a BAC of 0.05% results in comparable odds ratios for diﬀerent studies (i.e. diﬀerent set-
tings). Moreover the odds ratios calculated from the experiments for diﬀerent BACs reﬂect
approximately the odds ratios from well-known epidemiological alcohol surveys.
Conclusion: 
This pragmatic method of converting drug eﬀects on experimental performance measures to odds ratios
proofs to be valid in terms of describing approximately the actual risk from epidemiological studies. 
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Should we be concerned about alcohol in bicy-
cle crashes?
Haworth Narelle, CARRS-Q
Amy Schramm, Ms, CARRS-Q, Kelvin Grove, Australia
Objectives: 
This paper sets out to examine from published literature and crash data analyses whether alcohol in bicy-
cle crashes is an issue about which we should be concerned.  It discusses factors that have the potential
to increase the number of bicycle crashes in which alcohol is involved (such growth in the size and diver-
sity of the cyclist population, and balance and coordination demands) and factors which may reduce the
importance of alcohol in bicycle crashes (such as time of data factors and child riders).  It also examines
data availability issues that contribute to diﬃculties in determining the true magnitude of the issue.   
Methods: 
This paper reviews previous research and reports analyses of data from Queensland, Australia, that exa-
mine the role of alcohol in Police-reported road crashes.  In Queensland it is an oﬀence to ride a bicycle or
drive a motor vehicle with a BAC exceeding 0.05% (or lower for novice and professional drivers).  
Results: 
In the ﬁve years 2003-2007, alcohol was reported as involved in 165 bicycle crashes (4%).  The bicycle
rider was coded as  under the inﬂuence  or  over the prescribed BAC limit  in 15 were single unit crashes
(12%).  In multi-vehicle bicycle crashes, alcohol involvement was reported for 16 cyclists (0.4%) and 110
operators of other vehicles (3%).  Additional analyses including characteristics of the cyclist crashes in-
volving alcohol and the importance of missing data will be discussed in the paper.
Conclusion: 
The increase in participation in cycling and the vulnerability of cyclists to injuries support the need to exa-
mine the role of alcohol in bicycle crashes.  Current data suggest that alcohol on the part of the vehicle
driver is a larger concern than alcohol on the part of the cyclist, but improvements in data collection are
needed before more precise conclusions can be drawn. 
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Prevalence of impaired drivers in the general
driving population in Europe
Hels Tove, DTU
Inger Marie Bernhoft, Senior Research Scientist, Department of Transport, Technical University of Den-
mark, Kgs. Lyngby, Denmark; Kira Janstrup, ., ., .
Objectives: 
To estimate and explain the prevalence of alcohol and drugs in the driving population in European coun-
tries. 
Methods: 
In 13 countries across Europe (DK, S, N, FI, NL, BE, ES, PT, IT, PL, LT, HU, CZ), sampling of saliva and/or
blood from the driving population has taken place from 2006 to 2009. The sampling has been stratiﬁed in
country regions, time of the day and week, seasons and road types (urban roads/rural roads). Within each
stratum, sampling has been random. Samples and data from about 50,000 drivers have been collected. All
samples have been analysed for: ethanol, amphetamines, cocaine, cannabis, illicit opiates, benzodiazepi-
nes/z-drugs and medicinal opiates/opioids. Logistic regression models have been constructed for the
highly prevalent substances alcohol, cannabis and benzos, with countries, age groups, genders and time
periods as explanatory variables. Prevalences have then been weighted according to traﬃc volume.
Results: 
Signiﬁcant diﬀerences in prevalence of alcohol and cannabis were found between countries. Italy had the
highest and Hungary the lowest alcohol prevalence. Spain had the highest and Finland, Lithuania and Swe-
den the lowest cannabis prevalence. Signiﬁcant diﬀerences in alcohol and cannabis prevalence between
age groups were found across study countries. Alcohol was most prevalent in the group of 25-34 and can-
nabis in the group of 18-24, whereas both substances were least prevalent in the 50+ group. Finally, a sig-
niﬁcant time diﬀerence in alcohol and benzo prevalence was found across study countries. Alcohol was
most prevalent on weekend nights, least prevalent on weekdays. Benzos were most prevalent on week-
days, least prevalent on weeknights.
Conclusion: 
The results reveal big diﬀerences in substance prevalence, not only between countries, but also between
age groups and time periods.   
Disclaimer:
This report has been produced under the EU 6th Framework Program. The European Community is not li-
able for any use that may be made of the information contained therein. 
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Road Traﬃc Injuries And Alcohol In México
Hijar Martha, Instituto Nacional de Salud Pública
Low- and middle-income countries own only a third of the world s motor vehicles but they account for
over 85% of deaths and 90% of the disability-adjusted life years lost due to road traﬃc injuries. Road
traﬃc Injuries in Mexico are the most important cause of death among the population from 5-49 years
old in México. The mortality due to Road Traﬃc Injuries in México during the period 2000-2008 shows a
slight trend to increase and Pedestrian Injuries are the most important cause among this group. Adjusted
Mortality rates varies from 18.3/100,000 inhabitants in 2000, to 20.5 in 2008.Related to motorcyclists,
the mortality trend is to increase. Young men are the most aﬀected age groups.
Alcohol Intake is reported as the risk factor associated with 30-50% of the deaths by RTI, from 15 al 35%
of severe injuries and 10% of the minor injuries cases. A study done in México showed the speciﬁc weight
of alcohol intake like risk factor for injury severity, and its association with others risk factors like: non-
use of seat belt and speed, ORa for alcohol 5.35  CI 2.35-12.24 for minor injuries, and ORa 8.43 CI 3.10-23.0
for severe injuries.The risk of to be involved in a RTI after 6 hours of  alcohol consumption shows a OR 3.9
and CI (95%) 2.6-8.0.
Discussion:
Law of not drinking alcohol if you are a car driver is mandatory in Mexico, but there is not enforcement.
There is not any interventions evaluation done on this issue. Drinking and driving varies considerably
around the country. There is not a comprehensive policy to regulate patterns of alcohol consumption.
Interventions like increase taxes and prices, to alcohol sales like: day time, Kind of store and not sale to
young population, has been implemented but not enforced and even included into an integral intervention. 
ORAL ABSTRACT
75
Alcohol and Drug Use in Fatally Injured Drivers
in States that Test over 80% for Both Alcohol
and Drugs
Hingson Ralph, ICADTS
Michael Winter, Boston University School of Public Health, Boston, United States; Timothy Heeren,
Boston University School of Public Health, Boston, United States
Objective: 
To examine personal and crash characteristics of fatally injured drivers who tested positive for alcohol, al-
cohol and other drugs, other drugs but not alcohol, and neither.
Methods: 
U.S. Fatality Analysis Reporting System data for 2008 were examined in 10 states where 80%+ of fatally
injured drivers were tested for both alcohol and other drugs.  
Results: 
Of 2,604 driver fatalities, 29% tested positive for alcohol but not drugs, 9% for both alcohol and drugs,
11% for drugs but not alcohol, and 51% negative.  The personal and crash characteristics were quite simi-
lar for drivers who tested positive for alcohol only and for alcohol and drugs, but diﬀered signiﬁcantly
from those who tested negative for both.  Compared to drivers negative for alcohol and drugs, a signiﬁ-
cantly higher percentage who tested positive for alcohol or alcohol and drugs were involved in nighttime,
weekend, and single-vehicle crashes with ﬁxed objects.  They were more often younger, male, and less li-
kely to wear seat belts.  Two-thirds had BACs at 0.15%+.  Drivers who tested positive for drugs but not al-
cohol were much more similar in their driver and crash characteristics to those who tested negative for
alcohol or drugs.  These two groups did not signiﬁcantly diﬀer on whether their crashes occurred at night,
on weekends, involved single vehicles, and involved a collision with a ﬁxed object.  Compared to drivers
who tested positive for both alcohol and drugs, those who tested positive for drugs only were slightly
more often male and younger and were more likely to have used cannabis (32% vs. 19%) and stimulants
(22% vs. 9%) but less likely to have used narcotics (14% vs. 30%).  Similar percentages used depressants
(17%), hallucinogens (<1%), and PCP (=1%). 
Conclusion:
Case-control studies are needed to determine whether drug use by itself or in combination with alcohol
heightens crash risk. 
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ORAL ABSTRACT
Alcohol eﬀects on driving performance:
Compensation may protect controlled actions
Huemer Anja Katharina, Department of Traﬃc and Engineering Psychology
Alcohol is clearly detrimental to driving-related performance and increases the risk of an accident. Meta-
analyses found that alcohol eﬀects for automatic behavior begin at about 0.05g/dl. Performance decre-
ments in controlled actions are found earlier at about 0.03g/dl BAC. Thus, controlled actions seem more
susceptible to alcohol eﬀects than automatic behavior. However, this notion has not yet been directly te-
sted for diﬀerent sub-tasks within a driving situation. Based on task analyses of driving one basic auto-
matic behavior (lane keeping) and one basic controlled action (a lane change maneuver) were compared in
a driving simulator study. Twenty-one participants were tested under alcohol (target BAC of 0.08 g/dl)
and placebo in a cross-over within-subjects design measuring diﬀerent performance indicators. First of
all it was interesting to note that alcohol eﬀects were signiﬁcant but so small that from the test results a
clear impairment could not be demonstrated. Contrary to expectations, automatic behavior in lane kee-
ping phases turned out to be the most sensitive measure to the impact of alcohol demonstrating alcohol
eﬀects at below 0.04 g/dl. The lane change sub-task including controlled actions was only aﬀected at the
highest BAC of 0.08 g/dl. Compensatory behavior of the drivers may explain this result. The performance
level in controlled actions can be better self-monitored by the drivers and there are more possibilities to
counteract these changes. If drivers are motivated to drive safely they will try to counteract perceived
detrimental eﬀects focusing on controlled actions neglecting the automatic behavior. Thus, in driving
controlled actions may be to some extent protected against alcohol. It would be interesting to examine
whether a similar pattern can also be found in alcohol accidents. 
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Paired Oral Fluid and Whole Blood Cannabi-
noids From the National Roadside Study
Huestis Marilyn, Chemistry and Drug Metabolism, NIDA, NIH
John Lacey, Mr., PIRE, Calverton, MD, United States; Tara Kelley-Baker, Senior Research Scientist, PIRE,
Calverton, MD, United States; Eduardo Romero, Pire, Calverton; Allan Barnes, National Institute on
Drug Abuse, Baltimore, United States; Cynthia Coult
Objective:
Oral ﬂuid is the specimen of choice for roadside evaluation of impaired drivers, but the relationship bet-
ween oral ﬂuid and blood ?9-tetrahydrocannabinol (THC) is not yet clear. Specimens from the 2007 US
National Roadside Survey were utilized to evaluate cannabinoid concentrations and ratios in paired oral
ﬂuid and blood specimens. 
Methods:
Data were from 556 matched oral ﬂuid and blood specimens obtained from nighttime weekend drivers in
which either oral ﬂuid, blood or both were positive for one or more drugs. Specimens were initially scree-
ned by Immunalysis cannabinoid ELISA, with positive specimens conﬁrmed by GCMS (THC only in oral
ﬂuid, 2 ng/mL) and LCMSMS (THC, 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH) in
blood, 1 ng/mL).
Results:
THC was detected in 201 OF specimens (36.2% of drug positive specimens), with concentrations up to
1183 ng/mL; in blood, 229 specimens (41.2%) were positive for one or more cannabinoid biomarkers, with
THC, 11-OH-THC, and THCCOOH maximum concentrations of 61, 12 and 233 ng/mL, respectively. 129 pai-
red OF and blood specimens contained THC, with concentrations from 2-995 ng/mL (oral ﬂuid) and 1-61
ng/mL (blood). Oral ﬂuid to blood THC ratios varied greatly (0.68-360.0), with a weak correlation between
the matrices (r=0.362). 11-OH-THC was never the only cannabinoid detected. THC was found in oral ﬂuid
but not blood in 72 cases; however, THCCOOH in blood documented prior cannabis exposure in 43 of
these specimens. Furthermore, there were 57 cases where one or more biomarkers were present in blood,
but only THC was quantiﬁed in oral ﬂuid.
Conclusion:
These data document that oral ﬂuid is an important alternative matrix for documenting cannabis use in
roadside screening for DUID. Analyses of the variability in saliva/blood ratios in 129-paired specimens
suggests that prediction of THC whole blood concentrations from oral ﬂuid levels is not currently recom-
mended. 
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ORAL ABSTRACT
The eﬀect of socio-demographic determinants
on drinking and driving. Retrospective analysis
of 80 000 drunk drivers
Impinen Antti, Institute of health and welfare
Karoliina Karjalainen, National Institute for Health and Welfare, Helsinki, Finland; Pia Mäkelä, Dr., Insti-
tute of health and welfare, Helsinki, Finland; Jari Haukka, University of Helsinki, Department of Public
Health, Helsinki, Finland; Aini Ostamo, Nat
Objectives:
Social background is known to aﬀect many types of health behaviours. The main objective of this study
was to examine how social factors predict drunk driving.
Methods:
Data on suspected drunk driving were combined with a register of socio-demographic factors including
education, marital status, employment status, income, socio-economic status and other information. This
exceptionally large data contained 83 630 drivers with ﬁrst drunk driving arrest and 88 718 references
with no history of driving under the inﬂuence between the years 1993 and 2007. Logistic regression mo-
dels were ﬁtted to compute odds ratios and 95% conﬁdence intervals separately for men and women and
diﬀerent age groups. Drugged driving was excluded from the study.
Results:
Unemployment, low and medium education, not being married, blue collar work or being entrepreneur, li-
ving alone or in a single-parent family and car ownership predicted drunk driving. Respectively high edu-
cation, being married, upper white collar position, studying or being in military service and living in family
with parents and children were protective factors.  The eﬀect of socio-demographic factors was mainly
similar between diﬀerent groups of age and sex.
Discussion:
Socio-demographic factors contribute to in drunk driving. In general, people in lower socio-demographic
position are more prone to drive after drinking. As drunk driving might often be a signal of more serious
substance abuse problems more eﬀort should be put on early recognizing of such problems. More sup-
port should be provided to those in lower or vulnerable social position. 
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Development of a driving simulator test
battery for assessing drug inﬂuence on driving
performance
Jenssen Gunnar, SINTEF
Objectives:
Using ethanol as test substance, we conducted a study in order to assess the predictive value of a driving
simulator on driving ability. The purpose was to develop a validated driving simulator tool for future as-
sessment of drugs with unknown eﬀects on driving performance.
Methods:
We recruited 20 healthy male volunteers.  After screening and test driving, the subjects underwent a total
of six driving trials of 1 hour s duration each; three in an instrumented vehicle on a closed-circuit test track
and three in an advanced driving simulator with a driving scenario modelled after the test track. Test sub-
jects were titrated to BAC levels of approx. zero, 0,50 and 0,90. The study was conducted in a randomised,
cross-over, single-blind fashion, using placebo drinks and placebo pills as confounders. The outcome mea-
sures were standard deviation of lateral position (SDLP), mean speed, speed ﬂuctuations, steering wheel
movements, braking/acceleration, and reaction time to unexpected events.
Results:
18 test subjects completed all six driving trials.  Mean measured BAC levels were slightly lower than in-
tended, at 0,380 and 0,860 for the proposed levels of 0,50 and 0,90, respectively.
Outcome data analyses are not available at abstract deadline, but will be presented at the time of the
conference. 
Conclusions:
To our knowledge, this is the ﬁrst reported experiment using ethanol as a test substance to validate a dri-
ving simulator by comparing driving on a test track with simulator driving in a virtual copy of the scenario.
By this, we purport to conﬁrm that test track and simulator data correlate. This will allow us to utilize the
driving simulator for the future assessment of other drugs. 
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A Field Experiment on the Eﬀect of Norms
Correction on Alcohol Consumption
Johnson Mark, PIRE
Objectives:
Social norms marketing strategies have been widely used to combat risky drinking, to mixed eﬀects. The
research described herein employed a ﬁeld experiment to examine the impact on alcohol consumption of
providing drinkers with accurate normative information. Potential moderators of the norms intervention
were experimentally manipulated as well. 
Methods:
Participants were sampled from a natural, high-risk drinking environment and randomly assigned to one
of nine experimental conditions. The experimental manipulations consisted of whether participants re-
ceived accurate drinking norms, the salience of the normative information, the believability of the infor-
mation, and whether the norms were based on a general or speciﬁc reference group. The participant s
level of alcohol consumption (as measured by a calibrated breathalyzer) after receiving the experimental
manipulations served as the primary dependent measure. 
Results: 
The vast majority of drinkers overestimated the actual level of alcohol consumption in the natural drin-
king environment. Over the course of the study, participants who received accurate normative informa-
tion, relative to controls, tended to change their normative beliefs to be more accurate. Furthermore,
changes in perceived drinking norms (towards greater accuracy) were associated with reductions in alco-
hol consumption. However, the direct eﬀect of the experimental manipulations on drinking was mixed and
varied considerably as a function of participant sex and ethnicity.  
Conclusion:
The results provided some direct evidence consistent with the hypothesis that correcting inaccurate
norms can change behaviour. Normative information and instructions that were simpler appeared to be
more eﬀective than complicated normative messages. 
ORAL ABSTRACT
81
What non-alcohol drugs are used by drinking
drivers in Sweden? Toxicological results from
10-years of forensic blood samples
Jones Wayne, Forensic Toxicology
Introduction:
The punishable blood-alcohol concentration (BAC) for driving in Sweden is 0.20 mg/g (~0.02 g%) and
since 1999 there is a zero-limit law for scheduled drugs in the blood of drivers. Here we report the demo-
graphics of traﬃc delinquents in Sweden apprehended by the police for driving under the inﬂuence of al-
cohol with and without another licit or illicit substance in the blood samples.
Methods:
We identiﬁed 116,324 cases of driving under the inﬂuence of alcohol or drugs (DUI/DUID) over a 10-year
period (1998-2007). In 40,905 cases the driver had a punishable BAC (> 0.2 mg/g). 
Results:
There were N = 35,700 cases with alcohol as the only drug (mean age 40 ± 15 y, 89% men) and the mean
BAC was 1.60 mg/g. There were N = 3149 cases with alcohol + an illicit drug in blood (mean age 36 ± 11 y,
92% men) at a mean BAC of 1.06 mg/g. We found N = 1255 cases of alcohol combined with a prescription
(licit) drug (mean age 38 ± 13 y, 85% men) and the mean BAC was 1.31 mg/g. Finally there were N = 801 dri-
vers with a punishable BAC an illicit and a licit drug in blood. For these poly-drug users (mean age 34 ± 10 y,
92% men) the mean BAC was 1.04 mg/g. The results show a strong predominance of male oﬀenders in all
sub-groups. The alcohol-only cases were 4-6 y older than those with alcohol + other drugs (p<0.01). The
mean BAC was signiﬁcantly higher in the alcohol-only cases compared with drug-alcohol combinations
(p<0.001). The major illicit drugs identiﬁed in blood together with alcohol were THC (median conc. 0.001
mg/L), amphetamine (0.2 mg/L), cocaine metabolite benzoylecognine (0.2 mg/L) and the heroin metabo-
lite morphine (0.02 mg/L). The major prescription drugs were sedative-hypnotics, exempliﬁed by diaze-
pam (0.2 mg/L), alprazolam (0.05 mg/L), ﬂunitrazepam (0.001 mg/L), zolpidem (0.15 mg/L) and zopiclone
(0.07 mg/L) as well as other benzodiazepines. The opiate tramadol (0.4 mg/L) was also a common ﬁnding. 
Conclusions:
Those who drive under the inﬂuence of alcohol in combination with other psychoactive substances, whet-
her licit or illicit, are likely to pose a greater danger for traﬃc safety compared with people having a simi-
lar BAC but without the drug. 
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Occurrence of alcohol and other drugs in
femoral blood samples from drivers killed in
road-traﬃc crashes in Sweden
Jones Wayne, Forensic Toxicology
Introduction:
This presentation concerns the prevalence of alcohol and other drugs (licit, illicit or both) in femoral blood
obtained at autopsy from drivers killed in road-traﬃc crashes in Sweden over a 5 y period (2003-2007). 
Methods:  We identiﬁed 1,403 traﬃc crashes in which the driver was killed. In over 97% of these deaths a
forensic autopsy was performed as well as a complete toxicological analysis for alcohol and other drugs
in femoral blood samples. 
Results:
In 60% of cases (N = 835, 83% men and 17% women) the toxicological results were negative. The blood-
alcohol concentration (BAC) of drivers killed was above the legal limit (> 0.2 g/L in Sweden) in 22% of
cases (N = 315). The mean, median and highest BAC were 1.7 g/L, 1.7 g/L and 4.9 g/L, respectively. The alco-
hol-positive drivers were mainly men (93%) and alcohol as well as another drug was identiﬁed in 73 cases.
In single vehicle crashes (N = 575) the driver s BAC was above the legal limit in 55% of cases. In 253 cases
(18%) drugs other than alcohol were identiﬁed; illicit drugs only in 39 cases (2.8%), an illicit drug and a
prescription drug in 28 cases (2.0%) and in 186 cases (13.3%) one or more licit drugs. Amphetamine was
the major illicit drug at mean, median and highest concentrations of 2.1 mg/L, 1.3 mg/L and 12.1 mg/L, re-
spectively (N = 53). The major prescription drugs were sedative-hypnotics (N = 93), opiates/opioids (N =
69) as well non-scheduled substances, such as paracetamol (N = 78) and antidepressants (N = 93). 
Conclusions:
Alcohol is the dominant psychoactive substance identiﬁed in the blood of drivers killed in road-traﬃc
crashes in Sweden. Because 55% of drivers were above the legal alcohol limit in single vehicle crashes
compared with 22% in all types of crashes, this suggests culpability on the part of the alcohol-impaired
driver in causing the crash. 
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Physiological and usability aspects of breath
alcohol estimation
Kaisdotter Andersson Annika, Mälardalen University/Hök Instrument AB
Bertil Hök, Hök Instrument AB, Västerås, Sweden; Håkan Pettersson, Autoliv Development AB,
Vårgårda, Sweden
In many screening applications, including alcolocks, it would be useful to reduce the time and eﬀort to
provide a valid breath alcohol test, especially for the vast majority of sober persons. State of the art in-
struments require forced and prolonged expiration into a tight-ﬁtting mouthpiece which is troublesome
for persons with reduced lung capacity. We have performed a series of investigations to explore the pos-
sible advantages of using CO2 as tracer gas, to indicate the degree of sample dilution by normalizing to
the normal end tidal concentration.
The investigations include the following tests: 1) Analysis of expirograms of alcohol (EtOH), CO2 and H2O
from 30 test persons with highly varying lung capacity 2) Analysis of expirograms from 30 healthy test
persons with respect to provocative breathing manoeuvres 3) Tests with handheld prototypes enabling
breath tests without a mouthpiece, performed on 153 test persons. The expirograms were recorded using
a modiﬁed evidential breath analyser (Evidenzer, Nanopuls AB, Uppsala, Sweden), and the prototypes
were designed and fabricated in our laboratories.
The results of studies 1) and 2) show that deadspace expiration is invariably completed within two se-
conds, followed by steadily increasing CO2, EtOH and H2O concentrations, mentioned in the order of de-
creasing slope. Hyperventilation and breath holding has relatively strong and similar eﬀect on early
estimation of EtOH and CO2 concentration, whereas the H2O vapour is less aﬀected. Sampling in freely
expired breath with prototypes 3) gave an average CO2 concentration of 3.7 kPa with a standard deviation
of 0.6 kPa.
The observed CO2 variability is surprisingly low, considering the range of usability and physiological fac-
tors. Multiplying early readings of alcohol with the ratio between end tidal and instantaneous CO2 con-
centrations provides a conservative estimate of breath alcohol concentration, enabling more shallow
expirations to be performed without increasing the rate of false negatives. 
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Individual psychological rehabilitation
programmes and their eﬀectiveness on
DUI-oﬀenders
Kalwitzki Klaus-Peter, AFN
Brigitte Krohn, Dr., AFN, Köln, Germany
Driving under the inﬂuence (DUI) of alcohol or drugs is still a very serious problem for traﬃc safety. Over
30 years ago the AFN began implementing the focal lifestyle analysis method ( Lebensstilanalyse ) into
rehabilitation programmes for diﬀerent groups of DUI-oﬀenders. Our lecture summarises the experience
we have gained whilst working with this method and we will pay particular attention to its eﬃcacy and
therefore its contribution towards improving road safety.
Methods:
The focal lifestyle analysis is based on the individual psychology of Alfred Adler. A specially-trained, quali-
ﬁed psychologist acquires the personal background of each individual road traﬃc oﬀence from groups of
four to twelve participants and thus derived possible ways to change behaviour for eﬀective re-oﬀence
prevention.
The four rehabilitation programmes, IRaK (DUI-oﬀenders/alcohol), DRUGS (DUI-oﬀenders/drugs), ALFA
(for new drivers as DUI-oﬀenders) and IRaK-S (ﬁrst-time drunk drivers who are currently banned from
driving), were presented whilst taking into consideration target group-speciﬁc characteristics such as di-
dactic aspects, information distribution and materials.
All four rehabilitation programmes have now been evaluated, with the results of the latest study due in
summer 2010. The main focus is on the likelihood of participants re-oﬀending in the years following the
course. Questionnaires show how the participants perceived and evaluated the courses.
Results:
The focal lifestyle analysis method proved to be an eﬀective approach for driver rehabilitation. In the par-
ticipant questionnaires the courses were rated positively and were described as being useful. The results
regarding re-oﬀence show an extremely low relapse rate amongst participants (around 10% depending
on the course programme).
Conclusions:
This depth-psychological approach to the rehabilitation of DUI-oﬀenders provides access to the problem
with the promise of success. The tool  focal lifestyle analysis  is to be used in the future for road safety
work and should be tested on other target groups as well. 
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Socio-economic determinants of drugged 
riving  a register-based case-control study
Karjalainen Karoliina, National Institute for Health and Welfare
Tomi Lintonen, Police College of Finland, Tampere, Finland; Antti Impinen, National Institute for Health
and Welfare, Helsinki, Finland; Pirjo Lillsunde, Dr, National Institute for Helth and Welfare, Helsinki, Fin-
land; Pia Mäkelä, National Institute for H
Objectives:
There is a very little information about the social background of drivers suspected of driving under the in-
ﬂuence of drugs (DUID). We aimed to describe the associations between socio-economic characteristics
and drugged driving, and to elaborate possible determining factors of drugged driving in Finland.
Methods:
A register-based case-control study was conducted. The group of cases consisted of 2,631 DUID suspects
apprehended by the police during 1993-2006. The control group of 74,809 individuals was drawn from the
general Finnish population not suspected of DUI. The information about socio-economic background was
traced from the Employment register of Statistics Finland. Socio-economic factors predicting driving
under the inﬂuence of benzodiazepines and alcohol (BZDA) or amphetamines among under 45-year-old
men were estimated by using logistic regression model. 
Results:
In the basic model DUID with BZDA was predicted by parents  and own lower education, urban municipa-
lity, lower white-collar and blue-collar work, unemployment, disability pension, lower income, being single,
divorced or widowed, and living alone. After adjusting for other socio-economic variables, parents  and
own lower education, semi-urban environment, blue-collar work, unemployment, disability pension, being
divorced or widowed, and living alone had an independent eﬀect on DUID with BZDA.
DUID with amphetamines was predicted by all the characteristics mentioned above and in addition by
being entrepreneur. With the exception of parents  basic education and lower white-collar work, these
also were independent predictors of DUID with amphetamines after adjusting for other socio-economic
variables. Being a student was a signiﬁcant protective factor of DUID with amphetamines after control-
ling for other factors.
Conclusions:
Disadvantaged social background was a signiﬁcant predictor of DUID. This information is vital in the pre-
ventive work targeted on drugged driving. Especially young men who are at risk of social exclusion should
be identiﬁed and actions be made before they need police and remedial services. 
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Incorporation of Ethyl Glucuronide into
rat hair: inﬂuence of hair pigmentation and
ethanol dose
Kharbouche Hicham, University Center of Legal Medicine, Lausanne - Geneva
Objectives: 
The aims of the present study were to evaluate the relationship between the administered ethanol doses
and the measured ethyl glucuronide (EtG) concentrations in rat hair and to investigate the inﬂuence of
hair pigmentation on EtG hair incorporation. The time courses of ethanol and EtG in blood after a single
dose administration were also evaluated.
Methods:
Ethanol was administered by intragastric route to Long Evans rats at three doses (1, 2 and 3 g ethanol/kg
body weight for the G1, G2 and G3 groups, respectively). Rats received ethanol on 4 consecutive days per
week for 3 weeks. Twenty-eight days after the ethanol administration, the newly pigmented and nonpig-
mented grown hair was collected and separately analyzed by gas chromatography tandem mass spectro-
metry for EtG. Blood samples were collected within 12-h after the ethanol administration. Blood EtG and
ethanol concentrations were measured by liquid chromatography tandem mass spectrometry and head-
space gas chromatography with ﬂame ionization detection, respectively.
Results:
No statistically signiﬁcant diﬀerence was observed in EtG concentrations between pigmented and non-
pigmented hair (Spearman s rho= 0.95, p<0.001). Higher doses of ethanol resulted in greater blood etha-
nol AUC and in greater EtG AUC. A positive correlation was found between blood ethanol AUC and blood
EtG AUC (Spearman s rho=0.84, p<0.001). The median hair EtG concentration in groups G3 and G2 was sig-
niﬁcantly higher than the one in groups G2 and G1, respectively (Wilcoxon Mann Whitney test, p<0.01 and
p<0.001, respectively). There was a signiﬁcant positive correlation between EtG concentrations in hair
and EtG AUC in blood (r=0.89, P < 0.001).
Conclusion:
The EtG incorporation into rat hair was not inﬂuenced by hair pigmentation. The EtG concentration in hair
increased with the administered ethanol. The EtG concentration in hair appeared to reﬂect the EtG con-
centration in blood. 
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Trends in road traﬃc crashes and associated
injury and fatality in Pakistan, 1956-2008
Khoso Ajmal Khan, National Highways & Motorways Police
Objectives:
To carry out comprehensive analysis of available Road Traﬃc Crash data from National Transport Rese-
arch Centre and Statistics Bureau of Pakistan for the period 1956- 2008 and to estimate magnitude of
Road Traﬃc Crashes  and associated injuries and fatalities in Pakistan and judge its trends with respect
to population and number of vehicles in Pakistan.
Method:
Data from National Transport Research Centre and Statistics Bureau of Pakistan from  1956 to 2008 was
analysed; absolute number of crashes, fatalities and injuries as well as fatality Risk and fatality Rate were
used as indices to measure the trends.   
Result:
There is considerable increase of 13 fold in RTCs in Pakistan, from796 in 1956 and 10466 in 2008. The in-
jury increased by more than 13 fold, from 882 to 11865, and fatalities increased by 15 fold  from 302 to
4754, over the same period. Likewise, Fatality Risk has increased ﬁve fold, with 1 in 1961 and 5 in 2008.Ho-
wever; Fatality Rate has decreased considerably from 58 in 1956 to 16 in 2007. The data shows inconsis-
tent trends and considerable variations between the two data sources, which suggests that data
collected by diﬀerent sources are incomplete and not coordinated with other sources. 
Conclusion:
The RTC data collection process in Pakistan is not eﬃcient to measure the true magnitude of the pro-
blem. It is imperative that injury surveillance should be improved to gauge actual severity of the problem
eﬃciently in order to make road safety priority agenda of national development and for developing eﬀec-
tive road safety policies. 
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Analysis of National Highways & Motorway
Police Injury Surveillance System with respect
to WHO Injury Surveillance Guidelines
Khoso Ajmal Khan, National Highways & Motorways Police
Objectives:
To analyze the components of the injury surveillance system being used by National Highways & Motor-
way Police, and determine if this system meets standard criteria for ISSs as described in WHO Injury Sur-
veillance Guidelines.
Methods: 
The Injury Surveillance System of National Highways & Motorway Police of Pakistan is analyzed on three
diﬀerent criteria; ﬁrstly on the basis of eight processes as mentioned in WHO Injury Surveillance Guideli-
nes; secondly ,on the basis of twelve steps which are involved in designing and building a injury surveil-
lance systems that are recommended by WHO; thirdly and lastly, the injury surveillance systems will be
analyzed with respect to nine attributes of a good surveillance systems as mentioned in Injury Surveil-
lance Guide published by WHO.
Result: 
The results were collected in three categories as per Injury Surveillance Guidelines. 
(1) The ISS follows all the steps necessary for establishing an Injury Surveillance System except two last
steps of using the results to plan interventions and evaluation of a surveillance system. Due to such deﬁ-
ciencies, the faults of the injury surveillance system have not been identiﬁed and it also fails to produce
desired results of cost eﬀective injury prevention.
(2) The ISS fulﬁlls only three steps involved in designing and building and it partially fulﬁlls remaining nine
steps. Therefore, the system fails to meet the criteria mentioned in Injury Surveillance Guidelines.
(3) The ISS fulﬁls only two attributes of an ideal injury surveillance system and fails to meet remaining
seven attributes, which suggests that the system did not meet criteria of an ideal surveillance system.  
Conclusion:
The ISS of NH&MP fails to meet all the criteria as mentioned in WHO Injury Surveillance Guidelines. The-
refore, there is need of a lot of modiﬁcations and improvements to make this system useful. 
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Goals and current status of experimental work
in DRUID
Knoche Anja, Bundesanstalt fuer Strassenwesen
Objective:
The goal of the experimental work in DRUID is to receive risk estimates from driving under the inﬂuence
of alcohol, drugs and medicines. The experimental results will be incorporated into the ﬁnding of epidemi-
ological case-control studies which present risk estimates of impaired driving, also.
Methods:
- Conduction of 15 experimental studies referring to diﬀerent psychoactive substances.
- Development of an integration methodology for experimental and epidemiological risk estimations.
Results:
A comparable set of study results could be established by the determination of a uniform study protocol
for epidemiological and experimental studies. 
For experimental studies a standard set of parameters and instructions to calculate the associate mea-
sures were established. 
To integrate experimental and epidemiological risk estimates three major challenges need to be met:
- Epidemiological studies deliver risk estimates (odds ratios) based on case control studies. On the other
hand, no method to calculate odds ratios in case of experimental studies is known. Therefore, a new met-
hod was established to calculate such odds ratios.
- In order to determine the crucial level of impairment a reference data base on alcohol was established to
be used in experimental and epidemiological studies. It allows to directly comparing drug inﬂuenced dri-
ving performance with alcohol impaired driving.
- Experimental studies determine driving impairment in regard to dosages (amount of substance consu-
med) whereas epidemiological studies measure substance concentrations in body ﬂuids. A pharmacok-
inetic model was developed to calculate substance dosages into blood concentration.
Conclusion:
Risk thresholds (comparable to BAC levels) will be deﬁned for most prominent substances and analytical
thresholds (in case of zero tolerance) will be determined for all substances. 
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An introduction to hair analysis in driving
license regranting
Kronstrand Robert, RMV
The society s standpoint against driving under the inﬂuence of alcohol or drugs has resulted in eﬀective
legislation to enable the investigation and prosecution of this oﬀence. However, the means to regrant
those individuals their revoked license are not suﬃcient. Most countries have laws, recommendations or
practise to control abstinence from illegal drugs using urine samples and blood samples are used to con-
trol abstinence from alcohol. During a surveillance period of several months so few urine samples are ob-
tained that they provide little evidence of abstinence. Over the recent years, the interest in hair in driving
license regranting has increased and there are some publications that address this. Their main conclusion
is that the analysis of hair samples reveals more drug use than does urine samples. This is due to the in-
creased detection window. Therefore, hair has been included in some countries recommendations on how
to control abstinence.
The objective of this talk is to give the audience an overview of hair as a matrix for the assessment of
drug abstinence regarding illegal drugs in particular but will also address alcohol overconsumption. Both
theoretical and practical aspects will be covered and data from the existing literature will be reviewed. 
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Simulator driving performance after
oral dextroamphetamine
Kronstrand Robert, RMV
Gunnel Ceder; Johan Ahlner; Magnus Hjälmdahl, VTI, Linköping, Sweden
Objectives:
The main objective of the study was to investigate driving performance, but we also studied how diﬀerent
doses of dextroamphetamine aﬀected the subjects  sleepiness. 
Methods:
Twenty experienced drivers were recruited and randomized into a double blind testing scheme with three
overnight driving occassions one week apart. At each occasion there were three driving sessions: one in
the late afternoon, one at night and one in the early morning, meaning that the test subjects drove under
three levels of sleep deprivation: alert, slightly sleep deprived, and sleep deprived. Blood samples were
drawn before and after driving sessions and analyzed for amphetamine. Sleepiness was measured by the
Karolinska Sleepiness Scale. Driving performance was investigated by 12 variables regarding speed and
reaction time.
Results:
ANOVA showed a signiﬁcant diﬀerence in sleepiness between doses and between driving sessions. Hig-
her doses lead to increased alertness (from 5.47 to 4.07 on the KSS-scale). Only the driving performance
variable crossing car reaction time showed signiﬁcant eﬀect of dose. The reaction time for the event of
crossing car was 2.17 s when placebo was given and 1.9 s when 40 mg was given. However, the two other re-
action time variables were not signiﬁcant. 
The driver performance was also analysed with respect to changes in blood concentration instead of
dose to compensate for diﬀerent drug uptake. However, the results did not improve even though blood
amphetamine concentrations varied within dosing groups. As before, only crossing car reaction time was
signiﬁcant.
Conclusion: 
We conclude that the small doses given to the subjects resulted in only few eﬀects on driving perfor-
mance. Driving performance was neither improved nor made worse, however the drivers felt more alert
after having taken a small dose dextroamphetamine. 
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National Roadside Survey 2007:
Results from paired Specimens of Oral Fluid
and Whole Blood
Lacey John, PIRE
The National Roadside Survey conducted in 2007 provided a large amount of data regarding the preva-
lence of drugs in drivers.  Overall, 5,869 oral ﬂuid samples (OF) and 3,276 blood samples were collected
from night-time drivers.  Of the paired specimens, 559 pairs showed at least one matrix as drug positive;
326 pairs were positive in both matrices.
Both positive: Of the 326 pairs, 75.7% were exact drug matches in both OF and blood; 21.4% had at least
one drug in common; 2.7% of the specimens were a mismatch.
Most common exact matches Number of pairs
Cannabinoids 130
Cocaine & metabolites 19
Amphetamines 11
Alprazolam 8
Hydrocodone 6
Oxycodone 5
Dextromethorphan 5
Cocaine metabolites and cannabinoids 5
One matrix negative the other positive: Either blood or OF was negative in 233 cases.  In 129 cases, OF was
negative with a corresponding positive blood; in 104 cases, the blood was negative with a corresponding
positive OF.  A breakdown shows blood to be superior to OF for sertraline, phentermine and benzodiaze-
pine analysis; OF was superior for cocaine as well as several pain medications.
There were numerous combinations of drugs detected; many pain medications found in combination with
THC. The interpretation of concentrations where multiple drugs are present, some at therapeutic levels,
is problematic. 
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2007 U.S. National Roadside Survey:
Drug Results
Lacey John, PIRE
John Lacey, Mr., PIRE, Calverton, MD, United States; Tara Kelley-Baker, Senior Research Scientist, PIRE,
Calverton, MD, United States; Robert Voas, Dr., PIRE, Calverton, MD, United States; Eduardo Romano,
Research Scientist, PIRE, Calverton, MD, United St
Objective:
New to the 2007 U.S. National Roadside Survey was the collection of additional types of biological sam-
ples (oral ﬂuid and blood) to determine the presence of drugs other than alcohol in the driving population.
Methods:
Oral ﬂuid and blood samples were collected from survey participants and were analyzed in a laboratory
using enzyme-linked immunosorbent assay (ELISA) screening, followed by a conﬁrmatory analysis by Li-
quid Chromatography-Tandem Mass Spectrometry (LC/MS-MS) or Gas Chromatography/Mass Spectro-
metry (GC/MS). Analyses of the oral ﬂuid and blood samples were conducted to identify the presence of
some 75 drugs and metabolites, including illegal, prescription, and over-the-counter drugs. Further, to
make the results most useful, we identiﬁed three broad categories of drugs: illegal, prescription, and
over-the-counter.
Results:
Comparison of overall drug prevalence by time of day indicates that 11 percent of drivers in the daytime
sample were drug-positive. This level was signiﬁcantly lower than the 14.4 percent of night-time drivers
who tested positive for drugs (p < .01).  Comparison of drug categories by time of day revealed that, based
on oral ﬂuid analyses, almost 6 percent of daytime drivers tested positive for drugs in the  Illegal  cate-
gory (primarily marijuana and cocaine), as opposed to over 10 percent of night-time drivers. There was a
statistically signiﬁcant diﬀerence between daytime and night-time drivers (p < .01). Overall, 16.3% of sur-
vey night-time drivers were positive for at least one drug. 
Conclusion:
This 2007 NRS is more extensive than any previous NRS study and provides a much broader perspective
on alcohol and drug use in the driving population than previously available. These data are essential to de-
veloping more precise estimates of the presence of alcohol and other drugs in drivers, and in measuring
the prevalence of alcohol- and drug-involved driving. 
Keywords: Alcohol- and drug-involved driving 
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2007 U.S. National Roadside Survey:
Alcohol Results
Lacey John, PIRE
Tara Kelley-Baker, Senior Research Scientist, PIRE, Calverton, MD, United States; John Lacey, Mr., PIRE,
Calverton, MD, United States; Robert Voas, Dr., PIRE, Calverton, MD, United States; Eduardo Romano,
Research Scientist, PIRE, Calverton, MD, United St
Objective:
This presentation will report the prevalence estimates for alcohol-involved driving derived from the re-
cently completed fourth U.S. National Roadside Survey (NRS) of night-time weekend drivers. 
Method:
The 2007 National Roadside Survey involved randomly stopping drivers at 300 locations across the 48
contiguous states in the United States. Data were collected during four 2-hour night-time periods (10 p.m.
- 12 a.m. and 1 a.m. - 3 a.m. on Fridays and Saturdays) at 240 locations. A unique feature of the 2007 survey
was that data were also collected during two 2-hour Friday daytime sessions (9:30 a.m. - 12:30 p.m. and
1:30 p.m. - 3:30 p.m.) at 60 locations. Breath samples were obtained from 9,413 drivers. 
Results:
Compared to the 1996 survey, there was a signiﬁcant reduction in 2007 in the percentage of night-time
drivers on the road with positive BACs in the low range, between .005 and .049 g/dL. There were also sta-
tistically signiﬁcant reductions in drivers with BACs in the .05 to .079 g/dL range, and .08 to .149 g/dL
range. Reductions at BAC levels of .15 g/dL or higher were recorded in each successive survey, although
due in part to the small sample size at these BACs, these reductions were not statistically signiﬁcant.
Conclusions:
The comparison of the BAC test results from the four NRS studies suggests that there continues to be a
downward trend in the proportion of drivers with positive BACs on U.S. roads on weekend nights.
Keywords: Alcohol- and drug-involved driving 
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2007 U.S. National Roadside Survey:
Methodology
Lacey John, PIRE
Richard P. Compton; John Lacey, Mr., PIRE, Calverton, MD, United States; Tara Kelley-Baker, Senior Re-
search Scientist, PIRE, Calverton, MD, United States; Robert Voas, Dr., PIRE, Calverton, MD, United Sta-
tes; Eduardo Romano, Research Scientist, PIRE, Calv
Objective:
This presentation will describe the methodology for the 2007 U.S. national ﬁeld study to estimate the
prevalence of alcohol-, drug-, and alcohol-and-drug-involved driving, primarily among night-time weekend
drivers, but also daytime Friday drivers. 
Methods:
This study involved randomly stopping drivers at 300 locations across the continental United States;
sites were selected through a stratiﬁed random sampling procedure. Data were collected during a 2-hour
Friday daytime session at 60 locations and during four 2-hour nighttime periods (10 p.m.   12 a.m. and 1 a.m.
- 3 a.m. on both Friday and Saturday nights) at 240 locations. Both self-report and biological measures
were taken. An objective was to obtain at least 7,500 oral ﬂuid samples for analysis. 
Results:
Biological measures included breath alcohol measurements on 9,413 respondents, oral ﬂuid samples
from 7,719 respondents, and blood samples from 3,276 respondents. Oral ﬂuid and blood samples were
subjected to laboratory screening and LC/MS-MS and GC/MS conﬁrmation respectively for both alcohol
and 20 categories of drugs. These data were analyzed to develop the ﬁrst national prevalence estimate of
alcohol- and drug-involved driving.
Conclusion:
The 2007 NRS data collection procedures represent a breakthrough in roadside survey techniques. These
data extend our knowledge of the prevalence of alcohol- and drug-involved driving on our Nation s roads.
Participation rates for the 2007 NRS were fairly high (83.4% for the total sample of eligible drivers) and
the number of drivers who were selected to participate approximately doubled from 1986 to 1996 and
again from 1996 to 2007.
Keywords: Alcohol- and drug-involved driving 
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Enforcing drug drivers by the Norwegian Police
Service
Larsen Roar Skjelbred, National Mobile Police Service
Objective:
The purpose of the lecture is give an introduction to how the NPS are planning and carrying out control to ex-
pose drivers aﬀected by drugs.  The current Road Traﬃc Act § 22 states that it is illegal to drive under the in-
ﬂuence of all intoxicating and anaesthetic agents.   Drug driving is an impairment law.  That means the police
must prove through a blood sample and a specialist statement that the driver is under the inﬂuence when
driving.  
To make a control of a driver suspected of the inﬂuence of drugs, the police must have reasonable grounds
for suspicion of an oﬀence.  That is, the suspicion must be justiﬁed on the basis of visual observation e.g
large pupils, pale and stressed behaviour.
It is the Medicines Act that regulates what is considered to be drugs (illicit) and medicines.  The most com-
ments drugs when drug driving in Norway are Benzodiasepam, Cannabis (THC), Amphetamine, Cocaine and
Morphine (Heroin, Methadone).  The illicit drugs are not divided into diﬀerence classes. 
Methods:
If the police suspect a driver for the reasonable grounds to be under the inﬂuence of drugs, the driver will be
asked to conduct a clinical trial by the police oﬃcer.  The test is called  the sign and symptoms of drugs or
other medicines.  Norwegian police oﬃcers have been trained in the methods since the 1990s.   To use the
methods  the sign and symptoms of drugs or other medicines  a police oﬃcer had to go to a three-day theo-
retical course at the Norwegian Police University College.
Results:
The results of using the method of  Signs and symptoms  have led to many drivers prosecuted for driving
under the inﬂuence of drugs or misuse of medicine.  Annually reviewed the police report approximately 4500
drivers for driving under the inﬂuence of drugs or medicines.
Conclusion
In 2010, the Norwegian Parliament presumably adopts a change of the Road traﬃc law that gives police the
power to test the drivers  saliva without reasonable grounds for suspicion.  This will increase the detection
risk. In addition, a regulation providing instruction for limits of sentence for drug driving similar to the BAC li-
mits.  This will free up police resources for investigation and reduce the need for expert opinions. The goal is
to reduce the fatal accidents caused by drug or drink driving.
Today, blood from the suspended driver is approved as evidence in cases where the driver is suspected of
driving under the inﬂuence of drugs.  As screening and a temporarily test we would like to use oral ﬂuid tes-
ting before taking blood as evidence.  We do not use urine as screening roadside, because a positive urine
test can just be used as suspicion of use of drugs but not inﬂuence according to the Road Traﬃc Act. 
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Successful Implmentation of New Legislation
Leonard Anne, arrive alive DRIVE SOBER
Purpose: 
To maximize the deterrent eﬀect of new provincial and federal legislation intended to:
- prevent impaired and distracted driving;
- reinstate convicted drivers with restrictions and education that changes their behavior;
- address repeat oﬀenders/drivers who fail to comply with driving restrictions/prohibitions
To reach fully licensed drivers including professional drivers and employers and refresh their knowledge
of consequences for impaired and distracted driving.
Method:
Provide employers with current information on latest legislation/consequences around impaired driving
and other transit-related issues including short-term licence suspensions and vehicle impoundment;
share suggestions and resources to establish and facilitate policies for same. Create and promote a pac-
kage of information for employers/human resource departments.
Results :
Drinking Driving 101: What you need to know about latest provincial and federal legislation has been sha-
red with municipalities, public health, police, and other professionals via workshops and conferences. The
resource has required frequent updating because of continuous changes to Ontario s HTA legislation;
changes have been made regarding short term suspensions, escalating sanctions, vehicle impoundments,
and more. Drinking and Driving 101 has been shared at conferences, for taxi driver training, and with public
health. The concept of a province-wide version that can be identiﬁed and oﬃcially adapted has been dis-
cussed with the Minister of Community Safety and Correctional Services and members of the policing in-
dustry.
Conclusion:
Having and enforcing tough measures has been acknowledged by Traﬃc Injury Research Foundation as
fundamental in preventing impaired driving. Drivers need to know the legislation with all its current con-
sequences and the many changes that have been brought in over the last few years. Employers are
equally well-advised to know what s at stake in terms of their ﬂeet s exposure and employers should have
policies in place for drivers who may come to work without a valid driver licence. 
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Road Stories for Young Drivers
Leonard Anne, arrive alive DRIVE SOBER
Purpose: 
To address the disproportionate numbers of young people involved in serious and fatal collisions: Ontario
drivers aged 16-24 are four times more likely to be in a fatal crash while speeding and three times more li-
kely to be in a fatal collision while drinking and driving (ORSAR). Traﬃc Injury Research Foundation identi-
ﬁed teenagers as being at a high level of risk on our roads with 40% of all teenage fatalities resulting
from road crashes.  Our purpose was to create an educational product for youth that includes drivers and
passengers and addresses all forms of risky driving: drunk, drug-impaired, distracted, aggressive, and fa-
tigue.
Method:
arrive alive DRIVE SOBER®, Ontario Students Against Impaired Driving, Student Life Education Com-
pany and Ontario s Ministry of Transportation collaborated on the production of iDRIVE: Road Stories.
The video reﬂects most current legislation. Road Stories was ﬁlmed in  reality style  with an entertaining,
interactive, social norming approach. Even promotional materials engage viewers by asking:  3 seconds x
60 km/h = ? meters    the same question forms the basis for a  Road Stories POP Quiz .
Results :
Road Stories was launched at OSAID s annual conference in Oakville on May 8th 2009. Almost 1,900 co-
pies were shared within the ﬁrst six months; a further 2,000 copies were purchased by Ontario Public He-
alth Educators Association for inclusion in Ontario s high school curriculum. Road Stories is part of
Ontario s approved driver education curriculum. The video has been shared with youth through conferen-
ces and workshops,  tour dates  with motivational speakers, at professional sporting events, and on-line.
Road Stories is available in French.
Conclusion:
iDRIVE: Road Stories is well received at every level and has become a valuable tool in raising awareness
of new legislation and strategies for prevention. Road Stories is currently being evaluated by a Queen s
University Bachelor of Education student. 
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Eﬀects of insomnia and chronic use of
hypnotics on driving performance
Leufkens Tim, Maastricht University
Jan Ramaekers, Prof. Dr., Maastricht University, Maastricht, Netherlands; Al de Weerd, Dr., Sleep Cen-
tre SEIN, Zwolle, Netherlands; Wim Riedel, Prof. Dr., Maastricht University, Maastricht, Netherlands;
Annemiek Vermeeren, Dr., Maastricht University, Maas
Objectives:
The severity of residual eﬀects of hypnotics on driving performance has been mainly determined in stu-
dies using healthy volunteers. Responses to these eﬀects may diﬀer, however, between insomniacs and
healthy volunteers due to the underlying sleep disorder. Insomniacs  performance is expected to improve
due to the sleep improving eﬀects of hypnotics and, consequently, the net eﬀects of hypnotics on day-
time performance may be less in patients than in healthy volunteers. In addition, a majority of insomniacs
uses hypnotics chronically resulting in the development of tolerance to the impairing eﬀects. Impaired
driving performance in healthy volunteers may then be an overestimation of the eﬀects in patients.
Methods:
The study consisted of two parts. Part 1 compared driving performance between 22 insomniacs chroni-
cally using hypnotics, 20 unmedicated insomniacs and 21 healthy, age-matched good sleepers. Driving
performance was assessed by a standardized driving test on a primary highway in normal traﬃc.
Part 2 compared driving performance following evening administration of zopiclone 7.5 mg between 16 in-
somniacs chronically using hypnotics, 16 unmedicated insomniacs and 16 healthy, age-matched good slee-
pers in a 3x2, double-blind, placebo controlled crossover design.
Results:
Results of the ﬁrst part showed that driving performance was not aﬀected in insomniacs, irrespective of
use of hypnotics.
In the second part it was shown that zopiclone 7.5 mg signiﬁcantly impaired driving performance in both
insomnia groups and healthy controls. The magnitude of impairment was, however, signiﬁcantly less in pa-
tients chronically using hypnotics.
Conclusion:
Insomniacs appear to be able to successfully perform a one hour driving task that requires prolonged at-
tentional demands. Chronic use of hypnotics does not seem to change driving performance. The residual
eﬀects of zopiclone 7.5 mg on driving performance are attenuated in patients chronically using hypnotics.
Yet, this does not result in an absence of impairing eﬀects in these patients. 
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The life course of Dui Oﬀenders
Lillsunde Pirjo, National Institute for Helth and Welfare
Objectives:
The main questions in  The life course of DUI oﬀenders  study were: 1) what are the factors that lead to
driving under inﬂuence of alcohol and/or drugs? 2) what happens to DUI oﬀenders during their subse-
quent life span in terms of health and social position? 3) what kind of preventive conclusions can be
drawn? The project is part of the Addiction Research Programme of the Academy of Finland in 2007-2010.
Methods:
As the principal data set, the study employed the register of all suspected DUI cases in Finland during
1977 2007 The data included over 450 000 DUI oﬀenders apprehended by the police with positive ﬁnding
for alcohol and/or illicit/licit drugs. The DUI register was linked with other national registers, e.g. Census
ﬁles of Statistics Finland, Police Statistics, Motor Vehicles Registration Centre, National Prescription Re-
gister, Hospital Discharge Register, Pension Statistics and Causes of Death Register.
Results:
The changes in the number of drink driving cases during 1989 2007 followed changes in trends of econo-
mic development and changes in overall alcohol consumption. Young men aged 18 19 years were at the hig-
hest risk of committing drink-driving oﬀences. The incidence of suspected drugged driving cases
increased 18-fold during 1977 2007. The most frequently found drugs were benzodiazepines, amphetami-
nes, cannabinoids and opioids. Poly-drug ﬁndings were common (77%). Drivers with amphetamines only
had the highest re-arrest rates. Also young age, male sex, high blood alcohol level, arrest during the night
time and during weekdays were the factors that constituted the risk for re-arrest. 
DUI suspects had an increased risk for premature death overall, and for all observed causes of death. Dis-
advantaged social background was a signiﬁcant predictor of DUI.
Conclusion:
A comparison of results would be interesting with other countries where these kinds of linked, register-
based studies are possible. 
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Analysis of Opiates, Amphetamines and
Buprenorphine in Oral Fluid by Rapid Screen
Device, GC-MS, and LC-MSMS
Liu Ray, Fooyin University
Ray H. Liu; Hsiu-Chuan Liu; Dong-Liang Lin,  Institute of Forensic Medicine, Taipei , Taiwan; Yu-Shan
Wang, Institute of Forensic Medicine, Ministry of Justice, Taipei, Taiwan; Meng-Yan Wu, Fooyin Univer-
sity, Kaohsiung Hsien 831, Taiwan, Kaohsiung Hsien,
Objective: 
Study using oral ﬂuid as the diagnostic and performance-related test specimen has increased signiﬁ-
cantly in recent years. In this preliminary study, three categories of analytical methodologies were asses-
sed to explore their potential for the analysis of abused drugs using oral ﬂuid as the test specimen.
Method:
SYNTRON Saliva Screen Drug Test (Method I), Agilent LC-(triple quadrupole) tandem MS (Method II), and
Agilent GC-MS (Method III) methodologies were used to analyze two sets of oral ﬂuid specimens collec-
ted from patients under a substitution therapy program. Specimens were analyzed directly, with centrifu-
gation, and with extraction-derivatization for the analysis by Methods I, II, and III, respectively.
Results:
Compared to Method II, Method I was found to exhibit less favourable detection limits for the analysis of
opiates and amphetamines. On the other hand, Method III was found to achieve lower detection limits,
than Method II, when applied to the analysis of buprenorphines. The detection limits of Method II were
around 1, 1, and 3 ng/mL, respectively, when applied to the analysis of amphetamines, opiates, and bupre-
norphines.
Conclusion:
Direct analysis of oral ﬂuid by LC-tandem MS, without using extensive specimen pre-treatment proto-
cols, was found to achieve reasonably favourable detection limit and quantitation data. GC-MS methods
require extensive sample preparation steps and larger size of specimen that may not be available, while
the rapid screen approach does not provide quantitative data and may not reach the desired level of de-
tection limit.
Oral ﬂuid, Drug of abuse, Liquid chromatography-tandem mass spectrometry 
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Approaches to Estimating Measurement Un-
certainty in Forensic Breath Alcohol Analysis
Logan Barry, NMS Labs
Objective:
Present an empirical approach to estimating measurement uncertainty in forensic breath alcohol analy-
sis.  There is am emerging demand for calculations of uncertainty in legal metrology of blood and breath
alcohol concentrations.   This is being driven by the recent National Academies of Science Report as well
as requirements of accrediting organizations.  In jurisdictions where per se thresholds have been set for
alcohol, and the potential diﬀerence in sanctions for being above or below a set administrative threshold,
the decision maker should be provided with the measurement results along with a clear statement of the
uncertainty.  Reporting forensic breath alcohol results along with an estimate of their measurement un-
certainty will demonstrate their ﬁtness-for-purpose as well as enhance the conﬁdence of the courts and
other decision makers in accepting them.  While understood conceptually by forensic toxicologists, the
computation and interpretation of measurement uncertainty is often daunting, and is currently perfor-
med only rarely.  
Methods:
This presentation illustrates a well established empirical approach for estimating the combined uncer-
tainty for breath alcohol determinations.  The estimations combine the uncertainty from major contribu-
tors including:  1) Traceability, 2) Bias, 3) Simulator, 4) Breath test instrument and 5) the Breath Sampling
component.  
Results:
For assumed breath alcohol results of 0.085 and 0.089 g/210L, the combined uncertainty is estimated to
be 0.0022 g/210L with and expanded uncertainty (k=2) of 0.0044 g/210L.  The 95% conﬁdence interval
would be 0.0785 to 0.0924 g/210L.  Other approaches to estimating uncertainty include: 1) applying inter-
laboratory or proﬁciency test results, 2) subtracting a constant value such as 0.006 or 6%, 3) ensuring the
lower 99.9% conﬁdence limit exceeds the critical legal value.
Conclusions:
Computing measurement uncertainty will become a more common practice in forensic toxicology.  We
have presented a straightforward and well established empirical method for computing such uncertain-
ties in breath alcohol analysis, and compared it to other approaches.  These methods can also be automa-
ted in spreadsheet programs such as Microsoft Excel.  The 99% expanded uncertainty for breath alcohol
analysis amounts to approximately the mean measurement result +/- 9%.  These results are ﬁt-for-pur-
pose in DUI litigation. 
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Case Reports of Impaired Driving Resulting
from Butalbital Use
Logan Barry, NMS Labs
Objective:
Butalbital (Fiorinal, Fioricet) is a barbiturate commonly used in the treatment of tension headaches. The
sedative hypnotic eﬀects of the drug make it a potentially high-risk medication for drivers, and it is fre-
quently reported as being the most commonly encountered barbiturate in driving populations.     This pre-
sentation will describe a series of DUI arrests where the impairment was attributed to butalbital.
Methods:
Twenty-one drivers arrested for driving under the inﬂuence, who later tested positive for butalbital were
evaluated by drug recognition expert (DRE) oﬃcers, and their driving pattern, ﬁeld sobriety test perfor-
mance, DRE evaluations scores, and toxicology results evaluated.
Results:
Driving behaviors included erratic lane travel, no headlights, weaving, driving on the shoulder or curb, stri-
king parked vehicle, hits and rub, slow speeds, stopping in intersection, driving oﬀ the road, collisions and
near collisions, striking ﬁxed objects, driving into oncoming traﬃc, failing to stop at traﬃc signals. Overall
the driving patterns were consistent with marked psychomotor intoxication, with obvious problems in
gross motor vehicle control.  Subjects commonly could not perform or performed very poorly on ﬁeld so-
briety tests having marked balance problems, and sway. Subjects also displayed horizontal gaze nystag-
mus, and at concentrations above therapeutic routinely displayed vertical gaze nystagmus also.
Butalbital concentrations ranged from 1 to 30.3mg/L, with a mean and median of 16mg/L. Eight of the 21
subjects had concentrations within the recognized therapeutic range of 1-10mg/L, although these fre-
quently had other drugs present including codeine, and nortriptyline, the concentrations were low or the-
rapeutic. Alcohol was present in only two cases at low concentrations (0.02g/100mL). 
Conclusions:
Butalbital has a side eﬀect proﬁle of drowsiness, sedation, dizziness, and feelings of intoxication. Conse-
quently, it should be used with caution by drivers, or others in safety sensitive occupations. 
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State of the drugs problem in Europe:
Innovations in the drug market challenge
routine detection
Lopez Dominique, EMCDDA (European Monitoring Centerfor Drugs and Drug Addiction)
Objective and methods:
The EMCDDA publishes an annual report on the state of the drugs problem in Europe, based on informa-
tion provided by the EU Member States, candidate countries and Norway. The report provides an over-
view of the drug phenomenon in 30 countries, and contains facts, ﬁgures and analysis for Europe as a
whole and by country. 
Results:
The 2009 report shows that although levels of use of the more established drugs remain high, Europe ap-
pears to be entering a relatively stable phase regarding these substances. No major increases were noti-
ced and, in some areas, trends appear to be downward. Indicators for amphetamine and ecstasy use, for
example, suggest an overall steady or declining trend. New data conﬁrm a continued fall in cannabis use,
particularly among young people. Despite such positive developments, the dynamic nature of the drug
problem presents ongoing concerns and future challenges. Among the issues underscored is Europe s in-
creasingly complex and volatile synthetic drug market, where highly innovative suppliers circumvent drug
controls by oﬀering unregulated alternatives to controlled drugs. While this practice is not new, what is
new is the wide range of substances now on oﬀer; the growing use of the Internet and the rapidity with
which the market reacts to controls.
Conclusion: 
The appearance of new substances (Spice-like products, mephedrone etc.), alternatives to controlled
drugs, and their increased use may pose more challenges for interventions and detection, monitoring and
risk appraisal. Indeed, some users declared using legal alternatives to circumvent drug testing. While the
range of available substances grows and polydrug use increases, detection becomes more complex; the
implications on the European roads might be almost immediate. 
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Multiple DWI Oﬀenders Show Poorer Decision-
making Performance than Healthy Controls
Maldonado Sioui, Douglas Mental Health University Institute
Thomas Brown, Dr., Douglas Hospital Research Center, Montreal, Canada; LOUISE NADEAU
Objectives: 
A deﬁcient somatic marker of the emotional signalling system may lead to poor decision-making in ambi-
guous high-risk situations, such as driving while impaired (DWI) by alcohol. In this pilot study, we test the
hypothesis that DWI recidivists will exhibit a poorer decision-making performance on the Iowa Gambling
Task (IGT) and weaker somatic activation (using anticipatory skin conductance response as index) than
healthy controls (HC).  As a preliminary step, we present here the results from our decision-making data. 
Methods:
Two groups were recruited, [DWI (n=25) and HC (n=16), mean (± SE) ages 45.4 (1.87) for DWI and 37.3 (2.9)
years for HC]. Selection criteria included being 18 years old or older and two or more DWI convictions (for
DWI), or lifetime zero DWI convictions and a driver s license (for HC). The dependent variable was the
mean number of cards chosen from bad decks throughout a 100-cards IGT task (divided into ﬁve blocks
for analysis).  Analyses were conducted on blocks 1-3 only due to blocks 4 & 5 response anomalies.
Results: 
ANOVA repeated measures on blocks 1 to 3 with age as a covariate produced a signiﬁcant eﬀect of group
by block interaction (F[2, 78]=3.64, p<.05, ?2 = .06).  Dunn Sidak alpha adjusted two-sample post hoc t-
tests revealed the signiﬁcant eﬀect at block 3, indicating that recidivists (M=11.12, SD=4.32) chose signiﬁ-
cantly more cards from the bad decks than controls (M=7.23, SD=4.57) in block 3 (t[40]=2.79, p<.05).
Conclusion: 
DWI recidivists performed more poorly than controls on the IGT, failing to learn over time, and persi-
stently making decisions based on potential immediate gains rather than long-term outcome, neglecting
associated loss risks. This suggests they may have neurocognitive decision-making deﬁcits distinguis-
hable from the general population.  While DWI recidivists  behaviour appears as impulsive, these results
suggest that it is more speciﬁcally decision-making that is impaired. 
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Mass screening for drug abuse in traﬃc
Mansson Per, Biosensor Applications Sweden AB
Bengt Hagander, Biosensor Applications Sweden AB, solna, Sweden
Biosensor Applications has developed a novel rapid on-site drug screening method. The method has been
evaluated in traﬃc situations as well as in several controlled studies. 
The objective in the studies was to determine the performance of the method to collect and analyse oral
and sweat samples in two minutes for use in mass screening, especially in traﬃc situations.
Methods:
Volunteers were given a single dose of either around 30mg of D-methamphetamine (30 study persons),
100mg MDMA (29 study persons) placebo (30 persons) or one cannabis joint (5 study persons). Sweat
samples and oral samples from the tongue were collected and analysed by using a Biosens instrument. 
We also conducted studies in drug rehabilitation centre (two studies) and in collaboration with the traﬃc
police.
Results:
The results from the controlled studies show a signiﬁcant positive response in 16 of the study persons in
the sweat samples from both the D-methamphetamine group (n=30) as well as in the MDMA group (n=29). 
The cannabis study showed that THC could be detected in oral samples more than three hours after smo-
king. 
Separate studies in a naïve cohorts show a false alarm rate on <5%.
The results from the studies conducted at drug rehabilitation centre show an agreement between urine
analysis and sweat analysis between 60-95% depending on type of drug. 
Conclusions:
The Biosens on-site mass screening method opens up for a completely new possibility to detect driving
under the inﬂuence of drugs. Both the oral as well as sweat can be used to probe use of drugs. The detec-
tion window is generally shorter than urine analysis. Until today available on-site screening devices are
expensive and have capacity constraints particularly in limited personnel situations.  
The whole procedure including collecting and analysis of the oral or sweat samples takes around two
minutes 
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Changes in alcohol biomarkers during an
average 8 months of interlock controlled driving
Marques Paul, PIRE
Objective:
To use a panel of alcohol biomarkers to evaluate change in drinking (as distinct from drinking-driving) du-
ring a period of ignition interlock installation. We know interlocks reduce drinking-driving. Much evidence
shows during the months of interlock use, DWI recidivism decreases, the rate of failed interlock BAC
tests decline, even while total driving remains unchanged.  But do interlocks reduce drinking per se?
Methods:
Convicted DUI oﬀenders, who installed alcohol ignition interlocks as a path to license reinstatement, sig-
ned informed consent and agreed to participate in a research study.  From among 302 individuals who
provided a baseline biological samples (blood, urine, and/or hair), 169 were also willing to provide a subse-
quent set of samples at an average 8 months after the initial sample.  Blood was analyzed for the markers
GGT, PEth, %CDT as well as conventional markers (ALT, AST, MCV).  
Results:
Among 169 participants providing paired blood samples there was no signiﬁcant change in levels of the
medium and high sensitivity alcohol biomarkers (GGT, %CDT, PEth, gamma-CDT) from initial to followup
blood samples an average of 8 months apart.  However, if the analysis is restricted to the 68 subjects
(40%) having %CDT> 2.5 IU at the ﬁrst measurement, or the 58 (34%) having PEth >.7 μmol/L, or the 45
(27%) having GGT>50, then after log normalizing the data series to reduce skew there is a signiﬁcant drop
(P=.001, .003, .001 respectively) in blood marker levels an average of 8 months later. The same is true for
gamma-CDT, a combination of GGT and CDT.
Conclusion:
For the average user, interlocks do not appear to alter drinking, but when the analysis is restricted to
those with higher program entry alcohol biomarkers, levels decline signiﬁcantly during the interlock pe-
riod. Whether this is true change or simply regression to the mean is not clear. Support
NIAAA5R01AA014206 
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Comparison of First and Repeat Oﬀenders on
Independent Drinking Indicators: Interlock BAC
Test Positives and Alcohol Biomarker Levels
Marques Paul, PIRE
Objective: 
To compare independent risk estimates of ﬁrst- relative to repeat-oﬀender drinking using alcohol bio-
marker and the BAC results from interlock breath tests.
Method:
Convicted DUI oﬀenders (346 ﬁrst time and 183 repeat oﬀenders), who installed an alcohol interlocks as
a path to license reinstatement, signed informed consent and agreed to participate in a research study.
Not all participants provided biological specimens but among those who did, blood, hair and urine sam-
ples for GGT, PEth, %CDT, ALT, AST, MCV, EtS, EtG, and FAEE were measured in up to 302 oﬀenders for
blood markers and at least 91 for hair derived alcohol markers.  BAC tests, calculated as a rate of tests
above .02 g/dL or .04 g/dL from the interlock served as a parallel source of information. All participants
also ﬁlled in psychometric assessments.
Results:
First time oﬀenders had alcohol biomarkers levels signiﬁcantly lower for three of four blood markers
(PEth, gamma CDT, GGT) and urine EtG and EtS relative to those found in the biological materials of re-
peat oﬀenders. This was the case whether analyzed with log normalized parametric or rank order non-
parametric statistics. ALT, AST, MCV, hair FAEE and hair EtG did not diﬀer. Beyond biomarkers, the rate of
failed BAC tests much more strongly and signiﬁcantly discriminated the ﬁrst time oﬀenders from the re-
peat oﬀenders in this sample. Repeat oﬀenders had a higher density of failed BAC tests, both the overall
rate of fails and the failed morning BAC tests.
Conclusions:
First oﬀenders are known to be a signiﬁcant public safety risk, but they appear to drink less than repeat
oﬀenders as indicated by two independent measures: high sensitivity alcohol biomarkers and rates of
total positive interlock BAC tests and positive morning BAC tests, a proxy for heavy evening drinking.
Support NIAAA 5R01AA014206 
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Eﬀects of dexamphetamine with and without
alcohol on simulated driving
Martens Marieke, TNO Defense, Security, and Safety   dept. of Traﬃc Behaviour
Ries Simons, MD, ., .
Objectives:
The aim of the present study was to assess the eﬀects of dexamphetamine (d-AMP) with and without al-
cohol (EtOH) on simulated driving and driving-related cognitive performance.
Method:
In a randomized, within-subject, placebo-controlled study, 18 participants were included in each of the fol-
lowing treatments: 10 mg d-AMP + 0.8 g/kg EtOH, 10 mg d-AMP + EtOH-free drink, 0.8 g/kg EtOH + pla-
cebo, and placebo + EtOH-free drink. The study was double-blind for dexamphetamine, whereas alcohol
was not administered in a blinded fashion. Performance was assessed using cognitive tasks (critical trac-
king and divided attention (CTT-DAT), Psychomotor Vigilance Task (PVT), and Vigilance and Tracking Task
(VigTrack)) and a driving task in a simulator, studying driving performance indicators, risk taking behavi-
our and situation awareness. 
Results:
BAC-levels were 0.090 % at the start and 0.064 % at the end of the simulated driving test. VigTrack, PVT,
and CTT-DAT scores were signiﬁcantly impaired in the EtOH condition and impaired to a lesser degree in
the d-AMP+EtOH condition. Best performance of these tests was found in the d-AMP+placebo condition.
Results of the driving test are presently analysed with speciﬁc reference to indices of risk taking behavi-
our.
Conclusion:
Cognitive performance was signiﬁcantly impaired by 0.09-0.06 % EtOH, while a single dose of 10 mg am-
phetamine was associated with improved performance. Data concerning the simulated driving test, as
presently under analysis, may learn whether or not the combination of d-AMP with EtOH may conﬁrm the
hypothesis that such combination may lead to increased risk taking. 
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Drinking and other traﬃc accident risk factors
in Africa: Data from the World Health Surveys
Martinez Priscilla, Norwegian Center for Addiction Research
Priscilla Martinez, Norwegian Center for Addiction Research, OSLO, Norway; Jørgen Bramness, Norwe-
gian Center for Addiction Research, OSLO, Norway; Thomas Clausen, Norwegian Center for Addiction
Research, OSLO, Norway
Objectives:
Traﬃc accidents are an important cause of death in Africa. This study aims to determine risk factors for
traﬃc accidents at the population level among 18 African countries. 
Methods:
Data were collected during the World Health Survey between 2002 and 2004 in 18 Sub-Saharan African
countries, 65,712 adults aged 18 and older were included. Standardized questionnaires via face-to-face
interviews collected data. Risk factors considered were alcohol use, smoking, and depression. Smokers
were deﬁned as current, daily smokers. Alcohol measures were based on daily consumption over the pre-
vious 7 days. Depression was based on ICD-10 and involvement in a traﬃc accident over the previous 12
months recorded. Bivariate associations between risk factors and traﬃc accidents were examined, and
multivariate logistic regression was used to determine the relation of these factors to traﬃc accidents.  
Results:
Overall, 2.1% had been involved in a traﬃc accident, 6.5% met criteria for depression, 13.1% were smo-
kers, and 19.9% were current drinkers. All drinking patterns had higher rates of current smoking (p<0.01),
and depression was more common among current drinkers (p<0.01) and smokers (p<0.05) than their ab-
staining counterparts. In bivariate analysis, current drinking (p<0.05) was associated with traﬃc acci-
dents. Controlling for signiﬁcantly associated covariates (gender, education, marital status, working for
pay, smoking, depression, drinking), traﬃc accidents were associated with male gender (OR 1.6, 95% CI
1.1-2.4), education (1.2, 1.1-1.3), depression (1.6, 1.2-2.2), and smoking (2.5, 1.4-4.2) 
Conclusion:
Smoking and depression as independently associated with traﬃc accidents could represent risk factors
for and consequences of traﬃc accidents in Africa. The lack of an association between current drinking
and traﬃc accidents could be due to the frequency based measure of alcohol use instead of a measure of
alcohol exposure while driving. Nonetheless, the overall model suggests understanding how risk factors
interact is important for traﬃc accident research. 
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Guidelines for DRIUD roadside surveys,
and the resulting design for the Netherlands
Mathijssen René, SWOV Institute for Road Safety Research
Sjoerd Houwing, Mr., SWOV Institute for Road Safety Research, Leidschendam, Netherlands
Objectives:
To guarantee representative and comparable survey results for each of the 13 participating countries.
Methods:
Stratiﬁcation of the roadside driver sample by place (region, research area, road type and research loca-
tion) and time (division of the whole week into eight DRUID day/time categories). During the survey sessi-
ons, drivers had to be selected at random from moving traﬃc. 
Since some prevalence data were intended to be used as control data in a case-control study, where blood
samples were collected from injured drivers, the preferential body ﬂuid to be collected at the roadside
was also blood.
Results:
In the Netherlands, six research areas have been selected, covering the various regions of the country.
Within each research area, twelve survey sessions have been conducted, each covering four research lo-
cations. In each research area, all eight DRUID day/time categories were covered. 
Out of a total of 5,064 randomly selected drivers, 242 (4.8%) refused to cooperate. Among the remaining
4,822 valid subjects, 77.9% delivered a blood sample and 22.1% a saliva sample.
Conclusions:
After adjustment for diﬀerences between the traﬃc and sample distributions by time and place, the re-
sulting distribution of psychoactive substances among the survey sample was probably fairly representa-
tive of the substance distribution among the general driving population in the Netherlands. Non-response
bias was probably small.
This abstract has been produced under the research project "DRUID", funded by the European Commis-
sion within the framework of the EU 6th Framework Programme. 
This abstract reﬂects only the authors  views. The European Commission is not liable for any use that may
be made of the information contained therein. 
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Evaluation of a checklist of clinical signs of
impairment (CSI) during drug
Mathijssen René, SWOV Institute for Road Safety Research
Sjoerd Houwing, Mr., SWOV Institute for Road Safety Research, Leidschendam, Netherlands
Objectives:
To evaluate a preselection method for the detection of drugged drivers, aimed at promoting roadside
drug testing eﬃciency.
Methods:
- In the framework of EU research project IMMORTAL, SWOV developed a CSI checklist, supplemented
with a short questionnaire regarding recent use of psychoactive medicines and illicit drugs. All signs and
symptoms could be observed without performing complicated tests. The checklist was based on several
existing checklists, among others one developed for the German police.
- The checklist was evaluated analytically in the framework of both the IMMORTAL project and the subse-
quent DRUID project. Based on comparison of the checklist outcomes with the results of toxicological
analyses, sensitivity and speciﬁcity of the checklist have been assessed.
Results:
- In the framework of DRUID, a sample of 4082 drivers were evaluated using the checklist. Sensitivity tur-
ned out to be rather low (32%), while speciﬁcity was rather high (98%).
- A similar evaluation among a sample of 954 drivers in the framework of IMMORTAL produced better re-
sults: 61% sensitivity and 99% speciﬁcity.
- Two factors may have caused the diﬀerences between DRUID and IMMORTAL results. In IMMORTAL,
urine and blood were analysed, against blood and oral ﬂuid in DRUID. Additionally, in IMMORTAL most
evaluations were conducted by only one police oﬃcer, who got more and more experienced throughout
the project, whereas in DRUID many diﬀerent police oﬃcers conducted the evaluations.
Conclusions:
Outcomes of the CSI checklist may improve by training police oﬃcers. Enforcement activities at times
and places with high drug driving incidence may also positively inﬂuence the reliability of the checklist.
This abstract has been produced under the project DRUID, funded by the European Commission within
the framework of the EU 6th Framework Programme. 
This abstract reﬂects only the authors  views. The European Commission is not liable for any use that may
be made of the information contained therein. 
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Drink-driving trend 2000-2008 and the actual
alcohol-related road toll in the Netherlands
Mathijssen René, SWOV Institute for Road Safety Research
Sjoerd Houwing, Mr., SWOV Institute for Road Safety Research, Leidschendam, Netherlands
Objectives:
To assess the drink-driving trend, the actual state of drink driving and the resulting road toll.
Methods:
- Roadside surveys of drink driving. Between 2000 and 2008, a national roadside survey was conducted
by the Ministry of Transport.
- Case-control study of drink driving. In the Netherlands, fatally injured drivers, for various reasons, are
not tested for alcohol and drugs. In order to estimate the road toll resulting from drink driving, a case-
control study was conducted by SWOV, between May 2000 and March 2004.
- Prevalence study of drink-driving. Between January 2007 and July 2009, SWOV conducted a representa-
tive roadside survey of drink driving, covering the whole year, all days of the week and all times of the day.
Results:
- Between 2000 and 2008, the proportion of drivers with BAC = 0.5 g/L decreased from 4.4 to 2.9%. The
proportion of drivers with BAC = 1.3 g/L, however, remained stable around 0.5% during the whole period. 
- Based on the 2000-2004 case control study by SWOV, one quarter of the severe and fatal road injuries
were estimated to be alcohol-related. Approximately three qarters of these injuries were caused by into-
xicated drivers with  BAC =1.3 g/L.
- Results of the 2007-2009 prevalence study, like the results of the Ministry's roadside surveys, indicate
that the proportion of high-BAC drivers hardly changed between 2000 and 2009. Consequently, neither
did the proportion of alcohol-related injuries. The absolute number of alcohol-related fatalities, however,
decreased signiﬁcantly due to a general reduction of road fatalities. High-BAC drivers are especially over-
represented during Saturday and Sunday mornings (4-10 AM) and during Friday, Saturday and Sunday
nights (10 PM-4 AM). 
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LEGISLATION PACKAGE - regarding law and
enforcement for driving under the inﬂuence of
other drugs than alcohol.
Mathisrud Grete, Norwegian Ministry of Transport and Communications
Garnes Lennart
LEGISLATION PACKAGE - regarding law and enforcement for driving under the inﬂuence of other drugs
than alcohol.
Through the last 10-20 years Norway has seen an increase in driving under the inﬂuence of other drugs
than alcohol. 
Although Norwegian police is rated as very competent in the detection of impaired drivers (e.g. through
road side drug recognition expert-testing), Norwegian legislation addressing driving under the inﬂuence
of other drugs than alcohol has been considered to have weaknesses.
It may be argued that current legislation represents an imbalance between the rules on alcohol related to
impaired driving (per se based 0,2 BAC limit and legal authority for the police to conduct random road
side breathalyzer testing) and the rules regarding drug-impaired driving (no per se based limits, individual
impairment assessment conducted by the court based inter alia on a medical doctors clinical examina-
tion,  blood sample analysis and opinion of expert toxicologist.  At present there is no legal basis for the
Police to conduct random roadside testing, e.g. salvia based tests). 
As an answer to these shortcomings, and with the objective to improve road safety and facilitate a more
eﬀective use of resources, the Norwegian government will thus propose a legislation package foreseen
several amendments to the Norwegian Road Traﬃc Act introducing, inter alia: 
" Very low zero-tolerance based per se limits for when a driver is considered legally impaired.
" Limits for other drugs than alcohol (e.g. THC and benzodiazepines) corresponding to BAC levels 0,5 and
1,2, which if exceed may lead to considerably stricter sentencing, i.e.  imprisonment.   
" Legal competence for the police to conduct random road side salvia based testing (non-evidential scree-
ning).
" Lower threshold for driving license withdrawal for novice drivers.
" Legal basis for the police to impose drivers with a suspected alcohol or drug abuse-problem to undergo
medical examination. 
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Trends in the Alcohol-Fatal Crash Problem in
Canada
Mayhew Daniel, Traﬃc Injury Research Foundation
Ward Vanlaar, Dr., Traﬃc Injury Research Foundation, Ottawa, Canada; Robyn Robertson, Ms., Traﬃc In-
jury Research Foundation, Ottawa, Canada; Katie Wood, Research Associate, Traﬃc Injury Research
Foundation, Ottawa, Canada
Objectives:
This paper examines trends in the magnitude of the alcohol-fatal crash problem in Canada overall and for
diﬀerent groups of fatally injured drivers deﬁned in terms of age, gender, and type of vehicle driven   e.g.,
automobile, motorcycle, truck.
Methods:
Information on the presence of alcohol in fatally injured drivers is used in this paper as an index of the al-
cohol fatal-crash problem in Canada.  In this regard, the overall rate of testing for alcohol in fatally injured
drivers in Canada exceeds 80% annually. The results of alcohol tests on fatally injured drivers are exami-
ned by blood alcohol concentration (BAC) levels (e.g., 0 mg%, 1-49 mg%, 50-80 mg%, 81-160 mg%, 161
mg% and over) over a 21-year period from 1987 to 2007.   
Results:
The magnitude of the alcohol-fatal crash problem in Canada declined dramatically in the 1980s, increased
during the early 1990s, and then declined again between 1992 and 1999.  In 1992, 48% of fatally injured
drivers were positive for alcohol compared to 33% in 1999, the lowest point in the past three decades.  In
2000 and 2001, however, there have been increases in the alcohol-fatal crash problem and since then
there has been little change with 35% to 38% of fatally injured drivers positive for alcohol.  A similar
trend is apparent for fatally injured legally impaired drivers with BACs over 80 mg%.
Conclusion:
The paper considers the factors that could have contributed to these trends and the reasons for the lack
of progress recently. 
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Eﬀects of Washington State's First-Oﬀender
Alcohol Ignition Interlock Law
McCartt Anne, Insurance Institute for Highway Safety
William Leaf, Preusser Research Group, Inc., Trumbull, United States; Mark Solomon, Preusser Research
Group, Trumbull, United States
Objectives:
In 1999, Washington State began to require courts to order alcohol ignition interlock installation for re-
peat DUI oﬀenders and ﬁrst-time oﬀenders who refused the alcohol test or had a  high  BAC >0.15%. Im-
portant subsequent law changes included moving the program from the courts to the Department of
Licensing in July 2003 and requiring interlocks for all people convicted of DUI in June 2004. The study exa-
mines how these law changes aﬀected case adjudications, the number of interlocks assigned and instal-
led, and rates of recidivism among ﬁrst-time oﬀenders. 
Methods:
Based on driver license records, ﬁrst-time oﬀenders were classiﬁed by type of adjudication (e.g., high-
BAC DUI conviction). Trends were examined during 1999-June 2009 for overall adjudication and adjudica-
tion types, interlock assignment and installation, and recidivism. 
Results:
During 1999-June 2009 274,127 people received adjudications related to ﬁrst-time alcohol-impaired dri-
ving oﬀenses, including deferred prosecutions (11%), reductions to non-alcohol charges (27%), high-BAC
DUIs (10%), DUIs with BAC<0.15% (45%), and DUIs with test refusal (7%). Over the study period two-year
recidivism rates varied by adjudication, ranging from 3.6% for deferred prosecution to 14.6% for high-
BAC DUIs. Adjudication types were tracked over time. Counts of orders requiring interlocks increased
over time but were far fewer than the numbers of oﬀenders who appeared to qualify for orders; interlock
installations recorded on the driver record lagged even more. Recidivism rates were tracked overall and
by adjudication type in relation to law changes, trends in interlock orders and installations, and whether
oﬀenders installed interlocks.
Conclusions:
US states increasingly require interlocks of all DUI oﬀenders, and it is important to examine how these
requirements aﬀect the actual imposition of an interlock requirement and drivers  decisions to install
interlocks. The ﬁnal report will include analysis of law eﬀects on recidivism. 
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Signs of impairment: Clinical or behavioral ?
From medicine to ﬁeld evaluation
Mercier-Guyon Charles, cermt
Michel Mallaret, cermt, Anency, France
Objectives:
If some countries have implemented procedures for clinical evaluation of impaired drivers many other
countries focus on biological evidence.
The countries where detection needs a suspicion of impairment have trained police force to use behavi-
our tests in place of required medical doctors.
The countries where biological detection is allowed have left their procedures of behavioural evaluation,
and replaced them by biological evidence.
today, the complexity of the causes of impairment in drivers lead to many questions about which proce-
dure has to be used and by who
Methods:
The purpose of this paper is to open the discussion in the working group session on clinical signs of im-
pairment through comparisons between countries and police or justice procedure, 
Results:
Some signs like hearth rate, blood pressure, should oﬀend the public opinion in certain countries as be-
longing only to medical personals.
Detection of clinical signs of drugs use is also considered as a medical ﬁeld. Even an interview by a police-
man about medical diseases is also considered, in many countries, as something that would be refused in
justice courts.
On the other hand, traditional impairment test batteries have reached their limits with the new drugs and
combination of multiple drugs.
Conclusions:
Medicine has developed new clinical tools to explore the use of psychotropic substances. 
New tests or new batteries could be proposed to detect their use. 
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Evaluation of 3 levels pictograms on medicines
boxes in drivers and health professionals in
France
Mercier-Guyon Charles, cermt
D.Carra, M.Mallaret, I. de Beauchamp, C.Mercier-Guyon  
Following a request from the French Road Safety Council (Prevention Routiere), CERMT gave in 2000 a
report on the categorisation of medicinal drugs regarding to driving ﬁtness. This report was the base of a
regulation implemented in France by the French medical Agency (AFSSAPS) in 2005.
The 3 level pictogram is based on a four level categorisation
The Class 0 concerns the drugs which have no demonstrated eﬀects on driving ability.
The Class I requires caution from the driver
The Class II requires the advice of a health professional
The Class III requires the authorization of a medical doctor before driving.
Such categorisation seems to be a necessary ﬁrst step for some changes in the prescriptions of drugs,
taking more into account the side eﬀects on driving, and proposing to the practitioners to use the safer
drugs for driving patients. 
This study was led in 3 populations:
Pharmacists and pharmacy s employees (81)
Medical doctors (38)
Patients driving (32)
Concerning the pharmacists and pharmacy s employees, the questionnaires concerned their knowledge
about the pictogram and the categorisation of drugs, the advices they use to give while delivering the me-
dicines and the usual questions from patients.
Concerning the medical doctors, the questionnaires concerned their knowledge about the pictogram and
the categorisation of drugs, the advices they use to give while prescribing the medicines and the usual
questions from patients.
Concerning the patients, the questionnaires concerned driving situation, opinion on driving risk, know-
ledge about eﬀects of medicines on driving, and questions about the impact of the diﬀerent pictograms
on their driving behaviour.
The study demonstrate the interest from booth population for more information about driving risk and
medicines, for more readable information in the package insert, and, from professionals, for more infor-
mation and training to inform and educate the patients. 
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Positive eﬀects of Red Bull® Energy Drink on
driving performance during prolonged driving
Mets Monique, Utrecht University
Monique Mets, MSc, Utrecht University, Utrecht, Netherlands; Sander Ketzer, Utrecht University, Ut-
recht, Netherlands; Camilla Blom, Utrecht University, Utrecht, Netherlands; Maartje van Gerven, Ut-
recht University, Utrecht, Netherlands; Gitta van Willigenb
Introduction:
Prolonged highway driving can be aﬀected by sleepiness. The purpose of this study was to examine the
eﬀects of Red Bull® Energy Drink versus placebo. 
Methods:
24 healthy volunteers participated in this double-blind placebo controlled crossover study. After 2 hours
of driving in the STISIM driving simulator subjects had a 15-minute break in which they consumed Red
Bull® Energy Drink (250 ml) or placebo (Red Bull® Energy Drink without the functional ingredients) be-
fore driving 2 additional hours. A third condition comprised 4 hours of uninterrupted driving. Primary
parameter of the highway driving simulator test was the Standard Deviation of Lateral Position (SDLP),
i.e. the weaving of the car. Secondary parameters included the standard deviation of Speed, subjective
driving quality, mental eﬀort to perform the test, and subjective sleepiness. 
Results:
In the ﬁrst two hours, no signiﬁcant diﬀerences between the treatments were observed on any parame-
ter. Relative to placebo, Red Bull® Energy Drink signiﬁcantly improved driving: SDLP values were signiﬁ-
cantly reduced during the 3rd (p<0.046) and 4th hour of driving (p<0.011). During the 3rd hours, Red Bull®
Energy Drink  signiﬁcantly reduced the standard deviation of Speed (p<0.004). In line, for the 3rd hour of
driving after consumption of Red Bull® Energy Drink subjects reported signiﬁcantly improved driving
quality (p<0.0001) and reduced mental eﬀort to perform the test (p<0.024). During both the 3rd and 4th
hour of driving, subjective sleepiness was signiﬁcantly less pronounced after Red Bull® Energy Drink
when compared to placebo (p<0.001 and p<0.009, respectively). Relative to prolonged driving, the eﬀects
of Red Bull® Energy Drink were signiﬁcant for each parameter during both the 3rd and 4th hour of dri-
ving, except for mental eﬀort during the 4th hour of driving.
Conclusion:
Red Bull® Energy Drink signiﬁcantly improves driving performance during prolonged driving. 
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Evaluating new ways to communicate risk: how
patients perceive pictograms about medicines
and driving ability
Monteiro Susana, University of Groningen
Rene Huiskes, University of Groningen, Groningen, Netherlands; Julia van Weert, PhD, University of
Amsterdam, Amsterdam, Netherlands; Liset van Dijk, PhD, Netherlands Institute for Health Services
Research, Utrecht, Netherlands; Han de Gier
Objectives: To evaluate the eﬀectiveness of a pictogram in communicating risk associated with driving impai-
ring medicines to patients. To assess patients  level of understanding, and intention to change behaviour when
looking at various pictograms.
Methods: A structured interview involving 270 patients visiting 1 of 3 Dutch community pharmacies, in the city
of Groningen, where two studies using a 2x3 design were conducted. In the ﬁrst study, the respondents (patients
with a driving license visiting a community pharmacy) were exposed to a condition in which the pictogram
(DRUID* or homologue French pictogram) and the risk category (category I, II or III) were manipulated. In this
study, both pictograms were accompanied by the same side-text. In the second study, the added value of the
side-text was examined. Here, the respondents were exposed to a DRUID pictogram with or without side-text
and again one of the three risk categories.
Results: 50.7% of the respondents were male with a mean age of 48.4 years-old and with a high education level
(45.6%). After observing either the DRUID and the French pictograms, respondents recognized the risk of dri-
ving while taking driving impairing medicines. 78.8% of the respondents stated being likely to change their be-
haviour in the presence of a medicine with such pictograms. 36.3% of the respondents said they would drive
less frequently and 40.7% wouldn t drive anymore. 81.5% of the respondents stated it would be unlikely to
change the intake of their medicines. Patients showed preference for the 3 categories presented in the DRUID
pictogram and 73.3% of the respondents felt that the side-text of the DRUID pictogram was helpful.
Discussion/Conclusion: Both the DRUID and the French pictograms appeared to be eﬀective in communicating
risk. The majority of the respondents recognized the risk of driving while taking driving impairing medicines and
were willing to change their driving behaviour by driving less frequently. The pictogram didn t inﬂuence respon-
dents  way of taking their medicines.
When comparing the DRUID and the French pictograms, respondents preferred the DRUID one. It was also clear
that the side-text in the DRUID pictogram was perceived as added value when compared to the other DRUID
pictogram, without any side-text.
*  Driving Under the Inﬂuence of Drugs, alcohol and medicines  is ﬁnanced by the European Community within
the framework of the EU 6th Framework Program. This abstract reﬂects only the authors  views. The European
Community is not liable for any use that may be made of the information contained therein.
ORAL ABSTRACT
121
Detection time of direct alcohol markers, ethyl
glucuronide (EtG) and ethyl sulfate (EtS), in
oral ﬂuid and urine after dosing to 0.08%
Moore Christine, Immunalysisi Corporation
Paul Marques, Dr., PIRE, Calverton, MD, United States; Cynthia Coulter, Laboratory Supervisor, Immu-
nalysis Corproation, Pomona, United States
Objective:
To determine if the surveillance window for detection of EtG and EtS in oral ﬂuid compares favorably to
their time course in urine, following consumption of ethanol. Both alcohol markers are known to be reco-
verable from urine for 2-6 times longer than ethanol can be measured in blood.
Methods:
Nine adult research subjects (4 female, 5 male) provided informed consent and agreed to self-dose with
an amount of alcohol calculated to raise blood alcohol content (BAC) to approximately 0.08% in 60-90
minutes.  BAC from breath was estimated with fuel cell breath test devices from zero baseline to zero re-
turn.  Urine samples and oral ﬂuid (via Quantisal" devices) were collected at 8 hour intervals for 2 days be-
ginning at dosing. EtG and EtS were measured by liquid chromatography with tandem mass spectral
detection (LC-MS/MS). Ethanol in both urine and oral ﬂuid were measured by EIA and headspace gas
chromatography.
Results:
As expected, both EtG and EtS were detected in urine up to 41 hours after the start of drinking; 32 hours
after the BAC had returned to zero. Surprisingly, EtG was not detected in any oral ﬂuid samples; however,
EtS was detected up to 18 hours after the start of drinking and eight hours after the BAC was zero.  Etha-
nol was present only in the samples taken approximately 6 hours after drinking commenced.
Conclusions: 
The presence of EtS in oral ﬂuid is reported for the ﬁrst time. EtS was detected in oral ﬂuid specimens for
an average of 9.2 hours following alcohol dosing calculated to reach 0.08% within 60   90 minutes. 
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Random drug tests among public vehicle
drivers of Iran
Motevalian Seyed Abbas, Iran University of Medical Sciences
Introduction: 
The national burden of disease study showed that road traﬃc injuries and opioid use-related mental dis-
orders were the ﬁrst and ﬁfth cause of burden of disease in Iran accordingly in 2003. International evi-
dence; which is mostly based on data related to patients using prescribed opioids; shows that opioid use
is not a risk factor for traﬃc injuries. Recent studies conducted in Iran; which is based on data related to
drivers who are either opioid abuser or opioid dependent; indicates that opioid use is a major risk factor
of traﬃc injures. To reduce this risk factor, a media campaign followed by random drug tests of public ve-
hicle drivers in roads of the country was started in 2007. The objective of this study was to assess the re-
sults of random drug test among large vehicle drivers before and after this campaign. 
Methods: 
Two diﬀerent national roadside surveys were conducted on 1168 and 680 drivers in 2002 and 2008 re-
spectively. In both studies, the subjects were bus and truck drivers and their urine samples were tested by
a rapid morphine test at study sites and positive samples were transferred for Thin Layer Chromato-
graphy (TLC).
Results:
In 2002, 168 drivers out of 1168 (14.4% CI95%: 12.4-16.4) were found to have positive morphine test. The
second roadside survey which was conducted after media campaign showed that this proportion has de-
creased to 9.0% (CI95%: 7.0-11.4).
Discussion:
Opioid use among large vehicle drivers is a major public health and road safety issue in Iran which needs
more attention. Random drug test supported by a media campaign seems to have promising eﬀects on
reducing driving under inﬂuence of drugs. 
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Women driving while intoxicated
Müller Karin, ABV Gesellschaft für Angewandte Betriebspsychologie und Verkehrssicherhei mbH
Lena Czupalla, c/o Impuls GmbH, Köln, Germany
Objectives:
In Germany 83441 driving licences have been withdrawn during the year of 2008 because of driving while
intoxicated (DWI). If there is determined a blood alcohol concentration amounting to 0,16% or more while
driving, a medical-psychological assessment (MPA) is necessary before the driving licence can be regran-
ted. The MPA consists of a psychological interview, a psychophysical assessment as well as a medical
examination. More than 90 % among the approx. 60000 persons, which had to participate in a MPA in
2008 because of DWI were male. However, the portion of female clients rises continuously, so it has to be
asked whether and to which extent gender-speciﬁc aspects have to be considered in the MPA. The pre-
sent study is based on current results about the behaviour diﬀerences between female and male drivers
as well as gender-speciﬁc alcohol drinking and abuse. 
Method: 
The documents of 111 female and 106 male MPA clients were retrospectively analyzed under the following
aspects: demographic characteristics, data about their behaviour in traﬃc, drinking habits, medical ﬁn-
dings. The results were presented to experts for evaluation.
Results:
Concerning the demography and behaviour in traﬃc, no signiﬁcant gender-speciﬁcs could be determined.
Female MPA clients rather seem to tend to a male self concept. Diﬀerences between women and men can
be ascertained regarding their drinking habits as well as the induced changes of behaviour. 
Conclusions:
Implications for the investigation of women in the MPA are discussed. It has to be asked, whether and to
what extent gender tendencies are reﬂected in a MPA and which relevance they have for the evaluation of
especially women s   driving aptitude. 
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Non-alcohol drugs and driving
Mørland Jørg, Norwegian Institute of Public Health
The impact of drugs of abuse and medicinal drugs on traﬃc safety is subject to increasing concern.  Vari-
ous roadside studies have revealed that a substantial percentage of drivers  has used psychoactive drugs
shortly before driving.  The number of drivers with drug ﬁndings in epidemiological studies will depend on
where and when sampling is performed (time of the day, day of the week), and on age and gender of the
driver.  In a recent Norwegian roadside study of a representative driving population, we found that 4.5 per
cent of the drivers had non-alcohol drugs (3.4 % psychoactive medicinal drugs, 1.0 % illegal drugs) and 0.4
alcohol, in oral ﬂuid samples. It could be estimated that approximately, 10-20 % of those with drugs pre-
sent, probably drove impaired by these drugs.
Among drivers killed in vehicle crashes, data from various countries have shown that non-alcohol drugs as
a group, are found as frequent as alcohol, and that various combinations of non-alcohol drugs are often
observed.  The most commonly detected non-alcohol drugs in such studies are THC, CNS-stimulants, ben-
zodiazepines and opioids.  Various analytical epidemiological studies have indicated that these drug clas-
ses are also associated with increased risk of involvement in crashes.  This evidence is not as ﬁrm as
existing evidence  for alcohol, and there are also very few studies on risk related to the blood non-alcohol
drug concentrations.
Experimental studies of traﬃc relevant impairment after intake of non-alcohol drugs are many, although
not as comprehensive as for alcohol, but as for alcohol the studies indicate increasing impairment with in-
creasing drug dose (and concentration in blood).  However, the most important CNS-eﬀects of any psy-
choactive drug (including alcohol) behind the increased risk of traﬃc accidents, have not been clearly
deﬁned, and accordingly the relevance of various experimental tests can be discussed.
The epidemiological literature on drivers with non-alcohol drug use demonstrating dangerous driving, has
indicated diﬀerences from ordinary drivers as overrepresentation of young age, male gender, regular and
multiple drug use, and driver psychopathology.  It seems therefore appropriate to look further into the
interactions between drug use (pattern of use) and the driver (personality) to better understand the me-
chanisms underlying the dangers of non-alcohol drug use and driving. 
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60 years of ICADTS  the past, present
and future
Nickel Wolf-Rüdiger, ICADTS
Ten years ago the International Council   i.e. ICADTS members celebrated their 50 years anniversary not
far from our current location. We had selected Stockholm, Sweden, because it was there the ICADTS
forerunner, the International Committee on Alcohol and Traﬃc had held its ﬁrst four days conference with
discussions on the role of alcohol and traﬃc safety. Today we have put another 10 years on top of that
and we are celebrating our 60th birthday in Oslo. Happy birthday ICADTS!
The history of ICADS will be covered brieﬂy, highlights, conferences, awards, satellite conferences, wor-
king groups, development of the Foundation, use of money, stipends for young scientists in the ﬁeld. The
scientiﬁc development in the ﬁeld will be elaborated and future needs fro research pointed out.
Further attention will be paid to the development of the membership within the past 60 years and its fu-
ture through attracting more young scientists and increase the number of members from transitional and
developing as well as low income countries. 
Proposals for further improvement will be made as to ICADTS rules and communication between ICADTS
members on all topics in the ﬁeld. The speciﬁc role of our quarterly newsletter, The Reporter, will be des-
cribed and emphasized. 
Finally as ICADTS has begun to develop closer relationships with other organizations in combating driving
under the inﬂuence of alcohol and drugs chances of cooperation for the sake of reducing harm caused by
drink and drug driving will be outlined. The current conference with more than 200 presentations on epi-
demiology, impairment issues, rehabilitation etc. will again be a milestone on the way ahead. 
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How to get high inclusion rates in prevalence
studies
Normann Per Trygve, Norwegian Institute of Public Health
Hallvard Gjerde, Dr, Norwegian Institute of Public Health, Oslo, Norway; Ilah Le Nygaard, Norwegian In-
stitute of Public Health, Oslo, Norway
Objectives:
About 20.000 ordinary vehicle drivers participated voluntary in two road-side surveys in Norway to inve-
stigate the use of alcohol, psychoactive medicines and narcotic drugs, with a participation rate of 88% -
94%. The aim of this study was to examine the success factors for the highest participation rate. 
Methods:
The data collection was performed in close collaboration with The National Police Mobile Force in Nor-
way. The research team met all the individual policeman/woman at seminars where key collaborating
tasks were agreed on. The police stopped the cars and one specially trained and motivated research team
informed the drivers, got an informed consent and collected saliva samples. Each driver spent less than 5
min on the participation. 
Results:
The drives had two possibilities to refuse participation, when they were stopped by the police and by the
research team. In the ﬁrst study the refusal rate was 8% when the drivers were approached by the police
and 4% when the drivers secondly met the research team. The total refusal rate in that study was 12%. In
the second study the police were instructed only to stop the cars and assign the drivers to go to the rese-
arch team. In that study the total refusal rate was 6%. 
Conclusion:
The most important success factor to get low refusal rate in road-side surveys in Norway was obtained
when the police only stopped cars and a dedicated research team gave brief and adequate information
before receiving informed consent. 
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Alcohol and Road Traﬃc Crashes in Kenya
Odero Wilson, Maseno University
Wilson Odero, Professor, Maseno University, Maseno, Kenya
This presentation discusses trends and causes of the growing problem of road traﬃc crashes in Kenya
with special reference to driving under the inﬂuence of alcohol.  The data are derived from traﬃc police
accident statistics, published articles and unpublished reports. 
Road traﬃc injuries are a major public health problem and a leading cause of death and injuries world-
wide.  Each year 1.2 million people are killed and up to 50 million injured from road crashes. In Kenya, more
than 3,000 people are killed on the roads annually and many more injured or disabled. Over the last 10
years, road carnage has increased by 22.5% from 2819 deaths in 2000 to 3633 in 2009. According to traf-
ﬁc police reports, the main cause of road crashes is human error   accounting for 82% of all causes, of
which 43% is attributed to drivers, pedestrians 22%, pedal cyclists 14% and passengers 4%.  Driving
under the inﬂuence of alcohol is common and plays a signiﬁcant role in traﬃc crashes. However, alcohol
use is not usually looked for, and there is no legislation on Blood Alcohol Concentration (BAC) limit for dri-
vers. At the same time, traﬃc police have no equipment and facilities for detecting alcohol. Eﬀorts to es-
tablish BAC limit legislation and enforcement measures have not succeeded, partly due to lack of
suﬃcient data. Few studies have reported alcohol use in more than 23% of accident-involved casualties,
with the highest incidence among males, weekend and night-time drivers. Similarly, in a roadside survey in
western Kenya, 20% of non-accident involved drivers were positive for alcohol by breathalyzer, with
8.4% having BAC in excess of 0.05gm/100ml.  There are no studies examining drugs and traﬃc safety in
Kenya.  
This review concludes that inadequate data on the contribution of alcohol and drugs on traﬃc crashes,
absence of legislation on BAC limit, together with lack of capacity for enforcement are major impedi-
ments to preventing alcohol-related crashes in Kenya. International collaboration is needed to stimulate
and support research on the problem, and to advocate for adoption of eﬀective interventions that will
contribute to overall reduction of road traﬃc crashes and their consequences. 
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The relationship between responsibility for
vehicle accident and presence of drugs in
blood of injured drivers in Victoria, Australia
Ogden Edward, Victoria Police
Carla Morris, Victoria Police, Melbourne, Australia; Tania Frederiksen, Victoria Police, Melbourne,
Australia; Martin Boorman, Inspector, Victoria Police, Brunswick, Australia; Con Stough, Professor,
Swinburne University of Technology, Hawthorn, Australia
ISSUE: To what extent are drivers who have drugs detected in blood samples taken after collision, more likely to
have been responsible for the collision in which they were injured compared with drivers who are drug free?  The
responsibility method has been well established for fatality collisions, but there has been little work matching
toxicology results with collision data for non-fatal collisions. 
OBJECTIVES: The ongoing study examines the incidence of a range of licit and illicit drugs in drivers involved in
non-fatal collisions, and the responsibility of drivers for accident causation.
METHODS: In Victoria, Australia, drivers taken to hospital after a collision have a legal obligation to provide
blood for analysis (Victorian Road Safety Act 1986). Routine screening for drugs other than alcohol commenced
in July 2009, and detected a wide range of drugs including cannabis, benzodiazepines, opiates, amphetamines,
antidepressants and antipsychotics. The current study began as a pilot in December 2008 to match the toxico-
logy results to an analysis of the police collision reports and assign the driver a degree of responsibility. The
hypothesis was that the odds ratio of responsible to not responsible for causing a collision would identify drugs
that cause impairment.
RESULTS: At the time of submission, 881 samples had been analysed and matched with collisions.  Of the inju-
red drivers that tested positive for alcohol, 94.7% were responsible for the collision in which they were injured.
The odds ratio of responsibility for collision showed the expected exponential relationship with blood alcohol
concentration > 0.10%. There was a small increased in culpability with blood alcohol concentration <0.10% asso-
ciated with inexperienced and elderly drivers.  
Benzodiazepines were detected in 14% of samples. There was a strong dose relationship between the level of
drug detected and responsibility for collision. Alprazolam appeared particularly hazardous perhaps reﬂecting
misuse rather than inherent toxicity. Stimulants were detected in 5.7% of drivers with no increase in responsibi-
lity for collision unless combined with another drug. THC was present in 14.1% of samples at levels suggesting
recent use (average 7.5μg/lL). Opiates are detected in 21.6% of samples with the majority being morphine admi-
nistered by paramedics or hospital staﬀ prior to obtaining the blood sample. Antidepressants were found alone,
or in combination with other substances, in 11.4% of injured drivers.
Combinations of drugs increased the likelihood of being responsible for collision. With no drugs or alcohol 53%
of drivers are responsible for the collision, with one or two drugs 75% are responsible, with three drugs 93% are
responsible and with 4 drugs all drivers were responsible.
CONCLUSIONS: This ﬁrst 18 months of this study have demonstrated the relative risk of collision and the risk of
collision associated with speciﬁc drugs. Alcohol was responsible for increased responsibility for collision even
at low levels for inexperienced and elderly drivers. The ongoing work will determine the relative importance of
speciﬁc drugs which will inform development of counter-measures. 
KEYWORDS: drugs, alcohol, non-fatal collision, responsibility analysis, toxicology 
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An integrated software model for alcohol
absorption and metabolism
Ogden Edward, Victoria Police
Henry Swoﬀord, BAC Tracker International, Atlanta, Georgia, United States
ISSUE: Toxicologists are often asked "How much alcohol was consumed to reach this B.A.C.?" "What was
the level of alcohol intoxication at the time of an incident?" or more challenging "What would the blood al-
cohol concentration have been if this individual consumed that amount of alcohol?" The court expects evi-
dence about uncertainty and error which is tedious, requires using several diﬀerent methods of
calculation, and can be awkward to explain.
OBJECTIVES: The pioneering work of Erik Widmark showed that blood alcohol concentration is related to
the amount of alcohol consumed, the time involved and the volume into which the alcohol was distributed.
Widmark assumed that the volume of distribution as a proportion of body weight could be estimated as
0.55 ± 0.11 for women and 0.68 ± 0.17 for men. Various regression formulae have been developed to reﬁne
the ability of predict body water from anthropomorphic data like age, gender, height, weight and age. No
single formula is more precise than the others. Posey and Mozayani (2007) suggested integrating the vari-
ous methods of estimating body water to give a balanced picture of the variability in blood alcohol con-
centration calculations.
RESULTS:  A software package has been developed that integrates the six published models for estima-
ting blood alcohol concentration. The user can set the range of absorption and elimination rates, the sub-
ject data and times of interest. The program estimates the amount of alcohol required to reach a
particular blood alcohol concentration, the range of likely blood alcohol concentrations reached from
given consumption and displays the results in graphs and tables making it easy to demonstrate the range
of possible interpretations of the facts at hand. This has application in providing expert evidence and edu-
cation.       
KEYWORDS: alcohol, metabolism, blood alcohol concentration , software
Disclaimer:  Edward Ogden is on the Faculty Advisory with no pecuniary interest;  Henry Swoﬀord is a Di-
rector of BAC-Tracker International Inc. 
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Girls take action
Ophus Carina, The Norwegian Council for Road Safety
The Norwegian Council for Road Safety (Trygg Traﬁkk) is responsible for promoting traﬃc education in
kindergarten and school, and to provide information about road safety to the public in general. About 25
% of fatal road-traﬃc accidents are involving young drivers and passengers in the age group 15-25. Pro-
moting road safety for this group is an important task for Trygg Traﬁkk. 
One of Trygg Traﬁkks main projects is  Girls take action . It is a campaign for girls age 16-19.  The campaign
combines old and new methods of communication, trying to change bad traﬃcal behavior like drinking
and driving. To communicate with the campaign s members, we use both personally addressed letters
(postage mail), and internet-based social medias as chatting rooms and sms. The goal of the campaign is
to give girls more knowledge, to increase their awareness of risk factors and encourages them to make
safer choices as car passengers. At the same time, the campaign wants the girls to promote road safety
to their friends.
The campaign started in 2007. The ﬁrst year 13 600 girls, age 16, were invited to participate. 16 % of the
girls joined. These girls have for the last three years received a letter four times per year, with diﬀerent
subjects about traﬃc safety. The girls are given tasks that involve talking about this subject with their fri-
ends. The exclusive chatting room provides an arena where they can chat, ask questions and advise each
other. The activity has been high. 
The girls who were invited in 2007 are ending their 3-year membership during spring 2010. An evaluation
of the campaign is conducted by The Institute of Transport Economics and will be presented in May 2010.
The results of this study are therefore not yet known   but will be by the time of ICADTS2010. 
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The neuroscience of recidivism in DWI
oﬀenders: implications for prevention and
intervention
Ouimet Marie Claude, University of Sherbrooke
Thomas Brown, Dr., Douglas Hospital Research Center, Montreal, Canada; Robyn Robertson, Ms., Traﬃc
Injury Research Foundation, Ottawa, Canada; Farah Averill, Douglas Hospital Research Center, Mon-
treal, Canada
Objectives:
The last decades have witnessed constant evolution in laws pertaining to driving while impaired (DWI)
and signiﬁcant decreases in DWI-related morbidity and mortality. These gains have stalled in many coun-
tries. Findings from our team and others suggest that neural factors may limit the eﬀectiveness of cur-
rent laws and relicensing programs in curbing DWI behavior in high-risk oﬀenders. This presentation
summarizes ﬁndings and considers their implications for prevention and intervention.
Methods:
The role of memory, visuospatial capacities, and other executive functions in DWI was explored in 100 re-
cidivists using tests such as the Rey Complex Figure Test and the Trail Making Test (Ouimet et al., 2007).
Oﬀenders delaying engagement in relicensing programs (n=46) were compared to non-delayers (n=74)
(Brown et al., 2008).  The role of decision-making impairments in DWI behavior was explored in 20 recidi-
vists and 20 controls using the Iowa Gambling Task (Maldonado-Bouchard et al., 2010). Finally, two studies
(N=62 and N=41) explored putative epigenetic underpinnings of DWI behavior, speciﬁcally hypothalamic-
pituitary-adrenal axis (HPA) dysregulation, using salivary cortisol (Brown et al., 2005; Couture et al., 2008).  
Results:
Two thirds of recidivists suﬀered from neuropsychological deﬁcits. Oﬀenders delaying engagement in re-
licensing programs had more deﬁcits than non-delayers. Recidivists were found to exercise decision-ma-
king favoring immediate reward. Attenuated cortisol response was the best predictor of recidivism
status over and above self-reported and biological measures of alcohol misuse. Finally, HPA-axis activity
was linked to experience-seeking and other risky behaviors.
Conclusions:
A web of neural factors inﬂuences DWI risk beyond alcohol misuse. Elsewhere, these factors have been
associated with persistent risk behavior, poor judgment, lack of intervention compliance, and poorer out-
comes. As ﬁndings run contrary to many assumptions of current DWI prevention strategies, ideological
and pragmatic challenges posed by alternate strategies (e.g, immediate, positive incentives for participa-
tion in prevention programs) are discussed. 
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What neurobiological deﬁcits in DWI
recidivists may mean for current and future
approaches to prevention
Ouimet Marie Claude, University of Sherbrooke
Thomas Brown, Dr., Douglas Hospital Research Center, Montreal, Canada; Robyn Robertson, Ms., Traﬃc
Injury Research Foundation, Ottawa, Canada; Farah Averill, Douglas Hospital Research Center, Mon-
treal, Canada
The past decades have witnessed constant evolution in laws pertaining to driving while impaired (DWI).
The most notable changes include an increase in the number of possible sanctions and the severity of
sentences, larger ﬁnes following conviction, longer look back periods for counting prior oﬀences for the
purposes of recidivism, and greater use of preventative methods such as the installation of interlock de-
vices and evaluation and treatment for substance misuse. While these initiatives have likely contributed
to the signiﬁcant decreases observed in DWI-related morbidity and mortality since the 1980 s, more re-
cently the rate of gains has levelled oﬀ in many countries. Recent research conducted by our team sug-
gests the potential for important neurobiological deﬁcits in some DWI recidivists. In the alcohol research
domain, these deﬁcits have been associated with the persistence of problem behavior, lack of interven-
tion compliance, and poorer intervention outcome. These ﬁndings raise questions about what current and
future DWI-preventative legal strategies can achieve with this high-risk population, and what innovations
may be needed to make further headway. The main objectives of this presentation are twofold: 1) to consi-
der the rationales neurobiology provide for deploying innovations such as more immediate installation of
restraint devices following a second DWI arrest and provision of incentives to do so; and 2) the conceptual
and pragmatic challenges related to these innovative approaches. 
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Preliminary eﬀorts to strengthen prevention
of drinking and driving in Vietnam
Passmore Jonathon, World Health Organization
Objectives:
Road traﬃc injuries are a leading cause of death and disability in Vietnam.  Oﬃcial reports cite more than
11,000 deaths each year on Vietnam's roads.  Despite the signiﬁcant burden of road traﬃc injuries, little is
known of the impact of speciﬁc risk factors, particularly drinking and driving.
Methods:
Through collaborative eﬀorts between WHO and road safety authorities in the Government of Vietnam, a
range of multidisciplinary good practice activities were implemented nationally and in three project pro-
vinces including:
1. Legislative review and revision
2. Enhanced enforcement training and operations using procured breathalysers
3. Mass media social marketing campaigns 
4. Alcohol blood testing for road traﬃc injured patients presenting at hospitals
Results:
1. Legislative revision reduced BAC thresholds from 0.08 to 0.05g/dl for drivers of four wheel vehicles and
ZERO for motorcycle riders.  A partition ratio error between BrAC and BAC was corrected and prescri-
bed penalties eﬀectively doubled.
2. 40 fuel cell breathalysers were procured and distributed to traﬃc police in three provinces where they
were used for enhanced enforcement operations that breath tested more than 2,700 drivers and riders,
penalising 20% for exceeding the legal limit.
3. The risks and dangers of drinking and driving were communicated through TV, radio, posters, newspa-
per and billboards distributed nationally.
4. Hospital BAC testing of more than 7,500 consenting road traﬃc injury patients from 5 hospitals found
that BAC results ranged from 0-0.606g/dl.  On average, 44% of injured motorcycle riders tested was
found to exceed the legal limit.
Conclusion:
Preliminary information suggests drink driving is a major risk factor for road traﬃc injury in Vietnam.
While further work is required, this introductory program highlighted the magnitude of the role of alcohol
in road traﬃc injuries as well as the willingness of the Government to take action to combat this problem. 
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Summary of presentation about the Brazilian
situation for the ICATDS workshop
Pechansky Flavio, Center for Drug and Alcohol Research, UFRGS
Fernanda Kreische, MD, .; Anne Orgler Sordi, MD, ., .; Raquel De Boni, UFRGS- HCPA, Porto Alegre, Brazil
Brazil had 653.000 traﬃc accidents (TA) victims in 2008, with approximately 38,000.fatal victims. TAs are
the second leading cause of death in the Brazilian young adult population, second only to homicides. TAs
have a high economic impact in the country, since an accident with a victim costs 11 times more than an ac-
cident with no victim, and 44 times more if it is fatal. The causal role of alcohol in this scenario is still un-
deﬁned, since there are no nationwide data on DUI-related accidents. The ﬁrst national eﬀort was
conducted by our research group, on a roadside survey with 3,400 drivers crossing highways near all Bra-
zilian state capitals; 25% of these drivers reported bingeing two to eight times/month, and the overall po-
sitive BAC rate found was 4.8%. Studies conducted in Porto Alegre found that 32% of fatal victims of TAs
had positive alcohol results, 51% of drivers leaving bars after drinking would drive in the next hour, and
47% of the economic costs of fatal accidents were due to alcohol in 2009. Alcohol is the most consumed
legal substance in the country after tobacco, and alcohol dependence seems to be increasing (12.3% ac-
cording to the last statistics). A new  Dry Law  was passed in 2008. According to the Brazilian Ministry of
Health, there was a 23% reduction in the number of hospitalizations and a 22.5% reduction in the number
of deaths related to TAs between 2007 and 2008. Even though surveys suggest reduction in the overall
rate of TAs in emergency rooms, our data suggest that alcohol related TAs are still a public health pro-
blem in the country, probably because of lack of enforcement, since the original reactions to the new law
seem to have faded with time, particularly in urban settings.
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Alcohol and Drugs in Fatal Road Crashes
in Western Switzerland in 2009
Plaut Olivier, CURML Médecine légale
Olivier Plaut, Dr, CURML Médecine légale, Genève 4, Switzerland; Marc Augsburger, Dr, CURML - UTCF,
Lausanne, Switzerland
Objectives:
Alcohol and drugs found in fatal crashes that occurred in western Switzerland in 2009 are reported.
Methods:
Most victims of fatal road crashes in the cantons of Geneva and Vaud are undergoing medical examina-
tion including autopsy and BAC determination, and for some of them comprehensive toxicological analy-
sis. In those cases, urine screening is performed using immunological and chromatographical methods,
followed by quantitation of relevant substances in blood. Relevant substances are primarily drugs of
abuse, followed by drugs that may have an inﬂuence on driving ability. Quantitation is done either by gas
or liquid chromatography coupled to mass spectrometry. Some drugs were analyzed by GC/ECD and
GC/NPD. 
Results:
Geneva and Vaud have about 1 million inhabitants, accounting for 13% of Switzerland residents. They had
in 2009 861732 registered vehicles. 8937 traﬃc accidents occurred, for a total of 65 fatal crashes. Age
ranged from 19 to 93 (mean 42). 85% were men. Out of these 65 accidents, 49 were investigated. 28
cases were negative. 16 cases had a positive BAC (above 0.50 g/kg). Half those 16 cases had alcohol comb-
ined with drugs, whereas 4 cases were positive for drugs only. Among the drugs, cannabis accounted for 5
cases and benzodiazepines were present in 4 cases. Detailed results will be presented in comparison with
living drivers.
Conclusion:
Although the ﬁrst cause of accidents, as reported by the police, is speeding, the problem of driving under
the inﬂuence remains signiﬁcant. About one quarter of deceased drivers had not fastened their seat belt.
This may contribute to transform an accident into a lethal accident independently of a consumption of al-
cohol or drugs. Although such data will be more diﬃcult to collect, comprehensive ﬁgures including dead
and wounded drivers may contribute to better evaluate this issue. 
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Simplifying the Process for Identifying Drugs
by Drug Recognition Experts
Porath-Waller Amy, Canadian Centre on Substance Abuse
Douglas Beirness, Dr., Canadian Centre on Substance Abuse, Ottawa, Canada
Objective:
The purpose of this study is to statistically identify the set of drug-related cues from Drug Evaluation and
Classiﬁcation (DEC) evaluations that signiﬁcantly predict the categories of drugs used by suspected
drug-impaired drivers. 
Methods:
Data from 819 completed Canadian DEC evaluations of central nervous system (CNS) stimulants/canna-
bis, CNS stimulants/narcotic analgesics, cannabis/alcohol and no-drug cases were analyzed using a multi-
nomial logistic regression procedure. 
Results:
Eleven clinical indicators from the DEC evaluations signiﬁcantly enhanced the prediction of drugs used by
suspected drug-impaired drivers, including condition of the eyes, lack of convergence, rebound dilation,
reaction to light, presence of visible injection sites, performance on the Horizontal Gaze Nystagmus Test,
pupil size in darkness, performance on the One Leg Stand Test, muscle tone, and performance on the Walk
and Turn Test. 
Conclusions: 
The ﬁndings from this study will facilitate the process of identifying the correct categories of drugs inge-
sted by suspected drug-impaired drivers by focusing on critical signs and symptoms of drug inﬂuence.
This work will have direct and immediate relevance to the training of Drug Recognition Experts (DREs) by
providing the foundation for an innovative, statistically based approach to drug classiﬁcation decisions
by DREs. This research will also facilitate the enforcement of drug-impaired driving laws in Canada to
help make Canadian roadways safer for all. 
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Predicting DUI recidivism: A study of the im-
pact of alcohol markers and previous drunken
driving
Portman Maria, National Institute for Health and Welfare
The aim of the study was to determine whether the alcohol biomarkers CDT, GGT, the biomarker gamma-
CDT index and previous drunken driving contributed signiﬁcantly to the prediction of DUI recidivism. The
subjects consisted of two diﬀerent samples of drivers, viz. drivers convicted during random breath tes-
ting surveys (RBT-drivers, n=237), and drunken drivers who were apprehended during ordinary police work
(n=193). The drunken driving events were monitored using a data-base both retrospectively (1990) and
prospectively (2006). 
It was found that the biomarker index, gamma-CDT, emerged as a notable predictor of recidivism in the
group of random breath tested drivers. Measurement of gamma-CDT and its impact on DUI recidivism
has not to our knowledge been applied to random breath tested drivers before. The apprehended drunken
drivers did not show a signiﬁcant relationship between gamma-CDT and DUI recidivism. It was also found
that the risk for recidivism increased 2.5 times for RBT-drivers with a blood alcohol concentration (BAC)
=1.20 0 compared with a lower BAC (HR=2.5, 95% conﬁdence level 1.7-3.7). However, the BAC was not a sig-
niﬁcant predictor of outcome among apprehended drunken drivers. In both groups of drivers it was found
that a previous conviction for drunken driving strongly predicted DUI recidivism. 
The results show that the two groups of drivers represent diﬀerent populations of drunken drivers. Thus,
results based on apprehended drunken drivers cannot as such be generalized to concern all drunken dri-
vers.  Random breath testing is the method of choice for eﬀectively studying the prevalence of drunken
driving. This method is also an eﬀective deterrent. The facts that a raised level of alcohol biomarkers and
a BAC =1.20 0  at the time of conviction  are associated with a greater risk of DUI recidivism, could easily
be implemented in the traﬃc safety work to combat drunken driving. 
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Residual eﬀects of esmirtazapine on actual
driving performance : overall ﬁndings and an
exploratory analysis into the role of CYP2D6
phenotype
Ramaekers Jan, Faculty of Psychology and Neuroscience, Maastricht University
Silke Conen, Maastricht university, Maastricht, Netherlands; Eef Theunissen, Ms., Maastricht univer-
sity, Maastricht, Netherlands
Objective:
Esmirtazapine is evaluated as a novel hypnotic drug. Esmirtazapine binds with high aﬃnity to 5HT2 and
H1 receptors, where it acts as an antagonist. H1 antagonists are well known for their sedating properties
and may increase sleep when taken in the evening. However, as with other sedating drugs, the risk of dri-
ving impairment increases if sedation persists during daytime. 
Method:
The study was designed to assess the eﬀects of single and repeated doses of esmirtazapine 1.5 mg and
4.5 mg on actual driving performance in 32 healthy volunteers in a double blind, placebo controlled study.
Treatment with single doses of zopiclone 7.5 mg was included as active control. Driving performance was
assessed by means of a standardized on-the-road highway driving test. The primary parameter was stan-
dard deviation of lateral position (SDLP), a measure of  weaving . All subjects were subjected to CYP2D6
phenotyping in order to distinguish poor metabolizers from extensive metabolizers of esmirtazapine. 
Results:
Overall, esmirtazapine 1.5 mg did not produce any change in SDLP after single and repeated dosing com-
pared to placebo. Driving impairment did occur after a single-dose of esmirtazapine 4.5 mg but was resol-
ved after repeated doses. Acute driving impairment was more pronounced after both doses of
esmirtazapine in a select group of poor metabolizers (N=7). In these individuals, impairment lasted after
repeated administration of the highest dose. A single dose zopiclone 7.5 mg also increased SDLP as ex-
pected. 
Conclusion:
Treatment with 1.5 mg esmirtazapine was not associated with residual impairment.  A single dose of 4.5
mg esmirtazapine produced residual impairment that resolved after repeated administration. Poor
CYP2D6 metabolizers were more sensitive to the impairing eﬀects of esmirtazapine.  These results
underscore the need to take inter-individual variability in either treatment response or drug metabolism
into account when designing studies that investigate drug eﬀects on car driving. 
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Prevalence of drugs in the general population
in Europe
Ravera Silvia, University of Groningen
Han de Gier
Objectives:
To describe the consumption of driving impairing psychoactive substances, both medicinal and illicit
drugs, in the general population, in Europe.
Methods:
Thirty European countries were invited to provide data on the use of driving impairing medicines for the
period 2000-2005, aggregated at the level of the active substance and presented in Deﬁned Daily Doses
per 1000 inhabitants per day. The data on the use of illicit drugs were provided by European Monitoring
Centre for Drugs and Drug Addiction (EMCDDA) and referred to the years 1990-2006. 
Results:
Twelve countries delivered national data on medicinal drug use for the years 2000-2005. Based on these
data, an increased consumption was only seen for the antidepressants. A slight increase, decrease or no
increase was seen for the rest of the study groups. Limitations were encountered when utilization data
were compared between countries, and, therefore, a cross-national comparison could not be performed. 
Despite the fact that tracking trends in illicit drug use was diﬃcult, the EMCDDA data showed that canna-
bis was the most frequently used illicit substance, followed by cocaine. In some European countries the
use of some synthetically produced drugs raised and almost reached the cocaine levels while the preva-
lence of opioid use was relatively stable.
Conclusion:
Our study showed a stable use of both medicinal and illicit drugs, with the exception of antidepressants,
amphetamines, and cocaine. Further research is needed to gain a better understanding of the scale of me-
dicinal and illicit drug utilization in the driving population and the relation between drug use and traﬃc sa-
fety. 
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Three editions of the Belgian drink driving
roadside survey: results and lessons learned
Riguelle François, Belgian Road Safety Institute (IBSR)
Since 2003, a biannual drink driving roadside survey is organised in Belgium by the Belgian Road Safety
Institute. It aims at estimating the rate of driving under the inﬂuence of alcohol and the characteristics of
people doing so. With the help of the police forces, at least 11000 drivers were tested during every survey.
The purpose of this paper is to discuss the methodology and the results from these surveys.
The survey consists of a two-stage clustered sample. In the ﬁrst stage, control locations and time spans
are randomly selected by the Belgian Road Safety Institute and validated by the police. The time spans
cover all the days of the week and all hours of the day. In the second stage, drivers are randomly picked
from traﬃc for a compulsory measure of their breath alcohol concentration (BrAC). Every driver ﬁlls out a
questionnaire about his or her personal characteristics. The data are analysed using the odds ratio techni-
que in order to identify the factors that signiﬁcantly inﬂuence drink driving.
The global percentage of drivers under the inﬂuence (deﬁned as the legal limit of BrAC = 0.22mg/l) was
2% in 2007, but this percentage rose up to 10% during weekend nights. The categories of drivers with the
higher rates of drink driving were the men and the drivers between 40 and 54 year old. No major evolution
was observed in 2007 compared to the previous surveys. The situation during weekend nights even seems
to be worsening.
The prevalence of drink driving is still worrying in Belgium and eﬀorts should be increased to tackle this
problem. The Belgian drink driving survey has proven its usefulness as a tool to monitor the drink driving
problem and to identify the target groups. It is thus an important element to help building the strategy
against drink driving. 
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A Case Study on the Implementation of First
Oﬀender Alcohol Interlock Programs
Robertson Robyn, Traﬃc Injury Research Foundation
Erin Holmes, Research Associate, Traﬃc Injury Research Foundation, Ottawa, Canada; Ward Vanlaar,
Dr., Traﬃc Injury Research Foundation, Ottawa, Canada
Objectives:
A trend toward mandatory participation in interlock programs for all oﬀenders has recently emerged in
the United States. The objectives of this study were to: assess the breadth and scope of activities invol-
ved in translating ﬁrst oﬀender interlock legislation into Administrative Rules, operational practices and
procedures; to determine what level of program eﬀectiveness was achieved; and, to provide guidance to
other jurisdictions either considering or undertaking the implementation of a ﬁrst oﬀender initiative.  
Method:  
This case study research began with the collection and review of relevant implementation materials in Illi-
nois to create the foundation for a detailed overview of the implementation process and a timeline of all
relevant activities and milestones that took place from the passage of the law to the time it took eﬀect.  
The detailed overview of the implementation and timeline provided structure and guidance for key infor-
mant interviews with staﬀ to further augment and expand these documents and measure the process. A
Delphi panel was subsequently organized to collect additional input from key stakeholders and to com-
pare experiences in other ﬁrst oﬀender jurisdictions. Additional follow up information was also gathered
from key informants throughout 2009 to gauge the impact of the implementation process and its outco-
mes. 
Results: 
Results are reported according to the type of implementation strategy selected, the scope and breadth
of tasks completed, the number of agencies and staﬀ  involved, the level of resources required and the
outcomes achieved.  
Conclusion: 
The debate regarding ﬁrst oﬀender interlock programs is complex and both sides are based on compel-
ling research and facts. The question is not whether ﬁrst oﬀender interlock laws should be implemented,
but in fact how these laws can best be implemented and executed. These are questions that jurisdictions
will have to address as the trend towards mandatory ﬁrst oﬀender programs grows. 
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Indication for the examination of drivers
ﬁtness after problematic alcohol consumption
Schubert Wolfgang, DEKRA Automobil GmbH
Caroline Stewin, cand. Dipl.-Psych., Humboldt University of Berlin, Department of Psychology, Berlin,
Germany
Objectives: 
The present study examines the relationship between alcohol consumption and ﬁtness to drive. The legal
basis for establishing the ﬁtness to drive by means of a medical-psychological ﬁtness assessment (0,16
g/100ml or 1,6 0) in Germany will be empirically analyzed. Finally, precise recommendations for the impro-
vement of the current legal situation and administrative practice will be presented.  
Methods:
103 published articles have been analyzed for this study. They had to meet the following criteria: comple-
teness, comprehensibility, and experimental manipulation of the blood alcohol concentration (BAC). The
number of studies that demonstrate alcohol-induced impairments is to be shown in a quantitative analy-
sis. The qualitative analyses of the studies will reveal the areas of psychological and medical functioning
that are impaired by alcohol.
Results:
On the quantitative level, it appears that the majority of 97% of the documented impairments occur at a
maximum BAC of 0,105 g/100ml. Numerous skills are impaired by low doses of alcohol: attention, elec-
trophysiological and brain activity, driving skills, memory, cognitive and intellectual skills, psychomotor
skills, simple and choice reaction time, visual functions, tracking, inhibitory control and perception.
Conclusion:
Alcohol-induced impairments arise at a BAC far below 1,6 promille, which marks the legal limit for a ruling
of a medical-psychological ﬁtness assessment for drunk driving in Germany (§13  Fahrerlaubnis-Verord-
nung/drivers license ordinance). The BAC limit in the current ordinance of 1,6 promille for assigning a me-
dical-psychological ﬁtness assessment is too high and cannot be conﬁrmed empirically. A reduction of
this BAC limit to a value that corresponds with scientiﬁc research and literature is proposed. 
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Druid: Review And Perspectives
Schulze Horst, BAST
Objective:
To present achievements of the RFP 6 IP DRUID, to explain challenges met and responses given.
Methods:
DRUID addresses the danger of all psychoactive substances - alcohol, medicines and illicit drugs - in traf-
ﬁc. The objective is to understand all facets of the problem: consumption, impairing eﬀects, accident risk,
detection, rehabilitation and prevention. BASt, as the Project Coordinator, coordinates joint research ef-
forts of 37 partners from 18 European states working within seven Working Packages who implement
state-of-the-art research and analysis, experimental and epidemiological studies. 
Results: 
- Methodological framework for integrating results of experimental and epidemiological studies
- International database of samples collected Europe-wide from 50.000 drivers and 3.000 injured drivers
using uniform study design 
- Recommendations concerning the practical use of oral ﬂuid screening devices
"- Consensus on 4-level-classiﬁcation system for medicines (more than 600 medicines reviewed and clas-
siﬁed) 
- Overview of European rehabilitation schemes, including recidivism reasons analysis, quality assurance
measures and best practices recommendations
- Overview of withdrawal/ licencing legislation in Europe (30 countries included)
- Recommendations for improving medical guidelines (assessing ﬁtness to drive for patients using psy-
chotropic medicines)
Conclusion:
Project objectives are highly relevant and compatible with EU agenda on the road safety. The Project is on
the good track and will achieve its objectives. Due to the diﬃculties with comparing substance concentra-
tion in saliva, whole blood and plasma, it will be impossible to embrace all psychoactive substances. 
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Alcohol Related Road Accidents in Germany -
Status Till 2008
Schönebeck Susanne, Federal Highway Research Institute (BASt)
Objectives:
In Germany 83441 driving licences have been withdrawn during the year of 2008 because of driving while
intoxicated (DWI). If there is determined a blood alcohol concentration amounting to 0,16% or more while
driving, a medical-psychological assessment (MPA) is necessary before the driving licence can be regran-
ted. The MPA consists of a psychological interview, a psychophysical assessment as well as a medical
examination. More than 90 % among the approx. 60000 persons, which had to participate in a MPA in
2008 because of DWI were male. However, the portion of female clients rises continuously, so it has to be
asked whether and to which extent gender-speciﬁc aspects have to be considered in the MPA. The pre-
sent study is based on current results about the behaviour diﬀerences between female and male drivers
as well as gender-speciﬁc alcohol drinking and abuse. 
Method:
The documents of 111 female and 106 male MPA clients were retrospectively analyzed under the following
aspects: demographic characteristics, data about their behaviour in traﬃc, drinking habits, medical ﬁn-
dings. The results were presented to experts for evaluation.
Results:
Concerning the demography and behaviour in traﬃc, no signiﬁcant gender-speciﬁcs could be determined.
Female MPA clients rather seem to tend to a male self concept. Diﬀerences between women and men can
be ascertained regarding their drinking habits as well as the induced changes of behaviour. 
Conclusions:
Implications for the investigation of women in the MPA are discussed. It has to be asked, whether and to
what extent gender tendencies are reﬂected in a MPA and which relevance they have for the evaluation of
especially women s   driving aptitude. 
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Drug Involvement in Road Traﬃc Oﬀences and
Fatalities in Scotland (1998-2009)
Scott Karen, University of Glasgow
Objective:
This paper will provide a review of the Road Traﬃc data from Scotland between 1998 and 2007 and an
overview of the ﬁndings of the BRITE and IMMORTAL projects.  
Methods:
Between 1990 and 2007, the Department of Forensic Medicine and Science, University of Glasgow, analy-
sed blood and urine samples from drivers suspected of Road Traﬃc Oﬀences in Scotland (with the excep-
tion of one region).  This work was in addition to the toxicological analyses for all post mortem cases in
the West of Scotland.    DUID oﬀences in Scotland have also been widely studied within the Department
through projects such as ROSITA (2001), BRITE (2003) and IMMORTAL (2005).  Observed trends between
the data sets will be presented.  This review will also consider the involvement of drivers, passengers and
pedestrians in road traﬃc fatalities (RTF).  
Results:
With regards to DUID cases the prevalence of cannabis remained relatively stable over the study period,
however the involvement of benzodiazepines and opioids has substantially increased.  In addition, in the
period 2008 to 2009, there were 115 road traﬃc fatalities recorded.  Of these, 112 (97%) were analysed for
alcohol of which 38% were positive.  Drug testing was requested in only 17 (15%) of the cases. When drugs
of abuse screening was carried out, 59% of the cases were positive for one or more drug groups, sugges-
ting that the involvement of drugs in RTF cases in Scotland has been signiﬁcantly underestimated.  
Conclusions: 
The results have shown a change in the pattern of drug use in DUID cases in Scotland.  In the West of Scot-
land there is a need for full toxicological investigation in RTF cases, as historically pathologists have ten-
ded to request alcohol analysis only, leading to a lack of drug toxicology data in these cases. 
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Rapid, Simple, High Perfomance Testing for
Dangerous Substances
Self Colin, Selective Antibodies Ltd
Objectives: 
There is a need for a new generation of rapid road-side tests to improve on those available. The majority
of existing tests are based on competitive-immunoassay-formats bringing well known limitations of this
format to bear: Reverse signal; Limited sensitivity; Control line needed to measure test against; Non-rea-
gent-excess methodology - producing compromises in speed, precision and shelf-life.  These problems
have stimulated interest into ﬁnding ways around the competitive-format, (in which the absence of ana-
lyte is measured) to non-competitive formats (in which the presence of analyte is directly measured).
While a number of formats have been developed, a need has remained for a system that achieves direct
measurement in a simple format that is not only easy to use but also manufacture and put into practice.
Our Selective Antibody system has been developed to meet this need.
Methods: 
Anti-drug (primary) antibody is conjugated to gold-sol and located at the base of a dipstick; sample is
added, allowing drug binding to antibody binding sites; remaining, unbound primary antibody is then  bloc-
ked  by binding a speciﬁc blocking material that blocks it from later being able to bind a secondary anti-
primary antibody against it. The mixture is allowed to migrate up a dipstick through a detector-zone of
secondary antibody. Gold-labeled primary antibody that has bound the drug is able to bind in the detector
zone whereas that bound by blocker is not.  Thus the amount of red gold binding in the detector zone is
proportional to the amount of drug in the sample. 
Results: 
Zero samples  produce no line whereas presence of drug is seen as a clearly observable red line (e.g. met-
hamphetamine at 10ng/ml). Visualisation by eye, or measurement by a simple hand-held reader is very
simple, sensitive and accurate. 
Conclusion: 
This new selective system allows the rapid sensitive detection of illicit drugs. 
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Social Control of the Drinking Driver
Sheehan Mary, CARRSQ
It is more that 20 years since the  Social Control of the Drink Driver  edited by Laurence, Snortum and
Zimring (1988) were published. It was, and remains a major examination of the issue involving 17 scientists
from all relevant disciplines and policy centres and represents the current practice and experience at the
time. While much of, but by no means all, the content  is centred on the North American experience the
scholarship and range of research data explored through the investigative lens of lawyers, pharmacolo-
gists, psychologists, sociologists, criminologists and economists covers all the major issues being exami-
ned in Europe, and Australia at the time. More importantly, it presents the policy aspirations and goals of
nine countries and includes a comparison of deterrence and the legal context in six countries; emerging
technologies for control and the potential contributions of education and rehabilitation.
The experience of promoting evidence based policies and practices are generally experienced in all coun-
tries as both laborious and painfully slow.  However, this ICADTS meeting in Norway provides an opportu-
nity to challenge these feelings by re-examining the current situation compared with that documented
over 20yrs ago.  This presentation will undertake a reality check on just what we have achieved within that
time and try to attribute success and failure towards recommendations for our future endeavours. 
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An Analysis Of Alcohol Breath Tests Results
With Portable And Desktop Breath Testers As
Surrogates Of Blood Alcohol Levels
Shinar David, Ben Gurion University of the Negev
Edna Schechtman, Prof, Ben Gurion University of the Negev, Beer Sheva, Israel
Background: 
There is a perceived tradeoﬀ between the ease of measuring alcohol in the body and the accuracy of the
result. Direct tests of blood alcohol concentrations (BAC) are considered most accurate, desktop statio-
nary breath testers (DBT) based on electro-chemical infra-red technology are slightly less accurate, but
generally acceptable for evidentiary purposes, and portable breath testers (PBT) based on fuel-cell tech-
nology are easiest to administer but unacceptable in many courts.
Objective: 
To compare the accuracies of DBT and PBT relative to BAC and to develop a model that would allow the
use of breath tests without compromising their validity. Method: 61 volunteers were tested for alcohol in
their blood and breath before drinking, and 20m, 40m, and 60m after drinking. Inverse regressions were
used to obtain conﬁdence limits for the alcohol levels as read by the breath testers that would provide
tradeoﬀs of false positives and false negatives (relative to the accepted limits by blood tests). A decision
tree model was developed for the optimal use of the three measures sequentially. 
Results:
The correlations among the methods are r(PBT,DBT)= 0.92, r(PBT,BAC)= 0.88, r(DBT,BAC)= 0.91. PBT
BrAC > 316 mcg/l (used as a ﬁrst screener) or DBT BrAC > 321 mcg/l indicate that the BAC level exceeds 50
mg/dl with a conﬁdence level of 98%. For example, using this DBT threshold in our sample would yield
sensitivity 70.2, speciﬁcity 92.3, false alarms 7.7 and misses 29.8.
Conclusions:
Direct measurement of BAC is the most accurate method. However, it is possible to limit the testing to
less accurate devices with a similar level of conﬁdence when the devices register high BrAC levels rela-
tive to the legal limit. The PBT can be suﬃcient for high BrAC, DBT can be suﬃcient for medium level
BrAC, and blood tests are recommended for still lower BrACs. 
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Death Trip
Skretteberg Henriette, MA
Objectives:
Death Trip is a non-scientiﬁc project. The objectives are:
- Create awareness and aﬀect youths attitudes to drunk driving
- Create and use innovative methods and campaigns to prevent drunk driving
Method:
Death Trip is a competition for youths in high school. They compete in making the best campaign against
drunk driving. Every year there is a ﬁnal in Oslo where 10 ﬁnalists present their campaign. The school with
the best campaign wins 30.000kr. Trough Death Trip MA gets new campaigns to use every year made by
teenagers to prevent drunk driving! 
We are visiting every school that is participating in the competition. At the Kick Oﬀ we give information
about the competition and we engage the students in discussions on how to make a good campaign. The
Kick Oﬀ is crucial for the youths understanding of the competition and of the seriousness of drunk dri-
ving. 
Result:
This year 22 schools participate in the competition. We are expecting approximately 60 diﬀerent cam-
paigns to be submitted and 10 of these will go to the ﬁnal. The ﬁnal will be hold at Filmens Hus in Oslo 28.
April. At the ICADTS conference in August we will be able to present the winner of Death Trip 2010. 
Every year we ask the students to evaluate the project. A lot of the students tell us that participating in
the competition and reﬂecting on their own attitudes towards dunk driving has changed and aﬀected
their attitudes in a positive matter. 
Conclusion:
Every year Death Trip gets diﬀerent campaigns against drunk driving made by youths for youths. By enga-
ging youth to participate in the competition they reﬂect, do research and make campaigns about drunk
driving.  Among other things Death Trip change and aﬀect their attitudes to drunk driving. 
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EtG as a possible indicator of hangover in
crash trauma patients with BAC=0
Smith Gordon, 
Paul Marques, Dr., PIRE, Calverton, MD, United States
Objective: 
To determine if the alcohol consumption biomarkers, ethyl glucuronide (EtG) and ethyl sulfate (EtS) can
be used as a possible indicator of hangover or residual eﬀects of alcohol  in trauma patients with a blood
alcohol level of zero. Elevation of blood alcohol concentration (BAC) is a well-recognized risk factor for
motor vehicle crashes (MVCs) but little is known regarding hangovers and crash risk. Experimental evi-
dence suggests that the residual eﬀects of alcohol impair performance in simulated tasks such as mari-
time and driving simulators but it is unknown if residual eﬀects increase the risk of automobile crashes in
the real world. A major limitation in evaluating the eﬀects of hangovers in non-experimental situations is
the reliance on self reports of heavy drinking the night before with no objective marker available to de-
tect residual eﬀects when the BAC is zero. This workshop seeks expert opinions and advice from partici-
pants on how we can use biomarkers to study alcohol s residual eﬀects and MV crash risk. 
Methods: 
We propose to quantify the role of alcohol s residual eﬀects in MVCs by assessing these biomarkers in
urine among drivers admitted to our trauma center and deaths from the medical examiner.  Culpability
studies  determining the extent to which injured zero BAC drivers with biomarker evidence of  residual ef-
fects are responsible for causing their crash, compared with drivers without hangover biomarkers will be
used as an estimate of risk. We evaluated previous studies of EtG and EtS to determine what levels of the
biomarkers in urine taken some time after heavy drinking could be used to identify individuals at risk of
residual eﬀects 12 to 20 hours later.
Results:
Most EtG studies were restricted to controlled dosing studies, and only BAC levels up to 100 mg/dl were
evaluated because of ethical concerns. We identiﬁed only 2 studies that evaluated biomarker levels se-
quentially in patients admitted for detoxiﬁcation with much higher BACs. These provide the data neces-
sary to suggest a deﬁned biomarker criterion to identify the residual eﬀects of heavy alcohol
consumption after the blood alcohol concentration (BAC) has returned to zero.  We suggest that those
persons with biomarker evidence of residual eﬀects but a zero BAC are those with an EtG level of 45 mg/l
(45,000 ng/ml) or higher; 450 times greater than the minimum detectable levels. 
Conclusion:
We anticipate that participants in this workshop will be able to assist us in deﬁning if we can use EtG and
EtS levels to identify BAC negative individuals who recently had a high BAC. We also seek advice on the
biomarker levels related to time since last drink that can be used to identify individuals at high risk of
hangovers. 
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Medication Warnings About Driving:
Risk Perceptions Among French And
Australian Communities
Smyth Tanya, CARRS-Q
Increased crash risk is associated with sedative medications and researchers and health-professionals
have called for improvements to medication warnings about driving. The tiered warning system in France
since 2005 indicates risk level, uses a color-coded pictogram, and advises the user to seek the advice of a
doctor before driving. In Queensland, Australia, the mandatory warning on medications that may cause
drowsiness advises the user not to drive or operate machinery if they self-assess that they are aﬀected,
and calls attention to possible increased impairment when combined with alcohol.
Objectives:
The reported aims of the study were to establish and compare risk perceptions associated with the
Queensland and French warnings among medication users. It was conducted to complement the work of
DRUID in reviewing the eﬀectiveness of existing campaigns and practice guidelines.
Methods:
Medication users in France and Queensland were surveyed using warnings about driving from both con-
texts to compare risk perceptions associated with each label. Both samples were assessed for percepti-
ons of the warning that carried the strongest message of risk. The Queensland study also included
perceptions of the likelihood of crash and level of impairment associated with the warning.
Results:
Findings from the French study (N = 75) indicate that when all labels were compared, the majority of re-
spondents perceived the French Level-3 label as the strongest warning about risk concerning driving. Re-
spondents in Queensland had signiﬁcantly stronger perceptions of potential impairment to driving ability,
z = -13.26, p <.000 (n = 325), and potential chance of having a crash, z = -11.87, p < .000 (n = 322), after taking
a medication that displayed the strongest French warning, compared with the strongest Queensland war-
ning.
Conclusions:
Evidence suggests that warnings about driving displayed on medications can inﬂuence risk perceptions
associated with use of medication. Further analyses will determine whether risk perceptions inﬂuence
compliance with the warnings. 
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Eﬀectiveness of Alcohol-Oriented Road Safety
Measures in Selected EU Countries
Stastna Lenka, Charles University in Prague / Co author Matus Sucha
Background:
Objectives: Presented study seeks to identify the eﬀectiveness of diﬀerent road safety interventions
across the countries under investigation using road safety indicators.
Methods:
The road safety measures under study include: a) The permitted level of blood alcohol in drivers; b) The
classiﬁcation of driving under the inﬂuence of alcohol as a misdemeanour or an oﬀence with a view to
sanctions; c) The number of penalty points assigned, or deducted, for impaired driving.  The following road
safety indicators were selected: the number of road accidents under the inﬂuence of alcohol; the number
of fatalities under the inﬂuence of alcohol.
Results:
A summary of countries, divided according to their levels of road safety and the numbers of road safety
measures being implemented, is presented. In addition, speciﬁc road safety measures and their eﬀecti-
veness, expressed by the degree of closeness of their relationship with road safety indicators across the
countries under study, are provided.  The results suggest that the permitted level of blood alcohol in dri-
vers has no major eﬀect on the safety indicators (the numbers of alcohol-related accidents and fatalities)
as set. It was shown, however, that there is a relationship between the law enforcement measures (ﬁne,
prohibition of a speciﬁc activity, suspended/unsuspended sentence; system of penalty points) and the
selected indicators (the numbers of accidents and fatalities under the inﬂuence of alcohol): the
longer/more severe sentences for drink-driving (in terms of all the measures under study), the lower indi-
cator levels. 
Conclusion:
The closest relationships between measures and indicators, as well as the correlations between the im-
plementation of diﬀerent measures (the degree to which one measure may be inﬂuenced by another) are
identiﬁed. We may conclude that the measures generally oriented at enforcement appear eﬀective in re-
ducing the accident and fatality rates in relation to the driving under the inﬂuence of alcohol. The question
which remains unanswered is the preventive eﬀect of the measures. 
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Social Media and Its Impact on Introducing
Legislation Aﬀecting Young Drivers
Stewart Katherine, arrive alive DRIVE SOBER
Objective:
To examine opportunities and challenges within the realm of social media that inﬂuences the introduction
of new legislation aﬀecting young drivers.
Method:
Conduct a critical review and analysis of various social media and how youth interact with new legislation
through them. Case studies include the 2008 Facebook incident in Ontario when legislation was announ-
ced, aﬀecting young drivers, extending existing G2 licence restriction (midnight - 5:00 a.m.) to 24/7.  In
four days, a Facebook page  Young Drivers Against New Ontario Laws  gained support of 95,000 users.
This caused the withdrawal of the proposal despite supportive research.  
Results:
Social media platforms are a demonstrated meeting ground for rapid exchange of information and are an
inﬂuential force amongst youth.  The information and opinions being exchanged and disseminated are ra-
rely fact based, resulting in frantic, inaccurate discussion leading to a misinformed public. Information
posted on YouTube and speciﬁc websites is a growing priority for youth awareness and dissemination of
information. These sites serve as a cyber forum for opinions, inadvertently or intentionally misleading and
misinforming their audience. Government has not kept pace with this shift towards the Internet for infor-
mation and dialogue.
Conclusion:
New mediums of social media potentially can educate young drivers, however governments should consi-
der strategies that take into account the potential for social media to hijack legislation or contradict road
safety research through baseless opinion. Strategies should include alliances with youth to better sup-
port and manage on-line dialogue regarding legislation impacting young drivers, such as Ontario Students
Against Impaired Driving (400 chapters; interactive website; alumni of 20,000 student leaders). Such
partnerships would allow real time, on-line response from informed youth leaders to misinformation re-
garding legislation and preclude a repeat of the 2008 incident. 
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A Proﬁle of Stunt Drivers in Ontario
Stewart Sheilagh, Ministry of the Attorney General
J MacPherson, *
Objectives:
To proﬁle drivers issued immediate driver licence suspensions for speeding at 50 kilometres per hour or
more over the limit in Toronto, Ontario, in the ﬁrst two years of the law, to determine alcohol or drug invol-
vement. 
Methods:
Criminal and provincial records of the 875 drivers were reviewed to proﬁle drivers prior to and after the
incident as well as to determine what other actions were taken at the time of the incident.
Results:
Criminal records were found for almost 30% of drivers, with 20% of these having entries for drug oﬀen-
ces and 25% for criminal driving oﬀences, including alcohol-related oﬀences.  Nine drivers had both crimi-
nal driving and drug oﬀences on record.  At the time of the stunt driving only 1% had been drinking, with 2
drivers issued an ADL S suspension (over 80mgs) and 9 issued a warn range suspension (over 50 mgs). Al-
most 90% of the drivers had entries on the provincial record in addition to the stunt driving, but only 4%
had alcohol- related suspensions on record. The predominant oﬀences amongst this population were in-
surance and permit- related, with convictions for seat belt oﬀences representing 10% of other convicti-
ons. Five percent of the population had multiple stunt suspensions in the two years.
Conclusion:
Drivers committing stunt driving merit further study to determine if these results are consistent in a lar-
ger population. Based on a 3-year record, over 80% are experienced violators yet the combination of dri-
ving and alcohol occurred in only 1% of the population with no reports of drug involvement. Although
preliminary, these drivers appear to engage in distinctive high risk driving behaviour not associated with
alcohol or drugs. The population has little regard for provincial driving laws and licencing requirements
yet few have crossed the threshold of alcohol or drug involvement while driving. Further study is needed
to determine if this result is consistent in a larger population so that enforcement and education can be
better targeted. 
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A Preliminary Proﬁle of Warn Range
Suspended Drivers in Ontario
Stewart Sheilagh, Ministry of the Attorney General
Objectives:
To conduct a preliminary proﬁle of drivers in Ontario issued a warn range driver licence suspension (blood
alcohol concentration of 50mgs   80mgs); to determine if further study of these drivers is warranted. 
Methods:
The criminal and provincial records of almost 900 drivers issued a warn range suspension in four months
post-implementation, in three cities, were reviewed to proﬁle driver behaviour prior to and after the sus-
pension. 
Results:
The population was relatively experienced, with 27% having prior licence suspensions. Almost one-quar-
ter of the population had a criminal record, including alcohol-related driving, with 2% having multiple such
entries. In one centre, almost 20% of the drivers had criminal driving entries. Only 6% had entries for
drugs. Prior to this suspension, 3% had ADLS suspensions (over 80 mgs). Within four months, 2% of the
population had multiple warn range suspensions and 7% had incurred another suspension of some type.
At time of search, 10% were not licenced. Just over 13% were G2 licence drivers, in violation of the zero
BAC requirement.  Time of day is now available and data shows very diﬀerent patterns emerging for time
as well as age of the drivers depending on location.  Examples include almost 50% (overall 20%) of dri-
vers in the smallest centre were under 25 years of age; in the mid-sized centre almost 25% (overall 11%)
and 40% (overall 60%) were detected between 9:00p.m. and midnight and midnight and 3:00a.m. respec-
tively.  Overall, 10% were detected during daytime hours.
Conclusion:
Although preliminary, certain patterns are already emerging despite the limited data. The percentage of
drivers who have engaged in the same or similar behaviour is higher than anticipated. Suspensions may
not create a suﬃcient deterrent for these drivers. Further study is needed to determine if the preliminary
results are consistent in a larger population; to enhance enforcement and education eﬀorts based on
time of day and centre size and support the development of a risk assessment model for these drivers. 
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The Young Impaired Driver Problem: A Status
Report and Plan for the Future
Stewart Kathryn, Safety and Policy Analysis International
Objectives:
Young drivers pose particular risks in traﬃc safety.  Until they reach their mid to late twenties, drivers
have a higher crash risk in general.  Lack of experience in driving coupled with immature judgment make
impairment by alcohol and drugs particularly dangerous.  This paper summarizes current research on the
risks posed by impairment among young drivers and the strategies that ameliorate these risks. An analy-
sis of this research suggests how future progress may be made.
Methods:
Epidemiological research on traﬃc crashes indicates that, compared to older drivers, drivers in their
teens drink and drive less often, but when they do drive after drinking, they are at considerably greater
risk of being involved in a crash.  Drugs also play a role in crashes among young drivers.  This paper revi-
ews this research and links level of risk to the variety of factors that inﬂuence the problem.  The review in-
cludes research on the characteristics of typical crashes.
The paper also reviews research about the education, enforcement and policy strategies that have been
shown to reduce impaired driving and crashes among young drivers.  These strategies have been widely
implemented and studied.  The review also moves into less well researched areas, including technologies
that have the potential to improve traﬃc safety among young drivers. These strategies are in develop-
ment and have not been extensively tested but may prove to be crucial to future progress in enhancing
safety among young drivers.
Results:
The nature of the crash risk posed by young impaired drivers is described and the most eﬀective and pro-
mising strategies for reducing impaired driving among young drivers are identiﬁed.
Conclusions:
Impaired driving by young drivers is a continuing problem. A variety of very eﬀective strategies have been
developed and promising technology based strategies are in development.  Signiﬁcant progress can be
made in improving traﬃc safety if these strategies are adopted. 
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Psychomotor and cognitive functions in sub-
jects receiving methadone and buprenorphine
Strand Maren, Norwegian Institute of Public Health, Department of Toxicological and Pharmacological
Assessment
Bente Fjeld, Folkehelseinstituttet, Divisjon for rettstoksikologi og rusmiddelforskning, Oslo, Norway;
Marianne Arnestad, Dr, Norwegian Institute of Public Health, Division of Forensic Toxicology and Drug
Abuse, Oslo, Norway; Jørg Mørland, prof., Dr.med,
Aims:
The main purpose of the study was to perform a systematic review of the scientiﬁc literature on eﬀects
of methadone and buprenorphine intake in experimental studies of psychomotor and cognitive function
of relevance to driving. The review also included the inﬂuence of acute intake of methadone and bupre-
norphine. The review was performed as part of the DRUID project. 
Methods:
Literature search were conducted in MEDLINE, EMBASE and PSYCINFO. The search strategy consisted
of several words representing psychomotor and cognitive tasks related to driving combined with the
drug of interest. A total of 35 studies were included, and summarized in a standardized way in evidence
tables 
Results:
Single doses of methadone and buprenorphine appeared to be followed by impairment in drug naïve sub-
jects. Less pronounced impairment was observed after single doses to current users of opiates/opioids
and in methadone and buprenorphine maintained patients. Impairment was observed in methadone and
buprenorphine maintained patients compared to controls. It seemed that buprenorphine maintained pati-
ents were less impaired that methadone maintained patients. 
There were several limitations and problems when assessing the results: Few studies included, no phar-
macokinetic data or blood drug concentration measurements, eﬀects on group level while there was large
dose span within groups, lack of comparator drug (alcohol), use of other (un)reported drugs in subjects te-
sted, eﬀects observed could be due to previous drug history and/or individual factors and/or present use
of maintenance drug use. 
Conclusions:
The literature in this ﬁeld is too limited to draw clear conclusions regarding maintenance use of metha-
done/buprenorphine and driving, but it cannot be excluded that maintained patients can have only slight
drug eﬀects of relevance to driving. It seems, however, quite clear that low doses of both methadone and
buprenorphine cause impairment in performance tasks related to driving in drug naïve. 
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Eﬀectiveness of Breath Testing of Drivers for
Alcohol at Road Checks
Sucha Matus, Charles University in Prague
Stastna Lenka, Charles University in Prague, Prague, Czech Republic
Background:
As of 1 January 2010, mandatory screening breath testing of drivers for alcohol during all road checks was
introduced in the Czech Republic by virtue of a binding guideline of the Czech Traﬃc Police Directorate.
Until then tests for alcohol had been carried out as part of speciﬁc one-oﬀ campaigns or, as required
practice, after accidents. As a result, the Czech Republic has become the ﬁrst country in the EU to intro-
duce such rigorous checks for drink-driving.
Objectives:
To test the eﬀectiveness of the new measure in terms of a reduction in the rate of road accidents caused
by drink-driving, the number of alcohol-related road fatalities, and the number of traﬃc law violations
and criminal oﬀences committed in relation to drink-driving. We assume that a higher number of traﬃc
law violations and criminal oﬀences will be detected (as a result of the higher number of checks), while
the number of road accidents caused by impaired drivers and the number of fatalities (as a result of the
preventive eﬀect of the newly introduced measure) will decline.
Methods:
The above-speciﬁed indicators for 2009 (prior to the mandatory testing being introduced) are compared
to the indicator levels for the ﬁrst six months of 2010 (after the testing was introduced) using statistical
analysis. The data were obtained from the statistics of the Czech police.
Results:
The results conﬁrm our hypotheses   in all the months under study (January-March) there was a year-on-
year (2009-2010) reduction in the rate of road accidents caused by drivers under the inﬂuence of alcohol
and a decline in the number of road fatalities in relation to drink-driving.
Conclusions:
The above data support our assumption of a preventive eﬀect of the otherwise enforcement-oriented
measure: the growing proportion of the detection of all violations and criminal oﬀences involving driving
under the inﬂuence of alcohol and drivers thinking that their illegal conduct is more likely to be disclosed
make them act more responsibly and contribute to reductions in accident and mortality rates. 
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Acute and subchronic eﬀects of bilastine (20
and 40mg) and hydroxyzine 50mg on actual
driving performance in healthy volunteers
Theunissen Eef, Maastricht university
Silke Conen, Maastricht university, Maastricht, Netherlands; Johannes Ramaekers, Dr, Maastricht uni-
versity, Maastricht, Netherlands; Roman Valiente, Faes Farma S.A., Vizcaya, Spain
Bilastine is a new second generation antihistamine indicated for the treatment of allergic rhinitis and
chronic urticaria. Although bilastine has been demonstrated to produce no or little performance impair-
ment on laboratory performance tests, it cannot be excluded that the drug produces performance impair-
ments in driving. Objectives - The present study was designed to assess the eﬀects of single and
repeated administration of bilastine in two doses (20 and 40 mg) on actual driving. Hydroxyzine 50 mg, a
highly sedative ﬁrst generation antihistamine, was included as a control treatment. Methods - The study
was conducted according to a placebo-controlled, randomized, double blind, 4 way cross-over design in 22
healthy volunteers (11 males, 11 females). Participants were treated with once daily doses for 8 consecu-
tive days. On day 1 and 8 of each treatment period participants conducted an actual highway driving test.
Results - On day 1 and 8 of treatment, hydroxizine signiﬁcantly impaired driving as demonstrated by an in-
creased standard deviation of lateral position (SDLP). Bilastine had no eﬀect on SDLP. Conclusion - It is
concluded that hydroxizine produces severe driving impairment after acute dosing and that this impair-
ment only partly mitigates over time due to a lack of complete tolerance. Bilastine on the other hand did
not produce any driving impairment after single or repeated doses and can be safely used in traﬃc in
doses up to 40 mg. 
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Tolerance and cross-tolerance to neuro-
cognitive eﬀects of THC and alcohol in heavy
cannabis users
Theunissen Eef, Maastricht university
Johannes Ramaekers, Dr, Maastricht university, Maastricht, Netherlands; Stefan Toennes, Dr, Goethe
University of Frankfurt, Frankfurt, Germany; Manfred Moeller, Professor; Gerold Kauert, Dr, Goethe
University of Frankfurt, Frankfurt, Germany
Previous research has shown that heavy cannabis users develop tolerance to the impairing eﬀects of THC
on neurocognitive functions. Animal studies suggest that chronic cannabis consumption may also pro-
duce cross-tolerance for the impairing eﬀects of alcohol, but supportive data in humans is scarce. Objec-
tives - The present study was designed to assess tolerance and cross-tolerance to the neurocognitive
eﬀects of THC and alcohol in heavy cannabis users. Methods - Twenty-one heavy cannabis users partici-
pated in a double-blind, placebo-controlled, 3 way study. Subject received 3 alcohol dosing conditions that
were designed to achieve a steady blood alcohol concentration (BAC) of about 0, 0.5 and 0.7 mg/ml during
a 5 h time window. In addition, subjects smoked a THC cigarette (400 μg/kg) at 3 hrs post onset of alcohol
dosing during every alcohol condition. Performance tests were conducted repeatedly between 0-7 hrs
after onset of drinking and included measures of perceptual motor control (Critical tracking task), dual
task processing (Divided attention task), motor inhibition (Stop signal task) and cognition (Tower of Lon-
don).  Results - Alcohol signiﬁcantly impaired critical tracking, divided attention and stop signal perfor-
mance. THC generally did not aﬀect task performance. However, combined eﬀects of THC and alcohol on
divided attention were bigger than those by alcohol alone. Conclusion - The present study generally con-
ﬁrms that heavy cannabis users develop tolerance to the impairing eﬀects of THC on neurocognitive task
performance. Yet, heavy cannabis users did not develop cross-tolerance to the impairing eﬀects of alco-
hol, and the presence of the latter even selectively potentiated THC eﬀects on measures of divided atten-
tion. 
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Driver Drug Testing - The South Australian
Enforcement Model
Thompson Peter, South Australia Police
The objective is to present the success of the driver drug testing regime established in SA.
Driver drug testing in SA using saliva or blood became operative 1 July, 2006.  A dedicated group of 13 traf-
ﬁc members was formed and conducted driver drug testing full time over a 12 month trial.  The success
saw the Government commit $11.1 million over 4 yrs for the expansion of the regime.
The expansion was based on 260 traﬃc oﬃcers across SA performing drug testing.  It moved away from
the centralised model established in SA & other Jurisdictions in Australia where all operations were under
the one command.  This enabled drug testing to be conducted in a similar fashion to RBT in that tests
could be conducted in multiple locations at any one time & coordinated independently of each other.
The model retained the existing 13 oﬃcers in the full-time centralised group.
The trained oﬃcers have been independently testing drivers for drugs since April, 2008 across SA.
SAPOL screens 40,000 drivers for drugs each year.  With a population base of 1.68 million, SAPOL scre-
ens drivers for drugs 5 times greater than other Australian Jurisdictions.  State average of drivers posi-
tive to drugs is 2.3% with trained oﬃcers operating drug testing full time detecting at a positive rate of
4.7%.  A breakdown on the regime & the results will be provided.
The drug testing regime and expansion across SA is helping to achieve goals set in the SA Police Road Sa-
fety Strategy 2006-2010 & the SA Road Safety Action Plan 2008-2010.
Expansions of the regime have also seen an enforcement model introduced in 2008 for the testing of rail
safety workers for drugs pursuant to the Rail Safety Act and in February 2010, for the testing of opera-
tors and crew of marine vessels for drugs pursuant to the Harbors and Navigation Act. 
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Patterns of DWI Recidivism by Diﬀerent Court
Adjudications
Tison Julie, Preusser Research Group
Julie Tison, Dr, Preusser Research Group, Hamden, United States; Neil Chaudhary, Dr.; Anne McCartt,
Dr., Insurance Institute for Highway Safety, Arlington, VA, United States
Objective:
First oﬀenders  recidivism rates in Maryland were examined to explore how these re-arrests rates vary as
a function of adjudication.
Methods:
Ten years of alcohol-impaired driving arrest and adjudication data were obtained from the Maryland
court data system. Drivers whose ﬁrst arrest occurred in the period 1998-2000 were selected for analy-
sis (N=46,449). Four groups were formed based on adjudication: 1) Guilty/Probation before Judgement
(PBJ), 2) Nolle Prosequi, (Nol Prossed) 3) Not Guilty, and 4) Other. Recidivism was assessed by compiling
instances of re-arrest for an alcohol-related driving oﬀense in the three years following adjudication.  Re-
cidivism rates were compared across groups. 
Results:
Ten percent of all ﬁrst oﬀenders were re-arrested within three years. The Not Guilty group showed the
highest recidivism rate (14%) followed by the Nolle Prossed group (12%), Guilty/PBJ (9%), and Other
group (8%). Survival analyses indicated that the Not Guilty and Nolle Prossed groups were signiﬁcantly
more likely to recidivate than the Guilty/PBJ group. Compared to their Guilty/PBJ counterparts, drivers
found Not Guilty were 66% more likely to be re-arrested for an alcohol-related driving oﬀense; those
Nolle Prossed were 31% more likely to recidivate than those having received a Guilty/PBJ adjudication.
Among those re-arrested, individuals judged Not Guilty, Nolle Prossed, and Other recidivated signiﬁcantly
sooner than those who received a Guilty/PBJ judgement. 
Conclusion:
The large majority of alcohol-impaired driving arrests in Maryland lead to a Guilty/PBJ judgement (82%).
The small minority (2%) found Not Guilty is more likely to recidivate and recidivates faster than those
found Guilty/PBJ. Possible legal and behavioral reasons for these high re-arrest rates are discussed. 
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?
Tørring Terje, MA
Catharina Frostad, MA-Ungdom, Oslo, Norway
Objectives:
I CAN`T AFFORD TO LOOSE ANY FRIENDS - DON`T DRINK AND DRIVE  is a non-scientiﬁc project. The
objectives are:
- Create awareness and aﬀect youths attitudes towards drunk driving
Method:
Use social media to reach the youth in their own arena. The idea behind this is that the youth can share
their stories and opinions, and by reading this, create awareness. By taking a stand against drinking and
driving, and by showing other youths their stand, spread further awareness.
Our wish is that the users of these social Medias should create the correct attitude against this cause and
take the right stand without us pointing any moralizing ﬁngers.
To make these changes in attitude towards drinking and driving we need to establish awareness about the
problem. In addition to this we need to make sure that the users have the knowledge needed to take a
stand, a stand that they will live by and share with others. 
Result:
This project has created one of the biggest Norwegian Facebook pages to this date with rapidly increa-
sing numbers of users. After one day there were 2000 and after one week there were 120 000 people who
had taken a stand. In addition it has created a lot of media interest which has resulted in bringing the
cause into the spotlight. 
The success of this project can be measured by the focus it has created and by the way that the project
has been getting people to actively discuss the cause. 
Conclusion:
By reaching the youth at their own arena, we can communicate and discuss important issues like this with
a likely outcome of increased awareness and a broader understanding of the problem. This will also trig-
ger the discussion between the youths themselves. The act of taking a stand will not only be for themsel-
ves, but also shown to their mates and fellow youths for inspiration. 
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ORAL ABSTRACT
An illustration of knowledge utilization to
inform implementation and delivery of an
alcohol interlock program
Vanlaar Ward, Traﬃc Injury Research Foundation
Robyn Robertson, Ms., Traﬃc Injury Research Foundation, Ottawa, Canada; Desirée Schaap, Dutch
Ministry of Transport, Den Haag, Netherlands; Jan Vissers, DHV, Amersfoort, Netherlands
Objectives:
In a growing number of jurisdictions around the world an increased demand for the use of alcohol inter-
locks is evident. In order to inform decision-making regarding the use of interlocks it is crucial that pro-
gram administrators and practitioners understand behavioural patterns of oﬀenders on an interlock. The
objectives of this study are to provide insight into compliance rates of interlocked oﬀenders throughout
their time on the interlock. Such information can guide administrators with regard to program develop-
ment and implementation, particularly in relation to logistical aspects of programs and the requisite re-
sources to support it. This study was conducted to provide empirical information needed to inform the
implementation of the Dutch interlock program.
Methods:
Data used in this study come from a random sample of 7,743 interlocked oﬀenders from over 30 jurisdicti-
ons in the U.S. Over 15 million events generated by the interlock devices have been included in the analy-
ses. A variety of indicators have been calculated including the percent of oﬀenders who blow failed tests,
the percent of failed tests, circumvention rates, and blood alcohol concentrations, as well as trends in
these indicators over time.
Results:
The behavioural patterns emerging in this study reveal that oﬀenders violate the conditions of the inter-
lock program at a relatively high rate at the beginning of their participation and this behaviour quickly di-
minishes among most oﬀenders as they become accustomed to the device. To illustrate, 54.0% (95%-CI:
52.9-55.1) of oﬀenders blow fails during their ﬁrst three months of participation in the program whereas
this percent decreases to 22.2% (95%-CI: 19.0-25.7) during the last three months of participation (i.e.,
months 22 through 24).
Conclusions:
This study shows that utilization of knowledge coming from interlocks is useful to inform decision-ma-
king when preparing the implementation and delivery of an interlock program. More precisely, the behavi-
oural pattern that emerges from this study supports the notion of a learning eﬀect among oﬀenders.
Speciﬁcally with regard to the Dutch interlock program, this pattern has aﬀected the allocation of resour-
ces and the development of a reﬁned reinforcement scheme. 
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Risk taking in traﬃc: comparing simulated
driving with on-road GPS measured driving
behaviour
Veldstra J.L., University of Groningen
Karel Brookhuis, Prof.Dr., University of Groningen, Groningen, Netherlands; Dick De Waard, dr, Univer-
sity of Groningen, Groningen, Netherlands
Aim:
Despite the obvious advantages of the driving simulator, it has its shortcomings. One crucial question is:
to what extent are results obtained in the driving simulator predictive of actual, on-road driving behavi-
our? Prior research focusing on the validity of the driving simulator has compared one artiﬁcial situation;
driving in the simulator, to another artiﬁcial situation; driving in an instrumented car. This limits the scope
of the validation research conducted so far. It is, for instance, still unclear how recorded behaviour in the
driving simulator corresponds to naturalistic driving behaviour in participants  own cars. In this study, we
compared on-road driving records obtained through GPS in participants  own cars with driving simulator
data of the same participants.
Method:
Thirty-six participants participated in this study, eighteen  violators  e.g. drivers that were known to vio-
late traﬃc rules and regulations and eighteen conservative drivers. Participants were selected based on
their driving performance from the control group of a ﬁeld study on insurance per kilometre. The focus of
the analyses was exploring both  relative  and  absolute  correspondence between black-box and simula-
tor data.  Basic vehicle control (acceleration decelleration and speed) was assed in a driving simulator and
in an on the road driving test.
Results:
Data are currently gathered and results will be presented at the conference. 
It is expected that the driving simulator will diﬀer from real driving in absolute terms; for example, parti-
cipants are epected to speed more in the simulator, then in there own car because the feedback is diﬀe-
rent. However, it is also expected that participants that are violators in their own car also violate traﬃc
rules in the simulator, establishing relative validity for the driving simulator. 
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ORAL ABSTRACT
Comparison of the concentrations of drugs
in saliva collected by two sampling methods
(Varian OraLab and Statsure Saliva?Sampler)
Verstraete Alain, Ghent University
An-Soﬁe Goessaert, Ghent University, Belgium; Jolien Veramme, Ghent University, Belgium
Objective: 
To determine the inﬂuence of saliva sampling methods on drug concentrations.
Methods: Saliva was obtained from 249 subjects (who had given informed consent) by Varian OraLab and
Statsure Saliva?Sampler. OraLab consists of foam-tipped saliva collector. The sponge contains an acid
that stimulates salivation. Statsure consists of a collector with a blue indication when 1ml of saliva is col-
lected. After sampling, the collector is transferred to a tube that contains 1ml of buﬀer. Saliva was analy-
sed with UPLC-MSMS.
Results:
For all the drugs, the concentrations in the saliva collected with OraLab are 50-70% compared to Stats-
ure, except for morphine (80%) and codeine (92%). Possible explanations are: a buﬀer could explain a
better extraction recovery with Statsure (particularly THC); the stimulation of salivation by an acid in Ora-
Lab could also explain the lower concentrations.
Drug COC BE THC AMP 6-AM MOR COD
Median concentration Statsure (ng/ml) 44.3 81.5 27.4 252.9 67.8 178.8 58.7
Median concentration OraLab (ng/ml) 17.7 31.1 12.1 310.4 24.7 131.0 41.7
* Regression:
Slope
Intercept
0.54
- 2.41
0.51
- 5.91
0.68
- 2.38
0.68
2.85
0.50
- 1.02
0.80
- 6.17
0.92
- 11.08
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R 0.62 0.83 0.90 0.83 0.80 0.82 0.61
COC: cocaine, BE: benzoylecgonine, THC: tetrahydrocannabinol, AMP: amphetamine, 6-AM: 6-acetylmor-
phine, MOR: morphine, COD: codeine 
Conclusions:
The correlation coeﬃcients are relatively low (0.61 0.90). For all drugs, the concentrations measured in
the saliva collected by OraLab are lower. This could have consequences for the determination of legal cut-
oﬀs.
Disclaimer:
This abstract has been produced under the project  Driving Under the Inﬂuence of Drugs, Alcohol and Me-
dicines  (DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework
Program.
This abstract reﬂects only the author's view. The European Community is not liable for any use that may
be made of the information contained therein. 
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External quality assessment of multi-analyte
chromatographic methods in oral ﬂuid
Verstraete Alain, Ghent University
Kristof Pil, Waters, Zellik, Belgium; Francis Esposito
Objectives:
DRUID (Driving Under the Inﬂluence of Drugs, Alcohol and Medicines) is a research project funded by the
European Commission in which oral ﬂuid is analysed by eleven laboratories. A common collection and ana-
lysis methodology has been used: collection with Statsure Saliva Sampler and LC-MS/MS or GC-MS ana-
lysis of 22 substances. Four rounds of proﬁciency testing (PT) were organized between March 2008 and
September 2009.
Methods:
Qualitative results were evaluated using sensitivity and speciﬁcity. Quantitative results were evaluated
using z-scores and the standard deviation of Horwitz.
Results: Speciﬁcity was above 99% for all analytes; sensitivity per analyte varied between 81.7 and 100%,
20 out of 22 analytes had a sensitivity >90%. The percentage of satisfactory z-scores increased from
79.4% to 89.2% over the test period. This trend was seen for all drugs, except zopiclone. Results were
discussed with participating laboratories and problems were addressed. 
Conclusions:
Because of these corrective actions, DRUID laboratories have a lower variation in results than previously
published PT schemes in oral ﬂuid. 
Disclaimer:
This abstract has been produced under the project  Driving Under the Inﬂuence of Drugs, Alcohol and Me-
dicines  (DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework
Program.
This abstract reﬂects only the author's view. The European Community is not liable for any use that may
be made of the information contained therein. 
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Survey of prevention and information
campaigns on psychoactive drugs and driving
Verstraete Alain, Ghent University
Sara-Ann Legrand, Ghent University, Gent, Belgium
Objectives:
One of the objectives of the DRUID project is to develop guidelines for spreading information regarding
driving under the inﬂuence of drugs and medicines, and this aiming at diﬀerent target groups, including
young drivers, patients, physicians, pharmacists,& We reviewed the state-of-the-art of existing informa-
tion campaigns regarding psychoactive drugs and driving, as well as the documented eﬀectiveness of
those campaigns.
Methods:
In total 55 institutes were contacted, of which 17 (31%) responded and 12 (22%) were able to give informa-
tion. Information was also gathered through the Internet by means of websites of relevant organizations,
Google and YouTube.
Results:
A total of 75 campaigns were found, from 13 diﬀerent countries. Twenty-four were launched to inform the
general public on the risks associated with driving under the inﬂuence of drugs, medicines and/or alcohol.
Twenty-nine campaigns were launched to inform young people and 16 campaigns to inform physicians
and/or pharmacists. Nine campaigns were designed for teachers, seven campaigns for patients and ﬁve
campaigns for other target populations. Some campaigns were designed for more than one target group.
Information on impact evaluation was available only for seven campaigns. All evaluations showed a posi-
tive impact of the campaigns. 
Conclusions:
The majority of the retrieved campaigns concerning driving under the inﬂuence of drugs were aiming at
young people. The type of medium that is used the most is brochures. Most campaigns are organized by
governmental organizations and road safety organizations.
As only a few evaluations were found, and these campaigns and their evaluations were performed in many
diﬀerent ways, it is not possible to draw conclusions concerning the association between the design of
the campaigns and their eﬀectiveness.
Key-words: information campaigns, psychoactive drugs, eﬀectiveness 
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ORAL ABSTRACT
Comparison of a checklist for clinical signs of
impairment and detection of drugs in saliva
Verstraete Alain, Ghent University
Sara-Ann Legrand, Ghent University, Gent, Belgium; An-Soﬁe Goessaert, Ghent University, Belgium; Jo-
lien Veramme, Ghent University, Belgium; Alain Verstraete, Professor, Ghent University, Gent, Belgium
Objectives:
In Belgium and some other countries, the police performs on-site drug screening when a driver is suspec-
ted of being drug impaired, since the test procedure is time consuming and the screening devices are re-
latively expensive. The objective of the study is to compare the results of a checklist with drug
concentrations in saliva.
Method:
The checklist used in the DRUID study in the Netherlands was used. Two ﬁfth-year medical students per-
formed the tests on 250 subjects, 50 drivers and 200 subjects attending a methadone clinic. Saliva analy-
sis was performed by UPLC-MS/MS. As several signs were rarely observed, the parameters were reduced
to those that were positive in at least 3 out of 250 test subjects. This selection led to a reduction to 13 (out
of 28) parameters. A statistical test (Fisher s exact test) was used to test for correlations between the
checklist parameters and the presence of substances in oral ﬂuid.
Results:
Most parameters did not correlate signiﬁcantly with drug intake. The pupil tests seemed to be the best
predicting parameters, especially for amphetamine and THC. Remarkably, some correlations were found
between parameters and drugs where no correlation was expected, e.g. sleepiness and amphetamines.
This can possibly be caused by the presence of combination use of drugs in a lot of subjects. The signs
were often observed when high drug concentrations were seen in saliva, but in many cases with high saliva
drug concentrations, no signs were observed.
Conclusions:
In general, the checklist correlated badly with drug presence in this population of chronic drug users, but
our results also conﬁrm other studies that found that checklists are not very sensitive.
Key-words: checklist parameters, correlation, presence of substances in oral ﬂuid. 
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The problem of collecting diﬀerent body ﬂuids
from drivers in the surveys
Verstraete Alain, Ghent University
Objectives:
It is not easy to obtain a blood sample from drivers at the roadside for use in epidemiological studies.
Therefore, use of saliva samples has become popular. On the other hand, in studies in injured drivers, ob-
taining a saliva sample can be problematic, e.g. because of injuries. When drug concentrations in blood
and saliva need to be compared e.g. in risk calculations, results from diﬀerent matrices need to be compa-
rable. Because of the diﬀerent recoveries with saliva collection devices, saliva:blood ratios should be de-
termined for each collection device.
Methods:
Drug concentrations in blood and saliva samples from diﬀerent studies (Rosita-2, roadside surveys) were
analysed by GC-MS and UPLC-MS/MS and the results were compared for diﬀerent drugs.
Results: 
While for some drugs like diazepam, relatively good correlation can be observed (r2 = 0.98, n=23, Saliva
blood ratio 0.033), for most other drugs there is a very wide scatter when comparing saliva and blood con-
centrations. These ﬁndings conﬁrm those of other published studies. One of the possible explanations is
the trapping of basic drugs in saliva because of the pH eﬀects.
Conclusion: 
The correlation between drug concentrations in saliva and whole blood is poor for most drugs. It might be
advisable to use whole blood also in a roadside surveys.
Disclaimer:
This abstract has been produced under the project  Driving Under the Inﬂuence of Drugs, Alcohol and Me-
dicines  (DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework
Program.
This abstract reﬂects only the author's view. The European Community is not liable for any use that may
be made of the information contained therein. 
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ORAL ABSTRACT
Gamma-hydroxybutyrate (GHB), pregabalin
and driving impairment
Vevelstad Merete, Norwegian Institute of Public Health, Division of forensic toxicology and drug abuse
Sandra Rinne Dahl, Norwegian Institute of Public Health, Division of forensic toxicology and drug
abuse, OSLO, Norway; Gerrit Middelkoop, Senior Engineer, Norwegian Institute of Public Health, Oslo,
Norway
Objectives: 
To evaluate the occurrence of the psychoactive substances gamma-hydroxybutyrate (GHB) and pregaba-
lin in blood samples from drivers suspected of driving under the inﬂuence of drugs or alcohol in Norway,
after the introduction in January 2010 of routine blood analysis for these increasingly used/abused sub-
stances. Further, the aim was to evaluate the relationship between blood concentration and impairment,
as measured by the clinical test of impairment (CTI). 
Methods: 
The Division of Forensic Toxicology and Drug Abuse (DFTDA) at the Norwegian Institute of Public Health
analyses blood samples from all drivers suspected of driving under the inﬂuence of drugs nation-wide.
Cases with positive results for pregabalin and/or GHB from January to August 2010 will be selected and
results presented at the ICADTS meeting. UPLC-MS/MS is used for analysis of GHB, GBL (gamma-buty-
rolactone), 1,4-butanediol (1,4-BD) and pregabalin. A sample volume of 100 μl whole blood is required. The
use of 96-well extraction plates has reduced the sample preparation time and increased the number of si-
multaneous analyses. Separation is obtained on a C18 column, using a linear gradient with 0.2% formic
acid (A) and methanol (B). The following transitions are monitored: GHB 105.06 > 87.05, 43.05, 69.03, 42.3;
pregabalin: 160.13 > 142.12, 55.05, 97.1; GBL: 87.04 > 44.95, 69.03; 1,4BD: 91.08 > 73.07, 55.05, 97.1. The met-
hod will be presented in detail at the meeting. 
Results and conclusion: 
As this is an ongoing study, the results and conclusions will be presented and discussed at the meeting. 
Keywords:   Drugs of abuse - GHB - Forensic - Impaired driving   Toxicology 
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Alcohol, Drugs and Street Racing:
Results from the Ontario Student Drug Use
and Health Survey
Vingilis Evelyn, University of Western Ontario
Reginald Smart, Dr., Centre for Addiction and Mental Health, Toronto, Canada; ROBERT MANN, MR.; An-
gela Paglia-Boak, Centre for Addiction and Mental Health, Toronto, Canada; Gina Stoduto, Ms
Objectives:
Various risky driving behaviours, such as street racing and impaired driving, have long been identiﬁed as
public health problems because of their potential negative consequences of motor vehicle crashes. Alt-
hough much research has focussed on individual problematic behaviours, evidence exists on the interrela-
tedness of these behaviours. This study examines the interrelationships of alcohol use, drug use, drinking
driving and street racing among a representative Ontario sample of secondary school students.
Method:
The Ontario Student Drug Use and Health Survey is a population-based survey of Ontario students in gra-
des 7 to 12. This self-administered, anonymous survey, conducted across the province every two years
with the purpose of identifying epidemiological trends in student alcohol and drug use, mental health,
physical activity, illegal activities, risk and protective factors, was examined for prevalence of self-repor-
ted street racing and correlates, as in 2009 a new question on street racing was added to the survey. 
Results:
The total sample of students in grades 9-12 that completed the questionnaire with the street racing ques-
tion was 3,053. Overall, 5.6% of students in grades 9-12, reported driving a car, truck or SUV in a street
race in the last 12 months. Alcohol and drug users were more likely to street race: 18% of weekly or more
drinkers reported street racing compared to 1.4% of non-drinkers. Almost 37% of students who reported
that they had driven after drinking within the last year reported that they had engaged in street racing in
the last year compared to 3.6% who had not driven after drinking. 
Conclusions:
This study is the ﬁrst in Canada to examine self-reported alcohol, drug use and drinking driving in relation
to street racing among students. It suggests that drinkers, drug users and drinking drivers are more likely
to report street racing, a worrisome combination. 
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Is monitoring drinking an eﬀective alternative
to the interlock?
Voas Robert, PIRE
Objective:
Experience demonstrates that oﬀenders convicted of driving while impaired (DWI) tend to drive illicitly
rather than install an alcohol interlock on their vehicles. The power of the courts to force the installation
of interlocks is limited by the requirement that the oﬀender have a vehicle. The result has been that, to
date, only 10% to at the most 50% of DWI oﬀenders install the devices. The objective of this paper is to
examine the potential for imposing an alcohol-monitoring program on oﬀenders who claim not to have ac-
cess to a vehicle. 
Methods:
This paper reviews previous studies designed to pressure DWI oﬀenders to install interlocks by making
the alternative less desirable than the interlock. Research has shown that such requirements do increase
the percentage of oﬀenders installing interlocks. The paper also reviews current technologies and pro-
grams for remotely monitoring drinking.
Results:
Systems for monitoring drinking are suﬃciently developed that they appear to oﬀer an eﬀective method
for ensuring that a driver is not drinking, which makes them a potential substitute for the interlock. It ap-
pears that they could be required as an alternative to installing the interlock with the advantage that they
could not be subverted by driving a non-interlock-equipped vehicle.
Conclusion:
Making devices that remotely monitor drinking a mandatory alternative to the interlock oﬀers the possi-
bility of increasing the percentage of oﬀenders who install interlocks or who are protected from impaired
driving by forced abstinence. If program providers can support both monitoring methods, oﬀenders could
be given the choice of which sanction program to accept. 
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Toward a National Model for Impaired Driver
Treatment and Monitoring Programs
Voas Robert, PIRE
Robert Voas, Dr., PIRE, Calverton, MD, United States; Robert DuPont, The Institute for Behaviiour and
Health Inc., Rockville, MD, United States; Stephen Talpins
Objective:
To describe a proposed national model for controlling the risk presented by oﬀenders convicted of dri-
ving while impaired and promoting behavioural change to reduce future recidivism.
Methods:
A review of the current policies for controlling the risk of drivers convicted of driving while impaired
(DWI) indicates that the 1.4 million drivers who are arrested for that oﬀence each year are 4.1 times more
likely than the average driver to be the drinking driver in a fatal crash. Current methods of controlling the
risk they present to the driving public are not adequate, as indicated by the fact that the crashes in which
they are involved result in 1,000 alcohol-related fatalities each year. There appears to be a trend toward a
comprehensive system applicable to ﬁrst and multiple oﬀenders focused on monitoring oﬀender drin-
king or monitoring driving with an interlock in which the ultimate sanction is based on oﬀender perfor-
mance in meeting monitoring requirements.
Results:
The specialized DWI and drug courts, which have been shown to be successful in reducing oﬀender recidi-
vism, have used close monitoring of alcohol and drug consumption as a key part of their program. Based
on their success, monitoring has become the central feature of DWI sanction programs in South and
North Dakota. New technologies are making it easier to remotely monitor drinking. Evidence indicates
that even dependent drinkers can conform to these monitoring programs and avoid the short-term jail
consequence for failure.
Conclusions:
Based on the apparent success of current monitoring systems and emerging technologies, it appears that
monitoring programs will play an increasingly important role in the future and will stimulate the need for
new and more ﬂexible court-mandated treatment programs. 
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Monitored Drinking: An Alternative to the
Interlock for Oﬀenders Without Cars?
Voas Robert, PIRE
Objective:
Determine whether monitoring abstinence can be an eﬀective alternative for preventing recidivism
among drivers convicted of driving while impaired (DWI) who avoid a court order to install an alcohol igni-
tion interlock. Experience in the U.S. indicates that, even in states with mandatory interlock laws, half or
more of the DWI oﬀenders avoid installing the devices by claiming not to have a car or pleading not to
drive. 
Method:
Research has shown that imposing home conﬁnement as an alternative to the interlock substantially in-
creases the proportion of all oﬀenders who install the devices. This study reviews current trends in the
criminal justice system in the use of alcohol monitoring as a sanction for DWI. 
Results:
Random BAC testing and newer technologies, such as transdermal alcohol sensors attached to the leg of
the oﬀender, are being widely used by the courts for controlling multiple DWI oﬀenders, and there appe-
ars to be a trend to apply those procedures to some ﬁrst DWI oﬀenders. New technologies just coming
into use by the courts will make monitoring drinking less intrusive and less expensive. 
Conclusions: 
AC monitoring can be implemented at roughly the same cost as the interlock and should be equally as or
more eﬀective than the interlock in reducing recidivism because oﬀenders can illicitly drive a non-inter-
lock-equipped vehicle. The threat of being forced to be abstinent through tight monitoring of drinking
may increase the proportion of oﬀenders installing interlocks. The extent to which the public and the
courts will accept abstinence monitoring for ﬁrst oﬀenders who do not demonstrate an alcohol use pro-
blem is unknown. 
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Is it really alcohol-induced impairment of
cognitive functions that leads to crashes?
Vollrath Mark, Department of Traﬃc and Engineering Psychology
A multitude of experimental studies in the laboratory and driving simulators has demonstrated that alco-
hol impairs cognitive functions. Controlled actions which are under conscious cognitive control are impai-
red at a lower BAC than well-learned automatic functions. Thus, alcohol seems to impair performance the
more, the more complex the task at hand is. From this research one would assume that alcohol leads to
more crashes in complex traﬃc situations as compared to simple, well-known situations. A 50% sample
of all German accidents from 2002 were examined with regard to diﬀerent accident types comparing ac-
cident with and without alcohol. The results are contrary to the hypothesis described with less alcohol-re-
lated accidents in complex situations like intersections. Diﬀerent explanations for this discrepancy
between experimental research and accident studies are discussed. 
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Situational Aspects of Drug-Driving Incidences
Results of the German Cell Phone Survey
Walter Martina, IZVW (Center for Traﬃc Sciences) / Department of Psychology / University of Würzburg
Florian Fischer, IZVW, University of Wurzburg, Germany; Volker Hargutt, IZVW, University of Wurzburg,
Germany; Hans-Petter Krüger, IZVW, University of Wurzburg, Germany
Objectives:
The study intended to obtain information about the frequency of drug driving and to specify characteris-
tics of drug impaired drivers for rehabilitation and prevention purposes.
Methods:
The sample consists of 200 drug users and 100 controls out of the normal driving population stratiﬁed for
sex, age (18-39 years) and residence (rural, city and metropolitan area). The questionnaire was installed on
Smartphones and was daily ﬁlled in for 28 consecutive days. All activities were listed in chronological
order with the focus on drug consumption and driving. Encrypted data were transmitted via GPRS and the
internet. Immediately after reception, data were checked for consistency by study assistants, in case of
inconsistencies or pecularities discussed by phone and corrected if necessary. To enhance compliance a
monetary reward system was developed. The credits were communicated via the Smartphone text mes-
saging system. 
Results:
The synchronisation of the reported driving and drug consumption patterns oﬀers to assess the fre-
quency of drug driving and the situational aspects of such incidences. Data were comparable to existing
mobility and drug prevalence data of the general German population. Without announcement one urine
sample was collected within the study period. The toxicological results correspond to the reported drug
consumption. The dropout rate was low and the subjects  responses to the study were very positive. 
Conclusion: 
The study demonstrates a promising way of investigating drug driving and its preventive and promotive
circumstances. The results serve as major input to the discussion on drug driving.
This report has been produced under the project  Driving Under Inﬂuence of Drugs, Alcohol and Medicines
(DRUID) ﬁnanced by the European Community within the EU 6th Framework Program.
This report reﬂects only the author's view. The European Community is not liable for any use that may be
made of the information contained therein. 
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Risk factors in car crashes: car, road, driver?
Wegman Fred, SWOV
When deﬁning risk we usually distinguish the probability of an event (a crash given a certain exposure to
risk) and the (negative) consequences of that event (injury, cost): risk = probability x consequence. A risk
factor is a factor that inﬂuences the probability of a crash occurring or the severity of the consequences
of a crash. In road safety research we try to establish and quantify risk factors. Results are often presen-
ted in terms of risk increasing factors. Researchers rarely express themselves in terms of too high a risk.
Researchers compare diﬀerent risks (risk factors, risk increasing factors) and try to understand diﬀeren-
ces between them. Their results are presented to decision makers (policymakers and/or politicians) and
they arrive at conclusions about the acceptability of certain risks (and of risk diﬀerences) and their wil-
lingness to take risk reducing actions. For each of the three components of the road traﬃc system
(human being, road, vehicle) we identiﬁed risk increasing factors. We identiﬁed road locations with relati-
vely high risks (road types, speciﬁc locations) and speciﬁc users groups (age, gender, or crash prone dri-
vers) running a relative high risk. Certain road user behaviour is associated with relatively high risk (speed,
distraction, alcohol, drugs, fatigue, etc.). And, ﬁnally, risks are related to vehicle characteristics (vehicle
types, vehicle defects). We learned over the years that diﬀerent risks are sometimes linked. Several rese-
arch results on risk increasing factors will be presented and compared as well as some results on how to
reduce 'peaks' in risk distributions.  
However, we learned that risk increasing factors describe only a part of the road safety problem. The pro-
blem also originates from three basic risk factors: speed, mass/protection (of/by vehicles) and physical
vulnerability (of man). This represents the more generic character of risks in road traﬃc; reducing these
generic risks requires a diﬀerent approach. This new approach, based on the Dutch Sustainable Safety vi-
sion, will also be introduced in this presentation. 
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Who are the real  ﬁrst oﬀenders ?
Wilson Hollie, Centre for Accident Research & Road Safety - Queensland (CARRS-Q), QUT
Mary Sheehan, Professor, CARRSQ, Australia; Gavan Palk, Dr, CARRS-Q, QUT, KELVIN GROVE, Australia
Objectives: 
Drink driving causes more fatal crashes than any other single factor on Australian roads, with a third of
crashes having alcohol as a contributing factor. In recent years there has been a plateau in the numbers of
drink drivers apprehended by RBT, and around 12% of the general population in self report surveys admit
to drinking and driving. There is limited information about the ﬁrst oﬀender group, particularly the sub-
group of these oﬀenders who admit to prior drink driving, the oﬀence therefore being the  ﬁrst time
caught .  This research focuses on the diﬀerences between those who report drink driving prior to appre-
hension for the oﬀence and those who don t. 
Methods: 
201 ﬁrst time drink driving oﬀenders were interviewed at the time of their court appearance.  Information
was collected on socio-demographic variables, driving behaviour, method of apprehension, oﬀence infor-
mation, alcohol use and self reported previous drink driving.
Results:
78% of respondents reported that they had driven over the legal alcohol limit in the 6 months prior to the
oﬀence.  Analyses revealed that those oﬀenders who had driven over the limit previously without being
caught were more likely to be younger and have an issue with risky drinking. When all variables were taken
into account in a multivariate model  using logistic regression, only risky drinking emerged as signiﬁcantly
related to past drink driving. High risk drinkers were 4.8 times more likely to report having driven over the
limit without being apprehended in the previous 6 months. 
Conclusion:
The majority of ﬁrst oﬀenders are those who are  ﬁrst time apprehended  rather than  ﬁrst time drink dri-
vers .  Having an understanding of the diﬀerences between these groups may alter the focus of educatio-
nal or rehabilitation countermeasures. This research is part of a larger project aiming to target ﬁrst time
apprehended oﬀenders for tailored intervention. 
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I-95 High-Risk Driver Program Analysis
Wood Katherine, Traﬃc Injury Research Foundation
Katherine Wood, Research Associate, Traﬃc Injury Research Foundation, Ottawa, Canada; Robyn Ro-
bertson, Ms., Traﬃc Injury Research Foundation, Ottawa, Canada; Ward Vanlaar, Dr., Traﬃc Injury Rese-
arch Foundation, Ottawa, Canada; Kyla Marcoux, Research
Objectives:
The I-95 Corridor Coalition represents sixteen member states and the District of Columbia along the I-95
corridor with a goal of improving transportation system performance. The Traﬃc Injury Research Founda-
tion (TIRF) conducted a project on high-risk drivers (HRDs) for this Coalition. HRDs are often described as
a relatively small group of persistent traﬃc violators who are responsible for a signiﬁcant portion of the
serious injury and fatal collisions on the highways. This group of persistent oﬀenders has not, until re-
cently, received the attention needed, so data on the dimensions of the problem are limited. For the pur-
poses of this study, HRDs were deﬁned as drivers who are either a hard core drinking driver and/or have
been involved in three distinct events (violations or crashes). The main objectives of this project are to
quantify the magnitude and characteristics of the HRD problem along the Corridor and gather informa-
tion from jurisdictions around the world to identify ways that the problem can be addressed. 
Methods.
Bivariate analyses and logistic regression were conducted comparing the HRD group to a non-HRD group
on various fatal collision characteristics using FARS data and State Driver Record data. An international
survey was administered to gauge the types of programs and polices that are being applied to HRDs in va-
rious jurisdictions along the I-95 Corridor and elsewhere. The survey consisted of 32 questions that focu-
sed on HRDs, especially high-risk impaired drivers.  
Results:
The magnitude and characteristics of the HRD problem along the Corridor varies depending on the data-
set being used. These results will be discussed along with promising solutions to overcome the problem. 
Conclusions:
This study provides recommendations as to the most promising practices and eﬀective polices to assist
jurisdictions in eﬀectively dealing with persistent HRDs and improving the safety for the travelling public. 
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Diﬀerences in duplicate breath alcohol testing
Zuba Dariusz, Institute of Forensic Research
Objectives: 
The procedure of sobriety testing requires duplicate measurements of breath alcohol concentrations
(BrAC). If the diﬀerence is signiﬁcant, the test must be repeated. The objective was to establish reliable
values, which could be used by police oﬃcers to make the proper decision about when to repeat the test. 
Methods: 
Results were obtained from expert opinions developed at the Institute of Forensic Research. In 260
cases, the defendant was tested by electrochemical (Alcotest 7410, AlcoSensor IV) or infrared (Alcomat,
Alkometr A2.0) breath analyzers, and the second measurement was performed within a 20min period. The
absolute (ABS) and relative (REL) diﬀerences between these tests were subjected to statistical calculati-
ons. 
Results:
In 6 of 260 tests (2.3%), the ABS was over ±0.2mg/L. The Grubbs test revealed that after their rejection
no outliers were present. Diﬀerences for electrochemical and infrared instruments were statistically in-
signiﬁcant (p>0.05) both for ABS (0.011 vs. 0.004mg/l) and REL (2.5 vs. 0.9%), therefore the data were po-
oled. The combined ABS was 0.008±0.052mg/l (mean ± standard deviation, SD). The 5   95th  percentiles
ranged from -0.08 to 0.095mg/l. The scatter (expressed as SD) of ABS increased with BrAC [mg/L], from
0.032L for BrAC lower than 0.5 to 0.064 for BrAC higher than 1.5. The REL was 1.8±7.9%, with 5-95th  per-
centiles being -9.9 and 16.0%. The scatter of REL decreased with BrAC, from SD=10.3% for BrAC lower
than 0.5mg/l to 5.2% for the highest concentrations. When compared to ranges given in OIML R126 re-
commendations, the SD of ABS was 0.025mg/l for BrAC lower or equal to 0.40mg/l (595 percentiles
being -0.03 and 0.04mg/l) and the SD of REL was 6.9% for higher concentrations (the corresponding per-
centiles were -8.5 and 13.9%).  
Conclusion: 
The study allowed us to establish the permissible limits for diﬀerence in duplicate tests: ABS=0.05mg/l
for BrAC lower or equal to 0.40mg/l and REL=15% for higher concentrations, which corresponded roughly
to 2SD and 5-95th  percentiles. 
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Comparison of drug concentrations in
whole blood and oral ﬂuid collected with the
StatSure collection device
Øiestad Elisabeth Leere, Norwegian Institute of Public Health
Wenche Andresen, Norwegian Institute of Public Health, Oslo, Norway; Hilde Marie Erøy Lund, Norwe-
gian Institute of Public Health, Oslo, Norway; Hallvard Gjerde, Dr, Norwegian Institute of Public Health,
Oslo, Norway; Asbjørg S. Christophersen, ., .
Objectives:
The objective of this study was to determine drug concentration ratios between oral ﬂuid collected with
the StatSure sampling device and whole blood.
Methods:
Oral ﬂuid collected with the StatSure collection device from 100 drivers suspected of driving under the
inﬂuence of drugs was analyzed with UPLC-MS-MS. Whole blood was screened with UPLC-MS-MS and
conﬁrmed with GC-MS, LC-MS(MS) or UPLC-MS-MS. The samples were screened for opioides, ampheta-
mines, benzodiazepines, cocaine, ?-9-tetrahydrocannabinol, zopiclone, zolpidem, carisoprodol and me-
probamate.
Results: 
Positive results were found for 84 oral ﬂuid and 77 whole blood samples. A total of 18 diﬀerent com-
pounds were found, and altogether 196 ratios were determined. Eight compounds had n>10. The following
median ratio, number of sample pairs (n) and the coeﬃcient of correlation (cc, R2) between oral ﬂuid and
whole blood were found: amphetamine 12.7, n=19, cc=0.669, metamphetamine 18.0, n=31, cc=0.594, alpra-
zolam 0.46, n=15, cc=0.437, clonazepam 0.14, n=23, cc=0.147, diazepam 0.037, n=18, cc=0.554, nordiazepam
0.052, n=21, cc=0.766, morphine 14.8, n=16, cc=0.622 and THC 17.1, n=25, cc=0.122.
Conclusion:
Oral ﬂuid/whole blood ratios have been determined for oral ﬂuid collected with the StatSure collection
device. High ratios were found for amphetamines, opiates and THC while low ratios were found for benzo-
diazepines, the correlation coeﬃcients were low for most compounds. 
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Correlation of ethanol concentrations in whole
blood and eye vitreous humor collected in
Cyprus: A four year study.
Afxentiou Maria, State General Laboratory-Cyprus
Katerina Liveri, Mrs, State General Lab - Cyprus, Nicosia, Cyprus; Maria Kouskoulli, MSc, State General
Laboratory-Cyprus, Nicosia, Cyprus; Nantia Kolokassidou, Phd, State General Laboratory-Cyprus,
Nicosia, Cyprus; Popi Kanari
M. Afxentiou*, Objectives: Many studies have been published comparing concentrations of ethanol in
blood and vitreous humor concentrations. These studies have shown a range of 0.91-1.34 ratio of vitreous
humor /blood. We conducted a similar study of routinely collected specimens from fatal road accidents
and unnatural deaths.  Samples from 218 forensic autopsies were collected during the period 2006-2009
analyzed and results evaluated.  The purpose of this study was a) to determine whether the calculated
ratio of vitreous humor /blood based on the national data bank that has built, falls within the reported in
the literature range of 0.91-1.34 and b) this factor to be used in court cases involving the investigation of
road accidents and unnatural deaths in Cyprus, based on national data.
Methods: All samples were analyzed using a Shimadzu Gas Chromatograph coupled with FID and Head-
space Autosampler. The internal standard of the method was n-propanol. For the calibration curves spi-
ked blood samples were used. The LOD of the method is 0.3mg/dL and the uncertainty is 3.43mg/dL. The
evaluation of results was based on Pearson s correlation.
Results: The correlation coeﬃcient between vitreous humor and blood was r=0.955 based on Pearson s
correlation. Therefore, the average ratio of vitreous humor /blood was calculated to be 1.08.
Conclusion: The value of correlation coeﬃcient (r) shows a strong correlation between concentrations of
ethanol in blood and vitreous humor concentrations. The average ratio of vitreous humor /blood (1.08) is
approximately in the middle of the above reported ranges and can be used in court cases involving the in-
vestigation of road accidents and unnatural deaths in Cyprus. 
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Drug Eﬀects on Driving Performance
in Australia
Allender William, Forensic Medicine Unit, Forensic Services Group
William Allender, Stuart Anderson, Susan Jennings & Judith Perl
Clinical Forensic Medicine Unit, 
Level 5, Sydney Police Centre
Forensic Services Group
New South Wales Police Force 
Surry Hills, NSW 2010
AUSTRALIA
There has been increasing concern about the prevalence of drug driving in Australia. In fact, there has
been a number of legislatory changes in the past 20 years in response to this. There is evidence that both
illicit and licit drugs, through their impact on mood, cognition and psychomotor functioning, increase the
risk of a motor vehicle accident. In New South Wales, it appears the main illicit drugs of concern are can-
nabis, methylamphetamine ( speed ,  ice ), morphine (heroin), MDMA ( ecstasy ) and cocaine. Whilst, with
the licit drugs these are, alcohol, oxycodone (also known as  hillbilly heroin ) benzodiazepines (eg. diaze-
pam, alprazolam, oxazepam), anti-histamines (eg. diphenhydramine, promethazine) and hypnotics (eg.zol-
pidem).Curiously, with the licit drugs they were all central nervous system (CNS) depressants, whilst with
the illicit drug drivers both stimulants and CNS depressants were used.  Changes in drug usage and preva-
lence in driving and eﬀects on driving performance will be presented. 
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DRUID prototypes of booklets, posters
and messages for risk communication on
substance use and driving
Álvarez Javier, Universidad de Valladolid
F. Javier Álvarez, Dr., University of Valladolid, Valladolid, Spain; Inmaculada Fierro, Mrs., University of
Valladolid, Valladolid, Spain; Soﬁe Boets, Dr., Belgisch Instituut voor de Verkeersveiligheid vzw , Brus-
sel, Belgium; Uta Meesmann, Dr., Belgisch Instituut voor de Verkeersveiligheid vzw , Brussel, Belgium;
Kristof Pil, Dr., University Hospital Ghent, Ghent, Belgium
Objectives: 
This abstract presents one part of the research activities of Work Package 7 on  Dissemination and Guidelines
of the integrated EU DRUID project: the development of prototype booklets, posters and messages in order to
disseminate the most relevant DRUID information to diﬀerent target groups. 
Methods: 
The development of the prototype documents is based on (1) an international online survey among experts in va-
rious ﬁelds (policy makers, physicians, pharmacists, researchers, people working in the ﬁeld of illicit drugs, etc)
and (2) an overview of relevant communication aspects to be taken into account while developing information
documents (derived from the EU project Campaigns and Awareness-raising Strategies in Traﬃc Safety (CAST)).
Results:
The following prototype documents will be presented by target group:
- General Public: (1) Medicines & driving, (2) Illicit drugs & driving.
- Driver as patients: (1) What to know about sleeping pills, (2) What to know about antidepressants and (3) What
to know about medicines and driving in senior drivers.
-Young Drivers: (1) Illicit drugs & driving.
- Physicians and pharmacists: (1) Medicines & driving.
Conclusions:
The most relevant results of the DRUID project will only be available at the end of the project, when updated do-
cuments will be developed. Work Package 7 provides the general lines for elaboration and development of pro-
totype information documents, taking background information on the diﬀerent relevant target groups into
account. It explains the developmental process and the proposed content of the prototype documents. 
Keywords: Risk communication, DRUID, CAST 
1. This abstract has been produced under the project Driving Under Inﬂuence of Drugs, Alcohol and Medicines
(DRUID) ﬁnanced by the European Community within the framework of the EU 6th  Framework Program.
2. This abstract reﬂects only the author's view. The European Community is not liable for any use that may be
made of the information contained therein. 
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The Culture of Older Women s Drinking
in Australia
Armstrong Kerry, CARRS-Q
Patricia Obst, Dr, School of Psychology and Counselling, Brisbane, Australia; Hanna Thunstrom, Ms,
CARRS-Q, Brisbane, Australia; Helen Haydon, Ms, CARRS-Q, Brisbane, Australia; Jeremy Davey, Profes-
sor, CARRS-Q, QUT, BRISBANE, Australia
Objectives:
The purpose of this investigation was to undertake pilot research to develop an understanding of the cur-
rent culture of older Australian women s (35-50 years) drinking behaviour from a uniquely female per-
spective.  
Methods:
Two separate focus group interviews were undertaken with women (N = 11) aged between 35 and 50 years
living in South-East Queensland, Australia. Women were asked to openly discuss how and why they drink
alcohol (ie., their regular drinking behaviour), how this has changed over time, and the attitudes and values
that inﬂuence their behaviour.
Results:
Participants reported that their consumption of alcohol was more regulated and controlled and although
some women drank more frequently, the quantity consumed at each drinking occasion had decreased sig-
niﬁcantly. Occasional consumption of large amounts of alcohol tended to be the result of  incidental drin-
king  as opposed to  determined drinking . The reasons for alcohol consumption were found to be internal
as well as social. Internal reasons included stress relief, increased relaxation and self reward. Further, al-
cohol was used as a social lubricant. This cohort also reported being inﬂuenced by the drinking patterns of
their partners. Social group matching was however found to have a negative impact on alcohol consump-
tion as social groups most commonly endorsed lesser levels of intoxication. Further, the women reported
that they were of an age in which they felt excessive drinking to be  undigniﬁed . Personal reasons such as
vocational and family responsibilities further modiﬁed the levels of consumption for individual women.
Finally, it was reported that perceived health risks that can result from excessive and/or repetitive drin-
king led to a decreased in consumption. 
Conclusion:
It is proposed that the ﬁndings of this investigation could be used to improve current knowledge regar-
ding more mature women s drinking culture, associated risks and risk prevention strategies. 
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Ethanol among randomly controlled drivers
Augsburger Marc, CURML - UTCF
Anna Jagusiewicz, CURML, Lausanne, Switzerland; Patrice Mangin, University Center of Legal
Medicine, Lausanne- Geneva, Switzerland; Jacques Cornuz, PMU-CHUV, Lausanne, Switzerland; Paul
Vaucher, CURML, Lausanne, Switzerland; Nicolas Donzé, ICHV, Sion, Switzerland; Bernard Favrat,
University Center of Legal Medicine, Lausanne- Geneva, Switzerland
Objectives:
Ethanol is well-known to impair driving ability. The major aim of this study was to evaluate the number of
drivers driving under the inﬂuence of ethanol in a population of randomly controlled drivers.
Methods:
1016 drivers were randomly controlled at 27 diﬀerent locations in Western Switzerland from October
2006 to April 2008. Drivers were controlled for alcohol consumption with a breathalyzer according to the
Swiss Road traﬃc law. If the result was equal or higher than an equivalent of a blood alcohol concentra-
tion of 0.8 g/kg, a blood sample was taken; otherwise, a saliva sample was obtained.
Blood and saliva were analysed for ethanol by Head-space gas chromatography coupled with a FID detec-
tor.
Results:
Among the controlled drivers, men (69%) predominated over female (31%). The mean age was 41 (range:
16   90).  For 968 drivers (95.3%) ethanol was not detected in blood or saliva. These drivers were not under
the inﬂuence of ethanol. Ethanol was detected in saliva or blood of 48 drivers (4.7%). Among these dri-
vers, blood alcohol concentration (BAC) was above the legal limit of 0.8 g/kg (serious oﬀence) in 14 cases
(1.4% of the total population). BAC were in the range of 0.91 to 2.43 g/kg (mean: 1.32 g/kg, median: 1.11
g/kg). Among these 14 cases, men (13 cases, 93%) were over represented. No ethanol was found in the po-
pulation of truck drivers (17 cases). 986 drivers were car drivers and 46 of them have drunk ethanol (5%).
13 bikers were controlled and 2 of them have drunk ethanol (15%).
Conclusion:
Driving under the inﬂuence of ethanol concerned about 5% of a population of randomly controlled dri-
vers, and 1,4% of the drivers had a blood alcohol concentration higer than 0.8 g/kg (legale limit for a seri-
ous oﬀence). 
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After the party:
Why young adults drink and drive?
Bianchi Alessandra, UFPR
Renata Torquato, Federal University of Paraná, Curitiba, Brazil; Marina Cuﬀa, Federal University of
Paraná, Brazil; Rafaele Miyashita, Federal University of Paraná, Brazil; Paula Rosseti, Federal University
of Paraná, Brazil; Cláudio Franco, Federal University of Paraná, Brazil
Each year over than 35,000 Brazilians are killed due to traﬃc accidents. Alcohol can alter perception and
behavior and is one of the many causes that contribute to a traﬃc accident. It is known that at least 33%
of deaths in traﬃc are due to high measures of alcohol. Studies have demonstrated that drivers that
drink and drive are from 28.9% to 63.5% of all drivers, most of them youngsters. Since 2008, Brazil has
adopted zero tolerance policy but low level of enforcement and poor awareness of the risk, contributes to
increase the mortality rates of drunk and driving in traﬃc. Although researches indicate that alcohol is a
major cause of traﬃc accidents in Brazil, there is few scientiﬁc knowledge about drink and drive behavi-
our. Objective: The aim of this study was to investigate why some drivers insist to drive under eﬀect of al-
cohol even knowing the danger and understanding how their behaviour can expose them to be injured in a
traﬃc accident. Method: Two focus group and twenty semi-structured interviews were conducted with
university students over 18 years who had driver's license. The material was recorded and transcribed.
Two researchers conducted the focus groups and the interviews were conducted individually by one of
the researchers. The data were analyzed qualitatively and the procedure used was content analysis. Re-
sults: Results shown that peer pressure to drive despite drinking is high. They can perceive risk and the
consequences of drinking and driving, but the consequences are usually considered unlikely to happen. In
the most common situations the ride happens are after social gatherings, mostly in bars and nightclubs.
Conclusion: These results indicate the need of further intervention programs that promote the adoption
of safe behavior in traﬃc environment especially among young adults that are a high-risk group. 
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Benzodiazepines and sleeping-hypnotics in
blood of drivers under the inﬂuence of drugs,
and their association with other common
illegal drug use and national sales ﬁgures
Blencowe Thomas, National Institute for Health and Welfare, Finland
Kari Raaska, Kellokoski Hospital, ., Finland; Pirjo Lillsunde, Dr, National Institute for Helth and Welfare,
Helsinki, Finland
Objectives:
One of the key drug groups encountered in Finnish driving under the inﬂuence (DUI) cases is benzodiaze-
pines and related sleeping-hypnotics. The aim of this study was to examine positive DUI cases in this ca-
tegory in Finland from 1997-2008. The associated use of amphetamine and cannabis in these DUI cases
was investigated and the relationship between DUI cases and Finnish sales for pharmaceuticals.
Methods:
Information about drug driving cases positive for such sedative drugs in the period 1997-2008 was obtai-
ned from the laboratory database of the Alcohol and Drugs Analytic Unit, THL. Sales ﬁgures for the years
1997 2008 were obtained from the Finnish National Agency for Medicine.
Results:
The drugs studied were present in the majority of all positive DUI cases in each year from 1997 to 2008,
typically at rates of over 60%. Although this proportion has decreased the actual number of such positive
cases continued to increase. Diazepam was the single most commonly detected benzodiazepine in each
year of the study. The introduction of  zero tolerance  legislation in 2003 corresponded with a signiﬁcant
increase in the number of benzodiazepines DUI cases, as well as in the number of DUI cases in which asso-
ciated use of sedative drugs and amphetamine was observed, which can be partially explained by the use
of eﬀective on-site screening devices for amphetamine, in conjunction with a more eﬃcient DUI legisla-
tive framework. Ratios for DUI cases to pharmaceutical sales showed both yearly variation for individual
benzodiazepines and variation between the individual pharmaceuticals. Clonazepam consistently exhibi-
ted the highest ratio, which increased sharply from 2003.
Conclusions:
Benzodiazepines and sleeping-hypnotics, often in combination with illicit drugs - particularly ampheta-
mine, constitute a major hazard in Finnish DUI. The number of cases involving these compounds continues
to rise. Enforcement for use of these legally available pharmaceuticals in Finnish traﬃc needs to be im-
proved.
Key words: driving under the inﬂuence, benzodiazepines, sleeping-hypnotics, amphetamine, cannabis,
drugs sales ﬁgures 
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Combinations of psychoactive substances are
equally common as alcohol in Norwegian road
traﬃc accidents
Bogstrand Stig Tore, Oslo University Hospital/  Norwegian Institute of Public Health
Per Trygve Normann, Norwegian Institute of Public Health, OSLO, Norway; Ingeborg Rossow, Norwe-
gian Institute for Alcohol and Drug Research, OSLO, Norway; Hallvard Gjerde, Dr, Norwegian Institute
of Public Health, Oslo, Norway; Øivind Ekerberg, Oslo University Hospital, OSLO, Norway
Objectives:
To determine the use of alcohol and other psychoactive substances among patients admitted to an emer-
gency department after road traﬃc accidents (RTA). 
Methods:
Cross-sectional data from patients admitted after car or motorbike accidents to the emergency depart-
ment (ED) of Oslo University Hospital, Ullevaal were collected consecutively over a one year period. All
patients 18 years or above admitted to the hospital because of traumas or other injuries were eligible for
study inclusion. Drug and alcohol analyses were performed on blood samples from all the patients inclu-
ded after they had given their informed consent. A group of 132 patients who had been injured in road traf-
ﬁc either as drivers (n=97) or motor bike riders (n=35), was analyzed for prevalence of psychoactive
substances. Twenty four percent of these patients were female.
Results:
The overall prevalence of any psychoactive substance was 26% for the whole group. Alcohol alone was
the most common psychoactive single substance (8%), though combinations of therapeutic or illegal
drugs or alcohol were equally common (8%). The most prevalent illegal drug group was amphetamines (21
% within all positive screens) second were THC (18% within all positive screens). The most prevalent the-
rapeutic drug was diazepam (29 % within all positive screens) second was zopiclone (12% within all posi-
tive screens). Patients screening positive were not signiﬁcantly younger (38 vs. 40 years of age, p =0.5)
and were not more likely to be male (OR: 1.0, 95% CI 0.42- 2.6).
Conclusion:
About a third of all patients involved in RTA admitted to a ED during one year screened positive any psy-
choactive substance. A quarter of all car drivers screened positive for a psychoactive substance, though
only 8 % for alcohol alone. 
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The Challenges of Implementing Alcohol
Ignition Interlock Best Practices in a Federal
State
Chamberlain Erika, Faculty of Law, University of Western Ontario
Andrew Murie, Mr., MADD; Robert Solomon, Professor, The University of Western Ontario, London,
Canada
Objectives:
Canada s Criminal Code provides authority for the provinces to use shortened licence suspensions as an
incentive for federally-convicted impaired drivers to participate in an alcohol ignition interlock program.
In addition, the provinces have broad legislative authority to create both mandatory and voluntary alcohol
ignition interlock programs for oﬀenders as a condition of licence reinstatement. However, to date, the
provinces have enacted a patchwork of programs, and participation rates vary widely across the country.
The purpose of this paper is to examine the barriers to eﬀective implementation of alcohol ignition inter-
lock best practices in a federal state, like Canada.
Methods:
This paper ﬁrst outlines a model provincial program that incorporates all best practices for alcohol igni-
tion interlocks. It then reviews and compares the alcohol ignition interlock programs that exist in Cana-
dian provinces and territories, including conditions for entry and continued participation in the program. It
also compares provincial participation rates in alcohol ignition interlock programs, and reviews the avai-
lable studies on the eﬀectiveness of Canadian alcohol ignition interlock programs.
Results:
Canada s provinces and territories have enacted a wide variety of mandatory and voluntary alcohol igni-
tion interlock programs, with varying rates of success. This means that impaired drivers are treated quite
diﬀerently depending on their province of residence. In spite of relative consensus on interlock best prac-
tices, they have not achieved their maximum eﬀectiveness in Canada.
Conclusion:
Greater incentive is needed if alcohol ignition interlock best practices are to be implemented in all Cana-
dian provinces and territories. The current Criminal Code provisions, which are permissive rather than
mandatory, are not a suﬃcient motivator for provincial action. Consequently, Canada has largely failed to
achieve the potential traﬃc safety beneﬁts aﬀorded by alcohol ignition interlock best practices. 
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Diseases and drug interactions versus
psychomotor abilities
Florek Ewa, Laboratory of Environmental Research, Department of Toxicology, University of Medical
Sciences
Wojciech Piekoszewski, Dr.
Objectives and Methods:
Literature review related to the impact of some diseases on the ability to drive mechanical vehicles. 
Results:
Apart from obvious diseases such as serious mental diseases or mental retardation, also cardiovascular
diseases in the case of which the sudden ineﬃciency of this system weakens brain functions, which  may
lead to a road hazard. Such diseases are, for instance, arrhythmia and angina pectoris during rest or in the
case of emotions. Also, serious neurological diseases such as, for instance, progressive epilepsy, are a
contraindication and the issuance of the driving license depends on its category and the decision of a phy-
sician. In general, the driving license is issued for an indeﬁnite period of time, to persons aged 18-20, whe-
reas most of the diseases that could lower the psychomotor abilities are developed much later. In the
scientiﬁc literature, most information is devoted to the subject of an increased risk of road accidents
caused by persons suﬀering from the Parkinson s or Alzheimer s diseases and epilepsy. The opinions on
the subject of impact of diabetes are divided, the European driving license - COM(2003)621-19/03/1435
documents prohibits the issuance of a  professional  driving license to persons suﬀering from diabetes
which requires administration of insulin. Most of the studies demonstrate, however, that diabetes has no
impact on psychomotor abilities when certain principles of medical procedure are observed.
The problem which is still underestimated in road safety concerns interactions between drugs which do
not aﬀect directly the functioning of the central nervous system, but lead to the occurrence of symptoms
of diseases that decrease the abilities to control and react appropriately during driving a mechanical ve-
hicle. 
Conclusions:
Not only the diseases concerning the central nervous system, but also the somatic disorders have an im-
pact on psychomotor abilities, and thus, the possibility of driving mechanical vehicles. 
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Eﬀects Of Low Blood Alcohol Concentration
On Visual Search
Giorgetti Raﬀaele, Institute of Legal Medicine, Polytechnic University
Raﬀaele Giorgetti, Professor, Section Of Legal Medicine, Department Of Neurosciences, Marche Poly-
technic University, Ancona, Italy; Monica D'amato, Doctor, Section Of Legal Medicine, Department Of
Neurosciences, Marche Polytechnic University, Ancona, Italy; Carmela Centola, Doctor, Section Of
Legal Medicine, Department Of Neurosciences, Marche Polytechnic University, Ancona, Italy; Fran-
scesco Brandimarti, Doctor, Section Of Legal Medicine, Department Of Neurosciences, Marche Poly-
technic University, Ancona, Italy; Adriano Tagliabracci, Professor, Section Of Legal Medicine,
Department Of Neurosciences, Marche Polytechnic University, Ancona, Italy
Objectives:
To investigate the eﬀects of low alcohol concentrations on visual search function using an automatic,
non-invasive tool, and to test its suitability to the study of psychomotor performance alterations. Neural
substrate of visual search is believed reside in an extensive network of cortical regions in the parietal,
frontal, and occipital cortex and the cerebellum. The cognitive and psychomotor functions that can be in-
vestigate through this task are: visual ability and orienting, but also attentive function, reaction time, con-
centration and memory. They are high related to drive ability. 
Methods:
Twenty-four healthy volunteers, aged 18-65 years, were recruited. A single dose of alcohol (0.5 g/Kg) or
placebo was administered according to a double-blind, cross-over design. Volunteers received the treat-
ment to which they had randomly been assigned and performed the test 0, 30 min, 90 min and 150 min
from drinking the beverage. A Tobii 1750 automatic eye-tracker equipped with a proprietary management
software was used. The following measures were considered in the task of visual search:  gaze time ,  time
of ﬁrst ﬁxation ,  ﬁxation count  and  pupil diameter.
Results:
Analysis of visual search yielded diﬀerences between treatment groups in  time of ﬁrst ﬁxation  (p >
0,0465), and  pupil diameter  (p > 0,0001) at 150 min from drinking the alcoholic beverage. 
Conclusion: Results indicated that low alcohol levels inﬂuence the visual search; the  time of ﬁrst ﬁxation
and  pupil diameter  (this later referable to accommodation eﬀort) particularly. It is interest to note that
impairment is signiﬁcant at 150 min, when blood alcohol concentration is very low (BAC < 0,5 g/l). The de-
vice used is useful for psychomotor performance assessment and presents some great advantages: no
need of instruction for subjects and no learning curve. 
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The prevalence of alcohol and drugs in
sampled oral ﬂuid is related to sample volume
Gjerde Hallvard, Norwegian Institute of Public Health
Per T. Normann, Dr., Norwegian Institute of Public Health, OSLO, Norway; Ilah Le Nygaard, Norwegian
Institute of Public Health, Oslo, Norway
Objectives: 
Some drugs may reduce salivary ﬂow. The aim of this study was to examine the relationship between the
volume of collected oral ﬂuid and analytical ﬁndings.
Methods: 
Samples of oral ﬂuid were collected in ﬁve population studies in Norway for analysis of alcohol and drugs.
The samples were collected using either Intercept® Oral Specimen Collection Device or Statsure" Saliva
Sampler; about 11 000 samples with each type of device. 
Results:
The Intercept device collected a smaller average amount of oral ﬂuid than the Statsure device (0.34 ml
versus 0.90 ml, respectively); however, a fairly large amount of oral ﬂuid-buﬀer mixture could not be reco-
vered from the Statsure device due to absorption to the collection pad. Therefore, about 10 % of the sam-
ples collected with the Statsure device in Norway had volumes of less than 0.5 ml. A similar problem was
not observed for the Intercept device. 
The prevalence of alcohol and drugs was found to be higher in oral ﬂuid samples with small volumes than
in those with large volumes. For the Statsure device, the prevalence of amphetamines was 21 times higher
in samples with less than 0.5 ml oral ﬂuid compared to samples of 1.0 ml or more, for tetrahydrocannab-
inol (THC) 16 times higher, and for alcohol 15 times. For samples collected with the Intercept device, the
prevalence of amphetamines in samples of less than 0.2 ml was twice as high as in samples of 0.4 ml or
more, for THC 8 times higher, and for alcohol 4 times.
Conclusion: 
We recommend that samples of oral ﬂuid with smaller volume than required by the analytical methods
should not be discarded but instead be analysed, if necessary after sample dilution. If not analysed, the
total prevalence of alcohol and drugs in the studied population will be under-estimated. 
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Alcohol and psychoactive substance related
Road Traﬃc Injuries in Pakistan
Khoso Ajmal Khan, National Highways & Motorways Police
Objectives:
To carry out comprehensive analysis of available Road Traﬃc Crash data from various sources to esti-
mate alcohol and psychoactive substance related Road Traﬃc Injuries in Pakistan and to analyse Police
road traﬃc accident recording system to know constrains which lead to underreporting of alcohol and
psychoactive substance related Road Traﬃc Injuries in Pakistan
Methods:
Road Traﬃc Accident Data of  National Highways & Motorways Police and Road Traﬃc Injury Research
and Prevention Centre was used for estimating alcohol and psychoactive substance related Road Traﬃc
Injuries in Pakistan and injury surveillance system of    National Highways & Motorways Police was analy-
sed to know the constrains which result in underreporting of alcohol and psychoactive related road traﬃc
crashes  in Pakistan.
Result:
Surprising,  alcohol or any psychoactive substance has not been   attributed as a cause of road traﬃc
crash in both the dataset, which shows high level of underreporting mainly due to absence of relevant
ﬁeld in the road accident reporting system, restrictions in prosecuting drunk and psychoactive drivers
and deﬁcient Police training  and capability to check drunk or driving under inﬂuence of psychoactive sub-
stance.
Conclusion:
There is either little or no understanding of issue of alcohol or psychoactive active related road traﬃc in-
juries in Pakistan due to which drunk or drugged driving has not been reported by National Highways and
Motorways Police or Road Traﬃc Injury Research and Prevention Centre. 
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Designing Injury Surveillance System for
National Highways & Motorway Police
of Pakistan
Khoso Ajmal Khan, National Highways & Motorways Police
Objectives:
To design a comprehensive road traﬃc injury surveillance system for National Highways & Motorway Po-
lice of Pakistan on the basis of WHO Injury Surveillance Guidelines and keeping in view several Police Ac-
cident Databases.
Methods:
The Injury Surveillance System for National Highways & Motorway Police of Pakistan has been designed
keeping in view the Injury Surveillance Guidelines published by World Health Organisation and several Po-
lice Accident Databases being used in diﬀerent countries. Important variables have been included in the
Injury Surveillance System as per WHO Injury Surveillance Guidelines and other Police Accident Databa-
ses.
Result:
The newly devised injury surveillance system for National Highways & Motorways Police of Pakistan has
been designed based upon important variables such as use of alcohol or psychoactive substance have
been adopted from WHO Injury Surveillance Guidelines and several Police Road Accident Databases
which are helpful in carrying out comprehensive analysis of road traﬃc accidents and associated injury.
Conclusion:
A new injury surveillance system has been designed which will be helpful in estimating true magnitude of
road traﬃc accidents and associated injury, and analyzing causes of road traﬃc accidents to devise ef-
fective preventive measures. It will also be helpful in establishing an eﬀective coordination between Nati-
onal Highways & Motorways Police of Pakistan and other important stakeholders so that eﬀective Road
Traﬃc Injury Prevention policies can be devised to tackle the problem. 
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New Designer Drug Of Abuse: 3,4-Methylene-
dioxypyrovalerone (Mdpv). Findings From
Apprehended Drivers In Finland
Kriikku Pirkko, Vita Health Care Services Ltd, Vita Laboratory
Janne Rintatalo, National Bureau of Investigation Forensic Laboratory, Vantaa, Finland; Lars Wilhelm,
LADR GmbH Medizinisches Versorgungszentrum Dr. Kramer und Kollegen, Geesthacht, Germany
Objectives:
To assess the incidence and impact of the use of MDPV, a psychoactive designer drug with stimulant ef-
fects, in drivers suspected of being under the inﬂuence of drugs (DUI) in Finland. 
Methods:
Since autumn 2009, blood samples from drivers suspected of being under the inﬂuence of drugs in Fin-
land have been analysed for the presence of MDVP. In MDPV positive cases, drug and alcohol ﬁndings
were compared with data from the clinical examination carried out while the suspect was under arrest.
The psycho-physical achievement deﬁciency information was used to evaluate the signiﬁcance of the
presence of MDPV.
Results:
Between September 2009 and May 2010 there were nearly 200 positive MDPV cases from apprehended
drivers in Finland (nearly 6 % of all DUI cases), the trend being upward. In 76 % of the cases, in which
MDPV was found, amphetamine was also present. Benzodiazepines were also frequently found together
with MDPV. In many MDPV positive cases the concentrations of amphetamine or other drugs were com-
paratively low and it could be concluded that MDPV was the main reason for the psycho-physical achieve-
ment deﬁciency.
Conclusions:
These results show that MDPV use is a growing problem in DUI cases in Finland. Since the ﬁrst seizure of
MDPV in Finland in 2008 there have been some MDPV-related deaths and the police have reported that
persons under the inﬂuence of the drug very often act violently and unpredictably. MDPV has not yet been
classiﬁed as an illegal drug in most European countries. However, the Finnish government is currently pre-
paring new legislation, which should be in force by summer 2010, which would allow for accelerated classi-
ﬁcation of future designer drugs. 
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Quantitation of drugs in post mortem whole
blood with a multi component UPLC-MS/MS
method
Kronstrand Robert, RMV
Linda Brinkhagen, RMV, Linköping, Sweden; Gunnel Ceder; Martin Josefsson, Dr, RMV, Linköping,
Sweden
Objectives:
In traﬃc fatalities it is important to investigate if the driver was impaired by any drugs. This is usually
done by a combination of immunochemical methods and gas- and liquid chromatography. The purpose of
this study was to develop a multi component UPLC-MS/MS method to reduce the workload. The method
was tested retrospectively in 169 killed drivers.
Methods:
Twenty-nine drugs and metabolites were included. We aimed at achieving LOQs as proposed in the
DRUID-project. Samples (0.2 g whole blood) were extracted on Bond Elute Certify cartridges using an
ASPEC robot. A Quattro Premier XE combined with an Acquity UPLC was used. Matrix eﬀects were stu-
died by post column infusion. Linearity studies were performed as 6 replicates at 9 levels. Imprecision
studies were performed at two levels as triplicates during 8 days.
Results:
Extraction recovery for the analytes ranged between 52-85% for 26 of the analytes. Morphine, THC, and
THCCOOH had less than 50% recovery. Matrix eﬀects were only seen for THC and THCCOOH. Low reco-
very and matrix eﬀects resulted in poor performance for THC and THCCOOH and the 1 ng/g and 5 ng/g
LOQ could not be achieved. Therefore, THC and THCCOOH were excluded from the method. For the re-
maining analytes the imprecision was lower than 20% for all but ﬂunitrazepam (29 %), nitrazepam (33 %),
7-aminonitrazepam (29 %) and 7-amino-klonazepam (36 %). Of the 169 killed drivers, 41 positive ﬁndings
were made by routine toxicology. Of those, 37 were found also with the LC-MS method. Instability during
storage may explain these diﬀerences.
Conclusion: 
Exchanging the existing battery of dedicated methods for one single method was not successful since
cannabis showed poor performance. Further work with an additional injection with a diﬀerent gradient to
overcome ion suppression might improve the LOQ of THC and THCCOOH. 
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First Driving While Impaired (DWI) by Alcohol
Convictions and Repeat Oﬀenses in Geneva
(Switzerland)
Lambert Sylvie Joris, Centre Universitaire Romand de Médecine Légale
Objectives:  
About one ﬁfth of drivers ﬁrst convicted for DWI by alcohol will repeat the same oﬀense during the three
following years. The goal of the study was to assess the predictors of DWI recidivism at 3 years for the
ﬁrst-time DWI alcohol oﬀenders. 
Methods: 
All drivers convicted for a ﬁrst-time DWI oﬀence with a blood alcohol concentration (BAC) between 0.80
and 2.490 from May 2001 to February 2004 were recorded. The predictive variables were: sex, age, dri-
ving experience, time of the DWI, BAC. 
Results: 
We recruited 1588 ﬁrst-time alcohol oﬀenders with a mean age of 35-36 years. They were licensed since
14 to 15 years on average and they were mostly men (89%). The mean BAC was between 1.510 and 1.550.
More than 800 convictions occurred between 2 to 6 am.
General repeat oﬀense rate (ROR) at 3 years was 12.5%, but 5.5% for women. Repeat oﬀenders were
younger and less experienced drivers (5 years diﬀerence for both) than non repeat oﬀenders. Half of re-
peat oﬀenses occur 10 to 25 months after the ﬁrst one.
First DWI oﬀences occurring between 6 to 10 am had a ROR of 20%. First DWI occurring between 2 to 6
pm had a ROR of 22%.  Initial BAC higher than 2.050 had a ROR of 17%. 
Conclusion:
The BAC and the time of the ﬁrst DWI are operational criteria to predict repeat oﬀenses. When the BAC
of a ﬁrst DWI is higher than 2.00 and when a ﬁrst DWI occurs during the day (6 am to 6 pm), the adminis-
trative authority should take measures to evaluate a possible alcohol problem before considering relicen-
sing. 
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Dried blood spot as a sample matrix in drug
analysis   a validated method for screening and
quantitation of 23 drugs of abuse by gas
chromatography-mass spectrometry
Langel Kaarina, National Institute for Health and Welfare
Objectives:
The stability of the analytes as well as the easy storage and handling of samples makes using dried blood
spots (DBS) an interesting alternative to traditional blood sampling in drug analytics. Blood spot samples
have been used in clinical settings for decades but very few applications have been published for drugs of
abuse. The objective of this study was to develop a quantitative method for analysing several drugs of
abuse from DBS samples with GC-MS. The drugs analysed include amphetamines, opiates, cocaine, can-
nabis, zopiclone, and benzodiazepines.
Methods:
DBS (100 μl) containing the analytes were cut into smaller pieces and 500 μl of saturated borate buﬀer
(pH 10) and 2 ml of BuAc, with the deuterated internal standards, were added. The samples were mixed
and centrifuged, and the solvent was separated into fraction A (benzodiazepines and zopiclone) and frac-
tion B (other substances) and evaporated to dryness. Samples were reconstituted in 30 μl of BuAc:ACN 1:1
and derivatization was done with 10 μl of MTBSTFA/MSTFA (fraction A/B). Fraction A was analysed with
GC-NCI/MS and fraction B with GC-EI/MS. Total run times for fractions A and B were 4.5 min and 7.8 min,
respectively.
Results:
The linear concentration range (R2>0.98) in ng/ml was 5-100 for THC and buprenorphine, 5-250 for loraze-
pam, 5-500 for alprazolam, clonazepam and THC-COOH, 10-1000 for codeine, morphine, methadone, zopi-
clone, midazolam and nitrazepam, 20-2000 for amphetamine, methamphetamine, MDA, MDMA and
nordiazepam, 20-1000 for phenazepam, 50-1000 for cocaine, 50-5000 for diazepam, temazepam and tra-
madol, and 50-1250 for oxazepam. The intra- and inter-day precision and accuracy was within the required
limits (<15% and <20% at LOQ). Extraction recoveries were >75% for all but THC, THC-COOH, morphine,
and buprenorphine.
Conclusion:
This sensitive and simple analysis method enables a quantitative determination of 23 drugs of abuse and
medicinal drugs from a low volume DBS sample by GC-MS. 
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Driving under drugs in Switzerland ; a descrip-
tive cross-sectional study
Latino Anna, University Centre of Legal Medicine
Objectives: 
Many drugs, both illicit or for medication, are known to inﬂuence driving abilities and increase risks of ac-
cidents. We explored the prevalence of psychoactive substances in a random sample of drivers in Swit-
zerland.
Methods:
Saliva samples from 1078 random drivers were collected at 24 diﬀerent locations in Western Switzerland
from October 2006 to April 2008 for complete toxicological analysis using liquid chromatography/tan-
dem mass spectrometry. 
Results:
Provisional results are available for 437 drivers. 6.2% (CI95% 4.1 to 8.9) were under the inﬂuence of illicit
drugs and 8.7% under psychoactive medication (CI95% 6.2 to 11.7). 37 drivers (8.5%) were under the inﬂu-
ence of alcohol of which 14 (3.2%) were above 0.8 mg/L.  21 drivers (4.8%) were under the combined inﬂu-
ence of more than one psychoactive substance; however only 4 drivers (0.9%) were under both the
inﬂuence of medication and alcohol. Looking more speciﬁcally at illicit substances, 22 (5.0%) were posi-
tive to cocaine, 5 (1.1%) to cannabis, and 2 (0.5%) to amphetamines ; for psychoactive medication,  17
(3.9%) were positive to benzodiazepines,  16 (3.7%) to antidepressors, 7 (1.6%) to opiates, 7 (1.6%) to
neuroleptics, and 3 (0.7%) to other substances inﬂuencing driving abilities. 17/21 drivers did not self-re-
port their consumption of drugs whereas only 9/35 failed mentioning their medication. Men drivers were
3.2 times (CI95% 1.1 to 9.5) more likely to be under the inﬂuence of illicit drugs than women. Full results
will be reported when laboratory data will be available in April.
Conclusions:
Driving under the inﬂuence of psychoactive substances is common. In Western Switzerland, prevention
messages could focus on men, driving under medication or cocaine. 
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Performance evaluation of the DrugWipe®
5/5+ on-site oral ﬂuid drug test: comparison
with conﬁrmation results in whole blood
Lillsunde Pirjo, National Institute for Helth and Welfare
Anna Pehrsson, M.Sc., National Institute for Health and Welfare, Helsinki, Finland; Kari Vimpari, M.Sc.,
National Institute for Health and Welfare, Helsinki, Finland; Tom Blencowe, M.Sc., National Institute for
Health and Welfare, Helsinki, Finland; Teemu Gunnar, M.Sc., National Institute for Health and Welfare,
Helsinki, Finland; Pirjo Lillsunde, Dr, National Institute for Health and Welfare, Helsinki, Finland
Objectives:
Oral ﬂuid (OF) is a preferable matrix for on-site testing of drugs in DUI cases. A number of devices have
been developed for testing of drugs in OF, including. The aim of this study was to evaluate the reliability of
the DrugWipe® 5/5+ device by comparing its results with conﬁrmation results in whole blood by GC-MS
as a reference method.
Methods:
The performance of the DrugWipe 5/5+ device was evaluated for amphetamines, cannabis, cocaine and
opiates. Data were based on 1809 cases in which the Finnish police had conducted the DrugWipe® 5/5+
tests in suspected DUI cases. Only cases with at least one positive screening result were included. Based
on the GC-MS conﬁrmation results and cut-oﬀs used in the laboratory, the cases have been classiﬁed as
true positives (TP), true negatives (TN), false positives (FP) and false negatives (FN). Sensitivity, speciﬁ-
city and accuracy were calculated based on these classiﬁcations.
Results:
Amphetamines (amphetamine, methamphetamine, MDA, MDMA) were the most frequent ﬁndings in the
studied population (1510 positive cases, 83%). By the DrugWipe® 5/5+ device, amphetamines were de-
tected in 1610 cases. Calculated values for sensitivity, speciﬁcity and accuracy were 97 %, 50 % and 89
%, respectively. Speciﬁcity (the ability to pick up the true negatives from all the negatives) was low, be-
cause only DrugWipe positive ﬁndings were included in the study. For cannabis (197 conﬁrmed cases),
sensitivity, speciﬁcity and accuracy were 43 %, 87 % and 82 %, respectively. Evaluation of the cocaine
and opiates tests resulted in low sensitivity values, but these substance groups were encountered quite
infrequently.
Conclusions:
DrugWipe® 5/5+ performed quite well in the group of amphetamines while this is the most widespread
group of illicit drugs in Finnish traﬃc. Sensitivity for cannabis needs to be improved. 
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The use of water vapour as a reference allows
distinction of mouth alcohol from deep airway
alcohol
Lindberg Lars, Clinical Science, BUS, BIVA
David Grubb, MD, Clinical Science, BUS, BIVA, Lund, Sweden; Sven-Gunnar Olsson, MDh, Servotek AB,
Arlöv, Sweden
Mouth alcohol (MA) is derived from recently ingested alcohol or from regurgitation of stomach alcohol
and is expired in the ﬁrst volume of exhaled air, before or together with water vapour, in contrast to alco-
hol expired later from the deep airways, which is derived from blood alcohol (BA).
Objective:
To evaluate the relationship between expired water vapour and alcohol in the expired volume of air as a
marker to distinguish between MA and deep airway alcohol.
Methods:
In eight volunteers who had ingested alcohol through a gastric tube, MA was introduced as a mouthwash.
Water vapour, alcohol concentrations and air ﬂow were measured using an infrared breath analyzer (Ser-
votek AB) with a mouth piece attached. Volumetric expirograms revealing the simultaneously expired
concentrations of alcohol and water vapour in a single breath plotted against the expired volume were
constructed. A deviation area (DA) deﬁned as the area between the alcohol and water vapour concentrati-
ons was determined by integrating area under curve analysis. The discriminatory power of DA to detect
MA amounts = 0.010 mg/L was assessed by receiver operating characteristic (ROC) curve analysis.  
Results:
The area under the ROC curve was signiﬁcantly larger (0.91) than what would have been expected if the
DA of the alcohol to water vapour plot had no discriminatory power. Using a DA of -0.094 as a cut-oﬀ
value for detection of MA amounts = 0.010 mg/L resulted in a sensitivity of 91.4 % and a false positive
rate of 4.8 %. 
Conclusion:
The accuracy to detect MA using water vapour concentration as a reference gas in expired air is excellent
according to the traditional grading of a ROC test result. 
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Breath alcohol concentrations measured by
a new alcohol breath analyzer in freely exhaled
air: Impact of the distance from mouth to
instrument
Lindberg Lars, Clinical Science, BUS, BIVA
David Grubb, MD, Clinical Science, BUS, BIVA, Lund, Sweden; Sven-Gunnar Olsson, MDh, Servotek AB,
Arlöv, Sweden
Objective: 
An instrument to measure alcohol in freely exhaled air, i.e. without a mouth piece, has been developed and
measurement includes standardization to alveolar saturated water vapor at 37ºC to compensate for dil-
ution by ambient air.  We report on the inﬂuence of distance from the mouth to the inlet of the analyzer on
the measurements.
Methods:
The breath alcohol concentration (BrAC) was determined using a new infrared breath analyzer (Servotek
AB, Arlöv, Sweden). Exhaled BrAC is standardized to alveolar saturated water vapour at 37ºC to compen-
sate for the dilution by ambient air. Exhalations were performed at three diﬀerent distances (5, 10 and 15
cm) between the mouth and the inlet of the analyzer in a randomized order in twelve healthy volunteers
who had received 0.6 g ethanol/kg bodyweight. On the basis of measurements (e.g. CO2 concentration) a
threshold value is determined for acceptance of measurements, and generally rejects exhalations from
more than approximately 10 cm. This threshold value was lowered to allow greater distances for this ex-
periment. The mean of breath alcohol concentrations at each distance and their standard deviations are
reported. The BrAC at diﬀerent distances were compared with t-test for dependent samples. 
Results:
Table 1 Inﬂuence of distance on BrAC 
n 5 cm 10 cm 15 cm
BrAC (mg/L) 48 0.328 ? 0.075 0.324?0.074 * 0.313?0.072 ***
* p<0.05, *** p<0.001
Conclusion:
The distance had a minor impact on the BrAC at distances normally accepted by the analyzer. At greater
distances the measurements produce lower values for BrAC. 
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Measurement of breath alcohol in freel
exhaled air is as precise as arterial blood-
alcohol determination by headspace gas
chromatography
Lindberg Lars, Clinical Science, BUS, BIVA
David Grubb, MD, Clinical Science, BUS, BIVA, Lund, Sweden; Kristian Linnet, Professor, Department of
Forensic Medicine, Section of Forensic Chemistry, University of Copenhagen, Copenhagen, Denmark;
Brian S Rasmussen, Department of Forensic Medicine, Copenhagen, Denmark; Sven-Gunnar Olsson,
MDh, Servotek AB, Arlöv, Sweden
The precision of venous blood alcohol concentration has traditionally been regarded as better than the
precision of breath alcohol measurements. Breath alcohol concentration (BrAC) with a new infrared bre-
ath alcohol analyzer (Servotek AB) predicts the alcohol concentration in arterial blood (ABAC), which bet-
ter reﬂects level of intoxication than that in venous blood. 
Objectives: 
To compare the precision of blood and breath alcohol analyses in simultaneously obtained duplicate arte-
rial blood and exhaled breath samples taken throughout the absorption, distribution and elimination pha-
ses of alcohol metabolism. 
Methods:
Twelve healthy volunteers received 0.6 g ethanol/kg bodyweight. Blood samples were obtained via an ind-
welling catheter in the left radial artery. The tubes were stored at 4-7ºC until BACs were determined by
head-space gas chromatography at the Department of Forensic Medicine. The breath alcohol concentra-
tion (BrAC) was determined using a new infrared breath analyzer (Servotek AB, Arlöv, Sweden), which al-
lows free exhalation, with no mouth piece. Exhaled BrAC is standardized to alveolar saturated water
vapour at 37ºC to compensate for dilution by ambient air. Imprecision of the duplicate analyses were deri-
ved from the diﬀerences between duplicate determinations and expressed both as standard deviation
(SD) of a single determination (sd) and as coeﬃcient of variation (CV%).
Results: 
Imprecision of duplicate measurements
n                  Mean conc Mean diﬀerence SD (sd) CV%
BrAC(mg/L) 167 0,288 0,0006 0,00694 2,41
ABAC(mg/g) 168 0,576 0,0026 0,01381 2,40
Conclusion: 
The new infrared breath analyzer measures BrAC as precisely as head space chromatography analyses
ABAC. 
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If measured correctly, the blood to breath
alcohol ratio (BBR) is stable 30 minutes after
intake
Lindberg Lars, Clinical Science, BUS, BIVA
David Grubb, MD, Clinical Science, BUS, BIVA, Lund, Sweden; Kristian Linnet, Professor, Department of
Forensic Medicine, Section of Forensic Chemistry, University of Copenhagen, Copenhagen, Denmark;
Brian S Rasmussen, Department of Forensic Medicine, Copenhagen, Denmark; Sven-Gunnar Olsson,
MDh, Servotek AB, Arlöv, Sweden
Objectives:
Breath alcohol corresponds to the alcohol concentration in the air phase of the deep lung, which equilibra-
tes with the pulmonary capillary blood, which becomes arterial blood, subsequently inﬂuencing the brain.
We were interested to determine how well breath alcohol concentration (BrAC) corresponds to arterial
blood alcohol concentration (ABAC) throughout the absorption, distribution and elimination phases of al-
cohol metabolism. Traditional investigations on the subject of BBR refer to peripheral venous blood alco-
hol concentration (VBAC), which is never in contact with the air in the lung, or passes the blood-brain
barrier. The purpose of this study was to determine the BBR from ABAC and BrAC. 
Methods: 
Alcohol (0.6 g/kg bodyweight) was administered to 12 healthy volunteers through a gastric tube to avoid
deposition of mouth alcohol. Samples for ABAC and BrAC were simultaneously obtained at regular inter-
vals 2   300 minutes after intake. Blood samples were obtained via an indwelling catheter in the left radial
artery into 2-mL Vacutainer Tubes and stored at 4-7ºC until ABACs were determined by head-space gas-
chromatography at Section of Forensic Chemistry in Copenhagen. The BrAC was determined using a new
infrared breath analyzer (Servotek AB, Arlöv, Sweden), which allows free exhalation, without the use of a
mouth piece. Exhaled BrAC is standardized to alveolar saturated water vapour at 37ºC to compensate for
dilution by ambient air. 
Results:
BBR is increased 2 (p<0.001) and 5 (p<0.05) minutes after alcohol intake compared with a stable level ob-
tained from 30 - 300 minutes. In between, at 10 and 15 minutes, the BBR is slightly, but not signiﬁcantly in-
creased.
Conclusion:
The BBR is stable 30 minutes after alcohol intake and corresponds to the ABAC. BrAC predicts conse-
quently level of intoxication with high precision. 
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THC in Icelandic drivers. A 10 year study and
possible inﬂuences of external factors
Magnusdottir Kristin, Department of Pharmacology and Toxicology, School of Health Sciences,
University of Iceland.
Svava Thordardottir; Ingibjorg Snorradottir, Department of Pharmacology and Toxicologi, Reykjavík,
Iceland; Jakob Kristinsson
Objectives:
The aim was to investigate the prevalence and concentration of THC in DUID-cases in Iceland 2000-2009
and possible external factors that may have contributed to the observed changes.
Methods:
Results from analysed blood samples from apprehended drivers and samples of seized cannabis were
collected. Information on cannabis seizures were collected from police statistics and information on pre-
valence of cannabis users seeking treatment was obtained from Iceland s largest treatment facility.
Results:
In June 2006 the Icelandic Parliament passed new zero-tolerance laws on driving under the inﬂuence of il-
legal substances. This change made prosecution and judgement much more eﬀective. At the same time
the number of DUID-cases increased more than ten-fold and the prevalence of THC in blood rose from
25% to 33%. The average THC blood concentration increased slowly over time, from 2.4 ng/ml in 2000 to
3.7 ng/ml in 2009, and no sharp changes occurring around 2006. The number of samples received from
seized cannabis varied between years. The average concentration of THC in hashish fell from 9.9% in
2000 to 3.4% in 2009. The proportion of herbal cannabis, representing local produce, increased conside-
rably toward the end of the period. The estimated average THC content of cannabis products on the Icel-
andic drug market fell markedly at the same time.  Statistics on prevalence of cannabis users seeking
treatment show that the numbers increased until 2006, but has been constant or slightly decreasing
since.
Conclusion:
Our results indicate that the primary external factor inﬂuencing increases in DUID cases and the preva-
lence of THC is the introduction of zero-tolerance laws in 2006. None of the variables tested correlated
with the observed increase in the average THC blood concentration. 
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Psychiatric Symptoms and Early Drinking and
Driving Experiences
Marczynski Kelly, Center for Health and Social Research at Buﬀalo State College
William Wieczorek, Dr.
Objective: 
Research on drinking-driving oﬀenders has shown them to have high rates of psychiatric symptoms.  Ho-
wever, this has rarely been examined in youthful samples.  This study hypothesized that psychiatric symp-
toms would be associated with self- reported drinking and driving in a general population of 16-22 year old
young men. 
Methods: 
A sample of 625 males initially aged 16-19 was recruited in the Buﬀalo, NY metropolitan area. The young
men were interviewed three times, 18 months apart, from 1992-1996.  Data collected included demograp-
hics, alcohol and drug use, measures of psychiatric symptoms (using the Brief Symptoms Inventory (BSI)),
and having driven a motor vehicle while feeling the eﬀects of alcohol (DWI).  To test the hypothesis, the
four BSI subscales (i.e., anxiety, psychoticism, obsessive-compulsivity (OC), and depression) were used as
independent variables in analysis of variance to examine whether they were positively correlated with
drinking and driving.  Associations were measured both cross-sectionally (i.e., BSI measures at each wave
with DWI during the 12-month period before the corresponding wave) and longitudinally (i.e., BSI measu-
res at each wave with DWI during the 12-month period before the corresponding and subsequent waves).
Results: 
There were no associations of any of the four BSI subscales at Wave 1 with DWI in the year previous to
Wave 1.  By Wave 2, however, anxiety, OC, and depression each correlated signiﬁcantly with DWI during the
year prior to Wave 2.  By Wave 3, anxiety measured at Waves 1 and 2 were signiﬁcantly related with DWI
before Wave 3, as were OC measured at Waves 2 and 3, and depression measured at Wave 3.
Conclusion: 
As these young men began to age, psychiatric symptoms started to show a signiﬁcant relationship to
DWI, cross-sectionally at Wave 2, and then longitudinally by Wave 3. 
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Beyond sanctions: Is there a need to treat
ﬁrst-time oﬀenders?
Maxwell Jane C, University of Texas at Austin
James Freeman, Postdoctoral Research Fellow, Queensland University of Technology, Kelvin Grove
QLD, Australia; Jeremy Davey, Professor, CARRS-Q, QUT, BRISBANE, Australia
Aims:
Driving Under the Inﬂuence (DUI) enforcement can be a broad screening mechanism for alcohol and other
drug problems. The current response to DUI is focused on using mechanical means to prevent inebriated
persons from driving, with little attention the underlying substance abuse problems. 
Methods:
This is a secondary analysis of an administrative dataset of over 345,000 individuals who entered Texas
substance abuse treatment between 2005 and 2008. Of these, 36,372 were either on DUI probation, re-
ferred to treatment by probation, or had a DUI arrest in the past year. The DUI oﬀenders were compared
on demographic characteristics, substance use patterns, and levels of impairment with those who were
not DUI oﬀenders and ﬁrst DUI oﬀenders were compared with those with more than one past-year of-
fense. T tests and chi square tests were used to determine signiﬁcance,
. 
Results:
DUI oﬀenders were more likely to be employed, to have a problem with alcohol, to report more past-year
arrests for any oﬀense, to be older, and to have used alcohol and drugs longer than the non-DUI clients
who reported higher ASI scores and were more likely to use daily. Those with one past-year DUI arrest
were more likely to have problems with drugs other than alcohol and were less impaired than those with
two or more arrests based on their ASI scores and daily use. Non-DUI clients reported higher levels of
mood disorders than DUIs but there was no diﬀerence in their diagnosis of anxiety. Similar ﬁndings were
found between those with one or multiple DUI arrests.
Conclusion:
Although ﬁrst-time DUIs were not as impaired as non-DUI clients, their levels of impairment were suﬃci-
ent to cause treatment. Screening and brief interveniton at arrest for all DUI oﬀenders and treatment in
combination with abstinence monitoring could decrease future recidivism. 
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Impaired drivers:
The need to yoke treatment and sanctions
Maxwell Jane, University of Texas at Austin
James Freeman, Postdoctoral Research Fellow, Queensland University of Technology, Kelvin Grove
QLD, Australia; Jeremy Davey, Professor, CARRS-Q, QUT, BRISBANE, Australia
Objective:
To understand the levels of substance abuse and dependence among impaired drivers by comparing the
diﬀerences in patients in substance abuse treatment programs with and without a past-year DUI arrest
based on their primary problem substance at admission (alcohol, cocaine, cannabis, or methampheta-
mine).
Method:
Records on 345,067 admissions to Texas treatment programs between 2005 and 2008 have been analy-
zed for diﬀerences in demographic characteristics, levels of severity, and mental health problems at ad-
mission, treatment completion, and 90-day follow-up. Methods will include t-tests,??, and multivariate
logistic regression.
Results:
The analysis found that DUI arrestees with a primary problem with alcohol were less impaired than non-
DUI alcohol patients, had fewer mental health problems, and were more likely to complete treatment. DUI
arrestees with a primary problem with cannabis were more impaired than non-DUI cannabis patients and
there was no diﬀerence in treatment completion. DUI arrestees with a primary problem with cocaine
were less impaired and more likely to complete treatment than other cocaine patients, and there was
little diﬀerence in levels of mental health problems. DUI arrestees with a primary problem with metham-
phetamine were more similar to methamphetamine non-arrestees, with no diﬀerence in mental health
problems and treatment completion.
Conclusions:
This study provides evidence of the extent of abuse and dependence among DUI arrestees and their need
for treatment for their alcohol and drug problems in order to decrease recidivism. Treatment patients
with past-year DUI arrests had good treatment outcomes but closer supervision during 90 day follow-up
after treatment can lead to even better long-term outcomes, including reduced recidivism. Information
will be provided on the latest treatment methodologies, including medication assisted therapies and
screening and brief interventions, and ways impaired driving programs and substance dependence pro-
grams can be integrated to beneﬁt the driver and society. 
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Development and validation of high-
performance liquid chromatography diode
array detector method for determination of
tramadol in human saliva using liquid liquid
extraction
Mohamed Khaled, Medico-Legal Department, Ministry of Justice
Abdel-Aziz Y. El-Sayed, Chemistry Department, Egypt; Maha A. Hilal, Forensic medicine and Clinical To-
xicology Departement, Egypt; Soheir A. Mohamed, 3Forensic Medicine and Clinical Toxicology Depart-
ment, Faculty of Medicine, Egypt; Khaled E. Aboul-Hagag, Forensic Medicine and Clinical Toxicology
Department, Faculty of Medicine, Egypt; Ahmed Y. Nasser, Biochemistry department, Faculty of Medi-
cine, Egypt
A high-performance liquid chromatography diode array detector method (HPLC-DAD) was developed and
validated for the determination of tramadol in human saliva. Samples of Saliva were prepared utilizing li-
quid liquid extraction with hexane-ethyl acetate (4:1, v/v). The experimental conditions of the separation
was achieved using a Zorbax SB-C18 (250 mm ×4.6 mm, 5 μm) column using acetonitrile-0.01M KH2HPO4
buﬀer (40:60, v/v) as mobile phase (pH 5.0)  at a ﬂow rate 0.5 mL/min and UV detection at 218 nm. Propra-
nolol was used as an internal standard (IS). The Linear range, limit of quantiﬁcation and average recovery
of tramadol were 250 4000 ng/mL, 250 ng/mL and 94.70%, respectively. The intra-assay precision for
low, intermediate and high concentrations ranged between 1.38 9.79%. The inter-assay precision and the
intra-day accuracy were 0.70-4.18% and 99.34% 107.16%, respectively. The proposed method was suc-
cessfully applied to determine saliva concentrations of T in three healthy volunteers for 24 hours after
administration of 100 mg oral doses of T. 
Keywords: Tramadol; determination, Saliva; HPLC-DAD; Validation 
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Simultaneous Determination Of Tramadol,
O-Desmethyltramadol And N-Desmethyl-
tramadol In Human Urine By Gas Chromato-
graphy-Mass Spectrometry
Mohamed Khaled, Medico-Legal Department, Ministry of Justice
Khaled M. Mohamed
Tramadol is a widely prescribed analgesic used in the treatment of moderate to severe pain and as an al-
ternative to opiates. 
Objectives:
To develop and validate analytical procedures for the determination of tramadol (T) and its major meta-
bolites, O-desmethyltramadol (ODT) and N-desmethyltramadol (NDT) in human urine using gas chromato-
graphy mass spectrometry (GC/MS). 
Methods:
Sample preparation involved liquid liquid extraction with tert.-butylmethyl ether (MTBE) and back extrac-
tion with 0.1M hydrochloric acid. Proadifen (SKF525A) was selected as internal standard (IS). For quanti-
tative analysis in SIM mode, selecting the ions m/z 58 for T and ODT, m/z 188 for NDT and m/z 86 for IS. 
Results:
Extraction eﬃciencies of T, ODT and NDT were 101.88%, 98.51% and 108.65%, respectively. The calibra-
tion curves were linear (r2 > 0.997) in the concentration range 10 1000 ng/mL for all compounds. The lower
limit of quantiﬁcation was 10 ng/mL for T and ODT, and 20 ng/mL for NDT. The intra-assay precision ran-
ged between 1.29 6.48% for low, intermediate, and high concentrations for all analytes; inter-assay preci-
sion was 1.28-6.84% for T, ODT and NDT; the intra-day accuracy was in the range 91.79% 106.89%. This
method detected urine concentrations of T, ODT and NDT in six healthy volunteers for seven days after
administration of 50 mg oral doses of T 
Conclusions:
The method has suitable linearity, accuracy and precision with high analyte recoveries for the simultane-
ous quantiﬁcation of T, ODT, and NDT in human urine. 
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Drugs and driving campaign in the Netherlands:
how  general practitioners (GPs) and community
pharmacists (CPs) prepared themselves
Monteiro Susana, University of Groningen
Liset van Dijk, PhD, Netherlands Institute for Health Services Research, Utrecht, Netherlands; Marcia
Vervloet, Netherlands Institute for Health Services Research, Utrecht, Netherlands; Han de Gier
Objectives:
Determine GPs and CPs knowledge about the inﬂuence of medicines on ﬁtness to drive and how they
rated the materials useful to inform patients. 
Methods:
Two separate, but identical, questionnaires were sent to a representative sample of 759 Dutch GPs and
500 CPs. Non-responders received a shorter version of the same questionnaire. Data was analysed with
SPSS 14 for windows.  
Results:
After sending a reminder, 23.6% GPs and 32.6% CPs responded to the questionnaires. The majority of the
respondents (69%) were well aware of the problems and risks of using driving impairing medicines (DIM)
but 68.2% of the GPs (against 26.7% of the CPs) are not familiarized with the category system for indica-
ting impairment potential of medicines.
58.6% of GPs and 75.8% of CPs remembered having received the information materials. However, 59.7%
of GPs were not aware of the materials to share with CPs and 69.1% didn t recognize a tool exclusively ad-
dressed toGPs. 
Both GPs (39.5%) and CPs (64.8%) were willing to provide specially designed patient brochures.
Discussion/Conclusion:
GPs and CPs have good knowledge on the risks of driving under the inﬂuence of medicines. CPs are more
prone to read the information materials than GPs, who need more triggers to use the materials. The infor-
mation is considered accessible, conveniently organized, clear and useful by the healthcare providers.
Both GPs and CPs felt they were better prepared to inform patients about DIM. 
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Blood concentrations of alprazolam or
clonazepam and state of clinical impairment
among apprehended drivers suspected of
drugged driving
Nygaard Ilah Le, Norwegian Institute of Public Health
Riikka Mari Berg-Pedersen, Statens Folkehelseinstitutt, Avd. for rettstoksikologi og rusmiddelforsk-
ning, Oslo, Norway; Liliana Bachs
Objectives:
We investigated cases involving drivers suspected of driving under the inﬂuence of drugs in Norway, and
examined the alprazolam or clonazepam blood concentrations in cases where only these drugs were de-
tected. We compared the concentration of these drugs with the conclusion concerning impairment or not
from the standardised clinical test of impairment (CTI).
Methods:
The Norwegian Institute of Public Health analyses blood samples from all suspected drugged drivers in
Norway. Most of the drivers have been examined by a physician using a standardised CTI.  Blood samples
from suspected drugged drivers are screened, and positive results conﬁrmed for common narcotics, et-
hanol and certain medicines at the Division of Forensic Toxicology and Drug Abuse (DFTDA). All results
are stored together with the results of the CTI in the DFTDA s database. The database was searched for
cases containing alprazolam or clonazepam in the blood samples of suspected drugged drivers in the pe-
riod from December 1999 to March 2010. Samples containing alprazolam or clonazepam as the only drug
present in blood were included in our study.  
Results:
The detected blood alprazolam concentrations were generally high (n=59; median 0.30μmol/l; range 0.05-
1.40μmol/l), and above what could be considered therapeutic use. For clonazepam the detected blood
drug concentrations were more compatible with therapeutic use of the drug (n=99; median 0.13μmol/l;
range 0.03-1.00μmol/l).  Independent of the concentration level, 81% (48 out of 59) of the cases contai-
ning alprazolam alone and 84% (84 out of 99) of the cases containing clonazepam were judged as impai-
red.  For both drugs there was a tendency that more drivers were judged as impaired at higher blood drug
concentration levels. 
Conclusions: 
Our study showed that alprazolam was present mainly at supratherapeutic levels, whereas clonazepam
was found mainly within the therapeutic range.  More than 80% of the drivers where alprazolam or clona-
zepam alone was found in the blood sample were judged as impaired by the examining physician on the
CTI.  For both alprazolam and clonazepam we found a signiﬁcant diﬀerence in the blood concentration
between the non-impaired and impaired drivers. 
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Psychiatric disorders, binge drinking and DUI
in Brazilian drivers
Pechansky Flavio, Center for Drug and Alcohol Research, UFRGS
Sibele Faller, CPAD-UFRGS, Porto Alegre, Brazil; Daniela Benzano, CPAD-UFRGS, Brazil; Lísia Von
Diemen, CPAD-UFRGS, Porto Alegre, Brazil; Raquel De Boni, CPAD-UFRGS, Porto Alegre, Brazil;
Matthew Webster, CDAR-UK, Lexington, United States
Objectives:
There are no studies examining problems that may be related to driving under the inﬂuence (DUI) of drugs
and alcohol in Brazil, making it diﬃcult for the development of programs to address this issue. One poten-
tial problem is the presence of co-morbid psychiatric disorders. The aim of the study was to examine po-
tential diﬀerences in psychiatric disorders between two groups of drivers   those who had consumed
alcohol and/or substances and those who had not.
Method:
A cross-sectional sample of 1,134 individuals driving on federal highways in Brazilian cities underwent al-
cohol breathalyzer tests, drug saliva tests, were asked about drugs consumption in the past 6 hours and
completed the MINI questionnaire. Participants were divided into two groups (drivers who tested posi-
tive for substances (n=141) and those who did not (n=993)). Data were compared by the Chi-square test
and with a logistic regression model using a set of independent variables derived from the literature (gen-
der, age, educational level, has been a passenger of a DUI driver, psychiatric disorder, binge drinking in the
past year).
Results:
According to the results of logistic regression analysis, there was a statistically signiﬁcant association
between psychiatric disorders, binge drinking and DUI. Even after variable adjustment, participants with
any lifetime psychiatric symptom were 2.35 times more likely to DUI. Similarly, participants with binge
drinking behavior in the last year were two times more likely to DUI.
Conclusion: Individuals who drive under the inﬂuence of drugs and alcohol may need assessments and
interventions targeted to behaviors related to substance use and to speciﬁc psychiatric disorders. These
results will inform the development of public policies in Brazil. 
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Predictors of positive BAC in a nationwide
sample of Brazilian drivers
Pechansky Flavio, Center for Drug and Alcohol Research, UFRGS
Background:
Recent statistics show that Brazil has 35,000 traﬃc accidents/year, but the true role of alcohol is still
unknown. A dry law was passed in June 2008, which lowered BAC levels to zero. Aims: to identify factors
associated with positive BAC among drivers in a nationwide cros-sectional study.
Method:
3,398 drivers were approached on highways crossing 27 Brazilian state capitals from 12pm to 12am (Fri-
days and Saturdays). They were breathalized, and data on driving characteristics and alcohol consump-
tion were collected. A multivariate logistic regression followed a conceptual framework and allowed to
adjust for potential confounding variables. In order to assess which variables were associated with alco-
holemia, a hierarchical model was developed. This framework posits that characteristics of the external
environment (socioeconomics and demographics characteristics), and the personal characteristics of the
population inﬂuence the studied outcome.
Results:
The multivariate analysis showed that the schooling (up to 8 years: OR=2.0; 95% CI: 1.3-3.0), age (>30
years: OR=2.6; 95% CI:1.8-3.8), type of vehicle (driving a car: OR= 3.0; 95% CI: 1.8-5.2; driving a motorcycle:
OR=3.8; 95% CI: 2.2-6.5), binge (OR=1.6; 95% CI: 1.2-2.3), been breathalized before (OR=2.6; 95% CI: 1.8-
3.7), and purpose of the trip (coming from a party: OR=1.9; 95% CI:1.2-2.9; leisure trip: OR=1.7; 95% CI: 1.3-
2.4, driving after 8 pm: OR= 1.8; 95% CI: 1.3-2.3) remained independently associated with alcoholemia. 
Conclusion:
Findings of this study suggest that external environmental factors such as socioeconomic and demograp-
hic characteristics, as well as personal characteristics like alcohol consumption and the association bet-
ween drinking and driving are associated with the positive BACs among Brazilian drivers after the dry law.
Results will help shape country policymaking and preventive approaches in the Brazilian drinking and dri-
ving scenario.
218
POSTER NO 34
Relative accident risk of patients using
psychotropic medicines in the Netherlands:
A pharmacoepidemiological study.
Ravera Silvia, University of Groningen
Lolkje T.W. de Jong - van den Berg, University of Groningen, Groningen, Netherlands; Han de Gier
Objectives:
To determine whether drivers who use psychoactive medications are more exposed to traﬃc accidents
than those who do not use psychoactive medications.
Methods:
A record-linkage database will be used to conduct a case-control study, in the Netherlands, between 2000
and 2006. The data will come from three sources: pharmacy prescription data (database coverage: appro-
ximately 1 million residents), police traﬃc accident data, and driving license data. Cases will be deﬁned as
adults, who had a traﬃc accident between 2000 and 2006 and were driving, and received medical assis-
tance. Controls will be deﬁned as adults, who had a driving license and had no traﬃc accident during the
study period. Four controls will be matched for each case; the matching will be by sex, age within ﬁve
years, zip-code, and date of the accident. Various variables, such as age, drug dosage, drug half-life, mono-
and combination-therapy, alcohol use will be considered for the analysis.
Results:
No results are currently available; however, available descriptive statistics and preliminary results will be
presented during the conference.
Disclaimers:
1. This abstract has been produced under the project  Driving Under Inﬂuence of Drugs, Alcohol and Medi-
cines  (DRUID) ﬁnanced by the European Community within the framework of the EU 6th Framework Pro-
gram.
2. This abstract reﬂects only the authors  view. The European Community is not liable for any use that
may be made of the information contained therein. 
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Improving the Delivery of Alcohol Interlock
Programs
Robertson Robyn, Traﬃc Injury Research Foundation
Erin Holmes, Research Associate, Traﬃc Injury Research Foundation, Ottawa, Canada; Ward Vanlaar,
Dr., Traﬃc Injury Research Foundation, Ottawa, Canada
Objectives:
Alcohol interlock programs in North America have historically experienced low participation rates and
low device installation rates due to gaps in implementation. The purpose of this study was to provide
technical assistance and training to selected states to improve implementation, using a system improve-
ment paradigm. The objectives were to: identify eﬀective program features; determine where and why
problems were occurring; and, provide recommendations for improvement.    
Method:  
Key agencies involved in each interlock program were identiﬁed. In each jurisdiction conference calls with
key informants were conducted to gather preliminary program information and documentation for re-
view. Meetings with program staﬀ were organized to determine the types of problems that were occur-
ring and why; and to gauge the level and type of support that was needed/requested. This information
formed the basis to develop and execute a comprehensive strategy to deliver assistance. 
Technical assistance included the review of and feedback on interlock program materials, the develop-
ment of program ﬂowcharts, expert input to guide the development of requests for information and/or
proposals, the provision of good examples of program documents from other jurisdictions, the delivery of
training initiatives and consultation on legislative eﬀorts. Strategies applied in individual jurisdictions va-
ried according to the needs. 
Results: 
An overview of some eﬀective interlock program practices developed in some jurisdictions are presented
in conjunction with ﬁndings about the main challenges that these interlock programs currently experi-
ence. Lessons learned and recommendations to improve the delivery of alcohol interlock programs are
discussed. 
Conclusion: 
The eﬀective implementation of interlock programs requires operational practices and procedures to
support legislation and policy, the allocation of adequate resources to accomplish tasks, and communica-
tion and coordination of activities across multiple agencies and/or departments. As more jurisdictions
strengthen program delivery the potential of alcohol interlock devices to reduce drunk driving can be re-
alized. 
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Blood GHB concentrations and results of medical
examinations in 25 car drivers in Norway
Samarrai Al, The Norwegian Institute of Public Health
Ritva Karinen, The Norwegian Institute of Public Health , Oslo, Norway; Jørg Mørland, The Norwegian In-
stitute of Public Health , Olso, Norway; Mimi Stokke Opdal, Department of Medical Biochemistry and
Clinical Pharmacology , OSLO, Norway
Objectives:
Knowledge of clinical eﬀects, associated with whole blood GHB concentrations, is sparse. We investiga-
ted possible relationships between GHB blood concentrations and clinical eﬀects in car drivers.
Methods:
In Norway, the police stop car drivers suspected of drug-driving. A physician performs a clinical test of im-
pairment (CTI). Blood samples are screened for drugs/medicines by immunological, enzymatic and chro-
matographic methods at the Division of Forensic Toxicology and Drug Abuse. Results are stored in a
database. This database was searched for car drivers positive only for GHB over the period 2000 to 2007.
Over this period, GHB was a part of our extended drug testing program. We studied the available police
reports and the clinical tests done by the physician in most of the cases. All data were treated anony-
mously.
Results:
Twenty-ﬁve car drivers had only GHB in blood. The police reported 78 % due to unsafe driving and seven
car accidents, without serious injury, and 61 % of the drivers were found sleepy or in an even more redu-
ced state of consciousness. The median GHB blood concentration was 1262 (592-2191) μmol/l, measured
median 69 minutes after ended driving. Physician ﬁndings showed that there is a tendency for increased
impairment and reduced consciousness with increasing GHB blood concentrations. 
Conclusions:
The median GHB blood concentration of the 25 car drivers was high. Most drivers had clinical impairment,
not explainable by injuries, with depressive eﬀects on the CNS and sympathomimetic eﬀects in the eyes.
Eﬀects on impairment and consciousness tended to be concentration-dependent. The drivers probably
drove unsafely due to impairment by GHB. 
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The necessity of evaluation of traﬃc
psychological procedures - and its practicability
Seidl Joachim, AFN Gesellschaft für Ausbildung, Fortbildung und Nachschulung e. V.
The necessity of evaluation of traﬃc psychological procedures (for example courses, traﬃc psychological the-
rapy) is indisputable. Seen from the political, judicial and scientiﬁcal dimension, it is indispensable to gain state-
ments about the eﬃciency of the procedures.
This question is set in the area of conﬂict of claim for assured perceptions on the one hand, and the feasibility
on the other.
Firstly, it is to be emanated from the aim of the procedure. Particular regard is demanded by the operationalisa-
tion of these aims.
In favour of concrete procedures, successive aims on various levels can be speciﬁed within the scope of eﬃci-
ency control:
- roadworthy behaviour 
- change of behaviour concerning alcohol consumption, abstinence from drugs
- driving without alcohol, driving without drugs, driving according to instructions (for example the abidance of
speed limits)
- legal conformity : recordation of avenged traﬃc violations within a certain period of time (for example 3 years)
- (repeated) revocation of driving licence  
Contrariwise, the following facts are applied within the scope of process evaluation:
- acquisition of settings
- accretion of knowledge
- self-assessment, external assessment of other group members
- assessment by the group leader
In favour of the scientiﬁcal judgement of the eﬀect of the procedures, covariables are indispensable, for example:
- age, gender, occupation, participance in traﬃc, delict record of the participants
- therapists-variables
- duration and sequence of procedures 
In Germany, the recordation of Legalbewährung (=probation), which is measured by entries in the Verkehrszen-
tralregister (VZR) (it is a centrally organized register for traﬃc violations/delicts), is frequently used. This pro-
ved of value within the scope of various researches. However, a series of failings appears. For instance, the level
of blood alcohol concentration is not captured in the notiﬁcations of the courts. 
Feasible alternatives of evaluation of traﬃc psychological procedures are to be presented. 
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Biological markers of alcohol consumption in
alcoholised drivers: Comparison of capillary
electrophoresis (CZE CDT) and a direct immu-
noassay (N Latex CDT) with the traditional
method of anion-exchange chromatography-
immunoturbidimetry (%CDT TIA).
Selz Roxane, University center of legal medecine, Lausanne-Geneva
Biological markers of alcohol consumption in alcoholised drivers: Comparison of capillary
electrophoresis (CZE CDT) and a direct immunoassay (N Latex CDT) with the traditional
method of anion-exchange chromatography-immunoturbidimetry (%CDT TIA).
Roxane Selz*1, Bernard Favrat1, Gregory Mantzouranis1, Magali Dovat1, Patrice Mangin1, Marc
Augsburger1. Department of Community Medicine and Public Health, University center of legal
medicine, Lausanne-Geneva, Switzerland
Objectives:
The aim of this study was to compare speciﬁcity and sensitivity of diﬀerent biological markers that
can be used in a forensic ﬁeld to identify potentially dangerous drivers because of their alcohol
habits.
Methods:
We studied 280 Swiss drivers after driving while under the alcohol inﬂuence. 33 were excluded for
not having CDT N results, 247 were included (218 men (88%) and 29 women (12%). Mean age was
42,4 (SD:12, min: 20 max: 76). The evaluation of the alcohol consumption concerned the month
before the CDT test and was considered as such after the interview: Heavy drinkers (>3 drinks per
day): 60 (32.7%), < 3 drinks per day and moderate: 127 (51.4%) 114 (46.5%), abstinent: 60 (24.3%)
51 (21%). Alcohol intake was monitored by structured interviews, self-reported drinking habits and
the C-Audit questionnaire as well as information provided by their family and general practitioner.
Consumption was quantiﬁed in terms of standard drinks, which contain approximately 10 grams of
pure alcohol (Ref. WHO).
Results:
comparison between moderate (less or equal to 3 drinks per day) and excessive drinkers (more than
3 drinks)
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Marker ROC area 95% CI cut-oﬀ sensitivity speciﬁcity
CDT TIA 0.852 0.786-0917 2.6* 0.93
LR+1.43
0.35
LR-0.192
CDT N latex 0.875 0.821-0.930 2.5* 0.66
LR+ 6.93
0.90
LR- 0.369
Asialo+disialo-tf 0.881 0.826-0.936 1.2* 0.78
LR+4.07
0.80
LR-0.268
1.7° 0.66
LR+8.9
0.93
LR-0.360
GGT 0.659 0.580-0.737 85* 0.37
LR+2.14
0.83
LR-0.764
* cut-oﬀ point suggested by the manufacturer
° cut-oﬀ point suggested by our laboratory
Conclusion:
With the cut-oﬀ point established by the manufacturer, CDT TIA performed poorly in term of
speciﬁcity. N latex CDT and CZE CDT were better, especially if a 1.7 cut-oﬀ is used with CZE 
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Quantitative determination of tetrahydro-
cannabinol in whole blood by UPLC-MS/MS
Simonsen Kirsten Wiese, University of Copenhagen, Section of Forensic Chemistry
Anni Steentoft, Department of Forensic Medicine, Section of Forensic Chemistry, University of Copen-
hagen, Copenhagen, Denmark; Kristian Linnet, Professor, Department of Forensic Medicine, Section of
Forensic Chemistry, University of Copenhagen, Copenhagen, Denmark
Objectives:
Tetrahydrocannabinol (THC) is widely abused in Denmark. Because of THC`s psychoactive eﬀect it can
give rise to severe impairment when driving under inﬂuence.
In 2007 ﬁxed limits for blood concentrations of drugs of abuse for drivers have been introduced into the
Danish legislation. Thus to aid enforcement of these regulations, a fast and sensitive analytical method is
required. In this context, we considered development of an UPLC-MS/MS method for THC. Examples of
cases with THC will be presented.
Methods:
Whole blood samples (0.200 g) were spiked with internal standard (THC-D3) and extracted with pentan.
After centrifugation, the organic phase was evaporated at room temperature under a stream of nitrogen
and redissolved in 200 μL mobile phase.
Spiked blood samples in the range 0.0002 - 0.050 mg/kg were used for the calibration curve including a
blank. The analyses were performed on an Acquity UPLC-Quattro Premier XE Tandem MS/MS system
(Waters). The separation column was a Waters Acquity  2.1 x 50 mm, 1.7 micron. The solvent consists of 2
mM ammoniumacetate pH 6.2:methanol (9:1). The mass m/z 193.05 was used for quantiﬁcation and the
masses m/z 259.15 was used as qualiﬁer ion for detecting the ion ratio. Run time was 3 min.
Results:
The quantiﬁcation limit was 0.0002 mg/kg. The calibration curve was linear in the measuring interval
(0.0002 - 0.050 mg/kg). The linearity was evaluated with polynomial regression. Mean extraction recovery
for spiked blood samples was 37%. The laboratory participates in an external quality control program.
Conclusion:
A validated method has been described. The method is useful for quantiﬁcation of THC. 
Keywords: Tetrahydrocannabinol, UPLC-MS/MS (Premier), validation. 
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Prevalence of chronic prescription medication
utilization in road traﬃc crashes
Sisneroz Dawn, University of Maryland School of Medicine
Prevalence of Chronic Prescription Medication Utilization in Road Traﬃc Crashes
Objective: 
Numerous studies have addressed the role of alcohol and/or illicit drugs with respect to driving risks; ho-
wever, the role of chronic prescription medications in RTC has not been suﬃciently explored. The goal of
this research is to document the overall prescription drug use among a U.S. population of injured drivers
hospitalized in a Level I trauma center.  
Methods: 
For the years 2007-2008, all drivers hospitalized following a road traﬃc crash were identiﬁed.  Their pre-
scription drug use prior to hospitalization was obtained by medication reconciliation.  Drug usage was
analyzed in terms of the numbers of drugs as well as the categories, and pharmacotherapeutic classiﬁca-
tion. 
Results: 
A total of 3210 injured drivers were identiﬁed; 732 (22.8%) were using prescription drugs for a total of 1719
prescriptions.  Drug usage increased with age, as did the numbers of prescriptions per driver. Among all
age groups, top therapeutic classes were cardiovascular 373 (21.7%), antidepressants/antipsychotics 274
(15.9%), analgesics 248 (14.4%), and gastrointestinal 91 (5.3%).   Of the drivers 25 years old and younger, 11
(4.9%) were on 3 or more chronic medications, whereas, 64 (69.6%) of drivers 65 years and older were on
3 or more drugs.  Rankings of therapeutic classes varied by age group; e.g.; drivers 44 years and younger
were mostly on antidepressants/antipsychotics, and narcotic analgesics, which are central nervous sys-
tem depressants, and known to be linked to responsibility for a traﬃc crash. In contrast, the top most ut-
ilized therapeutic classes for drivers 65 years and older were cardiovascular, NSAIDs, and
gastrointestinal agents.
Conclusion: 
Prescription drug usage in the U.S. population continues to increase.  The use of centrally acting prescrip-
tion medications while driving should be considered to improve roadway safety, prevent injuries, and de-
crease health care costs for preventable injuries and 
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Medication and Illicit drug use among Danish
drivers from 1997-2006 with comparison to
the situation in 2008 after the introduction of
ﬁxed concentration limits
Steentoft Anni, Department of Forensic Medicine, Section of Forensic Chemistry, University of
Copenhagen
Kirsten Wiese Simonsen, Ph.d, University of Copenhagen, Section of Forensic Chemistry, Copenhagen,
Denmark; Kristian Linnet, Professor, Department of Forensic Medicine, Section of Forensic Chemistry,
University of Copenhagen, Copenhagen, Denmark
Objective:
Investigation of the prevalence of medication and illicit drug use among Danish drivers for the period
1997-2006 with comparison to the situation in 2008 after the introduction of ﬁxed concentration limits in
2007.
Methods:
Results of blood samples from drivers suspected of being under the inﬂuence of medication and/or illicit
drugs were considered.  
Results:
A total of 2340 blood samples were analysed for the presence of medications and/or illicit drugs for the
period 1997-2006. The average number of cases per year was 234 (213-283), and on average 87% of the in-
vestigated cases were positive for one or more drugs. For 2008 the number of investigated traﬃc cases
was increased to 1176. 73% of the cases from 2008 were positive for one or more drugs. Benzodiazepines,
cannabis (THC), amphetamine, heroin/morphine, methadone, cocaine, and ecstasy were the most fre-
quently detected drugs for the period 1997-2006, and also in 2008. The number of these cases in which an
ethanol level was detected above 0.5 mg/g (the Danish legal limit) was on average 18% (9-26%) for the
period 1997-2006 and 19% for 2008. The average age of the drivers ranged from 31-34 years for the pe-
riod 1997-2006 and was 31 years for 2008. The percentage of females per year ranged from 3 to 20%. 
Conclusion:
The number of traﬃc cases investigated for substances other than ethanol were consistently low, in the
range of 200 to 300 per year during the period from 1997 to 2006, but after the introduction of ﬁxed con-
centration limits in 2007 a ﬁve-fold increase was seen already in 2008. 
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THC detection in oral ﬂuids:
Can the challenge be overcome?
Steinmeyer Stefan, Dräger Safety AG & Co. KGaA
Rainer Polzius, Dr., Drägerwerk AG & Co. KGaA, Lübeck, Germany; Thomas Wuske, Drägerwerk AG & Co.
KGaA, Lübeck, Germany; Kristian Lettau, Dr., Dräger Safety AG & Co. KGaA, Lübeck, Germany; Alexan-
der Slomian, Dräger Safety AG & Co. KGaA, Lübeck, Germany
Objectives:
The detection of cannabis use by oral ﬂuid is a particular challenge for onsite tests due to low concentra-
tion of the parent drug Delta-9-Tetrahydrocannabinol (THC) present. With most of the commercially avai-
lable POC systems providing THC cut-oﬀs in the range of 30 to 100 ng/ml, it appears to be diﬃcult to
achieve a detection window of more than 1 to 2 hours after drug consumption. More meaningful THC cut-
oﬀs in the range of 4 to 10 ng/ml have been suggested by diﬀerent groups and authorities.
The present investigation was performed in order to evaluate a new test-kit of Dräger DrugTest® 5000
POC system providing a THC cut-oﬀ of 5 ng/ml. 
Methods:
Patients enrolled in methadone substitution programs were asked to provide voluntarily two oral ﬂuid
samples (n=90). The ﬁrst sample was collected by means of Dräger DrugTest® 5000 and the second by
means of Dräger DCD 5000 for conﬁrmatory analysis by GC-MS. 
In a roadside study oral ﬂuid samples (n=200) from car drivers were analyzed by DrugTest® 5000 which
was used in two cut-oﬀ versions (25 ng/ml vs. 5 ng/ml). Blood samples were drawn from drivers with a po-
sitive drug-screening and analyzed by GC-MS.
Results:
Based on conﬁrmation analysis in oral ﬂuids at two conﬁrmation (GC-MS) cut-oﬀs of 5 ng/ml and 10
ng/ml, in the methadone population the sensitivity and the speciﬁcity of the THC-assay was 71% (83%)
and 100% (100%) respectively. The results from the roadside study showed that 95% of the positive THC
screening results were conﬁrmed in blood by GC-MS at a cut-oﬀ of 1 ng/ml. Using the 5 ng/ml version of
DrugTest® 5000, the hit-rate was increased by a factor of 2.6. 
Conclusion:
The new Dräger DrugTest® 5000 (THC cut-oﬀ: 5 ng/ml) demonstrated signiﬁcantly enhanced sensitivity
and a good correlation with blood THC levels. 
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Traﬃc Environment and Demographic Factors
Aﬀecting Impaired Driving and Crashes
Voas Robert, PIRE
Eduardo Romano, Research Scientist, PIRE, Calverton, MD, United States; Raymond Peck, Mr.; Robert
Voas, Dr., PIRE, Calverton, MD, United States
Problem:
Data availability has forced researchers to examine separately crash and non-crash data. Such a separa-
tion makes it diﬃcult to fully account for the transition from impaired driving to an alcohol-related crash.
This study provides information about the role that traﬃc-environment and driver demographic/socioe-
conomic status (SES) factors play in shaping the likelihood of impaired driving whether crash related or
not. 
Method:
We used data from a recent case-control study that included a comprehensive sampling of the drivers in
nonfatal crashes and a matched set of comparison drivers in two U.S. locations. We separated these data
into four groups: impaired, crash and non-crash, and non-drinking, crash and non-crash. Multinomial logis-
tic regression was applied to investigate the likelihood that a driver would crash or not, either with a
BAC=0.00 or a BAC=.05.  
Results:
This study conﬁrms previous ﬁndings about the role of traﬃc-environment, demographic, and SES varia-
bles in traﬃc crashes. It also suggests the existence of interactions and complexities not yet fully under-
stood. An interesting outcome from this study is the identiﬁcation of variables playing a diﬀerent role in
shaping alcohol-related and alcohol-free crashes. The factors that separate sober (BAC=.00) crash-invol-
ved drivers from sober (BAC=.00) non-crash-involved drivers were largely demographics and SES. Drivers
who are underage, male, and unemployed were more likely to be involved in those crashes. Thus, this
study suggests that the occurrence of crashes among BAC=.00 drivers is not as associated with the envi-
ronment (e.g., weather or road conditions) as much as it is with the drivers  attitudes toward risk and safe
driving. 
Discussion:
This study is to our knowledge the ﬁrst that examines how diﬀerent driver characteristics and environ-
mental factors simultaneously contribute to alcohol use by crash-involved and non-crash-involved dri-
vers. 
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Vehicle Impoundment Impacts on Crashes of
Prohibited Drivers
Wilson Jean, Safety Metrics West
Objectives:
Vehicle impoundment  (VI)programs are a proven countermeasure to control driving and therby reduce
crashes among prohibited drivers, many of whom have a history of  impaired driving.  In 2005, British Co-
lumbia lengthened the mandated impoundment periods from 30  to 60 days and from 60 to 90 days for
drivers convicted of driving while prohibited. This study measures the beneﬁcial eﬀect on crashes of
these extended periods and attempts to determine what factors explain crash reduction during and follo-
wing the end of the mandated impoundment period.
Method:
Drivers that received the extended VI sanction are compared to a cohort of drivers that received shorter
impoundments for the same oﬀence prior to the legislative change, statistically controlling for cohort dif-
ferences.  Crash frequencies are compared both during and for one year following the impoundment peri-
ods, using regression models. Crash involvement of drivers of abandoned vehicles are compared with
drivers of recovered vehicles to determine what proportion of crashes are explained by this factor.
Results:
Crash frequencies of drivers were very low during the impoundment periods and they remained suppres-
sed even after the mandated time had expired compared to pre-impoundment levels. Extending the im-
poundment periods has two major impacts: it extends the beneﬁt period of reduced crashes and it
increases the proportion of abandoned vehicles. 
Conclusions:
Vehicle impoundment appears to be an eﬀective means to control driving by prohibited drivers and the-
reby reduce crash risk.  The bulk of the beneﬁt is explained by removing vehicle access; however there
may also be a specifc deterrent eﬀect that is mediated through the punishment of vehicle removal and
associated costs. 
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Comparison of Stability of Drugs Collected
with the Intercept and StatSure Collection
Devices
Øiestad Elisabeth Leere, Norwegian Institute of Public Health
Hilde Marie Erøy Lund, Norwegian Institute of Public Health, Oslo, Norway; Hallvard Gjerde, Dr, Norwe-
gian Institute of Public Health, Oslo, Norway; Gerrit Middelkoop, Senior Engineer, Norwegian Institute
of Public Health, Oslo, Norway; Asbjorg S. Christophersen, ., .
Objectives:
The result of drug testing in oral ﬂuid can be aﬀected by drug stability. Possible sample degradation du-
ring e.g. transport or in storage must therefore be evaluated. The objective of this study was to compare
the stability of drugs of abuse and psychoactive medicinal drugs in oral ﬂuid collected with two commer-
cial collection devices, Intercept and StatSure.
Methods: 
Oral ﬂuid collected from patients admitted to an opiate maintenance treatment program (Intercept) or
from drivers suspected of driving under the inﬂuence of drugs (StatSure) was pooled to get samples with
multiple drugs in oral ﬂuid. The samples were analysed after one week at ambient temperature or -4 ºC,
and at 3 months at -20 ºC. The preserved oral ﬂuid was extracted with liquid-liquid-extraction with ethyla-
cetate:heptane (4:1), and analyzed with UPLC-MS-MS. 
Results: 
The compounds 6-monoacethylmorphine(6-MAM), morphine, codeine, amphetamine, metamphetamine,
zopiclone, alprazolam, 7-aminoclonazepam, oxazepam, n.desmethyl diazepam, diazepam, methadone, and
?-9-tetrahydrocannabinol (THC), were evaluated for both collection devices, and for Intercept  in addition
buprenorphine and for StatSure in addition clonazepam, nitrazepam, benzoylecgonine and cocaine. Most
compounds were stable at one week storage at -4 ºC as well as ambient temperature for both sample
sets. Zopiclone seemed to be less stable when collected by the Intercept device, but stability was impro-
ved by freezing the sample. For Intercept loss of 7-aminoclonazepam, codeine and 6-MAM with time was
observed, THC was however stable (data for StatSure not yet available). Cocaine collected by the StatS-
ure device degraded more rapidly to benzoylecgonine at ambient temperature than at -4 ºC. 
Conclusion:
For the majority of compounds investigated in this study transport at ambient temperature seemed ac-
ceptable, however both zopiclone and cocaine should preferentially be kept cool/frozen. Loss of com-
pound during long term storage was observed for some compounds with Intercept; data for StatSure will
be added. 
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Correlation of 6-MAM in oral ﬂuid and urine
with morphine in whole blood for driving under
the inﬂuence of drugs cases
Øiestad Elisabeth Leere, Norwegian Institute of Public Health
Wenche Andresen, Norwegian Institute of Public Health, Oslo, Norway; Hilde Marie Erøy Lund, Norwe-
gian Institute of Public Health, Oslo, Norway; Hallvard Gjerde, Dr, Norwegian Institute of Public Health,
Oslo, Norway; Asbjørg S. Christophersen, ., .
Objectives:
In cases of suspected driving under the inﬂuence of drugs (DUID-cases) it is important to determine if
morphine detected in blood originates from heroin use or as a result of intake of morphine or other opia-
tes. This is usually conﬁrmed by determination of 6-monoacetyl morphine (6-MAM) in urine. The objective
of this study was to evaluate whether oral ﬂuid can replace urine in determination of the origin of mor-
phine, as this could allow more acceptable and faster sampling and thereby save police resources. 
Methods:
Oral ﬂuid collected with the StatSure" collection device from 100 drivers suspected of driving under the
inﬂuence of drugs was analyzed with UPLC-MS-MS. Urine was screened with EMIT® immunoassay, and
conﬁrmed with UPLC-MS-MS and CEDIA® immunoassay. Whole blood was screened and conﬁrmed with
UPLC-MS-MS. The correlations between 6-MAM in oral ﬂuid and urine and morphine in whole blood were
studied. 
Results: 
Of the 100 collected cases, 94 had all 3 matrix types, while urine was not included in six cases. Approxima-
tely 22 % of the samples were positive for morphine in whole blood and 30 % for 6-MAM in oral ﬂuid. For
the 27 6-MAM positive oral ﬂuid samples with all 3 matrix types we found that all morphine positive sam-
ples had positive 6-MAM in both urine and oral ﬂuid, one sample had positive 6-MAM in oral ﬂuid and
urine and negative morphine in whole blood, while for 6 cases 6-MAM was only detected in oral ﬂuid.
Conclusion:
With the applied cut-oﬀ for 6-MAM in oral ﬂuid, full correspondence with urine in conﬁrmation of mor-
phine origin in DUID-cases was found. The time window appears to be similar or better than urine, and oral
ﬂuid can therefore be a good alternative for 6-MAM determination in DUID-cases. 
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